Acute Myeloid Leukemia	ABL1 (5):	--2-- |  1232_I-BET-151_GDSC1(4) |  1175_Rucaparib_GDSC2(2) | Acute Myeloid Leukemia	ABL2 (6):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1187_CCT245232_GDSC1(4) | Acute Myeloid Leukemia	AGO1 (4):	--2-- |  179_5-Fluorouracil_GDSC1(2) |  1451_PLK_6522_GDSC1(3) | Acute Myeloid Leukemia	AKT2 (7):	--2-- |  140_Vinorelbine_GDSC1(5) |  476_SB505124_GDSC1(5) | Acute Myeloid Leukemia	ALK (10):	--4-- |  172_Embelin_GDSC1(3) |  375_Voxtalisib_GDSC1(5) |  1030_KU-55933_GDSC1(4) |  1813_Fludarabine_GDSC2(2) | Acute Myeloid Leukemia	ARHGEF28 (9):	--2-- |  229_Enzastaurin_GDSC1(6) |  437_Trichostatin A_GDSC1(5) | Acute Myeloid Leukemia	ARID3B (4):	--3-- |  45_Z-LLNle-CHO_GDSC1(1) |  229_Enzastaurin_GDSC1(2) |  1088_Irinotecan_GDSC2(2) | Acute Myeloid Leukemia	ATXN7 (2):	--2-- |  1088_Irinotecan_GDSC2(1) |  1922_Cediranib_GDSC2(1) | Acute Myeloid Leukemia	AXL (5):	--2-- |  11_Paclitaxel_GDSC1(2) |  476_SB505124_GDSC1(4) | Acute Myeloid Leukemia	BCL6 (3):	--2-- |  204_Tipifarnib_GDSC1(1) |  1232_I-BET-151_GDSC1(2) | Acute Myeloid Leukemia	BCR (15):	--3-- |  271_VNLG/124_GDSC1(4) |  1254_GSK-J4_GDSC1(9) |  1458_PARP_9495_GDSC1(6) | Acute Myeloid Leukemia	BRAF (4):	--2-- |  1025_SB216763_GDSC2(3) |  1088_Irinotecan_GDSC2(2) | Acute Myeloid Leukemia	BRD3 (2):	--1-- |  1036_PLX-4720_GDSC1(2) | Acute Myeloid Leukemia	BRD4 (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1617_AZD5582_GDSC2(2) | Acute Myeloid Leukemia	CARD11 (6):	--3-- |  45_Z-LLNle-CHO_GDSC1(2) |  1008_Methotrexate_GDSC1(2) |  1786_AZD4547_GDSC2(4) | Acute Myeloid Leukemia	CCND1 (2):	--1-- |  1025_SB216763_GDSC1(2) | Acute Myeloid Leukemia	CCND3 (5):	--2-- |  88_Entinostat_GDSC1(3) |  1428_IAP_5620_GDSC1(4) | Acute Myeloid Leukemia	CCNE1 (2):	--2-- |  88_Entinostat_GDSC1(1) |  225_Genentech Cpd 10_GDSC1(1) | Acute Myeloid Leukemia	CDK8 (3):	--2-- |  1023_GW441756_GDSC1(2) |  1821_765771_GDSC2(2) | Acute Myeloid Leukemia	CRKL (1):	--1-- |  140_Vinorelbine_GDSC1(1) | Acute Myeloid Leukemia	CSF3R (8):	--3-- |  1259_Talazoparib_GDSC1(3) |  1560_Alpelisib_GDSC2(4) |  265_Tubastatin A_GDSC1(2) | Acute Myeloid Leukemia	CTLA4 (3):	--1-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) | Acute Myeloid Leukemia	DDR2 (5):	--2-- |  11_Paclitaxel_GDSC1(2) |  1184_AZ20_GDSC1(4) | Acute Myeloid Leukemia	DNMT1 (13):	--4-- |  1618_GSK2606414_GDSC2(8) |  1560_Alpelisib_GDSC2(5) |  1460_PARP_9482_GDSC1(8) |  172_Embelin_GDSC1(3) | Acute Myeloid Leukemia	EIF4A2 (8):	--3-- |  330_XMD13-2_GDSC1(4) |  476_SB505124_GDSC1(5) |  2046_MK-8776_GDSC2(4) | Acute Myeloid Leukemia	ERBB3 (1):	--1-- |  1219_PFI-1_GDSC1(1) | Acute Myeloid Leukemia	ERG (6):	--3-- |  406_LIMK1 inhibitor BMS4_GDSC1(2) |  427_Ara-G_GDSC1(3) |  1829_667880_GDSC2(2) | Acute Myeloid Leukemia	ESR1 (6):	--2-- |  1013_Nilotinib_GDSC1(3) |  1449_AZD1208_GDSC1(4) | Acute Myeloid Leukemia	ETV1 (8):	--2-- |  277_Linifanib_GDSC1(5) |  1049_PD173074_GDSC1(4) | Acute Myeloid Leukemia	EWSR1 (1):	--1-- |  88_Entinostat_GDSC1(1) | Acute Myeloid Leukemia	EZH1 (6):	--3-- |  1739_JAK_8517_GDSC2(1) |  1626_OTX015_GDSC2(3) |  1529_Pevonedistat_GDSC1(3) | Acute Myeloid Leukemia	FGFR1 (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1128_FS106_GDSC1(2) | Acute Myeloid Leukemia	FGFR2 (4):	--2-- |  1249_BMS-345541_GDSC2(2) |  1847_BEN_GDSC2(2) | Acute Myeloid Leukemia	FGFR3 (3):	--2-- |  1004_Vinblastine_GDSC1(2) |  1187_CCT245232_GDSC1(2) | Acute Myeloid Leukemia	FGFR4 (5):	--2-- |  219_AT-7519_GDSC1(3) |  1733_ULK1_4989_GDSC2(2) | Acute Myeloid Leukemia	FLI1 (4):	--2-- |  11_Paclitaxel_GDSC1(2) |  1249_BMS-345541_GDSC2(2) | Acute Myeloid Leukemia	FLT1 (7):	--2-- |  1058_Pictilisib_GDSC2(4) |  1259_Talazoparib_GDSC1(3) | Acute Myeloid Leukemia	FLT3 (10):	--2-- |  1007_Docetaxel_GDSC2(8) |  1089_Oxaliplatin_GDSC2(6) | Acute Myeloid Leukemia	FUS (4):	--2-- |  206_Ruxolitinib_GDSC1(3) |  1184_AZ20_GDSC1(3) | Acute Myeloid Leukemia	FYN (3):	--2-- |  312_Tivozanib_GDSC1(2) |  1023_GW441756_GDSC1(2) | Acute Myeloid Leukemia	GAB2 (3):	--2-- |  310_YM201636_GDSC1(2) |  1053_MK-2206_GDSC2(2) | Acute Myeloid Leukemia	GATA2 (3):	--3-- |  1011_Navitoclax_GDSC2(1) |  1494_SN-38_GDSC2(1) |  1922_Cediranib_GDSC2(1) | Acute Myeloid Leukemia	GLI1 (1):	--1-- |  219_AT-7519_GDSC1(1) | Acute Myeloid Leukemia	GNA12 (5):	--2-- |  1030_KU-55933_GDSC1(4) |  2037_GSK343_GDSC2(2) | Acute Myeloid Leukemia	GNAS (4):	--2-- |  281_Alectinib_GDSC1(3) |  1249_BMS-345541_GDSC2(2) | Acute Myeloid Leukemia	GNB1 (5):	--2-- |  133_Doxorubicin_GDSC1(2) |  1232_I-BET-151_GDSC1(4) | Acute Myeloid Leukemia	GSK3B (3):	--2-- |  310_YM201636_GDSC1(2) |  573_LGK974_GDSC1(2) | Acute Myeloid Leukemia	GTF2I (4):	--2-- |  380_BIBF-1120_GDSC1(1) |  1365_BAY-HDAC11_2_GDSC1(3) | Acute Myeloid Leukemia	HDAC7 (6):	--3-- |  41_S-Trityl-L-cysteine_GDSC1(2) |  310_YM201636_GDSC1(2) |  1249_BMS-345541_GDSC2(2) | Acute Myeloid Leukemia	HGF (5):	--2-- |  1365_BAY-HDAC11_2_GDSC1(3) |  265_Tubastatin A_GDSC1(2) | Acute Myeloid Leukemia	IGF1R (6):	--3-- |  127_GSK269962A_GDSC1(4) |  199_Pazopanib_GDSC1(3) |  1136_Capivasertib_GDSC1(2) | Acute Myeloid Leukemia	IKBKE (3):	--1-- |  2107_LJI308_GDSC2(3) | Acute Myeloid Leukemia	IL7R (3):	--2-- |  159_HG6-64-1_GDSC1(1) |  1931_MIRA-1_GDSC2(2) | Acute Myeloid Leukemia	INSR (8):	--4-- |  1089_Oxaliplatin_GDSC2(3) |  1073_5-Fluorouracil_GDSC2(3) |  1248_Daporinad_GDSC1(4) |  265_Tubastatin A_GDSC1(3) | Acute Myeloid Leukemia	JAK3 (6):	--2-- |  151_QS11_GDSC1(3) |  1011_Navitoclax_GDSC1(4) | Acute Myeloid Leukemia	KDM5A (9):	--3-- |  356_AT7867_GDSC1(6) |  1248_Daporinad_GDSC1(6) |  1038_NU7441_GDSC2(6) | Acute Myeloid Leukemia	KDR (4):	--3-- |  1249_BMS-345541_GDSC2(2) |  1378_Bleomycin (50 uM)_GDSC2(2) |  1835_Elephantin_GDSC2(1) | Acute Myeloid Leukemia	KIT (7):	--4-- |  88_Entinostat_GDSC1(3) |  134_Etoposide_GDSC1(4) |  1393_Gemcitabine_GDSC1(2) |  1088_Irinotecan_GDSC2(3) | Acute Myeloid Leukemia	KRAS (3):	--1-- |  1429_IAP_7638_GDSC1(3) | Acute Myeloid Leukemia	KSR2 (8):	--2-- |  1188_CCT245467_GDSC1(7) |  1428_IAP_5620_GDSC1(6) | Acute Myeloid Leukemia	LRP6 (5):	--2-- |  1866_BDP-00009066_GDSC2(4) |  2158_CPI-637_GDSC2(2) | Acute Myeloid Leukemia	LTK (6):	--2-- |  178_BAY-61-3606_GDSC1(4) |  1062_Selumetinib_GDSC1(4) | Acute Myeloid Leukemia	LYN (5):	--2-- |  435_C-75_GDSC1(3) |  1561_Taselisib_GDSC2(2) | Acute Myeloid Leukemia	MAP2K1 (3):	--2-- |  11_Paclitaxel_GDSC1(2) |  45_Z-LLNle-CHO_GDSC1(2) | Acute Myeloid Leukemia	MAP4K4 (7):	--4-- |  1187_CCT245232_GDSC1(4) |  1266_ICL1100013_GDSC1(2) |  1813_Fludarabine_GDSC2(2) |  1940_WIKI4_GDSC2(3) | Acute Myeloid Leukemia	MDM2 (5):	--3-- |  380_BIBF-1120_GDSC1(2) |  1037_BX795_GDSC1(2) |  1007_Docetaxel_GDSC2(2) | Acute Myeloid Leukemia	MECOM (9):	--2-- |  277_Linifanib_GDSC1(5) |  1188_CCT245467_GDSC1(7) | Acute Myeloid Leukemia	MEF2D (4):	--2-- |  1032_Afatinib_GDSC2(3) |  2110_GSK591_GDSC2(2) | Acute Myeloid Leukemia	MGAM (18):	--4-- |  1047_Nutlin-3a (-)_GDSC2(10) |  127_GSK269962A_GDSC1(7) |  254_Quizartinib_GDSC1(9) |  1618_GSK2606414_GDSC2(9) | Acute Myeloid Leukemia	MKI67 (7):	--3-- |  1498_Selumetinib_GDSC1(3) |  1526_Refametinib_GDSC1(3) |  1558_Lapatinib_GDSC2(4) | Acute Myeloid Leukemia	MLLT10 (3):	--2-- |  1058_Pictilisib_GDSC2(2) |  1908_Ulixertinib_GDSC2(1) | Acute Myeloid Leukemia	MLLT3 (6):	--2-- |  546_FTY-720_GDSC1(4) |  2011_ICL-SIRT078_GDSC2(3) | Acute Myeloid Leukemia	MSI2 (7):	--3-- |  140_Vinorelbine_GDSC1(5) |  204_Tipifarnib_GDSC1(5) |  1249_BMS-345541_GDSC2(3) | Acute Myeloid Leukemia	MST1R (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  236_IC-87114_GDSC1(2) | Acute Myeloid Leukemia	MTOR (7):	--2-- |  375_Voxtalisib_GDSC1(5) |  1048_Mirin_GDSC1(3) | Acute Myeloid Leukemia	MYBL1 (7):	--2-- |  1375_Temozolomide_GDSC2(5) |  2011_ICL-SIRT078_GDSC2(3) | Acute Myeloid Leukemia	NCOA3 (5):	--1-- |  1001_AICA Ribonucleotide_GDSC1(5) | Acute Myeloid Leukemia	NCSTN (2):	--1-- |  281_Alectinib_GDSC1(2) | Acute Myeloid Leukemia	NR4A3 (5):	--3-- |  301_PHA-793887_GDSC1(3) |  1184_AZ20_GDSC1(3) |  1835_Elephantin_GDSC2(1) | Acute Myeloid Leukemia	NRAS (8):	--2-- |  1128_FS106_GDSC1(5) |  330_XMD13-2_GDSC1(4) | Acute Myeloid Leukemia	NRG1 (8):	--2-- |  35_NVP-TAE684_GDSC1(3) |  1618_GSK2606414_GDSC2(7) | Acute Myeloid Leukemia	NSD2 (3):	--2-- |  11_Paclitaxel_GDSC1(2) |  1250_AZ960_GDSC2(2) | Acute Myeloid Leukemia	NT5C2 (6):	--2-- |  1463_AZD1332_GDSC2(4) |  2011_ICL-SIRT078_GDSC2(3) | Acute Myeloid Leukemia	NTRK3 (11):	--2-- |  221_TAK-715_GDSC1(9) |  254_Quizartinib_GDSC1(7) | Acute Myeloid Leukemia	NUP98 (10):	--3-- |  151_QS11_GDSC1(3) |  437_Trichostatin A_GDSC1(5) |  1428_IAP_5620_GDSC1(5) | Acute Myeloid Leukemia	PAK1 (4):	--2-- |  11_Paclitaxel_GDSC1(1) |  1441_AZD2014_GDSC1(3) | Acute Myeloid Leukemia	PAK5 (2):	--2-- |  219_AT-7519_GDSC1(1) |  1004_Vinblastine_GDSC1(1) | Acute Myeloid Leukemia	PAX8 (4):	--3-- |  229_Enzastaurin_GDSC1(2) |  1250_AZ960_GDSC2(2) |  1733_ULK1_4989_GDSC2(2) | Acute Myeloid Leukemia	PDGFRA (3):	--1-- |  345_KIN001-270_GDSC1(3) | Acute Myeloid Leukemia	PGR (2):	--1-- |  1013_Nilotinib_GDSC1(2) | Acute Myeloid Leukemia	PIK3CA (1):	--1-- |  1527_Pictilisib_GDSC1(1) | Acute Myeloid Leukemia	PIK3CB (5):	--2-- |  199_Pazopanib_GDSC1(3) |  206_Ruxolitinib_GDSC1(3) | Acute Myeloid Leukemia	PIK3CD (3):	--2-- |  437_Trichostatin A_GDSC1(1) |  1084_Rapamycin_GDSC2(2) | Acute Myeloid Leukemia	PLCG1 (7):	--3-- |  292_Masitinib_GDSC1(3) |  1459_PARP_0108_GDSC1(3) |  1560_Alpelisib_GDSC2(4) | Acute Myeloid Leukemia	PLCG2 (10):	--2-- |  104_Bortezomib_GDSC1(6) |  1049_PD173074_GDSC2(7) | Acute Myeloid Leukemia	PPARG (2):	--1-- |  1733_ULK1_4989_GDSC2(2) | Acute Myeloid Leukemia	PRKACA (4):	--2-- |  53_CGP-60474_GDSC1(2) |  1250_AZ960_GDSC2(3) | Acute Myeloid Leukemia	PRKCI (4):	--2-- |  83_JW-7-52-1_GDSC1(3) |  1847_BEN_GDSC2(2) | Acute Myeloid Leukemia	PSMB2 (2):	--2-- |  133_Doxorubicin_GDSC1(1) |  1058_Pictilisib_GDSC2(1) | Acute Myeloid Leukemia	RAC2 (2):	--1-- |  197_Bryostatin 1_GDSC1(2) | Acute Myeloid Leukemia	RET (5):	--2-- |  11_Paclitaxel_GDSC1(2) |  1997_WEHI-539_GDSC2(4) | Acute Myeloid Leukemia	REV3L (5):	--2-- |  1023_GW441756_GDSC1(3) |  1458_PARP_9495_GDSC1(4) | Acute Myeloid Leukemia	RHEB (3):	--2-- |  140_Vinorelbine_GDSC1(1) |  1494_SN-38_GDSC2(2) | Acute Myeloid Leukemia	RHOA (1):	--1-- |  1007_Docetaxel_GDSC2(1) | Acute Myeloid Leukemia	RICTOR (6):	--3-- |  292_Masitinib_GDSC1(3) |  1073_5-Fluorouracil_GDSC2(2) |  1249_BMS-345541_GDSC2(2) | Acute Myeloid Leukemia	ROS1 (6):	--2-- |  1428_IAP_5620_GDSC1(5) |  1073_5-Fluorouracil_GDSC2(3) | Acute Myeloid Leukemia	RPTOR (6):	--2-- |  199_Pazopanib_GDSC1(5) |  1598_LGK974_GDSC2(5) | Acute Myeloid Leukemia	SETD1A (4):	--2-- |  199_Pazopanib_GDSC1(3) |  258_STF-62247_GDSC1(3) | Acute Myeloid Leukemia	SGK1 (7):	--2-- |  179_5-Fluorouracil_GDSC1(4) |  1128_FS106_GDSC1(4) | Acute Myeloid Leukemia	SMYD3 (3):	--1-- |  1091_BMS-536924_GDSC2(3) | Acute Myeloid Leukemia	SOS1 (9):	--4-- |  172_Embelin_GDSC1(3) |  281_Alectinib_GDSC1(3) |  1249_BMS-345541_GDSC2(3) |  1378_Bleomycin (50 uM)_GDSC2(4) | Acute Myeloid Leukemia	SRC (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1365_BAY-HDAC11_2_GDSC1(3) | Acute Myeloid Leukemia	STAT3 (4):	--1-- |  3_Rapamycin_GDSC1(4) | Acute Myeloid Leukemia	STAT5B (3):	--2-- |  1059_AZD8055_GDSC2(2) |  1441_AZD2014_GDSC2(2) | Acute Myeloid Leukemia	TSHR (9):	--2-- |  1498_Selumetinib_GDSC1(3) |  1494_SN-38_GDSC2(6) | Acute Myeloid Leukemia	TYK2 (4):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  1187_CCT245232_GDSC1(3) | Acute Myeloid Leukemia	UBR5 (10):	--3-- |  293_Amuvatinib_GDSC1(5) |  1441_AZD2014_GDSC2(4) |  2046_MK-8776_GDSC2(6) | Acute Myeloid Leukemia	USP8 (6):	--2-- |  1529_Pevonedistat_GDSC1(3) |  1997_WEHI-539_GDSC2(5) | Acute Myeloid Leukemia	VAV1 (11):	--2-- |  41_S-Trityl-L-cysteine_GDSC1(5) |  1254_GSK-J4_GDSC1(8) | Acute Myeloid Leukemia	VAV2 (8):	--1-- |  1527_Pictilisib_GDSC1(8) | Acute Myeloid Leukemia	VEGFA (5):	--2-- |  133_Doxorubicin_GDSC1(4) |  179_5-Fluorouracil_GDSC1(4) | Acute Myeloid Leukemia	WWP1 (3):	--1-- |  1558_Lapatinib_GDSC2(3) | Acute Myeloid Leukemia	XPO1 (5):	--2-- |  260_NG-25_GDSC1(3) |  1053_MK-2206_GDSC2(3) | Acute Myeloid Leukemia	YES1 (2):	--1-- |  281_Alectinib_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	ABL1 (7):	--3-- |  432_Flavopiridol_GDSC1(4) |  1031_Elesclomol_GDSC1(3) |  1187_CCT245232_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	ABL2 (8):	--3-- |  380_BIBF-1120_GDSC1(3) |  1261_rTRAIL_GDSC1(4) |  1053_MK-2206_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	ACVR1 (5):	--2-- |  229_Enzastaurin_GDSC1(2) |  1003_Camptothecin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	ADHFE1 (7):	--3-- |  134_Etoposide_GDSC1(4) |  229_Enzastaurin_GDSC1(3) |  1016_Temsirolimus_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	AFF4 (10):	--2-- |  1372_Trametinib_GDSC2(4) |  1912_Afuresertib_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	AGO1 (4):	--2-- |  127_GSK269962A_GDSC1(3) |  197_Bryostatin 1_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	AKT1 (6):	--2-- |  1038_NU7441_GDSC1(4) |  1377_Afatinib_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	AKT2 (4):	--1-- |  1042_Doramapimod_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	AKT3 (6):	--3-- |  38_Saracatinib_GDSC1(3) |  412_Venotoclax_GDSC1(4) |  1622_Wnt-C59_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	ALK (12):	--3-- |  275_I-BET-762_GDSC1(5) |  1259_Talazoparib_GDSC1(6) |  1047_Nutlin-3a (-)_GDSC2(9) | B-Cell Non-Hodgkin's Lymphoma	ARHGEF28 (8):	--3-- |  258_STF-62247_GDSC1(5) |  1005_Cisplatin_GDSC1(5) |  1453_RAF_9304_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	ATXN7 (3):	--2-- |  1058_Pictilisib_GDSC2(2) |  1624_I-BET-762_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	AXL (5):	--2-- |  197_Bryostatin 1_GDSC1(2) |  1168_Erlotinib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	BCL2 (13):	--3-- |  412_Venotoclax_GDSC1(8) |  1394_AZD6738_GDSC1(6) |  1909_Venetoclax_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	BCL9 (7):	--2-- |  1359_965-D2_GDSC1(5) |  1908_Ulixertinib_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	BRAF (6):	--2-- |  1261_rTRAIL_GDSC1(4) |  1931_MIRA-1_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	BRD3 (7):	--2-- |  1030_KU-55933_GDSC1(4) |  1494_SN-38_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	BTK (3):	--1-- |  1377_Afatinib_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	CARD11 (8):	--2-- |  416_CAY10566_GDSC1(5) |  1494_SN-38_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	CCNB3 (2):	--1-- |  1036_PLX-4720_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	CCND1 (3):	--2-- |  306_Fedratinib_GDSC1(1) |  1409_AZD4877_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	CCND3 (10):	--3-- |  59_WZ-1-84_GDSC1(3) |  1241_CHIR-99021_GDSC1(5) |  1382_AZD3514_GDSC1(6) | B-Cell Non-Hodgkin's Lymphoma	CCNE1 (3):	--2-- |  304_SB52334_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	CD276 (3):	--2-- |  1014_Refametinib_GDSC1(2) |  1017_Olaparib_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	CDC42 (3):	--2-- |  285_SU11274_GDSC1(2) |  1507_Ruxolitinib_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	CDK6 (3):	--3-- |  190_Bleomycin_GDSC1(1) |  301_PHA-793887_GDSC1(1) |  1250_AZ960_GDSC2(1) | B-Cell Non-Hodgkin's Lymphoma	CDK8 (2):	--2-- |  292_Masitinib_GDSC1(1) |  1250_AZ960_GDSC2(1) | B-Cell Non-Hodgkin's Lymphoma	COP1 (9):	--3-- |  152_CP466722_GDSC1(4) |  1042_Doramapimod_GDSC2(4) |  1910_ABT737_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	CREB1 (3):	--2-- |  285_SU11274_GDSC1(2) |  1003_Camptothecin_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	CSF3R (4):	--2-- |  1168_Erlotinib_GDSC2(3) |  1706_AZD5153_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	CXCR4 (9):	--3-- |  211_TL-2-105_GDSC1(4) |  1382_AZD3514_GDSC1(6) |  1629_ML323_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	CYP19A1 (5):	--2-- |  253_XMD14-99_GDSC1(3) |  1060_PD0325901_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	DDR2 (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1042_Doramapimod_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	DDX4 (7):	--2-- |  1003_Camptothecin_GDSC2(5) |  1080_Paclitaxel_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	DNMT1 (10):	--2-- |  1402_AZD7762_GDSC1(6) |  1917_AZD6738_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	DOT1L (13):	--3-- |  1236_UNC0638_GDSC1(9) |  1259_Talazoparib_GDSC2(6) |  1624_I-BET-762_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	E2F3 (3):	--2-- |  1017_Olaparib_GDSC1(2) |  1362_BAY ACCi_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	EGFL7 (3):	--2-- |  1020_Lenalidomide_GDSC2(2) |  1053_MK-2206_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	EGFR (13):	--4-- |  199_Pazopanib_GDSC1(5) |  258_STF-62247_GDSC1(5) |  1377_Afatinib_GDSC1(4) |  1061_SB590885_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	EIF4A2 (5):	--2-- |  288_WHI-P97_GDSC1(2) |  1003_Camptothecin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	EPOR (5):	--2-- |  1362_BAY ACCi_GDSC1(2) |  1578_Leflunomide_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	ERBB2 (5):	--2-- |  32_Tozasertib_GDSC1(4) |  285_SU11274_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	ERBB4 (9):	--3-- |  1050_ZM447439_GDSC1(6) |  1564_SCH772984_GDSC2(5) |  1939_UMI-77_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	ERG (6):	--2-- |  186_Bexarotene_GDSC1(3) |  1261_rTRAIL_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	EZH1 (7):	--2-- |  416_CAY10566_GDSC1(4) |  1003_Camptothecin_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	FGFR2 (8):	--2-- |  1003_Camptothecin_GDSC2(6) |  1912_Afuresertib_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	FGFR3 (5):	--2-- |  17_Cyclopamine_GDSC1(3) |  199_Pazopanib_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	FGFR4 (1):	--1-- |  194_Luminespib_GDSC1(1) | B-Cell Non-Hodgkin's Lymphoma	FLT1 (9):	--2-- |  1594_OSI-027_GDSC2(5) |  1996_MIM1_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	FLT3 (7):	--3-- |  59_WZ-1-84_GDSC1(3) |  1463_AZD1332_GDSC2(3) |  1629_ML323_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	FLT4 (12):	--2-- |  1419_FEN1_3940_GDSC1(7) |  1564_SCH772984_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	FYN (3):	--2-- |  165_DMOG_GDSC1(2) |  1243_Piperlongumine_GDSC1(1) | B-Cell Non-Hodgkin's Lymphoma	GAB1 (4):	--2-- |  288_WHI-P97_GDSC1(2) |  1168_Erlotinib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	GAB2 (5):	--2-- |  1016_Temsirolimus_GDSC1(3) |  1085_Sorafenib_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	GLI1 (4):	--2-- |  163_JQ1_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	GNA12 (6):	--2-- |  1367_BAY-HDAC11_4_GDSC1(3) |  1049_PD173074_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	GNA13 (9):	--2-- |  412_Venotoclax_GDSC1(5) |  1241_CHIR-99021_GDSC1(5) | B-Cell Non-Hodgkin's Lymphoma	GNAS (10):	--3-- |  304_SB52334_GDSC1(3) |  1241_CHIR-99021_GDSC1(5) |  1449_AZD1208_GDSC1(7) | B-Cell Non-Hodgkin's Lymphoma	GNB1 (6):	--2-- |  38_Saracatinib_GDSC1(3) |  1030_KU-55933_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	GSK3B (3):	--2-- |  1248_Daporinad_GDSC1(2) |  1451_PLK_6522_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	GTF2I (6):	--2-- |  416_CAY10566_GDSC1(4) |  1003_Camptothecin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	H1-4 (8):	--2-- |  412_Venotoclax_GDSC1(5) |  1005_Cisplatin_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	H2AC17 (3):	--2-- |  253_XMD14-99_GDSC1(2) |  1251_N22899-6-C1_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	HDAC7 (8):	--2-- |  306_Fedratinib_GDSC1(6) |  1084_Rapamycin_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	HGF (10):	--4-- |  35_NVP-TAE684_GDSC1(4) |  416_CAY10566_GDSC1(6) |  1046_Wee1 Inhibitor_GDSC1(5) |  1378_Bleomycin (50 uM)_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	HMGA2 (6):	--3-- |  288_WHI-P97_GDSC1(2) |  1003_Camptothecin_GDSC2(4) |  1014_Refametinib_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	IGF1R (5):	--2-- |  1053_MK-2206_GDSC2(2) |  1829_667880_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	IKBKE (3):	--2-- |  1020_Lenalidomide_GDSC2(2) |  1042_Doramapimod_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	IL6ST (9):	--2-- |  1409_AZD4877_GDSC1(5) |  1051_Alisertib_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	INSR (12):	--3-- |  416_CAY10566_GDSC1(6) |  1372_Trametinib_GDSC2(4) |  1912_Afuresertib_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	JAK2 (7):	--3-- |  275_I-BET-762_GDSC1(5) |  1378_Bleomycin (50 uM)_GDSC2(3) |  1624_I-BET-762_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	JAK3 (8):	--3-- |  275_I-BET-762_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(3) |  1786_AZD4547_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	KDM5A (12):	--3-- |  416_CAY10566_GDSC1(7) |  1026_Tanespimycin_GDSC2(5) |  1624_I-BET-762_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	KDR (9):	--3-- |  29_AZ628_GDSC1(5) |  238_Idelalisib_GDSC1(6) |  1451_PLK_6522_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	LGR5 (4):	--2-- |  1050_ZM447439_GDSC2(3) |  1916_AZD5363_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	LRP6 (10):	--3-- |  175_PAC-1_GDSC1(6) |  1089_Oxaliplatin_GDSC2(6) |  1631_PRT062607_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	LTK (6):	--2-- |  110_Seliciclib_GDSC1(4) |  1241_CHIR-99021_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	MAP2K1 (5):	--3-- |  1186_FS112_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) |  1812_Bleomycin_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	MAP2K2 (2):	--1-- |  1020_Lenalidomide_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	MAP3K13 (6):	--2-- |  1053_MK-2206_GDSC2(5) |  1080_Paclitaxel_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	MCL1 (5):	--2-- |  1042_Doramapimod_GDSC2(4) |  1919_Osimertinib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	MDM2 (6):	--3-- |  288_WHI-P97_GDSC1(2) |  1014_Refametinib_GDSC2(4) |  2110_GSK591_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	MDM4 (9):	--2-- |  1626_OTX015_GDSC2(8) |  1916_AZD5363_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	MECOM (8):	--2-- |  206_Ruxolitinib_GDSC1(3) |  1912_Afuresertib_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	MEF2B (2):	--1-- |  1017_Olaparib_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	MET (12):	--3-- |  32_Tozasertib_GDSC1(5) |  151_QS11_GDSC1(7) |  1444_AZD8186_GDSC1(8) | B-Cell Non-Hodgkin's Lymphoma	MGAM (15):	--2-- |  1026_Tanespimycin_GDSC2(11) |  1931_MIRA-1_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	MKI67 (11):	--3-- |  1236_UNC0638_GDSC1(7) |  1016_Temsirolimus_GDSC2(4) |  1917_AZD6738_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	MLLT10 (7):	--2-- |  211_TL-2-105_GDSC1(5) |  380_BIBF-1120_GDSC1(6) | B-Cell Non-Hodgkin's Lymphoma	MPL (4):	--2-- |  1251_N22899-6-C1_GDSC1(2) |  1268_XAV939_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	MSI1 (5):	--2-- |  362_CI-1033_GDSC1(3) |  1243_Piperlongumine_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	MST1R (7):	--2-- |  1058_Pictilisib_GDSC2(4) |  1089_Oxaliplatin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	MTOR (12):	--3-- |  176_IPA-3_GDSC1(5) |  1614_WZ4003_GDSC2(7) |  1910_ABT737_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	MYBL1 (6):	--2-- |  1017_Olaparib_GDSC1(2) |  1564_SCH772984_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	MYC (14):	--3-- |  29_AZ628_GDSC1(5) |  279_BIX02189_GDSC1(8) |  1019_Bosutinib_GDSC1(8) | B-Cell Non-Hodgkin's Lymphoma	MYD88 (2):	--2-- |  1089_Oxaliplatin_GDSC2(1) |  2159_UNC0379_GDSC2(1) | B-Cell Non-Hodgkin's Lymphoma	NCOA3 (8):	--2-- |  190_Bleomycin_GDSC1(3) |  1419_FEN1_3940_GDSC1(5) | B-Cell Non-Hodgkin's Lymphoma	NCSTN (7):	--3-- |  332_XMD15-27_GDSC1(2) |  412_Venotoclax_GDSC1(5) |  1362_BAY ACCi_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	NR4A3 (5):	--2-- |  1003_Camptothecin_GDSC2(3) |  1131_PRIMA-1MET_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	NRG1 (6):	--2-- |  427_Ara-G_GDSC1(3) |  1036_PLX-4720_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	NSD2 (8):	--2-- |  1003_Camptothecin_GDSC2(6) |  1561_Taselisib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	NT5C2 (6):	--2-- |  416_CAY10566_GDSC1(4) |  1036_PLX-4720_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	NTRK1 (3):	--1-- |  1392_Bleomycin (10 uM)_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	NTRK2 (5):	--2-- |  1168_Erlotinib_GDSC2(4) |  2110_GSK591_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	NTRK3 (9):	--3-- |  1419_FEN1_3940_GDSC1(4) |  1050_ZM447439_GDSC2(5) |  1058_Pictilisib_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	NUP214 (5):	--3-- |  1003_Camptothecin_GDSC2(3) |  1441_AZD2014_GDSC2(1) |  1624_I-BET-762_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	PAK5 (7):	--2-- |  1003_Camptothecin_GDSC2(5) |  1058_Pictilisib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	PDGFRA (7):	--2-- |  282_Pelitinib_GDSC1(4) |  1089_Oxaliplatin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	PDGFRB (9):	--2-- |  306_Fedratinib_GDSC1(6) |  1419_FEN1_3940_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	PIK3CB (6):	--3-- |  282_Pelitinib_GDSC1(4) |  288_WHI-P97_GDSC1(2) |  1003_Camptothecin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	PIK3CD (4):	--2-- |  1021_Axitinib_GDSC1(3) |  1392_Bleomycin (10 uM)_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	PIK3CG (8):	--2-- |  1419_FEN1_3940_GDSC1(4) |  1564_SCH772984_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	PLCG1 (7):	--3-- |  35_NVP-TAE684_GDSC1(3) |  332_XMD15-27_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	PLCG2 (11):	--2-- |  51_Dasatinib_GDSC1(6) |  1917_AZD6738_GDSC2(9) | B-Cell Non-Hodgkin's Lymphoma	PRKACA (5):	--2-- |  1560_Alpelisib_GDSC2(4) |  2110_GSK591_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	RAC1 (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1578_Leflunomide_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	RET (7):	--2-- |  235_QL-XII-47_GDSC1(6) |  1527_Pictilisib_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	REV3L (9):	--2-- |  1187_CCT245232_GDSC1(5) |  1626_OTX015_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	RHEB (3):	--2-- |  285_SU11274_GDSC1(2) |  1014_Refametinib_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	RICTOR (10):	--3-- |  175_PAC-1_GDSC1(6) |  1433_JAK1_3715_GDSC1(3) |  1931_MIRA-1_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	ROS1 (11):	--3-- |  416_CAY10566_GDSC1(6) |  1042_Doramapimod_GDSC2(5) |  1931_MIRA-1_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	RPS6KA4 (3):	--2-- |  1036_PLX-4720_GDSC1(2) |  1043_JNK Inhibitor VIII_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	RPTOR (12):	--3-- |  63_BMS-509744_GDSC1(4) |  175_PAC-1_GDSC1(7) |  1621_PCI-34051_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	RUNX1T1 (3):	--2-- |  134_Etoposide_GDSC1(2) |  1507_Ruxolitinib_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	SETBP1 (8):	--2-- |  1419_FEN1_3940_GDSC1(5) |  1042_Doramapimod_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	SETD1A (3):	--2-- |  282_Pelitinib_GDSC1(2) |  1251_N22899-6-C1_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	SF3B1 (9):	--4-- |  163_JQ1_GDSC1(4) |  416_CAY10566_GDSC1(5) |  1248_Daporinad_GDSC1(5) |  1054_Palbociclib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	SGK1 (8):	--3-- |  226_GSK1070916_GDSC1(3) |  1005_Cisplatin_GDSC1(5) |  1046_Wee1 Inhibitor_GDSC1(5) | B-Cell Non-Hodgkin's Lymphoma	SMO (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1629_ML323_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	SOS1 (7):	--2-- |  1050_ZM447439_GDSC2(6) |  1714_ERK_6604_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	SQSTM1 (9):	--2-- |  190_Bleomycin_GDSC1(6) |  1050_ZM447439_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	SRC (4):	--2-- |  275_I-BET-762_GDSC1(3) |  1624_I-BET-762_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	STAT3 (4):	--2-- |  332_XMD15-27_GDSC1(2) |  1268_XAV939_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	STAT5A (2):	--1-- |  1268_XAV939_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	STAT6 (7):	--2-- |  30_Sorafenib_GDSC1(5) |  1549_Sapitinib_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	SYK (5):	--2-- |  1003_Camptothecin_GDSC2(4) |  1578_Leflunomide_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	TSHR (8):	--2-- |  1014_Refametinib_GDSC2(5) |  1786_AZD4547_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	UBR5 (13):	--3-- |  226_GSK1070916_GDSC1(5) |  1261_rTRAIL_GDSC1(7) |  1378_Bleomycin (50 uM)_GDSC1(5) | B-Cell Non-Hodgkin's Lymphoma	USP8 (7):	--2-- |  1003_Camptothecin_GDSC2(6) |  1250_AZ960_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	VAV1 (10):	--3-- |  62_BMS-536924_GDSC1(7) |  1363_BAY AKT1_GDSC1(4) |  1020_Lenalidomide_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	VAV2 (6):	--2-- |  1042_Doramapimod_GDSC2(5) |  1786_AZD4547_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	VEGFA (4):	--2-- |  59_WZ-1-84_GDSC1(3) |  1706_AZD5153_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	WWP1 (10):	--3-- |  380_BIBF-1120_GDSC1(4) |  1375_Temozolomide_GDSC2(6) |  1594_OSI-027_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	WWTR1 (2):	--1-- |  1036_PLX-4720_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	YAP1 (3):	--1-- |  1021_Axitinib_GDSC1(3) | B-Lymphoblastic Leukemia	ABL2 (5):	--2-- |  1738_IGF1R_3801_GDSC2(3) |  2046_MK-8776_GDSC2(2) | B-Lymphoblastic Leukemia	ACVR1 (6):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1407_Dyrk1b_0191_GDSC1(4) | B-Lymphoblastic Leukemia	AFF4 (1):	--1-- |  1624_I-BET-762_GDSC2(1) | B-Lymphoblastic Leukemia	AKT1 (2):	--1-- |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	AKT3 (2):	--1-- |  1364_BAY-HDAC11_1_GDSC1(2) | B-Lymphoblastic Leukemia	ALK (9):	--3-- |  295_NVP-BHG712_GDSC1(4) |  1053_MK-2206_GDSC1(5) |  1378_Bleomycin (50 uM)_GDSC1(5) | B-Lymphoblastic Leukemia	ARHGEF28 (5):	--2-- |  53_CGP-60474_GDSC1(3) |  293_Amuvatinib_GDSC1(2) | B-Lymphoblastic Leukemia	ATXN7 (7):	--3-- |  11_Paclitaxel_GDSC1(3) |  176_IPA-3_GDSC1(4) |  375_Voxtalisib_GDSC1(2) | B-Lymphoblastic Leukemia	AXL (2):	--1-- |  1177_Niraparib_GDSC2(2) | B-Lymphoblastic Leukemia	BCL2 (4):	--2-- |  1853_OF-1_GDSC2(2) |  1926_GNE-317_GDSC2(2) | B-Lymphoblastic Leukemia	BCL6 (4):	--2-- |  332_XMD15-27_GDSC1(3) |  1932_NVP-ADW742_GDSC2(2) | B-Lymphoblastic Leukemia	BRD4 (5):	--2-- |  1196_FY069_GDSC1(3) |  1084_Rapamycin_GDSC2(4) | B-Lymphoblastic Leukemia	CALR (1):	--1-- |  45_Z-LLNle-CHO_GDSC1(1) | B-Lymphoblastic Leukemia	CCND1 (3):	--1-- |  2047_Ulixertinib_GDSC2(3) | B-Lymphoblastic Leukemia	CCND3 (3):	--2-- |  45_Z-LLNle-CHO_GDSC1(1) |  1168_Erlotinib_GDSC2(2) | B-Lymphoblastic Leukemia	CCNE1 (3):	--1-- |  2047_Ulixertinib_GDSC2(3) | B-Lymphoblastic Leukemia	CD276 (1):	--1-- |  279_BIX02189_GDSC1(1) | B-Lymphoblastic Leukemia	CDK8 (3):	--2-- |  1049_PD173074_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | B-Lymphoblastic Leukemia	COP1 (7):	--3-- |  86_A-443654_GDSC1(3) |  88_Entinostat_GDSC1(3) |  1218_JQ1_GDSC1(3) | B-Lymphoblastic Leukemia	CRKL (4):	--2-- |  1170_CCT-018159_GDSC1(3) |  2039_AGK2_GDSC2(2) | B-Lymphoblastic Leukemia	CSF3R (3):	--2-- |  279_BIX02189_GDSC1(2) |  310_YM201636_GDSC1(2) | B-Lymphoblastic Leukemia	CYP19A1 (4):	--2-- |  1218_JQ1_GDSC1(3) |  2037_GSK343_GDSC2(2) | B-Lymphoblastic Leukemia	DDR2 (8):	--2-- |  104_Bortezomib_GDSC1(3) |  1091_BMS-536924_GDSC1(6) | B-Lymphoblastic Leukemia	DNMT1 (10):	--4-- |  293_Amuvatinib_GDSC1(4) |  476_SB505124_GDSC1(4) |  1016_Temsirolimus_GDSC2(6) |  1558_Lapatinib_GDSC2(7) | B-Lymphoblastic Leukemia	DOT1L (7):	--1-- |  1363_BAY AKT1_GDSC1(7) | B-Lymphoblastic Leukemia	EGFR (8):	--2-- |  45_Z-LLNle-CHO_GDSC1(4) |  1363_BAY AKT1_GDSC1(6) | B-Lymphoblastic Leukemia	ERBB2 (2):	--1-- |  2110_GSK591_GDSC2(2) | B-Lymphoblastic Leukemia	ERBB3 (6):	--3-- |  53_CGP-60474_GDSC1(2) |  1046_Wee1 Inhibitor_GDSC1(4) |  1218_JQ1_GDSC1(3) | B-Lymphoblastic Leukemia	ERBB4 (6):	--2-- |  172_Embelin_GDSC1(3) |  1073_5-Fluorouracil_GDSC2(3) | B-Lymphoblastic Leukemia	ESR1 (3):	--1-- |  1564_SCH772984_GDSC2(3) | B-Lymphoblastic Leukemia	ETV5 (3):	--1-- |  1458_PARP_9495_GDSC1(3) | B-Lymphoblastic Leukemia	EZH1 (1):	--1-- |  1624_I-BET-762_GDSC2(1) | B-Lymphoblastic Leukemia	FGF3 (1):	--1-- |  45_Z-LLNle-CHO_GDSC1(1) | B-Lymphoblastic Leukemia	FGFR1 (1):	--1-- |  279_BIX02189_GDSC1(1) | B-Lymphoblastic Leukemia	FLT1 (3):	--1-- |  2047_Ulixertinib_GDSC2(3) | B-Lymphoblastic Leukemia	FLT3 (3):	--1-- |  1463_AZD1332_GDSC2(3) | B-Lymphoblastic Leukemia	FLT4 (5):	--2-- |  88_Entinostat_GDSC1(3) |  1720_AZD5991_GDSC2(3) | B-Lymphoblastic Leukemia	FURIN (2):	--1-- |  329_QL-XI-92_GDSC1(2) | B-Lymphoblastic Leukemia	FYN (2):	--1-- |  53_CGP-60474_GDSC1(2) | B-Lymphoblastic Leukemia	GAB1 (5):	--1-- |  253_XMD14-99_GDSC1(5) | B-Lymphoblastic Leukemia	GAB2 (5):	--2-- |  53_CGP-60474_GDSC1(2) |  1359_965-D2_GDSC1(4) | B-Lymphoblastic Leukemia	GLI1 (6):	--2-- |  53_CGP-60474_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC1(4) | B-Lymphoblastic Leukemia	GNA12 (4):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1720_AZD5991_GDSC2(2) | B-Lymphoblastic Leukemia	GNAQ (1):	--1-- |  294_MPS-1-IN-1_GDSC1(1) | B-Lymphoblastic Leukemia	GNAS (6):	--2-- |  41_S-Trityl-L-cysteine_GDSC1(3) |  285_SU11274_GDSC1(5) | B-Lymphoblastic Leukemia	HDAC7 (4):	--2-- |  1853_OF-1_GDSC2(2) |  1926_GNE-317_GDSC2(2) | B-Lymphoblastic Leukemia	HGF (4):	--2-- |  185_Linsitinib_GDSC1(2) |  2037_GSK343_GDSC2(2) | B-Lymphoblastic Leukemia	HIF1A (3):	--1-- |  158_PF-562271_GDSC1(3) | B-Lymphoblastic Leukemia	HMGA1 (3):	--1-- |  1458_PARP_9495_GDSC1(3) | B-Lymphoblastic Leukemia	IGF1R (8):	--2-- |  1133_Serdemetan_GDSC1(3) |  1382_AZD3514_GDSC1(6) | B-Lymphoblastic Leukemia	IL6ST (3):	--2-- |  11_Paclitaxel_GDSC1(1) |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	INSR (6):	--2-- |  253_XMD14-99_GDSC1(5) |  476_SB505124_GDSC1(3) | B-Lymphoblastic Leukemia	JAK2 (6):	--2-- |  64_CMK_GDSC1(2) |  1133_Serdemetan_GDSC2(4) | B-Lymphoblastic Leukemia	JAK3 (5):	--2-- |  53_CGP-60474_GDSC1(2) |  1359_965-D2_GDSC1(4) | B-Lymphoblastic Leukemia	KDR (5):	--3-- |  106_XMD8-85_GDSC1(1) |  265_Tubastatin A_GDSC1(2) |  1909_Venetoclax_GDSC2(2) | B-Lymphoblastic Leukemia	KRAS (4):	--2-- |  1062_Selumetinib_GDSC2(3) |  1820_123829_GDSC2(2) | B-Lymphoblastic Leukemia	KSR2 (6):	--2-- |  45_Z-LLNle-CHO_GDSC1(3) |  1054_Palbociclib_GDSC1(4) | B-Lymphoblastic Leukemia	LGR5 (4):	--1-- |  1036_PLX-4720_GDSC1(4) | B-Lymphoblastic Leukemia	LRP6 (8):	--3-- |  45_Z-LLNle-CHO_GDSC1(4) |  1732_TAF1_5496_GDSC2(4) |  2096_VX-11e_GDSC2(3) | B-Lymphoblastic Leukemia	LYN (2):	--1-- |  1634_AGI-6780_GDSC2(2) | B-Lymphoblastic Leukemia	MAP2K2 (5):	--2-- |  1129_PF-4708671_GDSC1(2) |  1394_AZD6738_GDSC1(3) | B-Lymphoblastic Leukemia	MAP4K4 (4):	--3-- |  11_Paclitaxel_GDSC1(1) |  53_CGP-60474_GDSC1(1) |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	MECOM (3):	--1-- |  171_AKT inhibitor VIII_GDSC1(3) | B-Lymphoblastic Leukemia	MEF2D (2):	--1-- |  1049_PD173074_GDSC1(2) | B-Lymphoblastic Leukemia	MET (6):	--2-- |  104_Bortezomib_GDSC1(4) |  1833_741909_GDSC2(4) | B-Lymphoblastic Leukemia	MKI67 (6):	--3-- |  1066_AZD6482_GDSC1(3) |  1007_Docetaxel_GDSC2(3) |  1631_PRT062607_GDSC2(2) | B-Lymphoblastic Leukemia	MLLT3 (1):	--1-- |  1624_I-BET-762_GDSC2(1) | B-Lymphoblastic Leukemia	MSI2 (6):	--3-- |  293_Amuvatinib_GDSC1(4) |  375_Voxtalisib_GDSC1(2) |  476_SB505124_GDSC1(3) | B-Lymphoblastic Leukemia	MTOR (5):	--3-- |  5_Sunitinib_GDSC1(2) |  372_Pilaralisib_GDSC1(3) |  1133_Serdemetan_GDSC2(2) | B-Lymphoblastic Leukemia	MYC (7):	--2-- |  1393_Gemcitabine_GDSC1(3) |  2171_BMS-754807_GDSC2(4) | B-Lymphoblastic Leukemia	NCOA3 (3):	--2-- |  1367_BAY-HDAC11_4_GDSC1(2) |  1820_123829_GDSC2(2) | B-Lymphoblastic Leukemia	NRG1 (6):	--3-- |  265_Tubastatin A_GDSC1(3) |  1053_MK-2206_GDSC1(3) |  1133_Serdemetan_GDSC2(2) | B-Lymphoblastic Leukemia	NSD2 (5):	--2-- |  32_Tozasertib_GDSC1(4) |  295_NVP-BHG712_GDSC1(3) | B-Lymphoblastic Leukemia	NT5C2 (9):	--2-- |  1558_Lapatinib_GDSC2(7) |  1630_Entospletinib_GDSC2(6) | B-Lymphoblastic Leukemia	NTRK2 (4):	--2-- |  1720_AZD5991_GDSC2(3) |  2046_MK-8776_GDSC2(2) | B-Lymphoblastic Leukemia	NTRK3 (3):	--2-- |  106_XMD8-85_GDSC1(1) |  1720_AZD5991_GDSC2(2) | B-Lymphoblastic Leukemia	NUF2 (1):	--1-- |  294_MPS-1-IN-1_GDSC1(1) | B-Lymphoblastic Leukemia	PAK1 (6):	--3-- |  45_Z-LLNle-CHO_GDSC1(3) |  104_Bortezomib_GDSC1(3) |  2046_MK-8776_GDSC2(3) | B-Lymphoblastic Leukemia	PDGFB (1):	--1-- |  1624_I-BET-762_GDSC2(1) | B-Lymphoblastic Leukemia	PDGFRA (7):	--3-- |  32_Tozasertib_GDSC1(2) |  106_XMD8-85_GDSC1(3) |  293_Amuvatinib_GDSC1(3) | B-Lymphoblastic Leukemia	PIK3CA (6):	--2-- |  295_NVP-BHG712_GDSC1(4) |  1133_Serdemetan_GDSC2(3) | B-Lymphoblastic Leukemia	PIK3CD (4):	--2-- |  11_Paclitaxel_GDSC1(1) |  1449_AZD1208_GDSC1(3) | B-Lymphoblastic Leukemia	PIK3CG (3):	--2-- |  41_S-Trityl-L-cysteine_GDSC1(2) |  88_Entinostat_GDSC1(2) | B-Lymphoblastic Leukemia	PLCG1 (1):	--1-- |  1624_I-BET-762_GDSC2(1) | B-Lymphoblastic Leukemia	PLCG2 (5):	--2-- |  1170_CCT-018159_GDSC1(4) |  1373_Dabrafenib_GDSC1(4) | B-Lymphoblastic Leukemia	PPARG (3):	--2-- |  563_Kobe2602_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(2) | B-Lymphoblastic Leukemia	PPM1D (2):	--2-- |  106_XMD8-85_GDSC1(1) |  1136_Capivasertib_GDSC1(1) | B-Lymphoblastic Leukemia	PTPN11 (4):	--3-- |  106_XMD8-85_GDSC1(1) |  140_Vinorelbine_GDSC1(2) |  476_SB505124_GDSC1(1) | B-Lymphoblastic Leukemia	RAC2 (3):	--2-- |  1026_Tanespimycin_GDSC1(2) |  1053_MK-2206_GDSC1(1) | B-Lymphoblastic Leukemia	RET (4):	--2-- |  106_XMD8-85_GDSC1(2) |  1218_JQ1_GDSC1(3) | B-Lymphoblastic Leukemia	RICTOR (3):	--2-- |  17_Cyclopamine_GDSC1(2) |  254_Quizartinib_GDSC1(2) | B-Lymphoblastic Leukemia	ROS1 (5):	--2-- |  372_Pilaralisib_GDSC1(4) |  1133_Serdemetan_GDSC2(2) | B-Lymphoblastic Leukemia	RPTOR (7):	--3-- |  1373_Dabrafenib_GDSC1(4) |  1177_Niraparib_GDSC2(4) |  2038_UNC0638_GDSC2(3) | B-Lymphoblastic Leukemia	RUNX1T1 (4):	--3-- |  11_Paclitaxel_GDSC1(1) |  53_CGP-60474_GDSC1(1) |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	SETD1A (4):	--2-- |  53_CGP-60474_GDSC1(3) |  295_NVP-BHG712_GDSC1(2) | B-Lymphoblastic Leukemia	SGK1 (5):	--2-- |  53_CGP-60474_GDSC1(2) |  1359_965-D2_GDSC1(4) | B-Lymphoblastic Leukemia	SMO (3):	--1-- |  1014_Refametinib_GDSC2(3) | B-Lymphoblastic Leukemia	SOS1 (6):	--3-- |  63_BMS-509744_GDSC1(2) |  375_Voxtalisib_GDSC1(2) |  476_SB505124_GDSC1(4) | B-Lymphoblastic Leukemia	SYK (2):	--1-- |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	TERT (4):	--3-- |  41_S-Trityl-L-cysteine_GDSC1(2) |  88_Entinostat_GDSC1(2) |  2046_MK-8776_GDSC2(1) | B-Lymphoblastic Leukemia	TFE3 (3):	--2-- |  17_Cyclopamine_GDSC1(2) |  154_CHIR-99021_GDSC1(2) | B-Lymphoblastic Leukemia	USP8 (6):	--2-- |  45_Z-LLNle-CHO_GDSC1(3) |  176_IPA-3_GDSC1(4) | B-Lymphoblastic Leukemia	VAV1 (8):	--2-- |  104_Bortezomib_GDSC1(3) |  1091_BMS-536924_GDSC1(6) | B-Lymphoblastic Leukemia	VAV2 (7):	--2-- |  1005_Cisplatin_GDSC1(6) |  1463_AZD1332_GDSC1(4) | B-Lymphoblastic Leukemia	VEGFA (2):	--1-- |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	YAP1 (1):	--1-- |  45_Z-LLNle-CHO_GDSC1(1) | Bladder Carcinoma	ACVR1 (7):	--2-- |  177_GSK650394_GDSC1(5) |  1051_Alisertib_GDSC2(6) | Bladder Carcinoma	ADHFE1 (3):	--2-- |  1429_IAP_7638_GDSC1(2) |  1449_AZD1208_GDSC1(2) | Bladder Carcinoma	AKT2 (4):	--2-- |  134_Etoposide_GDSC1(2) |  344_THZ-2-49_GDSC1(3) | Bladder Carcinoma	ARHGEF28 (4):	--2-- |  1463_AZD1332_GDSC1(2) |  1847_BEN_GDSC2(3) | Bladder Carcinoma	ARID3B (3):	--2-- |  272_AR-42_GDSC1(1) |  293_Amuvatinib_GDSC1(2) | Bladder Carcinoma	ATF1 (3):	--2-- |  203_BMS-345541_GDSC1(2) |  1136_Capivasertib_GDSC1(1) | Bladder Carcinoma	ATXN7 (3):	--1-- |  372_Pilaralisib_GDSC1(3) | Bladder Carcinoma	AXL (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	BCL6 (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1999_N25720-51-A1_GDSC2(3) | Bladder Carcinoma	BCR (11):	--3-- |  151_QS11_GDSC1(7) |  1185_KU-60019_GDSC1(6) |  2172_JQ1_GDSC2(7) | Bladder Carcinoma	BRAF (5):	--2-- |  1261_rTRAIL_GDSC1(3) |  1048_Mirin_GDSC2(3) | Bladder Carcinoma	BRD4 (3):	--2-- |  1006_Cytarabine_GDSC1(1) |  1413_EphB4_9721_GDSC1(2) | Bladder Carcinoma	BTK (4):	--3-- |  1248_Daporinad_GDSC1(1) |  1392_Bleomycin (10 uM)_GDSC1(2) |  1926_GNE-317_GDSC2(2) | Bladder Carcinoma	CARD11 (5):	--2-- |  1578_Leflunomide_GDSC2(3) |  1714_ERK_6604_GDSC2(3) | Bladder Carcinoma	CCNE1 (2):	--1-- |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	CYP19A1 (4):	--1-- |  1060_PD0325901_GDSC2(4) | Bladder Carcinoma	DNMT1 (4):	--2-- |  203_BMS-345541_GDSC1(2) |  1038_NU7441_GDSC1(3) | Bladder Carcinoma	DOT1L (5):	--3-- |  172_Embelin_GDSC1(2) |  1006_Cytarabine_GDSC1(1) |  1847_BEN_GDSC2(3) | Bladder Carcinoma	EGFR (7):	--2-- |  140_Vinorelbine_GDSC1(4) |  1008_Methotrexate_GDSC2(5) | Bladder Carcinoma	ERBB2 (3):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  275_I-BET-762_GDSC1(2) | Bladder Carcinoma	ERBB3 (4):	--2-- |  158_PF-562271_GDSC1(3) |  261_TL-1-85_GDSC1(3) | Bladder Carcinoma	ERBB4 (3):	--1-- |  1709_CDK9_5038_GDSC2(3) | Bladder Carcinoma	ETV1 (3):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(2) |  1463_AZD1332_GDSC1(2) | Bladder Carcinoma	EZH1 (3):	--2-- |  1006_Cytarabine_GDSC1(1) |  1843_LMP744_GDSC2(2) | Bladder Carcinoma	FGFR1 (5):	--2-- |  310_YM201636_GDSC1(3) |  1444_AZD8186_GDSC1(3) | Bladder Carcinoma	FLI1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(2) |  1053_MK-2206_GDSC2(3) | Bladder Carcinoma	FLT1 (4):	--2-- |  1060_PD0325901_GDSC1(2) |  1578_Leflunomide_GDSC2(3) | Bladder Carcinoma	FLT3 (2):	--1-- |  1073_5-Fluorouracil_GDSC2(2) | Bladder Carcinoma	FLT4 (5):	--2-- |  1019_Bosutinib_GDSC1(3) |  1261_rTRAIL_GDSC1(3) | Bladder Carcinoma	GAB2 (4):	--2-- |  1261_rTRAIL_GDSC1(3) |  1259_Talazoparib_GDSC2(3) | Bladder Carcinoma	GLI1 (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1051_Alisertib_GDSC2(5) | Bladder Carcinoma	GNAQ (3):	--2-- |  1019_Bosutinib_GDSC1(2) |  1073_5-Fluorouracil_GDSC2(2) | Bladder Carcinoma	GTF2I (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	HDAC7 (4):	--2-- |  185_Linsitinib_GDSC1(2) |  344_THZ-2-49_GDSC1(3) | Bladder Carcinoma	HGF (4):	--2-- |  1449_AZD1208_GDSC1(2) |  1593_Entinostat_GDSC2(3) | Bladder Carcinoma	HIF1A (3):	--2-- |  1449_AZD1208_GDSC1(2) |  1073_5-Fluorouracil_GDSC2(2) | Bladder Carcinoma	HMGA1 (4):	--2-- |  196_Phenformin_GDSC1(3) |  331_QL-X-138_GDSC1(1) | Bladder Carcinoma	HMGA2 (3):	--2-- |  134_Etoposide_GDSC1(2) |  173_FH535_GDSC1(2) | Bladder Carcinoma	IGF1R (8):	--2-- |  207_AS601245_GDSC1(6) |  1024_Lestaurtinib_GDSC2(6) | Bladder Carcinoma	IKBKE (2):	--1-- |  203_BMS-345541_GDSC1(2) | Bladder Carcinoma	IL6ST (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	INSR (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	JAK3 (5):	--2-- |  1394_AZD6738_GDSC1(2) |  1008_Methotrexate_GDSC2(4) | Bladder Carcinoma	KDM5A (5):	--2-- |  1053_MK-2206_GDSC2(3) |  1259_Talazoparib_GDSC2(3) | Bladder Carcinoma	KSR2 (5):	--2-- |  1377_Afatinib_GDSC1(3) |  1553_Uprosertib_GDSC2(4) | Bladder Carcinoma	LGR5 (4):	--2-- |  158_PF-562271_GDSC1(3) |  1008_Methotrexate_GDSC1(3) | Bladder Carcinoma	LRP6 (6):	--2-- |  1008_Methotrexate_GDSC1(3) |  1008_Methotrexate_GDSC2(4) | Bladder Carcinoma	LTK (3):	--2-- |  1527_Pictilisib_GDSC1(1) |  1089_Oxaliplatin_GDSC2(2) | Bladder Carcinoma	MDM2 (3):	--1-- |  1553_Uprosertib_GDSC2(3) | Bladder Carcinoma	MDM4 (3):	--1-- |  1803_Acetalax_GDSC2(3) | Bladder Carcinoma	MECOM (7):	--2-- |  177_GSK650394_GDSC1(5) |  305_TPCA-1_GDSC1(5) | Bladder Carcinoma	MET (3):	--2-- |  203_BMS-345541_GDSC1(2) |  275_I-BET-762_GDSC1(2) | Bladder Carcinoma	MGAM (11):	--2-- |  176_IPA-3_GDSC1(8) |  2172_JQ1_GDSC2(7) | Bladder Carcinoma	MKI67 (4):	--2-- |  276_CAY10603_GDSC1(2) |  293_Amuvatinib_GDSC1(2) | Bladder Carcinoma	MLLT10 (7):	--2-- |  1048_Mirin_GDSC1(6) |  2156_5-azacytidine_GDSC2(6) | Bladder Carcinoma	MSI1 (4):	--2-- |  134_Etoposide_GDSC1(2) |  262_VX-11e_GDSC1(3) | Bladder Carcinoma	MSI2 (5):	--2-- |  1367_BAY-HDAC11_4_GDSC1(2) |  1593_Entinostat_GDSC2(4) | Bladder Carcinoma	NADK (9):	--2-- |  225_Genentech Cpd 10_GDSC1(5) |  1553_Uprosertib_GDSC2(4) | Bladder Carcinoma	NCOA3 (7):	--3-- |  1019_Bosutinib_GDSC1(3) |  1578_Leflunomide_GDSC2(4) |  1873_Buparlisib_GDSC2(4) | Bladder Carcinoma	NRAS (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1038_NU7441_GDSC1(3) | Bladder Carcinoma	NRG1 (7):	--2-- |  1170_CCT-018159_GDSC1(6) |  1261_rTRAIL_GDSC1(4) | Bladder Carcinoma	NSD2 (5):	--2-- |  228_AKT inhibitor VIII_GDSC1(4) |  306_Fedratinib_GDSC1(4) | Bladder Carcinoma	NT5C2 (5):	--2-- |  1038_NU7441_GDSC1(3) |  1564_SCH772984_GDSC2(4) | Bladder Carcinoma	NTRK1 (5):	--2-- |  1038_NU7441_GDSC1(3) |  1713_ERK_2440_GDSC2(4) | Bladder Carcinoma	NTRK2 (2):	--1-- |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	NUF2 (2):	--1-- |  203_BMS-345541_GDSC1(2) | Bladder Carcinoma	NUP98 (3):	--1-- |  1005_Cisplatin_GDSC2(3) | Bladder Carcinoma	PAX8 (3):	--2-- |  203_BMS-345541_GDSC1(2) |  275_I-BET-762_GDSC1(2) | Bladder Carcinoma	PIK3CB (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Bladder Carcinoma	PLCG1 (4):	--2-- |  1261_rTRAIL_GDSC1(3) |  1259_Talazoparib_GDSC2(3) | Bladder Carcinoma	PLCG2 (6):	--2-- |  1219_PFI-1_GDSC1(5) |  1026_Tanespimycin_GDSC2(2) | Bladder Carcinoma	PRKCI (4):	--2-- |  1553_Uprosertib_GDSC2(3) |  1451_PLK_6522_GDSC1(2) | Bladder Carcinoma	RAF1 (1):	--1-- |  133_Doxorubicin_GDSC1(1) | Bladder Carcinoma	RET (6):	--1-- |  1820_123829_GDSC2(6) | Bladder Carcinoma	REV3L (2):	--1-- |  1069_EHT-1864_GDSC1(2) | Bladder Carcinoma	RHOA (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1128_FS106_GDSC1(2) | Bladder Carcinoma	ROS1 (7):	--2-- |  1038_NU7441_GDSC1(3) |  2109_AZ6102_GDSC2(5) | Bladder Carcinoma	RPTOR (5):	--2-- |  225_Genentech Cpd 10_GDSC1(4) |  1131_PRIMA-1MET_GDSC2(3) | Bladder Carcinoma	SCG5 (2):	--1-- |  1019_Bosutinib_GDSC1(2) | Bladder Carcinoma	SMYD3 (5):	--2-- |  372_Pilaralisib_GDSC1(3) |  1449_AZD1208_GDSC1(2) | Bladder Carcinoma	SOS1 (3):	--2-- |  190_Bleomycin_GDSC1(1) |  1631_PRT062607_GDSC2(2) | Bladder Carcinoma	SQSTM1 (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Bladder Carcinoma	STAT5B (4):	--2-- |  1052_RO-3306_GDSC1(3) |  1261_rTRAIL_GDSC1(3) | Bladder Carcinoma	SYK (5):	--2-- |  1001_AICA Ribonucleotide_GDSC1(4) |  1709_CDK9_5038_GDSC2(3) | Bladder Carcinoma	TERT (4):	--1-- |  1001_AICA Ribonucleotide_GDSC1(4) | Bladder Carcinoma	TFE3 (2):	--1-- |  1069_EHT-1864_GDSC1(2) | Bladder Carcinoma	TSHR (4):	--2-- |  474_ARRY-520_GDSC1(2) |  1709_CDK9_5038_GDSC2(3) | Bladder Carcinoma	TYK2 (2):	--1-- |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	UBR5 (7):	--2-- |  156_AZD6482_GDSC1(5) |  305_TPCA-1_GDSC1(5) | Bladder Carcinoma	USP8 (6):	--3-- |  172_Embelin_GDSC1(3) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(2) |  1827_Dihydrorotenone_GDSC2(3) | Bladder Carcinoma	VAV1 (5):	--3-- |  1038_NU7441_GDSC1(3) |  1367_BAY-HDAC11_4_GDSC1(2) |  1714_ERK_6604_GDSC2(3) | Bladder Carcinoma	WWP1 (4):	--2-- |  301_PHA-793887_GDSC1(3) |  372_Pilaralisib_GDSC1(3) | Bladder Carcinoma	WWTR1 (4):	--2-- |  203_BMS-345541_GDSC1(2) |  228_AKT inhibitor VIII_GDSC1(3) | Breast Carcinoma	ABL2 (21):	--3-- |  229_Enzastaurin_GDSC1(9) |  1184_AZ20_GDSC1(15) |  1377_Afatinib_GDSC1(12) | Breast Carcinoma	ACVR1 (12):	--2-- |  204_Tipifarnib_GDSC1(7) |  362_CI-1033_GDSC1(10) | Breast Carcinoma	ADHFE1 (8):	--3-- |  1070_CRT0105950_GDSC1(5) |  1494_SN-38_GDSC2(5) |  2109_AZ6102_GDSC2(5) | Breast Carcinoma	AFF4 (15):	--3-- |  1004_Vinblastine_GDSC1(10) |  1031_Elesclomol_GDSC1(8) |  1006_Cytarabine_GDSC2(5) | Breast Carcinoma	AGO1 (8):	--3-- |  1164_XMD8-92_GDSC1(2) |  1626_OTX015_GDSC2(5) |  2044_Pyridostatin_GDSC2(3) | Breast Carcinoma	AKT1 (5):	--2-- |  1164_XMD8-92_GDSC1(2) |  2111_VE821_GDSC2(3) | Breast Carcinoma	AKT2 (12):	--3-- |  446_MIM1_GDSC1(5) |  1032_Afatinib_GDSC1(6) |  2044_Pyridostatin_GDSC2(3) | Breast Carcinoma	AKT3 (17):	--3-- |  172_Embelin_GDSC1(9) |  179_5-Fluorouracil_GDSC1(9) |  257_NPK76-II-72-1_GDSC1(8) | Breast Carcinoma	ALK (22):	--3-- |  366_TWS119_GDSC1(18) |  573_LGK974_GDSC1(7) |  1196_FY069_GDSC1(7) | Breast Carcinoma	AR (4):	--2-- |  1584_BDOCA000347a_GDSC2(2) |  1845_Schweinfurthin A_GDSC2(3) | Breast Carcinoma	ARAF (2):	--1-- |  1096_Tozasertib_GDSC2(2) | Breast Carcinoma	ARHGEF28 (17):	--3-- |  260_NG-25_GDSC1(9) |  1048_Mirin_GDSC1(11) |  1932_NVP-ADW742_GDSC2(7) | Breast Carcinoma	ARID3B (3):	--1-- |  477_A-83-01_GDSC1(3) | Breast Carcinoma	ATXN7 (12):	--3-- |  178_BAY-61-3606_GDSC1(7) |  179_5-Fluorouracil_GDSC1(7) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	AURKA (6):	--2-- |  1464_TTK_3146_GDSC1(4) |  1050_ZM447439_GDSC2(5) | Breast Carcinoma	AXL (15):	--3-- |  1005_Cisplatin_GDSC1(6) |  1032_Afatinib_GDSC1(8) |  1128_FS106_GDSC1(8) | Breast Carcinoma	BAALC (11):	--4-- |  177_GSK650394_GDSC1(5) |  1129_PF-4708671_GDSC1(4) |  1458_PARP_9495_GDSC1(3) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	BCL6 (9):	--2-- |  1919_Osimertinib_GDSC2(5) |  1192_GSK269962A_GDSC2(5) | Breast Carcinoma	BCL9 (9):	--2-- |  151_QS11_GDSC1(5) |  1050_ZM447439_GDSC2(6) | Breast Carcinoma	BCR (21):	--2-- |  274_Belinostat_GDSC1(18) |  1066_AZD6482_GDSC1(12) | Breast Carcinoma	BRAF (17):	--3-- |  152_CP466722_GDSC1(10) |  576_RU-SKI 43_GDSC1(8) |  1011_Navitoclax_GDSC2(9) | Breast Carcinoma	BRD3 (8):	--2-- |  1873_Buparlisib_GDSC2(7) |  1932_NVP-ADW742_GDSC2(6) | Breast Carcinoma	BRD4 (17):	--2-- |  283_Omipalisib_GDSC1(14) |  2171_BMS-754807_GDSC2(9) | Breast Carcinoma	BTK (10):	--4-- |  221_TAK-715_GDSC1(3) |  285_SU11274_GDSC1(5) |  1561_Taselisib_GDSC2(5) |  2047_Ulixertinib_GDSC2(4) | Breast Carcinoma	CALR (6):	--2-- |  1050_ZM447439_GDSC2(5) |  2109_AZ6102_GDSC2(5) | Breast Carcinoma	CARD11 (17):	--4-- |  438_Panobinostat_GDSC1(12) |  1088_Irinotecan_GDSC2(5) |  1732_TAF1_5496_GDSC2(7) |  1778_GSK2110183B_GDSC2(7) | Breast Carcinoma	CCNB3 (4):	--2-- |  196_Phenformin_GDSC1(2) |  1559_Luminespib_GDSC2(2) | Breast Carcinoma	CCND1 (10):	--3-- |  552_BAM7_GDSC1(5) |  1458_PARP_9495_GDSC1(3) |  1003_Camptothecin_GDSC2(6) | Breast Carcinoma	CCND2 (7):	--2-- |  1453_RAF_9304_GDSC1(5) |  1833_741909_GDSC2(4) | Breast Carcinoma	CCND3 (14):	--3-- |  293_Amuvatinib_GDSC1(7) |  1031_Elesclomol_GDSC1(6) |  1560_Alpelisib_GDSC2(8) | Breast Carcinoma	CCNE1 (7):	--3-- |  1037_BX795_GDSC1(3) |  1083_Crizotinib_GDSC2(4) |  1259_Talazoparib_GDSC2(3) | Breast Carcinoma	CD274 (6):	--2-- |  272_AR-42_GDSC1(4) |  1070_CRT0105950_GDSC1(4) | Breast Carcinoma	CD28 (4):	--2-- |  1401_AZD5438_GDSC1(2) |  1168_Erlotinib_GDSC2(2) | Breast Carcinoma	CDK6 (9):	--2-- |  380_BIBF-1120_GDSC1(5) |  1453_RAF_9304_GDSC1(6) | Breast Carcinoma	CDK8 (5):	--3-- |  552_BAM7_GDSC1(3) |  1243_Piperlongumine_GDSC1(2) |  1133_Serdemetan_GDSC2(2) | Breast Carcinoma	COP1 (13):	--3-- |  1799_Ibrutinib_GDSC2(7) |  1432_AZD1480_GDSC1(7) |  2172_JQ1_GDSC2(8) | Breast Carcinoma	CREB1 (6):	--2-- |  230_GSK429286A_GDSC1(2) |  292_Masitinib_GDSC1(5) | Breast Carcinoma	CSF3R (10):	--2-- |  1180_Dinaciclib_GDSC2(8) |  2148_POMHEX_GDSC2(6) | Breast Carcinoma	CTLA4 (2):	--1-- |  1129_PF-4708671_GDSC1(2) | Breast Carcinoma	CTNNB1 (5):	--2-- |  238_Idelalisib_GDSC1(3) |  1014_Refametinib_GDSC1(4) | Breast Carcinoma	CYP19A1 (7):	--4-- |  1006_Cytarabine_GDSC2(3) |  1096_Tozasertib_GDSC2(3) |  1259_Talazoparib_GDSC2(3) |  1733_ULK1_4989_GDSC2(3) | Breast Carcinoma	DCUN1D1 (5):	--2-- |  1005_Cisplatin_GDSC1(4) |  1050_ZM447439_GDSC2(4) | Breast Carcinoma	DDR2 (10):	--2-- |  238_Idelalisib_GDSC1(5) |  2109_AZ6102_GDSC2(7) | Breast Carcinoma	DDX4 (12):	--2-- |  1032_Afatinib_GDSC1(7) |  2170_AT13148_GDSC2(6) | Breast Carcinoma	DEK (4):	--2-- |  238_Idelalisib_GDSC1(3) |  1557_LCL161_GDSC2(2) | Breast Carcinoma	DNMT1 (13):	--5-- |  238_Idelalisib_GDSC1(4) |  292_Masitinib_GDSC1(6) |  305_TPCA-1_GDSC1(7) |  1006_Cytarabine_GDSC2(4) |  1007_Docetaxel_GDSC2(8) | Breast Carcinoma	DOT1L (19):	--3-- |  301_PHA-793887_GDSC1(11) |  326_GSK690693_GDSC1(13) |  1059_AZD8055_GDSC1(10) | Breast Carcinoma	E2F3 (8):	--3-- |  1444_AZD8186_GDSC1(4) |  1050_ZM447439_GDSC2(5) |  1778_GSK2110183B_GDSC2(4) | Breast Carcinoma	EGFL7 (8):	--2-- |  275_I-BET-762_GDSC1(6) |  1932_NVP-ADW742_GDSC2(6) | Breast Carcinoma	EGFR (20):	--4-- |  293_Amuvatinib_GDSC1(10) |  1048_Mirin_GDSC1(13) |  1196_FY069_GDSC1(6) |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(9) | Breast Carcinoma	EIF4A2 (9):	--3-- |  176_IPA-3_GDSC1(6) |  1003_Camptothecin_GDSC2(5) |  1006_Cytarabine_GDSC2(4) | Breast Carcinoma	EIF4E (4):	--2-- |  274_Belinostat_GDSC1(3) |  1012_Vorinostat_GDSC1(2) | Breast Carcinoma	EPOR (9):	--3-- |  1005_Cisplatin_GDSC1(4) |  1037_BX795_GDSC1(4) |  1919_Osimertinib_GDSC2(5) | Breast Carcinoma	ERBB2 (12):	--2-- |  1377_Afatinib_GDSC1(9) |  1930_Telomerase Inhibitor IX_GDSC2(8) | Breast Carcinoma	ERBB3 (7):	--2-- |  1004_Vinblastine_GDSC1(6) |  1364_BAY-HDAC11_1_GDSC1(4) | Breast Carcinoma	ERBB4 (18):	--3-- |  1084_Rapamycin_GDSC2(8) |  1088_Irinotecan_GDSC2(6) |  1401_AZD5438_GDSC2(11) | Breast Carcinoma	ERG (11):	--3-- |  257_NPK76-II-72-1_GDSC1(7) |  1853_OF-1_GDSC2(6) |  2096_VX-11e_GDSC2(4) | Breast Carcinoma	ESR1 (10):	--3-- |  439_LCL161_GDSC1(4) |  1012_Vorinostat_GDSC1(6) |  1070_CRT0105950_GDSC1(5) | Breast Carcinoma	ETV1 (8):	--2-- |  1527_Pictilisib_GDSC1(5) |  1180_Dinaciclib_GDSC2(7) | Breast Carcinoma	EWSR1 (12):	--3-- |  1014_Refametinib_GDSC1(6) |  1180_Dinaciclib_GDSC2(9) |  1734_VSP34_8731_GDSC2(9) | Breast Carcinoma	EZH1 (12):	--3-- |  1032_Afatinib_GDSC1(7) |  1239_YK-4-279_GDSC1(5) |  1050_ZM447439_GDSC2(6) | Breast Carcinoma	FGF19 (4):	--2-- |  264_ACY-1215_GDSC1(3) |  272_AR-42_GDSC1(3) | Breast Carcinoma	FGF3 (3):	--2-- |  428_Pemetrexed_GDSC1(2) |  1062_Selumetinib_GDSC2(2) | Breast Carcinoma	FGFR1 (11):	--3-- |  1011_Navitoclax_GDSC1(5) |  1031_Elesclomol_GDSC1(6) |  1021_Axitinib_GDSC2(6) | Breast Carcinoma	FGFR2 (18):	--3-- |  167_OSU-03012_GDSC1(9) |  1242_(5Z)-7-Oxozeaenol_GDSC1(11) |  1549_Sapitinib_GDSC2(10) | Breast Carcinoma	FGFR3 (9):	--3-- |  291_KIN001-266_GDSC1(6) |  432_Flavopiridol_GDSC1(6) |  1414_Fulvestrant_GDSC1(3) | Breast Carcinoma	FGFR4 (8):	--2-- |  362_CI-1033_GDSC1(7) |  2169_AZD6482_GDSC2(5) | Breast Carcinoma	FLI1 (12):	--3-- |  172_Embelin_GDSC1(6) |  179_5-Fluorouracil_GDSC1(7) |  304_SB52334_GDSC1(5) | Breast Carcinoma	FLT1 (20):	--2-- |  180_Thapsigargin_GDSC1(15) |  1926_GNE-317_GDSC2(17) | Breast Carcinoma	FLT3 (10):	--2-- |  1011_Navitoclax_GDSC1(5) |  1401_AZD5438_GDSC1(8) | Breast Carcinoma	FLT4 (13):	--3-- |  222_BX-912_GDSC1(5) |  229_Enzastaurin_GDSC1(8) |  275_I-BET-762_GDSC1(8) | Breast Carcinoma	FURIN (11):	--3-- |  461_NSC319726_GDSC1(8) |  1192_GSK269962A_GDSC1(5) |  1496_Cisplatin_GDSC1(5) | Breast Carcinoma	FUS (7):	--3-- |  295_NVP-BHG712_GDSC1(2) |  1932_NVP-ADW742_GDSC2(4) |  2111_VE821_GDSC2(3) | Breast Carcinoma	FYN (8):	--3-- |  1026_Tanespimycin_GDSC1(4) |  1185_KU-60019_GDSC1(4) |  1196_FY069_GDSC1(4) | Breast Carcinoma	GAB1 (11):	--4-- |  1031_Elesclomol_GDSC1(6) |  1494_SN-38_GDSC2(5) |  1799_Ibrutinib_GDSC2(7) |  1932_NVP-ADW742_GDSC2(5) | Breast Carcinoma	GAB2 (13):	--3-- |  292_Masitinib_GDSC1(7) |  1007_Docetaxel_GDSC2(8) |  1088_Irinotecan_GDSC2(5) | Breast Carcinoma	GATA2 (2):	--1-- |  1526_Refametinib_GDSC1(2) | Breast Carcinoma	GLI1 (7):	--2-- |  171_AKT inhibitor VIII_GDSC1(4) |  362_CI-1033_GDSC1(5) | Breast Carcinoma	GNA11 (8):	--2-- |  269_NSC-207895_GDSC1(4) |  1004_Vinblastine_GDSC1(6) | Breast Carcinoma	GNA12 (7):	--2-- |  293_Amuvatinib_GDSC1(5) |  2109_AZ6102_GDSC2(5) | Breast Carcinoma	GNA13 (7):	--2-- |  1011_Navitoclax_GDSC1(4) |  2046_MK-8776_GDSC2(3) | Breast Carcinoma	GNAQ (2):	--1-- |  1873_Buparlisib_GDSC2(2) | Breast Carcinoma	GNAS (21):	--3-- |  326_GSK690693_GDSC1(12) |  1012_Vorinostat_GDSC1(13) |  1494_SN-38_GDSC1(12) | Breast Carcinoma	GSK3B (7):	--2-- |  1714_ERK_6604_GDSC2(3) |  2170_AT13148_GDSC2(5) | Breast Carcinoma	GTF2I (10):	--2-- |  461_NSC319726_GDSC1(6) |  1432_AZD1480_GDSC1(7) | Breast Carcinoma	HDAC1 (8):	--3-- |  1088_Irinotecan_GDSC2(4) |  1494_SN-38_GDSC2(5) |  1581_Bromosporine_GDSC2(2) | Breast Carcinoma	HDAC7 (8):	--3-- |  269_NSC-207895_GDSC1(4) |  1496_Cisplatin_GDSC1(4) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	HIF1A (6):	--2-- |  185_Linsitinib_GDSC1(2) |  304_SB52334_GDSC1(4) | Breast Carcinoma	HMGA2 (9):	--2-- |  222_BX-912_GDSC1(4) |  275_I-BET-762_GDSC1(7) | Breast Carcinoma	IDH1 (3):	--1-- |  1068_Obatoclax Mesylate_GDSC2(3) | Breast Carcinoma	IGF1R (17):	--3-- |  275_I-BET-762_GDSC1(9) |  1259_Talazoparib_GDSC1(8) |  1820_123829_GDSC2(7) | Breast Carcinoma	IGF2 (11):	--2-- |  1003_Camptothecin_GDSC2(6) |  275_I-BET-762_GDSC1(6) | Breast Carcinoma	IKBKE (5):	--2-- |  88_Entinostat_GDSC1(3) |  1359_965-D2_GDSC1(3) | Breast Carcinoma	IL6ST (10):	--4-- |  1037_BX795_GDSC1(5) |  1070_CRT0105950_GDSC1(6) |  1835_Elephantin_GDSC2(5) |  2169_AZD6482_GDSC2(5) | Breast Carcinoma	IL7R (7):	--2-- |  1039_SL0101_GDSC1(2) |  1050_ZM447439_GDSC2(6) | Breast Carcinoma	INSR (13):	--4-- |  265_Tubastatin A_GDSC1(3) |  1496_Cisplatin_GDSC1(5) |  1026_Tanespimycin_GDSC2(7) |  2096_VX-11e_GDSC2(5) | Breast Carcinoma	IRS1 (5):	--2-- |  304_SB52334_GDSC1(3) |  1739_JAK_8517_GDSC2(3) | Breast Carcinoma	JAK2 (19):	--4-- |  477_A-83-01_GDSC1(7) |  1005_Cisplatin_GDSC1(6) |  1401_AZD5438_GDSC1(15) |  1453_RAF_9304_GDSC1(9) | Breast Carcinoma	JAK3 (14):	--3-- |  165_DMOG_GDSC1(5) |  238_Idelalisib_GDSC1(5) |  1549_Sapitinib_GDSC2(8) | Breast Carcinoma	KDM5A (17):	--3-- |  293_Amuvatinib_GDSC1(8) |  1004_Vinblastine_GDSC1(11) |  1032_Afatinib_GDSC1(9) | Breast Carcinoma	KDR (10):	--2-- |  1032_Afatinib_GDSC1(7) |  1799_Ibrutinib_GDSC2(7) | Breast Carcinoma	KIT (12):	--3-- |  302_PI-103_GDSC1(7) |  428_Pemetrexed_GDSC1(4) |  1038_NU7441_GDSC2(7) | Breast Carcinoma	KLF5 (6):	--3-- |  197_Bryostatin 1_GDSC1(2) |  281_Alectinib_GDSC1(2) |  1088_Irinotecan_GDSC2(3) | Breast Carcinoma	KRAS (3):	--2-- |  281_Alectinib_GDSC1(2) |  1185_KU-60019_GDSC1(2) | Breast Carcinoma	KSR2 (9):	--2-- |  1496_Cisplatin_GDSC1(6) |  1613_VE-822_GDSC2(4) | Breast Carcinoma	LCK (7):	--2-- |  264_ACY-1215_GDSC1(6) |  1129_PF-4708671_GDSC1(3) | Breast Carcinoma	LGR5 (8):	--3-- |  306_Fedratinib_GDSC1(5) |  1011_Navitoclax_GDSC1(5) |  1778_GSK2110183B_GDSC2(5) | Breast Carcinoma	LMO2 (5):	--2-- |  1050_ZM447439_GDSC2(4) |  1932_NVP-ADW742_GDSC2(4) | Breast Carcinoma	LRP6 (13):	--3-- |  275_I-BET-762_GDSC1(6) |  1006_Cytarabine_GDSC2(4) |  1549_Sapitinib_GDSC2(8) | Breast Carcinoma	LTK (10):	--3-- |  330_XMD13-2_GDSC1(5) |  1833_741909_GDSC2(6) |  1845_Schweinfurthin A_GDSC2(4) | Breast Carcinoma	LYN (13):	--3-- |  179_5-Fluorouracil_GDSC1(8) |  1062_Selumetinib_GDSC1(3) |  1239_YK-4-279_GDSC1(7) | Breast Carcinoma	MAP2K1 (6):	--3-- |  1005_Cisplatin_GDSC1(3) |  1015_CI-1040_GDSC1(3) |  1133_Serdemetan_GDSC2(2) | Breast Carcinoma	MAP2K2 (7):	--2-- |  1732_TAF1_5496_GDSC2(5) |  1997_WEHI-539_GDSC2(5) | Breast Carcinoma	MAP3K13 (12):	--3-- |  177_GSK650394_GDSC1(7) |  203_BMS-345541_GDSC1(6) |  1932_NVP-ADW742_GDSC2(6) | Breast Carcinoma	MAP4K4 (13):	--3-- |  275_I-BET-762_GDSC1(8) |  1052_RO-3306_GDSC2(6) |  1734_VSP34_8731_GDSC2(10) | Breast Carcinoma	MAPK1 (8):	--2-- |  255_CP724714_GDSC1(4) |  1997_WEHI-539_GDSC2(5) | Breast Carcinoma	MAPK3 (4):	--2-- |  362_CI-1033_GDSC1(3) |  1733_ULK1_4989_GDSC2(3) | Breast Carcinoma	MDM2 (7):	--2-- |  172_Embelin_GDSC1(3) |  1444_AZD8186_GDSC1(4) | Breast Carcinoma	MDM4 (15):	--3-- |  165_DMOG_GDSC1(7) |  1364_BAY-HDAC11_1_GDSC1(10) |  1007_Docetaxel_GDSC2(11) | Breast Carcinoma	MECOM (20):	--3-- |  207_AS601245_GDSC1(13) |  221_TAK-715_GDSC1(4) |  1004_Vinblastine_GDSC1(16) | Breast Carcinoma	MEF2B (4):	--1-- |  1496_Cisplatin_GDSC1(4) | Breast Carcinoma	MEF2D (9):	--3-- |  269_NSC-207895_GDSC1(4) |  1006_Cytarabine_GDSC2(4) |  1007_Docetaxel_GDSC2(7) | Breast Carcinoma	MET (12):	--3-- |  1840_630600_GDSC2(5) |  1006_Cytarabine_GDSC2(4) |  293_Amuvatinib_GDSC1(7) | Breast Carcinoma	MGAM (32):	--3-- |  235_QL-XII-47_GDSC1(25) |  293_Amuvatinib_GDSC1(12) |  1021_Axitinib_GDSC2(11) | Breast Carcinoma	MKI67 (11):	--2-- |  1377_Afatinib_GDSC1(8) |  1549_Sapitinib_GDSC2(8) | Breast Carcinoma	MLLT10 (15):	--3-- |  432_Flavopiridol_GDSC1(11) |  1626_OTX015_GDSC2(8) |  1910_ABT737_GDSC2(10) | Breast Carcinoma	MLLT3 (10):	--2-- |  184_BMS-754807_GDSC1(8) |  1007_Docetaxel_GDSC2(7) | Breast Carcinoma	MPL (3):	--2-- |  238_Idelalisib_GDSC1(2) |  2010_HKMTI-1-005_GDSC2(2) | Breast Carcinoma	MSI1 (12):	--2-- |  275_I-BET-762_GDSC1(7) |  1873_Buparlisib_GDSC2(11) | Breast Carcinoma	MSI2 (19):	--4-- |  1847_BEN_GDSC2(6) |  293_Amuvatinib_GDSC1(8) |  1031_Elesclomol_GDSC1(11) |  1032_Afatinib_GDSC1(8) | Breast Carcinoma	MST1R (8):	--3-- |  439_LCL161_GDSC1(4) |  1062_Selumetinib_GDSC1(3) |  1932_NVP-ADW742_GDSC2(5) | Breast Carcinoma	MTOR (20):	--3-- |  167_OSU-03012_GDSC1(9) |  1058_Pictilisib_GDSC2(16) |  1720_AZD5991_GDSC2(11) | Breast Carcinoma	MYBL1 (10):	--3-- |  211_TL-2-105_GDSC1(3) |  1051_Alisertib_GDSC2(6) |  1613_VE-822_GDSC2(4) | Breast Carcinoma	MYC (3):	--2-- |  330_XMD13-2_GDSC1(2) |  1079_Dasatinib_GDSC2(2) | Breast Carcinoma	MYCN (2):	--1-- |  1047_Nutlin-3a (-)_GDSC2(2) | Breast Carcinoma	NADK (3):	--2-- |  344_THZ-2-49_GDSC1(2) |  1062_Selumetinib_GDSC1(2) | Breast Carcinoma	NCOA3 (8):	--2-- |  293_Amuvatinib_GDSC1(7) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	NCSTN (9):	--3-- |  184_BMS-754807_GDSC1(6) |  1070_CRT0105950_GDSC1(5) |  1432_AZD1480_GDSC1(6) | Breast Carcinoma	NFE2L2 (5):	--2-- |  1581_Bromosporine_GDSC2(2) |  2111_VE821_GDSC2(3) | Breast Carcinoma	NR4A3 (7):	--2-- |  285_SU11274_GDSC1(5) |  1083_Crizotinib_GDSC2(4) | Breast Carcinoma	NRAS (3):	--1-- |  1873_Buparlisib_GDSC2(3) | Breast Carcinoma	NRG1 (12):	--3-- |  203_BMS-345541_GDSC1(6) |  1038_NU7441_GDSC2(7) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	NSD2 (15):	--3-- |  1031_Elesclomol_GDSC1(10) |  1778_GSK2110183B_GDSC2(7) |  1932_NVP-ADW742_GDSC2(7) | Breast Carcinoma	NT5C2 (7):	--2-- |  283_Omipalisib_GDSC1(5) |  1054_Palbociclib_GDSC1(4) | Breast Carcinoma	NTRK1 (14):	--3-- |  261_TL-1-85_GDSC1(4) |  1453_RAF_9304_GDSC1(7) |  1778_GSK2110183B_GDSC2(7) | Breast Carcinoma	NTRK2 (15):	--4-- |  151_QS11_GDSC1(6) |  203_BMS-345541_GDSC1(7) |  1015_CI-1040_GDSC1(6) |  1631_PRT062607_GDSC2(4) | Breast Carcinoma	NTRK3 (24):	--4-- |  176_IPA-3_GDSC1(12) |  207_AS601245_GDSC1(14) |  304_SB52334_GDSC1(7) |  1732_TAF1_5496_GDSC2(10) | Breast Carcinoma	NUF2 (7):	--2-- |  1009_Tretinoin_GDSC1(3) |  1402_AZD7762_GDSC1(4) | Breast Carcinoma	NUP214 (14):	--3-- |  134_Etoposide_GDSC1(6) |  1004_Vinblastine_GDSC1(11) |  1184_AZ20_GDSC1(11) | Breast Carcinoma	NUP98 (13):	--3-- |  1059_AZD8055_GDSC1(8) |  1050_ZM447439_GDSC2(7) |  2096_VX-11e_GDSC2(4) | Breast Carcinoma	PAK1 (11):	--2-- |  344_THZ-2-49_GDSC1(8) |  1219_PFI-1_GDSC1(5) | Breast Carcinoma	PAK5 (6):	--2-- |  342_Tenovin-6_GDSC1(4) |  1853_OF-1_GDSC2(4) | Breast Carcinoma	PDCD1LG2 (8):	--3-- |  1011_Navitoclax_GDSC1(5) |  1494_SN-38_GDSC2(4) |  2111_VE821_GDSC2(3) | Breast Carcinoma	PDGFRA (16):	--3-- |  223_ZSTK474_GDSC1(10) |  1054_Palbociclib_GDSC1(6) |  1192_GSK269962A_GDSC1(6) | Breast Carcinoma	PDGFRB (10):	--2-- |  293_Amuvatinib_GDSC1(7) |  1133_Serdemetan_GDSC1(5) | Breast Carcinoma	PGR (6):	--3-- |  199_Pazopanib_GDSC1(4) |  1129_PF-4708671_GDSC1(3) |  1622_Wnt-C59_GDSC2(2) | Breast Carcinoma	PIK3CA (27):	--3-- |  156_AZD6482_GDSC1(17) |  415_CPI-613_GDSC1(18) |  1445_AZD8835_GDSC1(16) | Breast Carcinoma	PIK3CB (7):	--3-- |  265_Tubastatin A_GDSC1(3) |  1149_TW 37_GDSC2(3) |  1819_Docetaxel_GDSC2(5) | Breast Carcinoma	PIK3CD (14):	--3-- |  293_Amuvatinib_GDSC1(7) |  301_PHA-793887_GDSC1(9) |  1007_Docetaxel_GDSC2(8) | Breast Carcinoma	PIK3CG (14):	--3-- |  152_CP466722_GDSC1(8) |  293_Amuvatinib_GDSC1(7) |  1778_GSK2110183B_GDSC2(7) | Breast Carcinoma	PLCG1 (12):	--4-- |  179_5-Fluorouracil_GDSC1(7) |  1732_TAF1_5496_GDSC2(5) |  1021_Axitinib_GDSC2(7) |  255_CP724714_GDSC1(5) | Breast Carcinoma	PLCG2 (17):	--3-- |  176_IPA-3_GDSC1(11) |  203_BMS-345541_GDSC1(9) |  1008_Methotrexate_GDSC2(12) | Breast Carcinoma	PPARG (6):	--2-- |  1004_Vinblastine_GDSC1(5) |  1011_Navitoclax_GDSC1(4) | Breast Carcinoma	PPM1D (11):	--4-- |  176_IPA-3_GDSC1(6) |  221_TAK-715_GDSC1(4) |  1006_Cytarabine_GDSC2(4) |  1626_OTX015_GDSC2(6) | Breast Carcinoma	PRKACA (14):	--3-- |  1014_Refametinib_GDSC1(7) |  1932_NVP-ADW742_GDSC2(6) |  1847_BEN_GDSC2(6) | Breast Carcinoma	PRKCI (11):	--2-- |  1031_Elesclomol_GDSC1(7) |  1453_RAF_9304_GDSC1(7) | Breast Carcinoma	PSMB2 (2):	--1-- |  330_XMD13-2_GDSC1(2) | Breast Carcinoma	PTPN11 (5):	--2-- |  199_Pazopanib_GDSC1(3) |  2044_Pyridostatin_GDSC2(2) | Breast Carcinoma	RAC1 (5):	--2-- |  1005_Cisplatin_GDSC1(4) |  2111_VE821_GDSC2(3) | Breast Carcinoma	RAC2 (8):	--2-- |  1873_Buparlisib_GDSC2(7) |  1932_NVP-ADW742_GDSC2(6) | Breast Carcinoma	RAF1 (6):	--2-- |  1129_PF-4708671_GDSC1(3) |  1006_Cytarabine_GDSC2(4) | Breast Carcinoma	REL (6):	--3-- |  552_BAM7_GDSC1(3) |  1039_SL0101_GDSC1(2) |  1510_Linsitinib_GDSC2(2) | Breast Carcinoma	RET (11):	--3-- |  177_GSK650394_GDSC1(5) |  303_PIK-93_GDSC1(5) |  1079_Dasatinib_GDSC2(4) | Breast Carcinoma	REV3L (20):	--5-- |  275_I-BET-762_GDSC1(8) |  1032_Afatinib_GDSC1(8) |  1451_PLK_6522_GDSC1(8) |  1084_Rapamycin_GDSC2(7) |  1720_AZD5991_GDSC2(11) | Breast Carcinoma	RHEB (4):	--1-- |  1050_ZM447439_GDSC2(4) | Breast Carcinoma	RHOA (5):	--2-- |  219_AT-7519_GDSC1(2) |  376_Brivanib, BMS-540215_GDSC1(3) | Breast Carcinoma	RICTOR (18):	--4-- |  273_CUDC-101_GDSC1(14) |  304_SB52334_GDSC1(7) |  1026_Tanespimycin_GDSC1(10) |  1050_ZM447439_GDSC2(8) | Breast Carcinoma	RNASEH2A (5):	--2-- |  1495_Olaparib_GDSC1(2) |  2096_VX-11e_GDSC2(4) | Breast Carcinoma	ROS1 (17):	--4-- |  1732_TAF1_5496_GDSC2(9) |  1720_AZD5991_GDSC2(12) |  1819_Docetaxel_GDSC2(10) |  2057_Remodelin_GDSC2(5) | Breast Carcinoma	RPTOR (16):	--2-- |  159_HG6-64-1_GDSC1(13) |  1496_Cisplatin_GDSC1(6) | Breast Carcinoma	RRAGC (5):	--3-- |  1005_Cisplatin_GDSC1(3) |  1083_Crizotinib_GDSC2(3) |  1088_Irinotecan_GDSC2(3) | Breast Carcinoma	RRAS (3):	--2-- |  1496_Cisplatin_GDSC1(2) |  1005_Cisplatin_GDSC2(2) | Breast Carcinoma	RRAS2 (3):	--2-- |  1050_ZM447439_GDSC1(2) |  2111_VE821_GDSC2(2) | Breast Carcinoma	RUNX1T1 (14):	--4-- |  153_Midostaurin_GDSC1(6) |  304_SB52334_GDSC1(5) |  1186_FS112_GDSC1(6) |  1187_CCT245232_GDSC1(6) | Breast Carcinoma	SETBP1 (10):	--3-- |  173_FH535_GDSC1(8) |  1458_PARP_9495_GDSC1(3) |  1932_NVP-ADW742_GDSC2(5) | Breast Carcinoma	SETD1A (8):	--3-- |  211_TL-2-105_GDSC1(3) |  304_SB52334_GDSC1(4) |  1429_IAP_7638_GDSC1(4) | Breast Carcinoma	SF3B1 (15):	--3-- |  446_MIM1_GDSC1(7) |  1004_Vinblastine_GDSC1(11) |  1416_AZD8931_GDSC1(10) | Breast Carcinoma	SGK1 (12):	--3-- |  178_BAY-61-3606_GDSC1(7) |  1026_Tanespimycin_GDSC1(5) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	SMO (7):	--2-- |  344_THZ-2-49_GDSC1(3) |  1873_Buparlisib_GDSC2(5) | Breast Carcinoma	SMYD3 (17):	--3-- |  199_Pazopanib_GDSC1(6) |  1007_Docetaxel_GDSC2(10) |  1088_Irinotecan_GDSC2(5) | Breast Carcinoma	SOS1 (11):	--3-- |  1070_CRT0105950_GDSC1(7) |  1188_CCT245467_GDSC1(4) |  1219_PFI-1_GDSC1(6) | Breast Carcinoma	SQSTM1 (10):	--2-- |  204_Tipifarnib_GDSC1(6) |  1926_GNE-317_GDSC2(7) | Breast Carcinoma	SRC (13):	--2-- |  1005_Cisplatin_GDSC1(5) |  1911_Dactinomycin_GDSC2(12) | Breast Carcinoma	SS18 (8):	--3-- |  172_Embelin_GDSC1(4) |  1164_XMD8-92_GDSC1(2) |  1184_AZ20_GDSC1(6) | Breast Carcinoma	STAT3 (9):	--3-- |  446_MIM1_GDSC1(5) |  1164_XMD8-92_GDSC1(2) |  2044_Pyridostatin_GDSC2(3) | Breast Carcinoma	STAT5B (9):	--2-- |  1050_ZM447439_GDSC2(6) |  1919_Osimertinib_GDSC2(5) | Breast Carcinoma	SYK (11):	--5-- |  203_BMS-345541_GDSC1(5) |  576_RU-SKI 43_GDSC1(5) |  1196_FY069_GDSC1(4) |  1425_BPTES_GDSC1(3) |  1088_Irinotecan_GDSC2(4) | Breast Carcinoma	TCL1A (5):	--2-- |  1003_Camptothecin_GDSC2(4) |  2046_MK-8776_GDSC2(3) | Breast Carcinoma	TCL1B (3):	--2-- |  1079_Dasatinib_GDSC2(2) |  1613_VE-822_GDSC2(2) | Breast Carcinoma	TERT (15):	--3-- |  563_Kobe2602_GDSC1(5) |  1026_Tanespimycin_GDSC1(8) |  1809_Teniposide_GDSC2(8) | Breast Carcinoma	TFE3 (7):	--2-- |  255_CP724714_GDSC1(4) |  1191_Bortezomib_GDSC2(4) | Breast Carcinoma	TRIM27 (8):	--3-- |  177_GSK650394_GDSC1(4) |  219_AT-7519_GDSC1(4) |  477_A-83-01_GDSC1(4) | Breast Carcinoma	TSHR (13):	--2-- |  1131_PRIMA-1MET_GDSC2(9) |  1924_Ipatasertib_GDSC2(11) | Breast Carcinoma	TYK2 (14):	--3-- |  235_QL-XII-47_GDSC1(9) |  293_Amuvatinib_GDSC1(7) |  1050_ZM447439_GDSC2(7) | Breast Carcinoma	UBR5 (18):	--3-- |  165_DMOG_GDSC1(8) |  255_CP724714_GDSC1(8) |  326_GSK690693_GDSC1(13) | Breast Carcinoma	USP8 (16):	--3-- |  151_QS11_GDSC1(6) |  1022_AZD7762_GDSC1(10) |  300_CX-5461_GDSC1(5) | Breast Carcinoma	VAV1 (17):	--4-- |  134_Etoposide_GDSC1(8) |  1239_YK-4-279_GDSC1(8) |  1243_Piperlongumine_GDSC1(13) |  1180_Dinaciclib_GDSC2(12) | Breast Carcinoma	VAV2 (20):	--3-- |  1048_Mirin_GDSC2(12) |  1529_Pevonedistat_GDSC2(17) |  2109_AZ6102_GDSC2(10) | Breast Carcinoma	WWP1 (11):	--4-- |  1133_Serdemetan_GDSC1(5) |  1170_CCT-018159_GDSC1(5) |  1014_Refametinib_GDSC2(5) |  1845_Schweinfurthin A_GDSC2(4) | Breast Carcinoma	WWTR1 (8):	--2-- |  1496_Cisplatin_GDSC1(4) |  1778_GSK2110183B_GDSC2(6) | Breast Carcinoma	XBP1 (3):	--1-- |  362_CI-1033_GDSC1(3) | Breast Carcinoma	XIAP (10):	--4-- |  238_Idelalisib_GDSC1(4) |  260_NG-25_GDSC1(6) |  265_Tubastatin A_GDSC1(3) |  1581_Bromosporine_GDSC2(2) | Breast Carcinoma	XPO1 (15):	--5-- |  147_NSC-87877_GDSC1(3) |  1799_Ibrutinib_GDSC2(7) |  1088_Irinotecan_GDSC2(6) |  265_Tubastatin A_GDSC1(3) |  2109_AZ6102_GDSC2(8) | Breast Carcinoma	YAP1 (6):	--2-- |  1083_Crizotinib_GDSC2(4) |  1845_Schweinfurthin A_GDSC2(3) | Breast Carcinoma	YES1 (5):	--2-- |  330_XMD13-2_GDSC1(4) |  435_C-75_GDSC1(4) | Burkitt's Lymphoma	ABL2 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	ACVR1 (4):	--1-- |  1463_AZD1332_GDSC1(4) | Burkitt's Lymphoma	AFF4 (3):	--1-- |  1434_JAK3_7406_GDSC1(3) | Burkitt's Lymphoma	ALK (4):	--1-- |  1463_AZD1332_GDSC1(4) | Burkitt's Lymphoma	ATXN7 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	BRAF (1):	--1-- |  11_Paclitaxel_GDSC1(1) | Burkitt's Lymphoma	BRD3 (4):	--4-- |  11_Paclitaxel_GDSC1(1) |  45_Z-LLNle-CHO_GDSC1(1) |  294_MPS-1-IN-1_GDSC1(1) |  366_TWS119_GDSC1(1) | Burkitt's Lymphoma	CARD11 (5):	--5-- |  111_Salubrinal_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  1001_AICA Ribonucleotide_GDSC1(1) |  1187_CCT245232_GDSC1(1) |  1720_AZD5991_GDSC2(1) | Burkitt's Lymphoma	CDK8 (5):	--5-- |  111_Salubrinal_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  1001_AICA Ribonucleotide_GDSC1(1) |  1187_CCT245232_GDSC1(1) |  1720_AZD5991_GDSC2(1) | Burkitt's Lymphoma	CSF3R (5):	--1-- |  1561_Taselisib_GDSC2(5) | Burkitt's Lymphoma	EGFL7 (1):	--1-- |  366_TWS119_GDSC1(1) | Burkitt's Lymphoma	EGFR (4):	--4-- |  153_Midostaurin_GDSC1(1) |  1581_Bromosporine_GDSC2(1) |  1847_BEN_GDSC2(1) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(1) | Burkitt's Lymphoma	ERBB4 (3):	--3-- |  153_Midostaurin_GDSC1(1) |  576_RU-SKI 43_GDSC1(1) |  1136_Capivasertib_GDSC1(1) | Burkitt's Lymphoma	EWSR1 (4):	--4-- |  153_Midostaurin_GDSC1(1) |  1581_Bromosporine_GDSC2(1) |  1847_BEN_GDSC2(1) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(1) | Burkitt's Lymphoma	FGFR4 (1):	--1-- |  11_Paclitaxel_GDSC1(1) | Burkitt's Lymphoma	FLT3 (2):	--2-- |  60_BI-2536_GDSC1(1) |  1187_CCT245232_GDSC1(1) | Burkitt's Lymphoma	FLT4 (4):	--4-- |  153_Midostaurin_GDSC1(1) |  1581_Bromosporine_GDSC2(1) |  1847_BEN_GDSC2(1) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(1) | Burkitt's Lymphoma	FYN (2):	--2-- |  207_AS601245_GDSC1(1) |  1553_Uprosertib_GDSC2(1) | Burkitt's Lymphoma	GAB1 (4):	--4-- |  11_Paclitaxel_GDSC1(1) |  45_Z-LLNle-CHO_GDSC1(1) |  294_MPS-1-IN-1_GDSC1(1) |  366_TWS119_GDSC1(1) | Burkitt's Lymphoma	GNA13 (1):	--1-- |  207_AS601245_GDSC1(1) | Burkitt's Lymphoma	GNAS (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	HGF (2):	--2-- |  249_Cabozantinib_GDSC1(1) |  1847_BEN_GDSC2(1) | Burkitt's Lymphoma	HMGA2 (5):	--2-- |  1019_Bosutinib_GDSC2(4) |  1026_Tanespimycin_GDSC2(4) | Burkitt's Lymphoma	IGF2 (2):	--2-- |  60_BI-2536_GDSC1(1) |  1187_CCT245232_GDSC1(1) | Burkitt's Lymphoma	IL6ST (4):	--4-- |  207_AS601245_GDSC1(1) |  366_TWS119_GDSC1(1) |  1135_AZD4547_GDSC1(1) |  1939_UMI-77_GDSC2(1) | Burkitt's Lymphoma	INSR (1):	--1-- |  366_TWS119_GDSC1(1) | Burkitt's Lymphoma	JAK2 (1):	--1-- |  111_Salubrinal_GDSC1(1) | Burkitt's Lymphoma	KDM5A (2):	--2-- |  1053_MK-2206_GDSC2(1) |  1553_Uprosertib_GDSC2(1) | Burkitt's Lymphoma	KDR (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	KIT (2):	--2-- |  294_MPS-1-IN-1_GDSC1(1) |  1553_Uprosertib_GDSC2(1) | Burkitt's Lymphoma	KSR2 (4):	--4-- |  153_Midostaurin_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  300_CX-5461_GDSC1(1) |  1910_ABT737_GDSC2(1) | Burkitt's Lymphoma	LMO2 (3):	--1-- |  1908_Ulixertinib_GDSC2(3) | Burkitt's Lymphoma	LRP6 (1):	--1-- |  11_Paclitaxel_GDSC1(1) | Burkitt's Lymphoma	MAP3K13 (1):	--1-- |  1001_AICA Ribonucleotide_GDSC1(1) | Burkitt's Lymphoma	MAP4K4 (4):	--2-- |  439_LCL161_GDSC1(3) |  1434_JAK3_7406_GDSC1(3) | Burkitt's Lymphoma	MDM4 (4):	--2-- |  151_QS11_GDSC1(3) |  439_LCL161_GDSC1(3) | Burkitt's Lymphoma	MLLT10 (5):	--2-- |  1259_Talazoparib_GDSC1(4) |  1494_SN-38_GDSC2(4) | Burkitt's Lymphoma	MSI2 (2):	--2-- |  175_PAC-1_GDSC1(1) |  1080_Paclitaxel_GDSC2(1) | Burkitt's Lymphoma	NTRK1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	NUP98 (4):	--1-- |  1463_AZD1332_GDSC1(4) | Burkitt's Lymphoma	PDGFRB (5):	--1-- |  1561_Taselisib_GDSC2(5) | Burkitt's Lymphoma	PLCG2 (1):	--1-- |  249_Cabozantinib_GDSC1(1) | Burkitt's Lymphoma	PPM1D (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	PRKACA (4):	--1-- |  1463_AZD1332_GDSC1(4) | Burkitt's Lymphoma	RPTOR (5):	--5-- |  111_Salubrinal_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  1001_AICA Ribonucleotide_GDSC1(1) |  1187_CCT245232_GDSC1(1) |  1720_AZD5991_GDSC2(1) | Burkitt's Lymphoma	RUNX1T1 (2):	--2-- |  269_NSC-207895_GDSC1(1) |  294_MPS-1-IN-1_GDSC1(1) | Burkitt's Lymphoma	SETBP1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	SETD1A (4):	--4-- |  207_AS601245_GDSC1(1) |  366_TWS119_GDSC1(1) |  1135_AZD4547_GDSC1(1) |  1939_UMI-77_GDSC2(1) | Burkitt's Lymphoma	SGK1 (3):	--1-- |  1908_Ulixertinib_GDSC2(3) | Burkitt's Lymphoma	SOS1 (4):	--1-- |  1463_AZD1332_GDSC1(4) | Burkitt's Lymphoma	SS18 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	STAT3 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	TRIM27 (1):	--1-- |  380_BIBF-1120_GDSC1(1) | Burkitt's Lymphoma	TYK2 (2):	--2-- |  1713_ERK_2440_GDSC2(1) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(1) | Burkitt's Lymphoma	UBR5 (2):	--2-- |  1005_Cisplatin_GDSC2(1) |  1847_BEN_GDSC2(1) | Burkitt's Lymphoma	VAV1 (1):	--1-- |  300_CX-5461_GDSC1(1) | Burkitt's Lymphoma	XPO1 (1):	--1-- |  1136_Capivasertib_GDSC1(1) | Cervical Carcinoma	AFF4 (5):	--2-- |  1026_Tanespimycin_GDSC2(1) |  1732_TAF1_5496_GDSC2(4) | Cervical Carcinoma	ARID3B (2):	--1-- |  260_NG-25_GDSC1(2) | Cervical Carcinoma	ATF1 (2):	--1-- |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	BCR (3):	--2-- |  1372_Trametinib_GDSC1(1) |  1453_RAF_9304_GDSC1(2) | Cervical Carcinoma	BRAF (3):	--1-- |  446_MIM1_GDSC1(3) | Cervical Carcinoma	CD28 (3):	--2-- |  176_IPA-3_GDSC1(2) |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	COP1 (3):	--2-- |  1070_CRT0105950_GDSC1(2) |  1014_Refametinib_GDSC2(2) | Cervical Carcinoma	FGFR2 (4):	--2-- |  178_BAY-61-3606_GDSC1(3) |  2156_5-azacytidine_GDSC2(3) | Cervical Carcinoma	FLT1 (3):	--1-- |  1085_Sorafenib_GDSC2(3) | Cervical Carcinoma	GAB2 (3):	--2-- |  1070_CRT0105950_GDSC1(2) |  1014_Refametinib_GDSC2(2) | Cervical Carcinoma	IDH2 (3):	--1-- |  1032_Afatinib_GDSC1(3) | Cervical Carcinoma	KDM5A (2):	--1-- |  1014_Refametinib_GDSC2(2) | Cervical Carcinoma	LYN (5):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1079_Dasatinib_GDSC2(4) | Cervical Carcinoma	MAP2K2 (3):	--2-- |  186_Bexarotene_GDSC1(2) |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	MAP4K4 (5):	--2-- |  1079_Dasatinib_GDSC2(4) |  1088_Irinotecan_GDSC2(4) | Cervical Carcinoma	MET (7):	--2-- |  1196_FY069_GDSC1(5) |  1046_Wee1 Inhibitor_GDSC2(5) | Cervical Carcinoma	MGAM (6):	--2-- |  293_Amuvatinib_GDSC1(4) |  1732_TAF1_5496_GDSC2(4) | Cervical Carcinoma	MKI67 (5):	--2-- |  177_GSK650394_GDSC1(4) |  1046_Wee1 Inhibitor_GDSC2(4) | Cervical Carcinoma	MLLT3 (2):	--1-- |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	MSI2 (4):	--1-- |  1046_Wee1 Inhibitor_GDSC2(4) | Cervical Carcinoma	MTOR (5):	--2-- |  301_PHA-793887_GDSC1(3) |  1170_CCT-018159_GDSC1(4) | Cervical Carcinoma	NT5C2 (1):	--1-- |  276_CAY10603_GDSC1(1) | Cervical Carcinoma	NTRK1 (2):	--1-- |  1131_PRIMA-1MET_GDSC2(2) | Cervical Carcinoma	NUF2 (3):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  176_IPA-3_GDSC1(2) | Cervical Carcinoma	NUP214 (5):	--2-- |  1014_Refametinib_GDSC1(4) |  1498_Selumetinib_GDSC1(4) | Cervical Carcinoma	NUP98 (2):	--1-- |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	PAK1 (3):	--2-- |  260_NG-25_GDSC1(2) |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	PDCD1LG2 (3):	--2-- |  153_Midostaurin_GDSC1(2) |  186_Bexarotene_GDSC1(2) | Cervical Carcinoma	PDGFRA (2):	--2-- |  1026_Tanespimycin_GDSC2(1) |  1809_Teniposide_GDSC2(1) | Cervical Carcinoma	PIK3CA (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1053_MK-2206_GDSC2(3) | Cervical Carcinoma	PIK3CB (4):	--1-- |  1196_FY069_GDSC1(4) | Cervical Carcinoma	PIK3CD (2):	--2-- |  1559_Luminespib_GDSC2(1) |  1809_Teniposide_GDSC2(1) | Cervical Carcinoma	REV3L (2):	--1-- |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	RPS6KA4 (2):	--1-- |  260_NG-25_GDSC1(2) | Cervical Carcinoma	RPTOR (5):	--1-- |  1079_Dasatinib_GDSC2(5) | Cervical Carcinoma	SGK1 (5):	--2-- |  152_CP466722_GDSC1(4) |  1713_ERK_2440_GDSC2(3) | Cervical Carcinoma	TSHR (1):	--1-- |  252_WZ3105_GDSC1(1) | Cervical Carcinoma	WWP1 (3):	--2-- |  1070_CRT0105950_GDSC1(2) |  1014_Refametinib_GDSC2(2) | Cervical Carcinoma	XPO1 (1):	--1-- |  407_kb NB 142-70_GDSC1(1) | Chronic Myelogenous Leukemia	BCR (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Chronic Myelogenous Leukemia	CCNB3 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Chronic Myelogenous Leukemia	CSF3R (3):	--1-- |  106_XMD8-85_GDSC1(3) | Chronic Myelogenous Leukemia	GNAS (2):	--2-- |  1038_NU7441_GDSC2(1) |  2046_MK-8776_GDSC2(1) | Chronic Myelogenous Leukemia	JAK3 (3):	--1-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) | Chronic Myelogenous Leukemia	RUNX1T1 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1185_KU-60019_GDSC1(3) | Chronic Myelogenous Leukemia	SETBP1 (2):	--2-- |  1037_BX795_GDSC1(1) |  1526_Refametinib_GDSC1(1) | Chronic Myelogenous Leukemia	USP8 (4):	--2-- |  106_XMD8-85_GDSC1(3) |  1016_Temsirolimus_GDSC2(3) | Chronic Myelogenous Leukemia	WWP1 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Colorectal Carcinoma	ABL1 (19):	--3-- |  1834_743380_GDSC2(5) |  1046_Wee1 Inhibitor_GDSC2(12) |  208_Ispinesib Mesylate_GDSC1(12) | Colorectal Carcinoma	ABL2 (17):	--4-- |  133_Doxorubicin_GDSC1(5) |  300_CX-5461_GDSC1(8) |  1372_Trametinib_GDSC2(12) |  1558_Lapatinib_GDSC2(9) | Colorectal Carcinoma	ACVR1 (20):	--3-- |  1062_Selumetinib_GDSC2(7) |  228_AKT inhibitor VIII_GDSC1(11) |  1060_PD0325901_GDSC1(13) | Colorectal Carcinoma	ADHFE1 (14):	--2-- |  133_Doxorubicin_GDSC1(6) |  1142_HG-5-113-01_GDSC1(11) | Colorectal Carcinoma	AFF4 (21):	--4-- |  1131_PRIMA-1MET_GDSC2(6) |  1114_Cetuximab_GDSC1(5) |  208_Ispinesib Mesylate_GDSC1(13) |  1866_BDP-00009066_GDSC2(12) | Colorectal Carcinoma	AGO1 (11):	--3-- |  1014_Refametinib_GDSC2(7) |  1809_Teniposide_GDSC2(7) |  1919_Osimertinib_GDSC2(5) | Colorectal Carcinoma	AKT1 (8):	--2-- |  437_Trichostatin A_GDSC1(6) |  1835_Elephantin_GDSC2(5) | Colorectal Carcinoma	AKT2 (13):	--2-- |  1372_Trametinib_GDSC2(11) |  1916_AZD5363_GDSC2(9) | Colorectal Carcinoma	AKT3 (19):	--3-- |  182_Obatoclax Mesylate_GDSC1(12) |  300_CX-5461_GDSC1(9) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	ALK (27):	--3-- |  407_kb NB 142-70_GDSC1(15) |  1916_AZD5363_GDSC2(14) |  1922_Cediranib_GDSC2(16) | Colorectal Carcinoma	AR (15):	--3-- |  1032_Afatinib_GDSC1(6) |  1048_Mirin_GDSC2(11) |  1564_SCH772984_GDSC2(9) | Colorectal Carcinoma	ARHGEF28 (19):	--3-- |  1820_123829_GDSC2(14) |  1441_AZD2014_GDSC2(12) |  415_CPI-613_GDSC1(13) | Colorectal Carcinoma	ARID3B (9):	--2-- |  1372_Trametinib_GDSC2(8) |  1834_743380_GDSC2(4) | Colorectal Carcinoma	ATF1 (10):	--3-- |  326_GSK690693_GDSC1(4) |  1133_Serdemetan_GDSC1(3) |  1372_Trametinib_GDSC2(6) | Colorectal Carcinoma	ATXN7 (14):	--3-- |  356_AT7867_GDSC1(7) |  1048_Mirin_GDSC1(5) |  1048_Mirin_GDSC2(11) | Colorectal Carcinoma	AURKA (12):	--2-- |  157_JNK-9L_GDSC1(8) |  2040_Foretinib_GDSC2(9) | Colorectal Carcinoma	AURKB (9):	--2-- |  437_Trichostatin A_GDSC1(7) |  1558_Lapatinib_GDSC2(5) | Colorectal Carcinoma	AXL (23):	--3-- |  1091_BMS-536924_GDSC2(15) |  1048_Mirin_GDSC2(13) |  208_Ispinesib Mesylate_GDSC1(15) | Colorectal Carcinoma	BAALC (13):	--4-- |  153_Midostaurin_GDSC1(5) |  252_WZ3105_GDSC1(6) |  1060_PD0325901_GDSC2(7) |  1578_Leflunomide_GDSC2(5) | Colorectal Carcinoma	BCL2 (7):	--3-- |  288_WHI-P97_GDSC1(2) |  576_RU-SKI 43_GDSC1(2) |  1068_Obatoclax Mesylate_GDSC2(5) | Colorectal Carcinoma	BCL3 (7):	--3-- |  308_Foretinib_GDSC1(3) |  576_RU-SKI 43_GDSC1(2) |  1068_Obatoclax Mesylate_GDSC2(5) | Colorectal Carcinoma	BCL6 (10):	--2-- |  272_AR-42_GDSC1(8) |  1242_(5Z)-7-Oxozeaenol_GDSC1(6) | Colorectal Carcinoma	BCL9 (17):	--3-- |  1820_123829_GDSC2(11) |  1558_Lapatinib_GDSC2(8) |  303_PIK-93_GDSC1(10) | Colorectal Carcinoma	BCR (20):	--4-- |  153_Midostaurin_GDSC1(6) |  1613_VE-822_GDSC2(4) |  1085_Sorafenib_GDSC2(11) |  208_Ispinesib Mesylate_GDSC1(14) | Colorectal Carcinoma	BRAF (28):	--4-- |  366_TWS119_GDSC1(15) |  428_Pemetrexed_GDSC1(15) |  1006_Cytarabine_GDSC2(10) |  1593_Entinostat_GDSC2(18) | Colorectal Carcinoma	BRD3 (18):	--2-- |  1401_AZD5438_GDSC2(12) |  208_Ispinesib Mesylate_GDSC1(12) | Colorectal Carcinoma	BRD4 (17):	--3-- |  415_CPI-613_GDSC1(12) |  1617_AZD5582_GDSC2(10) |  2040_Foretinib_GDSC2(11) | Colorectal Carcinoma	BTK (15):	--3-- |  1427_AZD5582_GDSC1(9) |  1564_SCH772984_GDSC2(7) |  1803_Acetalax_GDSC2(9) | Colorectal Carcinoma	CALR (10):	--2-- |  260_NG-25_GDSC1(6) |  1617_AZD5582_GDSC2(7) | Colorectal Carcinoma	CARD11 (21):	--4-- |  303_PIK-93_GDSC1(11) |  415_CPI-613_GDSC1(13) |  1133_Serdemetan_GDSC1(5) |  1060_PD0325901_GDSC2(13) | Colorectal Carcinoma	CCNB3 (12):	--3-- |  5_Sunitinib_GDSC1(3) |  1048_Mirin_GDSC2(7) |  300_CX-5461_GDSC1(7) | Colorectal Carcinoma	CCND1 (5):	--3-- |  221_TAK-715_GDSC1(3) |  287_KIN001-244_GDSC1(3) |  1430_IGFR_3801_GDSC1(2) | Colorectal Carcinoma	CCND2 (7):	--2-- |  257_NPK76-II-72-1_GDSC1(5) |  1070_CRT0105950_GDSC1(5) | Colorectal Carcinoma	CCND3 (8):	--3-- |  221_TAK-715_GDSC1(4) |  260_NG-25_GDSC1(5) |  1372_Trametinib_GDSC1(3) | Colorectal Carcinoma	CCNE1 (12):	--2-- |  1048_Mirin_GDSC2(8) |  1847_BEN_GDSC2(8) | Colorectal Carcinoma	CD274 (3):	--1-- |  272_AR-42_GDSC1(3) | Colorectal Carcinoma	CD276 (7):	--3-- |  272_AR-42_GDSC1(4) |  326_GSK690693_GDSC1(3) |  1372_Trametinib_GDSC2(3) | Colorectal Carcinoma	CD28 (7):	--2-- |  1008_Methotrexate_GDSC1(5) |  1806_Oxaliplatin_GDSC2(3) | Colorectal Carcinoma	CD79B (6):	--2-- |  326_GSK690693_GDSC1(4) |  1631_PRT062607_GDSC2(3) | Colorectal Carcinoma	CDC42 (13):	--3-- |  252_WZ3105_GDSC1(6) |  1058_Pictilisib_GDSC1(8) |  1847_BEN_GDSC2(8) | Colorectal Carcinoma	CDK4 (3):	--2-- |  281_Alectinib_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(2) | Colorectal Carcinoma	CDK6 (9):	--2-- |  1188_CCT245467_GDSC1(6) |  1916_AZD5363_GDSC2(7) | Colorectal Carcinoma	CDK8 (9):	--2-- |  437_Trichostatin A_GDSC1(7) |  1068_Obatoclax Mesylate_GDSC2(7) | Colorectal Carcinoma	COP1 (16):	--4-- |  1048_Mirin_GDSC1(6) |  1142_HG-5-113-01_GDSC1(9) |  1048_Mirin_GDSC2(11) |  2171_BMS-754807_GDSC2(9) | Colorectal Carcinoma	CREB1 (8):	--3-- |  156_AZD6482_GDSC1(3) |  310_YM201636_GDSC1(4) |  1038_NU7441_GDSC2(4) | Colorectal Carcinoma	CRKL (7):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	CSF3R (20):	--3-- |  1242_(5Z)-7-Oxozeaenol_GDSC1(13) |  1011_Navitoclax_GDSC2(12) |  1613_VE-822_GDSC2(4) | Colorectal Carcinoma	CTLA4 (8):	--3-- |  171_AKT inhibitor VIII_GDSC1(3) |  1016_Temsirolimus_GDSC1(4) |  1052_RO-3306_GDSC2(4) | Colorectal Carcinoma	CTNNB1 (17):	--3-- |  1847_BEN_GDSC2(13) |  1441_AZD2014_GDSC2(12) |  1053_MK-2206_GDSC1(8) | Colorectal Carcinoma	CXCR4 (5):	--2-- |  287_KIN001-244_GDSC1(4) |  1037_BX795_GDSC1(3) | Colorectal Carcinoma	CYP19A1 (15):	--4-- |  275_I-BET-762_GDSC1(7) |  356_AT7867_GDSC1(6) |  1015_CI-1040_GDSC1(6) |  2040_Foretinib_GDSC2(9) | Colorectal Carcinoma	CYSLTR2 (4):	--2-- |  196_Phenformin_GDSC1(3) |  288_WHI-P97_GDSC1(2) | Colorectal Carcinoma	DCUN1D1 (15):	--3-- |  228_AKT inhibitor VIII_GDSC1(9) |  1060_PD0325901_GDSC1(10) |  1372_Trametinib_GDSC2(10) | Colorectal Carcinoma	DDR2 (18):	--3-- |  1392_Bleomycin (10 uM)_GDSC1(12) |  1372_Trametinib_GDSC2(14) |  1847_BEN_GDSC2(11) | Colorectal Carcinoma	DDX4 (14):	--3-- |  1373_Dabrafenib_GDSC2(5) |  1048_Mirin_GDSC2(12) |  1066_AZD6482_GDSC1(3) | Colorectal Carcinoma	DEK (10):	--2-- |  300_CX-5461_GDSC1(6) |  1006_Cytarabine_GDSC2(5) | Colorectal Carcinoma	DNMT1 (21):	--4-- |  178_BAY-61-3606_GDSC1(11) |  1866_BDP-00009066_GDSC2(12) |  1372_Trametinib_GDSC2(15) |  301_PHA-793887_GDSC1(11) | Colorectal Carcinoma	DOT1L (19):	--3-- |  1372_Trametinib_GDSC2(14) |  1866_BDP-00009066_GDSC2(11) |  300_CX-5461_GDSC1(9) | Colorectal Carcinoma	E2F3 (8):	--3-- |  576_RU-SKI 43_GDSC1(2) |  1068_Obatoclax Mesylate_GDSC2(6) |  1617_AZD5582_GDSC2(5) | Colorectal Carcinoma	EGFL7 (12):	--3-- |  221_TAK-715_GDSC1(5) |  1426_AZD7969_GDSC1(7) |  1809_Teniposide_GDSC2(8) | Colorectal Carcinoma	EGFR (25):	--4-- |  1085_Sorafenib_GDSC2(13) |  1073_5-Fluorouracil_GDSC2(12) |  1007_Docetaxel_GDSC1(14) |  301_PHA-793887_GDSC1(12) | Colorectal Carcinoma	EIF4A2 (18):	--2-- |  1048_Mirin_GDSC2(13) |  208_Ispinesib Mesylate_GDSC1(13) | Colorectal Carcinoma	EIF4E (7):	--3-- |  277_Linifanib_GDSC1(2) |  288_WHI-P97_GDSC1(2) |  1826_50869_GDSC2(3) | Colorectal Carcinoma	EPOR (10):	--2-- |  374_GSK1059615_GDSC1(7) |  1558_Lapatinib_GDSC2(7) | Colorectal Carcinoma	ERBB2 (14):	--3-- |  203_BMS-345541_GDSC1(10) |  301_PHA-793887_GDSC1(9) |  1133_Serdemetan_GDSC1(5) | Colorectal Carcinoma	ERBB3 (21):	--3-- |  439_LCL161_GDSC1(7) |  1419_FEN1_3940_GDSC1(12) |  1401_AZD5438_GDSC2(15) | Colorectal Carcinoma	ERBB4 (28):	--3-- |  1407_Dyrk1b_0191_GDSC1(16) |  1490_SN-38_GDSC1(17) |  228_AKT inhibitor VIII_GDSC1(14) | Colorectal Carcinoma	ERG (21):	--3-- |  1922_Cediranib_GDSC2(12) |  1564_SCH772984_GDSC2(11) |  1427_AZD5582_GDSC1(8) | Colorectal Carcinoma	ESR1 (22):	--5-- |  208_Ispinesib Mesylate_GDSC1(12) |  1032_Afatinib_GDSC1(7) |  1080_Paclitaxel_GDSC2(7) |  1558_Lapatinib_GDSC2(11) |  1866_BDP-00009066_GDSC2(11) | Colorectal Carcinoma	ETV1 (20):	--3-- |  1558_Lapatinib_GDSC2(9) |  1060_PD0325901_GDSC2(13) |  208_Ispinesib Mesylate_GDSC1(13) | Colorectal Carcinoma	ETV4 (8):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	ETV5 (13):	--3-- |  272_AR-42_GDSC1(11) |  330_XMD13-2_GDSC1(5) |  1114_Cetuximab_GDSC1(4) | Colorectal Carcinoma	EWSR1 (18):	--3-- |  1248_Daporinad_GDSC2(6) |  1427_AZD5582_GDSC1(7) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	EZH1 (18):	--4-- |  1810_Mitoxantrone_GDSC2(11) |  1494_SN-38_GDSC2(7) |  356_AT7867_GDSC1(8) |  207_AS601245_GDSC1(10) | Colorectal Carcinoma	FGF3 (7):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(5) | Colorectal Carcinoma	FGF4 (6):	--2-- |  308_Foretinib_GDSC1(3) |  1068_Obatoclax Mesylate_GDSC2(5) | Colorectal Carcinoma	FGFR1 (22):	--3-- |  221_TAK-715_GDSC1(7) |  300_CX-5461_GDSC1(11) |  1062_Selumetinib_GDSC1(13) | Colorectal Carcinoma	FGFR2 (18):	--3-- |  1441_AZD2014_GDSC2(12) |  1401_AZD5438_GDSC2(13) |  407_kb NB 142-70_GDSC1(10) | Colorectal Carcinoma	FGFR3 (14):	--2-- |  228_AKT inhibitor VIII_GDSC1(9) |  1553_Uprosertib_GDSC2(9) | Colorectal Carcinoma	FGFR4 (11):	--3-- |  221_TAK-715_GDSC1(5) |  300_CX-5461_GDSC1(7) |  1133_Serdemetan_GDSC1(4) | Colorectal Carcinoma	FLI1 (18):	--5-- |  1015_CI-1040_GDSC1(10) |  1155_QL-XII-47_GDSC1(3) |  1613_VE-822_GDSC2(4) |  1820_123829_GDSC2(11) |  1910_ABT737_GDSC2(6) | Colorectal Carcinoma	FLT1 (28):	--4-- |  275_I-BET-762_GDSC1(10) |  1847_BEN_GDSC2(15) |  1053_MK-2206_GDSC1(11) |  1046_Wee1 Inhibitor_GDSC2(16) | Colorectal Carcinoma	FLT3 (25):	--4-- |  208_Ispinesib Mesylate_GDSC1(15) |  1073_5-Fluorouracil_GDSC2(12) |  1401_AZD5438_GDSC2(15) |  1844_776928_GDSC2(12) | Colorectal Carcinoma	FLT4 (26):	--3-- |  1733_ULK1_4989_GDSC2(19) |  1046_Wee1 Inhibitor_GDSC2(16) |  1392_Bleomycin (10 uM)_GDSC1(14) | Colorectal Carcinoma	FURIN (14):	--3-- |  164_JQ12_GDSC1(8) |  303_PIK-93_GDSC1(9) |  1626_OTX015_GDSC2(9) | Colorectal Carcinoma	FUS (11):	--3-- |  300_CX-5461_GDSC1(7) |  303_PIK-93_GDSC1(8) |  1834_743380_GDSC2(4) | Colorectal Carcinoma	FYN (18):	--3-- |  5_Sunitinib_GDSC1(4) |  1932_NVP-ADW742_GDSC2(10) |  228_AKT inhibitor VIII_GDSC1(11) | Colorectal Carcinoma	GAB1 (15):	--3-- |  1739_JAK_8517_GDSC2(6) |  1060_PD0325901_GDSC2(9) |  1386_Doxorubicin_GDSC1(11) | Colorectal Carcinoma	GAB2 (15):	--3-- |  221_TAK-715_GDSC1(5) |  407_kb NB 142-70_GDSC1(9) |  1060_PD0325901_GDSC2(10) | Colorectal Carcinoma	GATA2 (6):	--2-- |  1068_Obatoclax Mesylate_GDSC2(5) |  1720_AZD5991_GDSC2(3) | Colorectal Carcinoma	GLI1 (15):	--4-- |  153_Midostaurin_GDSC1(5) |  300_CX-5461_GDSC1(8) |  1048_Mirin_GDSC1(5) |  1085_Sorafenib_GDSC2(8) | Colorectal Carcinoma	GNA11 (11):	--2-- |  1003_Camptothecin_GDSC2(7) |  356_AT7867_GDSC1(6) | Colorectal Carcinoma	GNA12 (10):	--2-- |  1048_Mirin_GDSC2(7) |  1060_PD0325901_GDSC2(7) | Colorectal Carcinoma	GNA13 (6):	--2-- |  1264_SGC0946_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(4) | Colorectal Carcinoma	GNAQ (14):	--3-- |  407_kb NB 142-70_GDSC1(9) |  1080_Paclitaxel_GDSC2(5) |  1558_Lapatinib_GDSC2(8) | Colorectal Carcinoma	GNAS (22):	--4-- |  1048_Mirin_GDSC2(13) |  207_AS601245_GDSC1(10) |  1133_Serdemetan_GDSC1(5) |  1809_Teniposide_GDSC2(11) | Colorectal Carcinoma	GNB1 (8):	--4-- |  310_YM201636_GDSC1(4) |  439_LCL161_GDSC1(4) |  1038_NU7441_GDSC2(4) |  1833_741909_GDSC2(3) | Colorectal Carcinoma	GSK3B (22):	--3-- |  1393_Gemcitabine_GDSC1(12) |  300_CX-5461_GDSC1(10) |  1866_BDP-00009066_GDSC2(13) | Colorectal Carcinoma	GTF2I (18):	--3-- |  1070_CRT0105950_GDSC1(9) |  1048_Mirin_GDSC2(11) |  1558_Lapatinib_GDSC2(9) | Colorectal Carcinoma	H1-4 (4):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1732_TAF1_5496_GDSC2(3) | Colorectal Carcinoma	HDAC1 (12):	--4-- |  287_KIN001-244_GDSC1(5) |  1019_Bosutinib_GDSC1(3) |  1048_Mirin_GDSC2(7) |  1250_AZ960_GDSC2(7) | Colorectal Carcinoma	HDAC7 (19):	--5-- |  221_TAK-715_GDSC1(6) |  344_THZ-2-49_GDSC1(6) |  1011_Navitoclax_GDSC2(11) |  1060_PD0325901_GDSC2(12) |  1732_TAF1_5496_GDSC2(5) | Colorectal Carcinoma	HGF (18):	--3-- |  203_BMS-345541_GDSC1(11) |  301_PHA-793887_GDSC1(10) |  1048_Mirin_GDSC2(12) | Colorectal Carcinoma	HIF1A (18):	--4-- |  1393_Gemcitabine_GDSC1(10) |  1089_Oxaliplatin_GDSC2(8) |  1613_VE-822_GDSC2(4) |  300_CX-5461_GDSC1(8) | Colorectal Carcinoma	HMGA2 (19):	--3-- |  164_JQ12_GDSC1(9) |  208_Ispinesib Mesylate_GDSC1(13) |  1085_Sorafenib_GDSC2(10) | Colorectal Carcinoma	HRAS (5):	--3-- |  432_Flavopiridol_GDSC1(3) |  1386_Doxorubicin_GDSC1(3) |  1430_IGFR_3801_GDSC1(2) | Colorectal Carcinoma	IDH1 (11):	--2-- |  1809_Teniposide_GDSC2(7) |  1085_Sorafenib_GDSC2(7) | Colorectal Carcinoma	IDH2 (11):	--3-- |  372_Pilaralisib_GDSC1(3) |  1016_Temsirolimus_GDSC1(6) |  1919_Osimertinib_GDSC2(5) | Colorectal Carcinoma	IGF1 (11):	--3-- |  164_JQ12_GDSC1(6) |  1372_Trametinib_GDSC1(5) |  1073_5-Fluorouracil_GDSC2(7) | Colorectal Carcinoma	IGF1R (21):	--3-- |  1372_Trametinib_GDSC2(15) |  1070_CRT0105950_GDSC1(10) |  228_AKT inhibitor VIII_GDSC1(12) | Colorectal Carcinoma	IGF2 (11):	--3-- |  300_CX-5461_GDSC1(6) |  1372_Trametinib_GDSC1(4) |  1558_Lapatinib_GDSC2(6) | Colorectal Carcinoma	IKBKE (19):	--3-- |  208_Ispinesib Mesylate_GDSC1(14) |  1048_Mirin_GDSC2(12) |  1372_Trametinib_GDSC2(14) | Colorectal Carcinoma	IL3 (7):	--2-- |  1016_Temsirolimus_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	IL6ST (15):	--3-- |  260_NG-25_GDSC1(8) |  1080_Paclitaxel_GDSC2(6) |  1008_Methotrexate_GDSC1(6) | Colorectal Carcinoma	IL7R (17):	--4-- |  228_AKT inhibitor VIII_GDSC1(9) |  1014_Refametinib_GDSC2(11) |  1494_SN-38_GDSC2(7) |  1594_OSI-027_GDSC2(4) | Colorectal Carcinoma	INSR (20):	--5-- |  207_AS601245_GDSC1(9) |  356_AT7867_GDSC1(8) |  415_CPI-613_GDSC1(13) |  1060_PD0325901_GDSC2(13) |  1820_123829_GDSC2(11) | Colorectal Carcinoma	IRS1 (19):	--3-- |  1558_Lapatinib_GDSC2(9) |  1617_AZD5582_GDSC2(10) |  1847_BEN_GDSC2(12) | Colorectal Carcinoma	IRS2 (10):	--3-- |  252_WZ3105_GDSC1(4) |  372_Pilaralisib_GDSC1(3) |  1558_Lapatinib_GDSC2(6) | Colorectal Carcinoma	JAK2 (22):	--3-- |  1827_Dihydrorotenone_GDSC2(9) |  1372_Trametinib_GDSC2(16) |  407_kb NB 142-70_GDSC1(11) | Colorectal Carcinoma	JAK3 (20):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1494_SN-38_GDSC2(7) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	KDM5A (22):	--3-- |  1626_OTX015_GDSC2(14) |  1048_Mirin_GDSC2(13) |  228_AKT inhibitor VIII_GDSC1(12) | Colorectal Carcinoma	KDR (22):	--4-- |  1426_AZD7969_GDSC1(12) |  1529_Pevonedistat_GDSC1(5) |  1011_Navitoclax_GDSC2(17) |  1809_Teniposide_GDSC2(12) | Colorectal Carcinoma	KIT (19):	--3-- |  1835_Elephantin_GDSC2(9) |  1626_OTX015_GDSC2(12) |  208_Ispinesib Mesylate_GDSC1(12) | Colorectal Carcinoma	KLF5 (3):	--2-- |  1114_Cetuximab_GDSC1(2) |  1999_N25720-51-A1_GDSC2(2) | Colorectal Carcinoma	KRAS (28):	--4-- |  1820_123829_GDSC2(15) |  45_Z-LLNle-CHO_GDSC1(6) |  1910_ABT737_GDSC2(13) |  2172_JQ1_GDSC2(15) | Colorectal Carcinoma	KSR2 (22):	--4-- |  1048_Mirin_GDSC2(12) |  1490_SN-38_GDSC1(13) |  1617_AZD5582_GDSC2(10) |  1916_AZD5363_GDSC2(11) | Colorectal Carcinoma	LCK (12):	--3-- |  300_CX-5461_GDSC1(7) |  1008_Methotrexate_GDSC1(7) |  1006_Cytarabine_GDSC2(7) | Colorectal Carcinoma	LGR5 (18):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1372_Trametinib_GDSC2(13) |  1820_123829_GDSC2(10) | Colorectal Carcinoma	LMO1 (5):	--2-- |  272_AR-42_GDSC1(4) |  1022_AZD7762_GDSC2(3) | Colorectal Carcinoma	LMO2 (8):	--2-- |  252_WZ3105_GDSC1(3) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	LRP6 (25):	--3-- |  1372_Trametinib_GDSC2(19) |  1464_TTK_3146_GDSC1(13) |  225_Genentech Cpd 10_GDSC1(14) | Colorectal Carcinoma	LTK (16):	--3-- |  228_AKT inhibitor VIII_GDSC1(10) |  407_kb NB 142-70_GDSC1(10) |  1142_HG-5-113-01_GDSC1(8) | Colorectal Carcinoma	LYN (16):	--3-- |  221_TAK-715_GDSC1(6) |  228_AKT inhibitor VIII_GDSC1(9) |  1553_Uprosertib_GDSC2(10) | Colorectal Carcinoma	MAFB (3):	--2-- |  288_WHI-P97_GDSC1(2) |  1010_Gefitinib_GDSC2(2) | Colorectal Carcinoma	MAP2K1 (8):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	MAP2K2 (11):	--3-- |  1050_ZM447439_GDSC1(5) |  1426_AZD7969_GDSC1(7) |  1834_743380_GDSC2(4) | Colorectal Carcinoma	MAP3K13 (21):	--3-- |  300_CX-5461_GDSC1(10) |  415_CPI-613_GDSC1(14) |  1401_AZD5438_GDSC2(15) | Colorectal Carcinoma	MAP4K4 (20):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1048_Mirin_GDSC2(12) |  1060_PD0325901_GDSC2(13) | Colorectal Carcinoma	MAPK3 (9):	--2-- |  300_CX-5461_GDSC1(6) |  1373_Dabrafenib_GDSC1(5) | Colorectal Carcinoma	MCL1 (8):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	MDM2 (11):	--2-- |  272_AR-42_GDSC1(8) |  431_Alisertib_GDSC1(6) | Colorectal Carcinoma	MDM4 (17):	--4-- |  221_TAK-715_GDSC1(6) |  1050_ZM447439_GDSC1(7) |  1613_VE-822_GDSC2(4) |  1844_776928_GDSC2(10) | Colorectal Carcinoma	MECOM (20):	--4-- |  1048_Mirin_GDSC2(13) |  275_I-BET-762_GDSC1(10) |  344_THZ-2-49_GDSC1(10) |  1008_Methotrexate_GDSC1(8) | Colorectal Carcinoma	MEF2B (9):	--3-- |  287_KIN001-244_GDSC1(5) |  1008_Methotrexate_GDSC1(5) |  1085_Sorafenib_GDSC2(7) | Colorectal Carcinoma	MEF2D (11):	--4-- |  156_AZD6482_GDSC1(3) |  356_AT7867_GDSC1(6) |  1085_Sorafenib_GDSC2(6) |  2170_AT13148_GDSC2(5) | Colorectal Carcinoma	MET (22):	--3-- |  366_TWS119_GDSC1(13) |  1048_Mirin_GDSC2(13) |  1080_Paclitaxel_GDSC2(8) | Colorectal Carcinoma	MGAM (29):	--3-- |  229_Enzastaurin_GDSC1(14) |  415_CPI-613_GDSC1(17) |  2156_5-azacytidine_GDSC2(20) | Colorectal Carcinoma	MKI67 (26):	--3-- |  1392_Bleomycin (10 uM)_GDSC1(14) |  1490_SN-38_GDSC1(16) |  1733_ULK1_4989_GDSC2(19) | Colorectal Carcinoma	MLLT10 (17):	--3-- |  356_AT7867_GDSC1(8) |  1050_ZM447439_GDSC1(7) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	MLLT3 (20):	--3-- |  1048_Mirin_GDSC2(11) |  208_Ispinesib Mesylate_GDSC1(13) |  1916_AZD5363_GDSC2(10) | Colorectal Carcinoma	MPL (13):	--3-- |  177_GSK650394_GDSC1(5) |  300_CX-5461_GDSC1(7) |  1558_Lapatinib_GDSC2(7) | Colorectal Carcinoma	MSI1 (9):	--2-- |  437_Trichostatin A_GDSC1(7) |  1068_Obatoclax Mesylate_GDSC2(7) | Colorectal Carcinoma	MSI2 (16):	--3-- |  221_TAK-715_GDSC1(5) |  1372_Trametinib_GDSC1(7) |  1553_Uprosertib_GDSC2(10) | Colorectal Carcinoma	MST1R (13):	--2-- |  300_CX-5461_GDSC1(7) |  1426_AZD7969_GDSC1(8) | Colorectal Carcinoma	MTOR (24):	--3-- |  1048_Mirin_GDSC2(14) |  134_Etoposide_GDSC1(14) |  301_PHA-793887_GDSC1(13) | Colorectal Carcinoma	MYBL1 (16):	--3-- |  1426_AZD7969_GDSC1(9) |  1820_123829_GDSC2(10) |  300_CX-5461_GDSC1(8) | Colorectal Carcinoma	MYC (9):	--2-- |  300_CX-5461_GDSC1(6) |  1085_Sorafenib_GDSC2(6) | Colorectal Carcinoma	MYCL (2):	--1-- |  374_GSK1059615_GDSC1(2) | Colorectal Carcinoma	MYCN (6):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  437_Trichostatin A_GDSC1(5) | Colorectal Carcinoma	MYD88 (10):	--2-- |  170_Shikonin_GDSC1(5) |  1709_CDK9_5038_GDSC2(7) | Colorectal Carcinoma	NADK (15):	--3-- |  228_AKT inhibitor VIII_GDSC1(9) |  275_I-BET-762_GDSC1(7) |  1048_Mirin_GDSC2(10) | Colorectal Carcinoma	NCOA3 (23):	--4-- |  71_Pyrimethamine_GDSC1(4) |  208_Ispinesib Mesylate_GDSC1(14) |  1372_Trametinib_GDSC2(17) |  1820_123829_GDSC2(12) | Colorectal Carcinoma	NCSTN (17):	--2-- |  1060_PD0325901_GDSC1(12) |  228_AKT inhibitor VIII_GDSC1(10) | Colorectal Carcinoma	NFE2 (5):	--3-- |  330_XMD13-2_GDSC1(3) |  1047_Nutlin-3a (-)_GDSC1(3) |  1373_Dabrafenib_GDSC1(3) | Colorectal Carcinoma	NFE2L2 (8):	--2-- |  1430_IGFR_3801_GDSC1(7) |  1060_PD0325901_GDSC2(5) | Colorectal Carcinoma	NR4A3 (11):	--2-- |  1014_Refametinib_GDSC2(9) |  1024_Lestaurtinib_GDSC2(6) | Colorectal Carcinoma	NRAS (7):	--2-- |  1114_Cetuximab_GDSC1(3) |  1809_Teniposide_GDSC2(5) | Colorectal Carcinoma	NSD2 (23):	--4-- |  1809_Teniposide_GDSC2(11) |  1490_SN-38_GDSC1(15) |  1133_Serdemetan_GDSC1(5) |  1007_Docetaxel_GDSC1(13) | Colorectal Carcinoma	NT5C2 (14):	--2-- |  407_kb NB 142-70_GDSC1(9) |  2040_Foretinib_GDSC2(10) | Colorectal Carcinoma	NTRK1 (18):	--4-- |  153_Midostaurin_GDSC1(5) |  208_Ispinesib Mesylate_GDSC1(12) |  221_TAK-715_GDSC1(6) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	NTRK2 (21):	--5-- |  356_AT7867_GDSC1(8) |  1007_Docetaxel_GDSC1(12) |  1048_Mirin_GDSC2(11) |  1613_VE-822_GDSC2(4) |  1910_ABT737_GDSC2(8) | Colorectal Carcinoma	NTRK3 (26):	--5-- |  1048_Mirin_GDSC2(14) |  428_Pemetrexed_GDSC1(14) |  1401_AZD5438_GDSC2(16) |  1844_776928_GDSC2(13) |  2106_Uprosertib_GDSC2(16) | Colorectal Carcinoma	NUF2 (11):	--3-- |  275_I-BET-762_GDSC1(7) |  356_AT7867_GDSC1(7) |  1085_Sorafenib_GDSC2(7) | Colorectal Carcinoma	NUP214 (23):	--5-- |  153_Midostaurin_GDSC1(6) |  1073_5-Fluorouracil_GDSC2(12) |  1062_Selumetinib_GDSC2(9) |  1038_NU7441_GDSC2(8) |  301_PHA-793887_GDSC1(12) | Colorectal Carcinoma	NUP98 (22):	--3-- |  268_Sepantronium bromide_GDSC1(14) |  1372_Trametinib_GDSC2(16) |  1401_AZD5438_GDSC2(14) | Colorectal Carcinoma	PAK1 (14):	--3-- |  356_AT7867_GDSC1(7) |  1114_Cetuximab_GDSC1(4) |  1402_AZD7762_GDSC1(11) | Colorectal Carcinoma	PAK5 (16):	--5-- |  1250_AZ960_GDSC2(8) |  1080_Paclitaxel_GDSC2(6) |  1060_PD0325901_GDSC2(9) |  1048_Mirin_GDSC2(9) |  381_AST-1306_GDSC1(8) | Colorectal Carcinoma	PAX8 (8):	--2-- |  170_Shikonin_GDSC1(4) |  437_Trichostatin A_GDSC1(7) | Colorectal Carcinoma	PDCD1 (2):	--1-- |  1999_N25720-51-A1_GDSC2(2) | Colorectal Carcinoma	PDCD1LG2 (12):	--3-- |  439_LCL161_GDSC1(5) |  1048_Mirin_GDSC1(5) |  1048_Mirin_GDSC2(7) | Colorectal Carcinoma	PDGFB (8):	--2-- |  287_KIN001-244_GDSC1(4) |  1038_NU7441_GDSC2(5) | Colorectal Carcinoma	PDGFRA (16):	--3-- |  1835_Elephantin_GDSC2(7) |  1080_Paclitaxel_GDSC2(6) |  300_CX-5461_GDSC1(9) | Colorectal Carcinoma	PDGFRB (18):	--3-- |  208_Ispinesib Mesylate_GDSC1(14) |  1048_Mirin_GDSC2(10) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	PGR (13):	--2-- |  303_PIK-93_GDSC1(9) |  1048_Mirin_GDSC2(10) | Colorectal Carcinoma	PIK3CA (21):	--3-- |  165_DMOG_GDSC1(13) |  1048_Mirin_GDSC2(13) |  1626_OTX015_GDSC2(14) | Colorectal Carcinoma	PIK3CB (15):	--2-- |  1048_Mirin_GDSC2(11) |  300_CX-5461_GDSC1(8) | Colorectal Carcinoma	PIK3CD (14):	--3-- |  1549_Sapitinib_GDSC2(7) |  1048_Mirin_GDSC2(9) |  380_BIBF-1120_GDSC1(8) | Colorectal Carcinoma	PIK3CG (14):	--3-- |  1844_776928_GDSC2(9) |  1809_Teniposide_GDSC2(10) |  1048_Mirin_GDSC2(10) | Colorectal Carcinoma	PLCG1 (19):	--3-- |  1372_Trametinib_GDSC2(14) |  1073_5-Fluorouracil_GDSC2(10) |  301_PHA-793887_GDSC1(10) | Colorectal Carcinoma	PLCG2 (29):	--4-- |  300_CX-5461_GDSC1(12) |  1266_ICL1100013_GDSC1(17) |  1617_AZD5582_GDSC2(13) |  1804_Acetalax_GDSC2(11) | Colorectal Carcinoma	PPARG (10):	--3-- |  186_Bexarotene_GDSC1(3) |  1427_AZD5582_GDSC1(5) |  1250_AZ960_GDSC2(7) | Colorectal Carcinoma	PPM1D (13):	--4-- |  153_Midostaurin_GDSC1(4) |  300_CX-5461_GDSC1(7) |  1073_5-Fluorouracil_GDSC2(9) |  1249_BMS-345541_GDSC2(5) | Colorectal Carcinoma	PRKACA (15):	--3-- |  356_AT7867_GDSC1(6) |  1460_PARP_9482_GDSC1(8) |  1810_Mitoxantrone_GDSC2(10) | Colorectal Carcinoma	PRKCI (16):	--3-- |  300_CX-5461_GDSC1(8) |  1426_AZD7969_GDSC1(10) |  1553_Uprosertib_GDSC2(10) | Colorectal Carcinoma	PSMB2 (8):	--2-- |  300_CX-5461_GDSC1(5) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	PTPN11 (13):	--3-- |  407_kb NB 142-70_GDSC1(9) |  1054_Palbociclib_GDSC1(8) |  1066_AZD6482_GDSC1(3) | Colorectal Carcinoma	RAB35 (9):	--2-- |  300_CX-5461_GDSC1(6) |  1372_Trametinib_GDSC2(6) | Colorectal Carcinoma	RAC1 (6):	--2-- |  222_BX-912_GDSC1(4) |  1054_Palbociclib_GDSC2(5) | Colorectal Carcinoma	RAF1 (16):	--3-- |  1809_Teniposide_GDSC2(10) |  1617_AZD5582_GDSC2(9) |  1048_Mirin_GDSC2(10) | Colorectal Carcinoma	REL (10):	--3-- |  260_NG-25_GDSC1(6) |  300_CX-5461_GDSC1(6) |  1558_Lapatinib_GDSC2(6) | Colorectal Carcinoma	RET (16):	--3-- |  326_GSK690693_GDSC1(5) |  1204_HG-6-71-01_GDSC1(4) |  1372_Trametinib_GDSC2(12) | Colorectal Carcinoma	REV3L (18):	--3-- |  221_TAK-715_GDSC1(7) |  1048_Mirin_GDSC2(12) |  1866_BDP-00009066_GDSC2(12) | Colorectal Carcinoma	RHEB (10):	--3-- |  437_Trichostatin A_GDSC1(6) |  1249_BMS-345541_GDSC2(5) |  1827_Dihydrorotenone_GDSC2(5) | Colorectal Carcinoma	RHOA (4):	--2-- |  165_DMOG_GDSC1(2) |  221_TAK-715_GDSC1(3) | Colorectal Carcinoma	RICTOR (17):	--3-- |  203_BMS-345541_GDSC1(10) |  1426_AZD7969_GDSC1(10) |  1809_Teniposide_GDSC2(10) | Colorectal Carcinoma	RIT1 (5):	--2-- |  272_AR-42_GDSC1(3) |  382_Apitolisib_GDSC1(3) | Colorectal Carcinoma	RNASEH2A (7):	--3-- |  153_Midostaurin_GDSC1(3) |  1786_AZD4547_GDSC2(3) |  1720_AZD5991_GDSC2(3) | Colorectal Carcinoma	ROS1 (28):	--3-- |  407_kb NB 142-70_GDSC1(14) |  415_CPI-613_GDSC1(16) |  2156_5-azacytidine_GDSC2(20) | Colorectal Carcinoma	RPS6KA4 (9):	--3-- |  177_GSK650394_GDSC1(5) |  1133_Serdemetan_GDSC1(3) |  1372_Trametinib_GDSC2(6) | Colorectal Carcinoma	RPS6KB2 (4):	--2-- |  330_XMD13-2_GDSC1(3) |  1430_IGFR_3801_GDSC1(2) | Colorectal Carcinoma	RPTOR (22):	--3-- |  11_Paclitaxel_GDSC1(7) |  300_CX-5461_GDSC1(12) |  1088_Irinotecan_GDSC2(10) | Colorectal Carcinoma	RRAGC (12):	--3-- |  153_Midostaurin_GDSC1(4) |  1014_Refametinib_GDSC2(8) |  1080_Paclitaxel_GDSC2(5) | Colorectal Carcinoma	RRAS (8):	--2-- |  1089_Oxaliplatin_GDSC2(5) |  1250_AZ960_GDSC2(5) | Colorectal Carcinoma	RUNX1T1 (20):	--3-- |  1085_Sorafenib_GDSC2(10) |  1053_MK-2206_GDSC1(9) |  366_TWS119_GDSC1(12) | Colorectal Carcinoma	SCG5 (7):	--3-- |  171_AKT inhibitor VIII_GDSC1(2) |  221_TAK-715_GDSC1(4) |  288_WHI-P97_GDSC1(2) | Colorectal Carcinoma	SET (7):	--3-- |  288_WHI-P97_GDSC1(2) |  1050_ZM447439_GDSC1(4) |  1143_HG-5-88-01_GDSC1(3) | Colorectal Carcinoma	SETBP1 (17):	--3-- |  407_kb NB 142-70_GDSC1(10) |  1050_ZM447439_GDSC1(6) |  1048_Mirin_GDSC2(13) | Colorectal Carcinoma	SETD1A (19):	--4-- |  71_Pyrimethamine_GDSC1(3) |  208_Ispinesib Mesylate_GDSC1(12) |  1372_Trametinib_GDSC2(13) |  1558_Lapatinib_GDSC2(9) | Colorectal Carcinoma	SF3B1 (18):	--3-- |  1372_Trametinib_GDSC2(13) |  1048_Mirin_GDSC2(10) |  301_PHA-793887_GDSC1(10) | Colorectal Carcinoma	SGK1 (20):	--3-- |  1142_HG-5-113-01_GDSC1(14) |  1372_Trametinib_GDSC1(12) |  1713_ERK_2440_GDSC2(10) | Colorectal Carcinoma	SHOC2 (9):	--3-- |  1015_CI-1040_GDSC1(3) |  1068_Obatoclax Mesylate_GDSC2(7) |  2171_BMS-754807_GDSC2(4) | Colorectal Carcinoma	SMO (20):	--5-- |  153_Midostaurin_GDSC1(6) |  1613_VE-822_GDSC2(4) |  1060_PD0325901_GDSC2(13) |  1392_Bleomycin (10 uM)_GDSC1(11) |  300_CX-5461_GDSC1(9) | Colorectal Carcinoma	SMYD3 (19):	--3-- |  203_BMS-345541_GDSC1(11) |  1558_Lapatinib_GDSC2(9) |  1266_ICL1100013_GDSC1(12) | Colorectal Carcinoma	SOS1 (20):	--3-- |  1401_AZD5438_GDSC2(12) |  1372_Trametinib_GDSC2(14) |  208_Ispinesib Mesylate_GDSC1(12) | Colorectal Carcinoma	SOX2 (3):	--2-- |  1019_Bosutinib_GDSC1(2) |  1434_JAK3_7406_GDSC1(2) | Colorectal Carcinoma	SQSTM1 (10):	--2-- |  1060_PD0325901_GDSC2(7) |  1558_Lapatinib_GDSC2(7) | Colorectal Carcinoma	SRC (15):	--3-- |  164_JQ12_GDSC1(6) |  203_BMS-345541_GDSC1(9) |  1048_Mirin_GDSC1(7) | Colorectal Carcinoma	SS18 (10):	--3-- |  153_Midostaurin_GDSC1(5) |  1249_BMS-345541_GDSC2(5) |  1809_Teniposide_GDSC2(6) | Colorectal Carcinoma	STAT3 (13):	--3-- |  203_BMS-345541_GDSC1(9) |  207_AS601245_GDSC1(7) |  300_CX-5461_GDSC1(8) | Colorectal Carcinoma	STAT5A (10):	--4-- |  156_AZD6482_GDSC1(3) |  293_Amuvatinib_GDSC1(5) |  1016_Temsirolimus_GDSC1(5) |  1047_Nutlin-3a (-)_GDSC1(4) | Colorectal Carcinoma	STAT5B (20):	--4-- |  1392_Bleomycin (10 uM)_GDSC1(12) |  1048_Mirin_GDSC2(12) |  1564_SCH772984_GDSC2(11) |  1910_ABT737_GDSC2(8) | Colorectal Carcinoma	STAT6 (19):	--3-- |  1820_123829_GDSC2(11) |  1372_Trametinib_GDSC2(14) |  208_Ispinesib Mesylate_GDSC1(12) | Colorectal Carcinoma	STK19 (2):	--1-- |  1066_AZD6482_GDSC1(2) | Colorectal Carcinoma	SYK (13):	--3-- |  356_AT7867_GDSC1(6) |  1048_Mirin_GDSC1(5) |  1048_Mirin_GDSC2(8) | Colorectal Carcinoma	TAL1 (3):	--2-- |  272_AR-42_GDSC1(1) |  326_GSK690693_GDSC1(2) | Colorectal Carcinoma	TCL1A (5):	--2-- |  1578_Leflunomide_GDSC2(3) |  1613_VE-822_GDSC2(3) | Colorectal Carcinoma	TCL1B (6):	--2-- |  356_AT7867_GDSC1(5) |  1114_Cetuximab_GDSC1(3) | Colorectal Carcinoma	TERT (13):	--2-- |  301_PHA-793887_GDSC1(8) |  1402_AZD7762_GDSC1(10) | Colorectal Carcinoma	TFE3 (11):	--3-- |  157_JNK-9L_GDSC1(7) |  1048_Mirin_GDSC2(7) |  1617_AZD5582_GDSC2(7) | Colorectal Carcinoma	TLX1 (3):	--2-- |  1631_PRT062607_GDSC2(2) |  1834_743380_GDSC2(2) | Colorectal Carcinoma	TLX3 (5):	--3-- |  287_KIN001-244_GDSC1(3) |  1133_Serdemetan_GDSC1(2) |  1430_IGFR_3801_GDSC1(2) | Colorectal Carcinoma	TRIM27 (11):	--3-- |  1427_AZD5582_GDSC1(5) |  1006_Cytarabine_GDSC2(5) |  1250_AZ960_GDSC2(7) | Colorectal Carcinoma	TSHR (18):	--3-- |  1820_123829_GDSC2(11) |  1401_AZD5438_GDSC2(12) |  208_Ispinesib Mesylate_GDSC1(12) | Colorectal Carcinoma	TYK2 (17):	--3-- |  1732_TAF1_5496_GDSC2(5) |  1372_Trametinib_GDSC2(12) |  407_kb NB 142-70_GDSC1(9) | Colorectal Carcinoma	UBR5 (25):	--3-- |  208_Ispinesib Mesylate_GDSC1(15) |  1558_Lapatinib_GDSC2(11) |  1866_BDP-00009066_GDSC2(13) | Colorectal Carcinoma	USP8 (23):	--4-- |  221_TAK-715_GDSC1(7) |  407_kb NB 142-70_GDSC1(12) |  1062_Selumetinib_GDSC1(13) |  1142_HG-5-113-01_GDSC1(13) | Colorectal Carcinoma	VAV1 (21):	--4-- |  415_CPI-613_GDSC1(13) |  1426_AZD7969_GDSC1(12) |  1048_Mirin_GDSC2(12) |  1553_Uprosertib_GDSC2(12) | Colorectal Carcinoma	VAV2 (23):	--3-- |  151_QS11_GDSC1(9) |  208_Ispinesib Mesylate_GDSC1(14) |  1401_AZD5438_GDSC2(14) | Colorectal Carcinoma	VEGFA (8):	--2-- |  153_Midostaurin_GDSC1(4) |  1427_AZD5582_GDSC1(5) | Colorectal Carcinoma	WWP1 (17):	--3-- |  308_Foretinib_GDSC1(11) |  1820_123829_GDSC2(11) |  1910_ABT737_GDSC2(7) | Colorectal Carcinoma	WWTR1 (14):	--4-- |  203_BMS-345541_GDSC1(9) |  372_Pilaralisib_GDSC1(3) |  1732_TAF1_5496_GDSC2(4) |  2040_Foretinib_GDSC2(10) | Colorectal Carcinoma	XBP1 (5):	--2-- |  94_TGX221_GDSC1(2) |  1624_I-BET-762_GDSC2(3) | Colorectal Carcinoma	XIAP (11):	--3-- |  182_Obatoclax Mesylate_GDSC1(6) |  221_TAK-715_GDSC1(5) |  252_WZ3105_GDSC1(6) | Colorectal Carcinoma	XPO1 (15):	--2-- |  133_Doxorubicin_GDSC1(5) |  1401_AZD5438_GDSC2(13) | Colorectal Carcinoma	YAP1 (12):	--3-- |  372_Pilaralisib_GDSC1(3) |  439_LCL161_GDSC1(5) |  1809_Teniposide_GDSC2(7) | Colorectal Carcinoma	YES1 (9):	--2-- |  300_CX-5461_GDSC1(6) |  1372_Trametinib_GDSC2(6) | Colorectal Carcinoma	YY1 (3):	--2-- |  374_GSK1059615_GDSC1(2) |  1373_Dabrafenib_GDSC1(2) | Endometrial Carcinoma	ABL2 (5):	--2-- |  1490_SN-38_GDSC1(4) |  1059_AZD8055_GDSC2(1) | Endometrial Carcinoma	AGO1 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1413_EphB4_9721_GDSC1(1) | Endometrial Carcinoma	ALK (3):	--3-- |  1058_Pictilisib_GDSC1(1) |  1561_Taselisib_GDSC2(1) |  1617_AZD5582_GDSC2(1) | Endometrial Carcinoma	AR (3):	--1-- |  1426_AZD7969_GDSC1(3) | Endometrial Carcinoma	ATXN7 (3):	--1-- |  1007_Docetaxel_GDSC2(3) | Endometrial Carcinoma	BCL3 (4):	--2-- |  1015_CI-1040_GDSC1(3) |  1021_Axitinib_GDSC2(3) | Endometrial Carcinoma	BRD4 (3):	--1-- |  1426_AZD7969_GDSC1(3) | Endometrial Carcinoma	CCNE1 (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1021_Axitinib_GDSC2(3) | Endometrial Carcinoma	CD28 (3):	--1-- |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	EIF4A2 (3):	--1-- |  1626_OTX015_GDSC2(3) | Endometrial Carcinoma	FGFR3 (6):	--2-- |  1239_YK-4-279_GDSC2(5) |  1511_Epirubicin_GDSC2(5) | Endometrial Carcinoma	FLT4 (4):	--2-- |  158_PF-562271_GDSC1(3) |  199_Pazopanib_GDSC1(3) | Endometrial Carcinoma	FURIN (4):	--2-- |  156_AZD6482_GDSC1(3) |  199_Pazopanib_GDSC1(3) | Endometrial Carcinoma	FYN (6):	--2-- |  184_BMS-754807_GDSC1(4) |  1266_ICL1100013_GDSC1(5) | Endometrial Carcinoma	GAB1 (3):	--1-- |  1007_Docetaxel_GDSC2(3) | Endometrial Carcinoma	GNA11 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1413_EphB4_9721_GDSC1(1) | Endometrial Carcinoma	KDR (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	KRAS (3):	--3-- |  1026_Tanespimycin_GDSC1(1) |  1394_AZD6738_GDSC1(1) |  1553_Uprosertib_GDSC2(1) | Endometrial Carcinoma	MAPK3 (5):	--2-- |  1490_SN-38_GDSC1(4) |  1059_AZD8055_GDSC2(1) | Endometrial Carcinoma	MEF2B (3):	--1-- |  1007_Docetaxel_GDSC2(3) | Endometrial Carcinoma	MPL (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1015_CI-1040_GDSC1(3) | Endometrial Carcinoma	MST1R (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	PAK5 (4):	--1-- |  1259_Talazoparib_GDSC1(4) | Endometrial Carcinoma	PDCD1 (4):	--2-- |  158_PF-562271_GDSC1(3) |  199_Pazopanib_GDSC1(3) | Endometrial Carcinoma	PDCD1LG2 (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	PIK3CD (2):	--2-- |  152_CP466722_GDSC1(1) |  1561_Taselisib_GDSC2(1) | Endometrial Carcinoma	PRKACA (3):	--1-- |  1007_Docetaxel_GDSC2(3) | Endometrial Carcinoma	PTPN11 (3):	--1-- |  158_PF-562271_GDSC1(3) | Endometrial Carcinoma	RET (3):	--1-- |  1007_Docetaxel_GDSC2(3) | Endometrial Carcinoma	SF3B1 (4):	--2-- |  1037_BX795_GDSC1(3) |  1021_Axitinib_GDSC2(3) | Endometrial Carcinoma	STAT6 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1413_EphB4_9721_GDSC1(1) | Endometrial Carcinoma	TFE3 (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1037_BX795_GDSC1(3) | Endometrial Carcinoma	YES1 (1):	--1-- |  372_Pilaralisib_GDSC1(1) | Endometrial Carcinoma	YY1 (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1015_CI-1040_GDSC1(3) | Esophageal Squamous Cell Carcinoma	ABL1 (7):	--2-- |  158_PF-562271_GDSC1(5) |  185_Linsitinib_GDSC1(4) | Esophageal Squamous Cell Carcinoma	ABL2 (10):	--3-- |  219_AT-7519_GDSC1(4) |  268_Sepantronium bromide_GDSC1(6) |  2149_CT7033-2_GDSC2(4) | Esophageal Squamous Cell Carcinoma	ADHFE1 (6):	--3-- |  199_Pazopanib_GDSC1(4) |  1561_Taselisib_GDSC2(3) |  1843_LMP744_GDSC2(2) | Esophageal Squamous Cell Carcinoma	AGO1 (5):	--2-- |  63_BMS-509744_GDSC1(3) |  1050_ZM447439_GDSC1(4) | Esophageal Squamous Cell Carcinoma	AKT1 (7):	--2-- |  1451_PLK_6522_GDSC1(6) |  1004_Vinblastine_GDSC2(4) | Esophageal Squamous Cell Carcinoma	AKT2 (5):	--3-- |  1734_VSP34_8731_GDSC2(3) |  2048_Vinorelbine_GDSC2(3) |  2149_CT7033-2_GDSC2(3) | Esophageal Squamous Cell Carcinoma	AKT3 (4):	--2-- |  1032_Afatinib_GDSC2(3) |  2040_Foretinib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	ARHGEF28 (14):	--3-- |  163_JQ1_GDSC1(8) |  1593_Entinostat_GDSC2(7) |  1829_667880_GDSC2(6) | Esophageal Squamous Cell Carcinoma	ARID3B (4):	--2-- |  1007_Docetaxel_GDSC1(3) |  1835_Elephantin_GDSC2(2) | Esophageal Squamous Cell Carcinoma	ATXN7 (5):	--2-- |  1734_VSP34_8731_GDSC2(4) |  1812_Bleomycin_GDSC2(3) | Esophageal Squamous Cell Carcinoma	AURKB (2):	--1-- |  1425_BPTES_GDSC1(2) | Esophageal Squamous Cell Carcinoma	AXL (8):	--2-- |  380_BIBF-1120_GDSC1(5) |  1451_PLK_6522_GDSC1(5) | Esophageal Squamous Cell Carcinoma	BCL6 (5):	--2-- |  203_BMS-345541_GDSC1(4) |  428_Pemetrexed_GDSC1(4) | Esophageal Squamous Cell Carcinoma	BCL9 (4):	--2-- |  552_BAM7_GDSC1(2) |  1360_993-D2_GDSC1(2) | Esophageal Squamous Cell Carcinoma	BRAF (11):	--3-- |  153_Midostaurin_GDSC1(3) |  1498_Selumetinib_GDSC1(6) |  1739_JAK_8517_GDSC2(5) | Esophageal Squamous Cell Carcinoma	BRD3 (3):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1495_Olaparib_GDSC1(2) | Esophageal Squamous Cell Carcinoma	BRD4 (8):	--3-- |  135_Gemcitabine_GDSC1(5) |  163_JQ1_GDSC1(4) |  1827_Dihydrorotenone_GDSC2(4) | Esophageal Squamous Cell Carcinoma	BTK (6):	--2-- |  1367_BAY-HDAC11_4_GDSC1(3) |  1073_5-Fluorouracil_GDSC2(5) | Esophageal Squamous Cell Carcinoma	CARD11 (11):	--3-- |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(4) |  1394_AZD6738_GDSC1(8) |  1079_Dasatinib_GDSC2(5) | Esophageal Squamous Cell Carcinoma	CCNB3 (4):	--2-- |  186_Bexarotene_GDSC1(2) |  1624_I-BET-762_GDSC2(2) | Esophageal Squamous Cell Carcinoma	CCND1 (4):	--1-- |  1378_Bleomycin (50 uM)_GDSC1(4) | Esophageal Squamous Cell Carcinoma	CCND2 (4):	--2-- |  164_JQ12_GDSC1(2) |  1091_BMS-536924_GDSC2(2) | Esophageal Squamous Cell Carcinoma	CCND3 (4):	--2-- |  196_Phenformin_GDSC1(2) |  2048_Vinorelbine_GDSC2(3) | Esophageal Squamous Cell Carcinoma	CD274 (2):	--1-- |  1495_Olaparib_GDSC1(2) | Esophageal Squamous Cell Carcinoma	CD276 (3):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1825_Podophyllotoxin bromide_GDSC2(1) | Esophageal Squamous Cell Carcinoma	CDK6 (5):	--3-- |  194_Luminespib_GDSC1(3) |  268_Sepantronium bromide_GDSC1(1) |  1392_Bleomycin (10 uM)_GDSC1(2) | Esophageal Squamous Cell Carcinoma	COP1 (11):	--2-- |  477_A-83-01_GDSC1(7) |  1232_I-BET-151_GDSC1(6) | Esophageal Squamous Cell Carcinoma	CSF3R (9):	--3-- |  158_PF-562271_GDSC1(6) |  1394_AZD6738_GDSC1(6) |  2055_Mycophenolic acid_GDSC2(3) | Esophageal Squamous Cell Carcinoma	CXCR4 (3):	--2-- |  574_Wnt-C59_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Esophageal Squamous Cell Carcinoma	CYP19A1 (10):	--2-- |  2106_Uprosertib_GDSC2(6) |  2172_JQ1_GDSC2(7) | Esophageal Squamous Cell Carcinoma	CYSLTR2 (4):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(3) |  1849_Sabutoclax_GDSC2(2) | Esophageal Squamous Cell Carcinoma	DCUN1D1 (6):	--3-- |  287_KIN001-244_GDSC1(3) |  428_Pemetrexed_GDSC1(4) |  2044_Pyridostatin_GDSC2(3) | Esophageal Squamous Cell Carcinoma	DDR2 (3):	--2-- |  1022_AZD7762_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Esophageal Squamous Cell Carcinoma	DDX4 (6):	--2-- |  175_PAC-1_GDSC1(5) |  326_GSK690693_GDSC1(3) | Esophageal Squamous Cell Carcinoma	DEK (3):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1495_Olaparib_GDSC1(2) | Esophageal Squamous Cell Carcinoma	DNMT1 (11):	--2-- |  152_CP466722_GDSC1(7) |  1024_Lestaurtinib_GDSC1(8) | Esophageal Squamous Cell Carcinoma	DOT1L (13):	--2-- |  1170_CCT-018159_GDSC1(9) |  1048_Mirin_GDSC2(8) | Esophageal Squamous Cell Carcinoma	EGFL7 (8):	--3-- |  156_AZD6482_GDSC1(3) |  1053_MK-2206_GDSC1(5) |  1847_BEN_GDSC2(4) | Esophageal Squamous Cell Carcinoma	EPOR (3):	--2-- |  346_THZ-2-102-1_GDSC1(2) |  1437_MCT4_1422_GDSC1(2) | Esophageal Squamous Cell Carcinoma	ERBB2 (9):	--2-- |  269_NSC-207895_GDSC1(5) |  1377_Afatinib_GDSC1(7) | Esophageal Squamous Cell Carcinoma	ERBB4 (8):	--1-- |  301_PHA-793887_GDSC1(8) | Esophageal Squamous Cell Carcinoma	ERG (5):	--2-- |  204_Tipifarnib_GDSC1(3) |  432_Flavopiridol_GDSC1(3) | Esophageal Squamous Cell Carcinoma	ESR1 (8):	--2-- |  1032_Afatinib_GDSC2(7) |  1804_Acetalax_GDSC2(2) | Esophageal Squamous Cell Carcinoma	ETV1 (8):	--2-- |  1413_EphB4_9721_GDSC1(5) |  1919_Osimertinib_GDSC2(5) | Esophageal Squamous Cell Carcinoma	ETV5 (1):	--1-- |  252_WZ3105_GDSC1(1) | Esophageal Squamous Cell Carcinoma	EZH1 (9):	--2-- |  163_JQ1_GDSC1(4) |  2040_Foretinib_GDSC2(6) | Esophageal Squamous Cell Carcinoma	FGF4 (6):	--2-- |  300_CX-5461_GDSC1(4) |  2111_VE821_GDSC2(3) | Esophageal Squamous Cell Carcinoma	FGFR2 (7):	--2-- |  1037_BX795_GDSC1(3) |  1827_Dihydrorotenone_GDSC2(4) | Esophageal Squamous Cell Carcinoma	FGFR4 (5):	--2-- |  1007_Docetaxel_GDSC1(3) |  1847_BEN_GDSC2(3) | Esophageal Squamous Cell Carcinoma	FLI1 (7):	--2-- |  1593_Entinostat_GDSC2(6) |  1829_667880_GDSC2(4) | Esophageal Squamous Cell Carcinoma	FLT1 (9):	--2-- |  1046_Wee1 Inhibitor_GDSC2(7) |  1825_Podophyllotoxin bromide_GDSC2(3) | Esophageal Squamous Cell Carcinoma	FLT3 (10):	--2-- |  461_NSC319726_GDSC1(6) |  1529_Pevonedistat_GDSC2(6) | Esophageal Squamous Cell Carcinoma	FLT4 (6):	--3-- |  574_Wnt-C59_GDSC1(4) |  1720_AZD5991_GDSC2(2) |  1922_Cediranib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	FURIN (2):	--2-- |  163_JQ1_GDSC1(1) |  2149_CT7033-2_GDSC2(1) | Esophageal Squamous Cell Carcinoma	FUS (6):	--2-- |  308_Foretinib_GDSC1(5) |  1001_AICA Ribonucleotide_GDSC1(2) | Esophageal Squamous Cell Carcinoma	FYN (6):	--2-- |  229_Enzastaurin_GDSC1(4) |  1926_GNE-317_GDSC2(3) | Esophageal Squamous Cell Carcinoma	GAB1 (3):	--2-- |  1425_BPTES_GDSC1(2) |  1437_MCT4_1422_GDSC1(2) | Esophageal Squamous Cell Carcinoma	GAB2 (9):	--2-- |  245_UNC0638_GDSC1(6) |  1080_Paclitaxel_GDSC2(5) | Esophageal Squamous Cell Carcinoma	GATA2 (4):	--2-- |  1052_RO-3306_GDSC2(3) |  1624_I-BET-762_GDSC2(2) | Esophageal Squamous Cell Carcinoma	GNA12 (10):	--3-- |  300_CX-5461_GDSC1(7) |  1037_BX795_GDSC1(5) |  1239_YK-4-279_GDSC1(6) | Esophageal Squamous Cell Carcinoma	GNAQ (9):	--3-- |  1022_AZD7762_GDSC1(7) |  1079_Dasatinib_GDSC2(4) |  1088_Irinotecan_GDSC2(5) | Esophageal Squamous Cell Carcinoma	GNAS (12):	--3-- |  1091_BMS-536924_GDSC1(5) |  1259_Talazoparib_GDSC1(9) |  1809_Teniposide_GDSC2(8) | Esophageal Squamous Cell Carcinoma	GTF2I (9):	--3-- |  1008_Methotrexate_GDSC1(4) |  1054_Palbociclib_GDSC1(6) |  1593_Entinostat_GDSC2(5) | Esophageal Squamous Cell Carcinoma	HGF (9):	--2-- |  158_PF-562271_GDSC1(6) |  2109_AZ6102_GDSC2(6) | Esophageal Squamous Cell Carcinoma	HIF1A (4):	--2-- |  366_TWS119_GDSC1(3) |  1024_Lestaurtinib_GDSC1(2) | Esophageal Squamous Cell Carcinoma	HMGA1 (4):	--3-- |  1187_CCT245232_GDSC1(2) |  1843_LMP744_GDSC2(1) |  1926_GNE-317_GDSC2(2) | Esophageal Squamous Cell Carcinoma	IDH2 (7):	--2-- |  1136_Capivasertib_GDSC1(3) |  1451_PLK_6522_GDSC1(6) | Esophageal Squamous Cell Carcinoma	IGF1 (2):	--1-- |  576_RU-SKI 43_GDSC1(2) | Esophageal Squamous Cell Carcinoma	IGF1R (11):	--3-- |  1037_BX795_GDSC1(5) |  1012_Vorinostat_GDSC2(7) |  1738_IGF1R_3801_GDSC2(4) | Esophageal Squamous Cell Carcinoma	IGF2 (2):	--2-- |  1031_Elesclomol_GDSC1(1) |  1559_Luminespib_GDSC2(1) | Esophageal Squamous Cell Carcinoma	IKBKE (12):	--2-- |  164_JQ12_GDSC1(6) |  1032_Afatinib_GDSC2(8) | Esophageal Squamous Cell Carcinoma	IL6ST (8):	--2-- |  1054_Palbociclib_GDSC1(6) |  1083_Crizotinib_GDSC2(5) | Esophageal Squamous Cell Carcinoma	IL7R (6):	--2-- |  1734_VSP34_8731_GDSC2(4) |  1810_Mitoxantrone_GDSC2(5) | Esophageal Squamous Cell Carcinoma	IRS2 (2):	--1-- |  1062_Selumetinib_GDSC1(2) | Esophageal Squamous Cell Carcinoma	JAK2 (7):	--3-- |  302_PI-103_GDSC1(3) |  407_kb NB 142-70_GDSC1(5) |  1021_Axitinib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	JAK3 (7):	--1-- |  356_AT7867_GDSC1(7) | Esophageal Squamous Cell Carcinoma	KDR (5):	--2-- |  172_Embelin_GDSC1(3) |  1812_Bleomycin_GDSC2(2) | Esophageal Squamous Cell Carcinoma	KIT (7):	--2-- |  225_Genentech Cpd 10_GDSC1(4) |  1005_Cisplatin_GDSC1(5) | Esophageal Squamous Cell Carcinoma	KLF5 (2):	--1-- |  1849_Sabutoclax_GDSC2(2) | Esophageal Squamous Cell Carcinoma	KSR2 (12):	--4-- |  1032_Afatinib_GDSC1(5) |  1401_AZD5438_GDSC2(5) |  1558_Lapatinib_GDSC2(7) |  1912_Afuresertib_GDSC2(4) | Esophageal Squamous Cell Carcinoma	LGR5 (5):	--2-- |  268_Sepantronium bromide_GDSC1(3) |  1031_Elesclomol_GDSC1(4) | Esophageal Squamous Cell Carcinoma	LRP6 (7):	--1-- |  1032_Afatinib_GDSC2(7) | Esophageal Squamous Cell Carcinoma	LTK (8):	--3-- |  272_AR-42_GDSC1(3) |  1407_Dyrk1b_0191_GDSC1(4) |  1829_667880_GDSC2(5) | Esophageal Squamous Cell Carcinoma	LYN (8):	--2-- |  308_Foretinib_GDSC1(5) |  474_ARRY-520_GDSC1(5) | Esophageal Squamous Cell Carcinoma	MAP2K1 (6):	--2-- |  1031_Elesclomol_GDSC1(4) |  1249_BMS-345541_GDSC2(3) | Esophageal Squamous Cell Carcinoma	MAP2K2 (8):	--3-- |  1031_Elesclomol_GDSC1(5) |  1080_Paclitaxel_GDSC2(5) |  1248_Daporinad_GDSC2(2) | Esophageal Squamous Cell Carcinoma	MAP4K4 (8):	--4-- |  274_Belinostat_GDSC1(3) |  328_SNX-2112_GDSC1(4) |  1016_Temsirolimus_GDSC1(3) |  1133_Serdemetan_GDSC1(3) | Esophageal Squamous Cell Carcinoma	MAPK1 (4):	--2-- |  135_Gemcitabine_GDSC1(1) |  1062_Selumetinib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	MCL1 (6):	--2-- |  1050_ZM447439_GDSC2(5) |  1083_Crizotinib_GDSC2(4) | Esophageal Squamous Cell Carcinoma	MDM4 (9):	--2-- |  134_Etoposide_GDSC1(5) |  1919_Osimertinib_GDSC2(5) | Esophageal Squamous Cell Carcinoma	MEF2D (3):	--2-- |  439_LCL161_GDSC1(2) |  1187_CCT245232_GDSC1(2) | Esophageal Squamous Cell Carcinoma	MKI67 (11):	--3-- |  328_SNX-2112_GDSC1(6) |  1133_Serdemetan_GDSC1(4) |  1918_AZD8186_GDSC2(5) | Esophageal Squamous Cell Carcinoma	MLLT10 (5):	--1-- |  1080_Paclitaxel_GDSC2(5) | Esophageal Squamous Cell Carcinoma	MLLT3 (7):	--3-- |  163_JQ1_GDSC1(3) |  1022_AZD7762_GDSC1(3) |  1016_Temsirolimus_GDSC2(4) | Esophageal Squamous Cell Carcinoma	MSI1 (5):	--3-- |  1050_ZM447439_GDSC1(3) |  1359_965-D2_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Esophageal Squamous Cell Carcinoma	MSI2 (8):	--2-- |  1016_Temsirolimus_GDSC1(4) |  1840_630600_GDSC2(6) | Esophageal Squamous Cell Carcinoma	MST1R (3):	--2-- |  432_Flavopiridol_GDSC1(2) |  1179_MK-1775_GDSC2(2) | Esophageal Squamous Cell Carcinoma	MTOR (7):	--2-- |  1057_Dactolisib_GDSC2(3) |  1734_VSP34_8731_GDSC2(4) | Esophageal Squamous Cell Carcinoma	NADK (3):	--1-- |  436_CAP-232, TT-232, TLN-232_GDSC1(3) | Esophageal Squamous Cell Carcinoma	NCSTN (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1908_Ulixertinib_GDSC2(2) | Esophageal Squamous Cell Carcinoma	NFE2L2 (7):	--2-- |  1494_SN-38_GDSC1(5) |  1004_Vinblastine_GDSC2(4) | Esophageal Squamous Cell Carcinoma	NRG1 (12):	--2-- |  1058_Pictilisib_GDSC1(11) |  1919_Osimertinib_GDSC2(6) | Esophageal Squamous Cell Carcinoma	NSD2 (8):	--3-- |  326_GSK690693_GDSC1(3) |  1613_VE-822_GDSC2(4) |  1939_UMI-77_GDSC2(5) | Esophageal Squamous Cell Carcinoma	NTRK1 (4):	--2-- |  574_Wnt-C59_GDSC1(3) |  1847_BEN_GDSC2(3) | Esophageal Squamous Cell Carcinoma	NTRK2 (6):	--2-- |  283_Omipalisib_GDSC1(3) |  1739_JAK_8517_GDSC2(3) | Esophageal Squamous Cell Carcinoma	NTRK3 (14):	--3-- |  1037_BX795_GDSC1(8) |  1133_Serdemetan_GDSC1(7) |  1427_AZD5582_GDSC1(8) | Esophageal Squamous Cell Carcinoma	NUP214 (5):	--2-- |  328_SNX-2112_GDSC1(4) |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(3) | Esophageal Squamous Cell Carcinoma	NUP98 (10):	--2-- |  1032_Afatinib_GDSC2(8) |  1593_Entinostat_GDSC2(7) | Esophageal Squamous Cell Carcinoma	PAK1 (11):	--2-- |  356_AT7867_GDSC1(8) |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(5) | Esophageal Squamous Cell Carcinoma	PAK5 (4):	--1-- |  1188_CCT245467_GDSC1(4) | Esophageal Squamous Cell Carcinoma	PAX8 (3):	--2-- |  1059_AZD8055_GDSC1(2) |  1026_Tanespimycin_GDSC2(2) | Esophageal Squamous Cell Carcinoma	PDCD1 (5):	--2-- |  1005_Cisplatin_GDSC1(4) |  1922_Cediranib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PDCD1LG2 (2):	--1-- |  285_SU11274_GDSC1(2) | Esophageal Squamous Cell Carcinoma	PDGFRA (7):	--3-- |  184_BMS-754807_GDSC1(3) |  436_CAP-232, TT-232, TLN-232_GDSC1(4) |  2044_Pyridostatin_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PIK3CA (11):	--3-- |  226_GSK1070916_GDSC1(5) |  1026_Tanespimycin_GDSC1(6) |  1496_Cisplatin_GDSC1(6) | Esophageal Squamous Cell Carcinoma	PIK3CB (9):	--2-- |  446_MIM1_GDSC1(7) |  1032_Afatinib_GDSC2(7) | Esophageal Squamous Cell Carcinoma	PIK3CD (3):	--2-- |  268_Sepantronium bromide_GDSC1(1) |  1529_Pevonedistat_GDSC2(2) | Esophageal Squamous Cell Carcinoma	PIK3CG (6):	--3-- |  576_RU-SKI 43_GDSC1(2) |  1378_Bleomycin (50 uM)_GDSC1(4) |  1561_Taselisib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PLCG1 (8):	--2-- |  415_CPI-613_GDSC1(6) |  1192_GSK269962A_GDSC1(5) | Esophageal Squamous Cell Carcinoma	PPARG (3):	--2-- |  288_WHI-P97_GDSC1(2) |  1618_GSK2606414_GDSC2(2) | Esophageal Squamous Cell Carcinoma	PPM1D (7):	--2-- |  415_CPI-613_GDSC1(4) |  1026_Tanespimycin_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PRKACA (7):	--3-- |  268_Sepantronium bromide_GDSC1(2) |  283_Omipalisib_GDSC1(4) |  308_Foretinib_GDSC1(4) | Esophageal Squamous Cell Carcinoma	PRKCI (7):	--2-- |  308_Foretinib_GDSC1(6) |  1561_Taselisib_GDSC2(6) | Esophageal Squamous Cell Carcinoma	PSMB2 (4):	--2-- |  1031_Elesclomol_GDSC1(2) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(2) | Esophageal Squamous Cell Carcinoma	RAB35 (3):	--2-- |  1072_Avagacestat_GDSC1(2) |  1378_Bleomycin (50 uM)_GDSC1(2) | Esophageal Squamous Cell Carcinoma	RAC1 (11):	--3-- |  1496_Cisplatin_GDSC1(7) |  1378_Bleomycin (50 uM)_GDSC2(6) |  1912_Afuresertib_GDSC2(8) | Esophageal Squamous Cell Carcinoma	RAC2 (3):	--2-- |  1359_965-D2_GDSC1(2) |  1425_BPTES_GDSC1(2) | Esophageal Squamous Cell Carcinoma	REL (3):	--2-- |  295_NVP-BHG712_GDSC1(2) |  1926_GNE-317_GDSC2(2) | Esophageal Squamous Cell Carcinoma	RET (6):	--3-- |  260_NG-25_GDSC1(4) |  574_Wnt-C59_GDSC1(3) |  1249_BMS-345541_GDSC2(3) | Esophageal Squamous Cell Carcinoma	REV3L (12):	--2-- |  356_AT7867_GDSC1(9) |  1091_BMS-536924_GDSC2(7) | Esophageal Squamous Cell Carcinoma	RHEB (6):	--2-- |  196_Phenformin_GDSC1(2) |  380_BIBF-1120_GDSC1(4) | Esophageal Squamous Cell Carcinoma	RHOA (3):	--2-- |  295_NVP-BHG712_GDSC1(2) |  1243_Piperlongumine_GDSC1(1) | Esophageal Squamous Cell Carcinoma	RICTOR (12):	--3-- |  1526_Refametinib_GDSC1(7) |  1739_JAK_8517_GDSC2(5) |  1840_630600_GDSC2(6) | Esophageal Squamous Cell Carcinoma	RPS6KA4 (3):	--1-- |  1428_IAP_5620_GDSC1(3) | Esophageal Squamous Cell Carcinoma	RRAGC (2):	--2-- |  308_Foretinib_GDSC1(1) |  1031_Elesclomol_GDSC1(1) | Esophageal Squamous Cell Carcinoma	RUNX1T1 (5):	--2-- |  221_TAK-715_GDSC1(4) |  1578_Leflunomide_GDSC2(3) | Esophageal Squamous Cell Carcinoma	SCG5 (2):	--1-- |  1021_Axitinib_GDSC2(2) | Esophageal Squamous Cell Carcinoma	SETBP1 (6):	--3-- |  185_Linsitinib_GDSC1(4) |  196_Phenformin_GDSC1(2) |  1813_Fludarabine_GDSC2(2) | Esophageal Squamous Cell Carcinoma	SETD1A (5):	--2-- |  1188_CCT245467_GDSC1(4) |  1190_Gemcitabine_GDSC2(2) | Esophageal Squamous Cell Carcinoma	SGK1 (6):	--2-- |  1021_Axitinib_GDSC2(3) |  1083_Crizotinib_GDSC2(5) | Esophageal Squamous Cell Carcinoma	SMO (6):	--2-- |  140_Vinorelbine_GDSC1(3) |  1919_Osimertinib_GDSC2(4) | Esophageal Squamous Cell Carcinoma	SMYD3 (8):	--1-- |  1809_Teniposide_GDSC2(8) | Esophageal Squamous Cell Carcinoma	SOS1 (9):	--2-- |  302_PI-103_GDSC1(6) |  1918_AZD8186_GDSC2(5) | Esophageal Squamous Cell Carcinoma	SRC (8):	--2-- |  283_Omipalisib_GDSC1(5) |  1248_Daporinad_GDSC1(3) | Esophageal Squamous Cell Carcinoma	SS18 (2):	--1-- |  1021_Axitinib_GDSC2(2) | Esophageal Squamous Cell Carcinoma	STAT3 (4):	--1-- |  428_Pemetrexed_GDSC1(4) | Esophageal Squamous Cell Carcinoma	STAT5A (4):	--2-- |  186_Bexarotene_GDSC1(2) |  439_LCL161_GDSC1(2) | Esophageal Squamous Cell Carcinoma	STAT5B (5):	--2-- |  1459_PARP_0108_GDSC1(2) |  1932_NVP-ADW742_GDSC2(4) | Esophageal Squamous Cell Carcinoma	STAT6 (5):	--2-- |  1026_Tanespimycin_GDSC2(3) |  2040_Foretinib_GDSC2(4) | Esophageal Squamous Cell Carcinoma	SYK (6):	--2-- |  64_CMK_GDSC1(3) |  1060_PD0325901_GDSC2(5) | Esophageal Squamous Cell Carcinoma	TAL1 (3):	--2-- |  552_BAM7_GDSC1(2) |  1451_PLK_6522_GDSC1(1) | Esophageal Squamous Cell Carcinoma	TERT (8):	--4-- |  252_WZ3105_GDSC1(5) |  308_Foretinib_GDSC1(5) |  1050_ZM447439_GDSC1(4) |  1128_FS106_GDSC1(5) | Esophageal Squamous Cell Carcinoma	TSHR (13):	--3-- |  1001_AICA Ribonucleotide_GDSC1(8) |  1014_Refametinib_GDSC2(5) |  1091_BMS-536924_GDSC2(9) | Esophageal Squamous Cell Carcinoma	TYK2 (9):	--2-- |  185_Linsitinib_GDSC1(5) |  1593_Entinostat_GDSC2(6) | Esophageal Squamous Cell Carcinoma	UBR5 (9):	--3-- |  1016_Temsirolimus_GDSC1(4) |  1032_Afatinib_GDSC1(4) |  1922_Cediranib_GDSC2(6) | Esophageal Squamous Cell Carcinoma	USP8 (11):	--2-- |  219_AT-7519_GDSC1(6) |  1170_CCT-018159_GDSC1(8) | Esophageal Squamous Cell Carcinoma	VAV1 (10):	--3-- |  1133_Serdemetan_GDSC1(4) |  1372_Trametinib_GDSC2(8) |  1441_AZD2014_GDSC2(2) | Esophageal Squamous Cell Carcinoma	VAV2 (9):	--2-- |  1079_Dasatinib_GDSC2(6) |  1922_Cediranib_GDSC2(8) | Esophageal Squamous Cell Carcinoma	VEGFA (3):	--2-- |  164_JQ12_GDSC1(1) |  1378_Bleomycin (50 uM)_GDSC1(2) | Esophageal Squamous Cell Carcinoma	WWTR1 (7):	--2-- |  226_GSK1070916_GDSC1(5) |  1088_Irinotecan_GDSC2(5) | Esophageal Squamous Cell Carcinoma	YAP1 (6):	--1-- |  308_Foretinib_GDSC1(6) | Esophageal Squamous Cell Carcinoma	YES1 (8):	--3-- |  1232_I-BET-151_GDSC1(3) |  1365_BAY-HDAC11_2_GDSC1(4) |  1079_Dasatinib_GDSC2(3) | Ewing's Sarcoma	ADHFE1 (4):	--2-- |  3_Rapamycin_GDSC1(3) |  1089_Oxaliplatin_GDSC2(3) | Ewing's Sarcoma	AKT2 (2):	--1-- |  1016_Temsirolimus_GDSC1(2) | Ewing's Sarcoma	ALK (6):	--3-- |  3_Rapamycin_GDSC1(3) |  1463_AZD1332_GDSC1(3) |  1819_Docetaxel_GDSC2(3) | Ewing's Sarcoma	AR (3):	--1-- |  271_VNLG/124_GDSC1(3) | Ewing's Sarcoma	ARID3B (5):	--3-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1738_IGF1R_3801_GDSC2(2) |  1803_Acetalax_GDSC2(3) | Ewing's Sarcoma	ATXN7 (4):	--2-- |  257_NPK76-II-72-1_GDSC1(2) |  1261_rTRAIL_GDSC1(3) | Ewing's Sarcoma	BAALC (3):	--2-- |  1718_JAK1_8709_GDSC2(2) |  1786_AZD4547_GDSC2(2) | Ewing's Sarcoma	BCL9 (3):	--2-- |  1359_965-D2_GDSC1(2) |  1999_N25720-51-A1_GDSC2(2) | Ewing's Sarcoma	BCR (1):	--1-- |  291_KIN001-266_GDSC1(1) | Ewing's Sarcoma	BRAF (4):	--2-- |  1618_GSK2606414_GDSC2(2) |  1918_AZD8186_GDSC2(3) | Ewing's Sarcoma	CARD11 (3):	--1-- |  2170_AT13148_GDSC2(3) | Ewing's Sarcoma	CDK6 (4):	--2-- |  127_GSK269962A_GDSC1(2) |  1052_RO-3306_GDSC2(3) | Ewing's Sarcoma	CDK8 (2):	--1-- |  294_MPS-1-IN-1_GDSC1(2) | Ewing's Sarcoma	CSF3R (4):	--2-- |  362_CI-1033_GDSC1(2) |  1196_FY069_GDSC1(3) | Ewing's Sarcoma	DDR2 (4):	--3-- |  173_FH535_GDSC1(1) |  287_KIN001-244_GDSC1(2) |  1490_SN-38_GDSC1(2) | Ewing's Sarcoma	DNMT1 (3):	--1-- |  1803_Acetalax_GDSC2(3) | Ewing's Sarcoma	EGFR (4):	--2-- |  298_OSI-930_GDSC1(2) |  1175_Rucaparib_GDSC2(2) | Ewing's Sarcoma	EPOR (2):	--1-- |  1827_Dihydrorotenone_GDSC2(2) | Ewing's Sarcoma	ERBB4 (7):	--3-- |  204_Tipifarnib_GDSC1(3) |  222_BX-912_GDSC1(3) |  1835_Elephantin_GDSC2(5) | Ewing's Sarcoma	FLT4 (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  225_Genentech Cpd 10_GDSC1(1) | Ewing's Sarcoma	FUS (3):	--2-- |  111_Salubrinal_GDSC1(2) |  127_GSK269962A_GDSC1(2) | Ewing's Sarcoma	GNA12 (4):	--2-- |  257_NPK76-II-72-1_GDSC1(2) |  1261_rTRAIL_GDSC1(3) | Ewing's Sarcoma	GNAS (3):	--2-- |  179_5-Fluorouracil_GDSC1(2) |  1016_Temsirolimus_GDSC1(2) | Ewing's Sarcoma	GTF2I (4):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  2047_Ulixertinib_GDSC2(3) | Ewing's Sarcoma	HMGA2 (1):	--1-- |  179_5-Fluorouracil_GDSC1(1) | Ewing's Sarcoma	IDH2 (1):	--1-- |  1057_Dactolisib_GDSC2(1) | Ewing's Sarcoma	IGF1R (8):	--2-- |  177_GSK650394_GDSC1(6) |  1051_Alisertib_GDSC2(5) | Ewing's Sarcoma	IKBKE (2):	--1-- |  30_Sorafenib_GDSC1(2) | Ewing's Sarcoma	INSR (4):	--2-- |  9_MG-132_GDSC1(3) |  1910_ABT737_GDSC2(2) | Ewing's Sarcoma	JAK2 (5):	--3-- |  179_5-Fluorouracil_GDSC1(2) |  257_NPK76-II-72-1_GDSC1(2) |  1051_Alisertib_GDSC2(2) | Ewing's Sarcoma	KDM5A (3):	--2-- |  29_AZ628_GDSC1(2) |  1451_PLK_6522_GDSC1(2) | Ewing's Sarcoma	KIT (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1191_Bortezomib_GDSC2(2) | Ewing's Sarcoma	KSR2 (5):	--2-- |  1136_Capivasertib_GDSC1(3) |  1052_RO-3306_GDSC2(4) | Ewing's Sarcoma	LTK (3):	--2-- |  56_WH-4-023_GDSC1(2) |  1024_Lestaurtinib_GDSC2(1) | Ewing's Sarcoma	MAP3K13 (2):	--2-- |  362_CI-1033_GDSC1(1) |  1917_AZD6738_GDSC2(1) | Ewing's Sarcoma	MAP4K4 (5):	--2-- |  291_KIN001-266_GDSC1(2) |  1997_WEHI-539_GDSC2(4) | Ewing's Sarcoma	MCL1 (1):	--1-- |  1057_Dactolisib_GDSC2(1) | Ewing's Sarcoma	MDM4 (2):	--1-- |  1463_AZD1332_GDSC1(2) | Ewing's Sarcoma	MET (3):	--2-- |  1463_AZD1332_GDSC1(2) |  1051_Alisertib_GDSC2(2) | Ewing's Sarcoma	MLLT10 (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  225_Genentech Cpd 10_GDSC1(1) | Ewing's Sarcoma	MSI2 (4):	--3-- |  222_BX-912_GDSC1(1) |  294_MPS-1-IN-1_GDSC1(2) |  2171_BMS-754807_GDSC2(2) | Ewing's Sarcoma	MTOR (4):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1024_Lestaurtinib_GDSC2(3) | Ewing's Sarcoma	NCOA3 (4):	--2-- |  1084_Rapamycin_GDSC2(2) |  1827_Dihydrorotenone_GDSC2(2) | Ewing's Sarcoma	NCSTN (1):	--1-- |  294_MPS-1-IN-1_GDSC1(1) | Ewing's Sarcoma	NRG1 (8):	--2-- |  295_NVP-BHG712_GDSC1(7) |  1177_Niraparib_GDSC2(3) | Ewing's Sarcoma	NUP98 (7):	--2-- |  1626_OTX015_GDSC2(5) |  1922_Cediranib_GDSC2(4) | Ewing's Sarcoma	PDGFRB (4):	--2-- |  127_GSK269962A_GDSC1(2) |  1170_CCT-018159_GDSC1(3) | Ewing's Sarcoma	PIK3CA (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  225_Genentech Cpd 10_GDSC1(1) | Ewing's Sarcoma	PIK3CD (5):	--2-- |  159_HG6-64-1_GDSC1(2) |  1997_WEHI-539_GDSC2(4) | Ewing's Sarcoma	PLCG2 (5):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1382_AZD3514_GDSC1(3) | Ewing's Sarcoma	PRKACA (2):	--1-- |  1057_Dactolisib_GDSC2(2) | Ewing's Sarcoma	PRKCI (2):	--1-- |  199_Pazopanib_GDSC1(2) | Ewing's Sarcoma	RICTOR (5):	--3-- |  291_KIN001-266_GDSC1(2) |  1006_Cytarabine_GDSC1(2) |  1007_Docetaxel_GDSC1(2) | Ewing's Sarcoma	ROS1 (3):	--2-- |  1249_BMS-345541_GDSC2(2) |  1558_Lapatinib_GDSC2(2) | Ewing's Sarcoma	RPTOR (5):	--2-- |  1393_Gemcitabine_GDSC1(4) |  1017_Olaparib_GDSC2(3) | Ewing's Sarcoma	SETBP1 (4):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1997_WEHI-539_GDSC2(3) | Ewing's Sarcoma	SGK1 (3):	--2-- |  298_OSI-930_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Ewing's Sarcoma	SHOC2 (4):	--2-- |  1046_Wee1 Inhibitor_GDSC1(2) |  1844_776928_GDSC2(2) | Ewing's Sarcoma	SMYD3 (5):	--2-- |  104_Bortezomib_GDSC1(2) |  372_Pilaralisib_GDSC1(4) | Ewing's Sarcoma	SOS1 (4):	--2-- |  1046_Wee1 Inhibitor_GDSC1(2) |  1844_776928_GDSC2(2) | Ewing's Sarcoma	SQSTM1 (3):	--2-- |  1131_PRIMA-1MET_GDSC2(2) |  1786_AZD4547_GDSC2(2) | Ewing's Sarcoma	TSHR (1):	--1-- |  1179_MK-1775_GDSC2(1) | Ewing's Sarcoma	UBR5 (8):	--3-- |  51_Dasatinib_GDSC1(4) |  203_BMS-345541_GDSC1(3) |  1463_AZD1332_GDSC1(4) | Ewing's Sarcoma	USP8 (4):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1024_Lestaurtinib_GDSC2(3) | Ewing's Sarcoma	VAV1 (3):	--2-- |  1131_PRIMA-1MET_GDSC2(2) |  1249_BMS-345541_GDSC2(2) | Ewing's Sarcoma	VAV2 (3):	--2-- |  304_SB52334_GDSC1(2) |  1128_FS106_GDSC1(2) | Ewing's Sarcoma	WWP1 (5):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1367_BAY-HDAC11_4_GDSC1(3) | Ewing's Sarcoma	WWTR1 (4):	--2-- |  1451_PLK_6522_GDSC1(2) |  2148_POMHEX_GDSC2(2) | Gastric Carcinoma	ABL1 (6):	--2-- |  249_Cabozantinib_GDSC1(4) |  1732_TAF1_5496_GDSC2(3) | Gastric Carcinoma	ABL2 (6):	--2-- |  177_GSK650394_GDSC1(4) |  224_AS605240_GDSC1(5) | Gastric Carcinoma	ACVR1 (12):	--3-- |  219_AT-7519_GDSC1(7) |  1032_Afatinib_GDSC1(5) |  1168_Erlotinib_GDSC2(4) | Gastric Carcinoma	ADHFE1 (4):	--2-- |  262_VX-11e_GDSC1(2) |  1168_Erlotinib_GDSC2(3) | Gastric Carcinoma	AFF4 (6):	--2-- |  249_Cabozantinib_GDSC1(4) |  1549_Sapitinib_GDSC2(4) | Gastric Carcinoma	AGO1 (13):	--3-- |  171_AKT inhibitor VIII_GDSC1(5) |  356_AT7867_GDSC1(8) |  1261_rTRAIL_GDSC1(5) | Gastric Carcinoma	AKT2 (9):	--3-- |  224_AS605240_GDSC1(6) |  1799_Ibrutinib_GDSC2(4) |  2055_Mycophenolic acid_GDSC2(4) | Gastric Carcinoma	AKT3 (8):	--2-- |  301_PHA-793887_GDSC1(6) |  1578_Leflunomide_GDSC2(6) | Gastric Carcinoma	AR (4):	--2-- |  173_FH535_GDSC1(3) |  1449_AZD1208_GDSC1(3) | Gastric Carcinoma	ARHGEF28 (15):	--4-- |  1453_RAF_9304_GDSC1(9) |  1249_BMS-345541_GDSC2(6) |  1578_Leflunomide_GDSC2(8) |  1804_Acetalax_GDSC2(6) | Gastric Carcinoma	ARID3B (2):	--1-- |  255_CP724714_GDSC1(2) | Gastric Carcinoma	ATF1 (3):	--2-- |  238_Idelalisib_GDSC1(2) |  255_CP724714_GDSC1(2) | Gastric Carcinoma	ATXN7 (8):	--2-- |  1219_PFI-1_GDSC1(6) |  1558_Lapatinib_GDSC2(5) | Gastric Carcinoma	AXL (7):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1249_BMS-345541_GDSC2(5) | Gastric Carcinoma	BAALC (2):	--1-- |  1054_Palbociclib_GDSC2(2) | Gastric Carcinoma	BCL2 (4):	--2-- |  293_Amuvatinib_GDSC1(3) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	BCL3 (2):	--1-- |  1403_AZD6094_GDSC1(2) | Gastric Carcinoma	BCL9 (5):	--2-- |  153_Midostaurin_GDSC1(4) |  1128_FS106_GDSC1(2) | Gastric Carcinoma	BCR (10):	--3-- |  1060_PD0325901_GDSC1(6) |  1578_Leflunomide_GDSC2(7) |  1829_667880_GDSC2(6) | Gastric Carcinoma	BRAF (12):	--3-- |  375_Voxtalisib_GDSC1(7) |  1527_Pictilisib_GDSC1(5) |  1060_PD0325901_GDSC2(9) | Gastric Carcinoma	BRD3 (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1266_ICL1100013_GDSC1(3) | Gastric Carcinoma	BRD4 (10):	--3-- |  172_Embelin_GDSC1(4) |  1453_RAF_9304_GDSC1(7) |  1052_RO-3306_GDSC2(5) | Gastric Carcinoma	CALR (3):	--1-- |  2046_MK-8776_GDSC2(3) | Gastric Carcinoma	CCNB3 (3):	--1-- |  156_AZD6482_GDSC1(3) | Gastric Carcinoma	CCND3 (8):	--3-- |  176_IPA-3_GDSC1(4) |  380_BIBF-1120_GDSC1(3) |  1736_Selumetinib_GDSC2(4) | Gastric Carcinoma	CCNE1 (10):	--2-- |  1219_PFI-1_GDSC1(6) |  2096_VX-11e_GDSC2(7) | Gastric Carcinoma	CD274 (1):	--1-- |  1179_MK-1775_GDSC2(1) | Gastric Carcinoma	CD28 (3):	--2-- |  1168_Erlotinib_GDSC2(2) |  1919_Osimertinib_GDSC2(2) | Gastric Carcinoma	CD79B (3):	--1-- |  1463_AZD1332_GDSC2(3) | Gastric Carcinoma	CDK6 (4):	--2-- |  1005_Cisplatin_GDSC2(2) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	COP1 (7):	--2-- |  165_DMOG_GDSC1(4) |  208_Ispinesib Mesylate_GDSC1(6) | Gastric Carcinoma	CSF3R (14):	--4-- |  171_AKT inhibitor VIII_GDSC1(5) |  1236_UNC0638_GDSC1(6) |  1372_Trametinib_GDSC2(6) |  1578_Leflunomide_GDSC2(7) | Gastric Carcinoma	CTNNB1 (5):	--2-- |  170_Shikonin_GDSC1(3) |  1192_GSK269962A_GDSC1(3) | Gastric Carcinoma	CYSLTR2 (2):	--1-- |  1009_Tretinoin_GDSC1(2) | Gastric Carcinoma	DCUN1D1 (5):	--3-- |  176_IPA-3_GDSC1(3) |  1022_AZD7762_GDSC1(3) |  1495_Olaparib_GDSC1(2) | Gastric Carcinoma	DDR2 (8):	--2-- |  431_Alisertib_GDSC1(5) |  1183_CRT0160829_GDSC1(6) | Gastric Carcinoma	DDX4 (5):	--2-- |  170_Shikonin_GDSC1(2) |  1036_PLX-4720_GDSC2(3) | Gastric Carcinoma	DEK (4):	--2-- |  211_TL-2-105_GDSC1(3) |  1016_Temsirolimus_GDSC2(3) | Gastric Carcinoma	DNMT1 (14):	--3-- |  310_YM201636_GDSC1(8) |  1453_RAF_9304_GDSC1(9) |  2048_Vinorelbine_GDSC2(8) | Gastric Carcinoma	DOT1L (10):	--3-- |  283_Omipalisib_GDSC1(5) |  1058_Pictilisib_GDSC1(5) |  1559_Luminespib_GDSC2(7) | Gastric Carcinoma	EGFL7 (9):	--3-- |  342_Tenovin-6_GDSC1(5) |  1031_Elesclomol_GDSC1(3) |  1191_Bortezomib_GDSC2(6) | Gastric Carcinoma	EIF4A2 (7):	--3-- |  1185_KU-60019_GDSC1(3) |  1498_Selumetinib_GDSC1(4) |  1939_UMI-77_GDSC2(4) | Gastric Carcinoma	EPOR (3):	--2-- |  151_QS11_GDSC1(2) |  1613_VE-822_GDSC2(2) | Gastric Carcinoma	ERBB2 (9):	--3-- |  158_PF-562271_GDSC1(5) |  221_TAK-715_GDSC1(5) |  1372_Trametinib_GDSC1(3) | Gastric Carcinoma	ERBB3 (6):	--2-- |  294_MPS-1-IN-1_GDSC1(4) |  1016_Temsirolimus_GDSC2(4) | Gastric Carcinoma	ERBB4 (11):	--4-- |  156_AZD6482_GDSC1(4) |  1236_UNC0638_GDSC1(4) |  1249_BMS-345541_GDSC2(5) |  1372_Trametinib_GDSC2(4) | Gastric Carcinoma	ERG (9):	--2-- |  228_AKT inhibitor VIII_GDSC1(7) |  1720_AZD5991_GDSC2(5) | Gastric Carcinoma	ESR1 (8):	--2-- |  179_5-Fluorouracil_GDSC1(6) |  1249_BMS-345541_GDSC2(5) | Gastric Carcinoma	ETV1 (8):	--2-- |  1428_IAP_5620_GDSC1(6) |  1844_776928_GDSC2(3) | Gastric Carcinoma	ETV5 (3):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1624_I-BET-762_GDSC2(2) | Gastric Carcinoma	EWSR1 (6):	--1-- |  1924_Ipatasertib_GDSC2(6) | Gastric Carcinoma	EZH1 (8):	--2-- |  224_AS605240_GDSC1(6) |  1847_BEN_GDSC2(5) | Gastric Carcinoma	FGF3 (5):	--2-- |  170_Shikonin_GDSC1(2) |  1510_Linsitinib_GDSC2(3) | Gastric Carcinoma	FGFR2 (14):	--5-- |  172_Embelin_GDSC1(5) |  1021_Axitinib_GDSC1(5) |  1016_Temsirolimus_GDSC2(5) |  1053_MK-2206_GDSC2(8) |  2046_MK-8776_GDSC2(5) | Gastric Carcinoma	FGFR3 (5):	--2-- |  1720_AZD5991_GDSC2(4) |  1778_GSK2110183B_GDSC2(2) | Gastric Carcinoma	FGFR4 (3):	--2-- |  1185_KU-60019_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Gastric Carcinoma	FLI1 (5):	--1-- |  272_AR-42_GDSC1(5) | Gastric Carcinoma	FLT1 (12):	--3-- |  303_PIK-93_GDSC1(7) |  474_ARRY-520_GDSC1(7) |  1048_Mirin_GDSC1(5) | Gastric Carcinoma	FLT4 (13):	--4-- |  201_Epothilone B_GDSC1(7) |  204_Tipifarnib_GDSC1(7) |  1066_AZD6482_GDSC1(6) |  1261_rTRAIL_GDSC1(5) | Gastric Carcinoma	FUS (4):	--2-- |  275_I-BET-762_GDSC1(3) |  1451_PLK_6522_GDSC1(1) | Gastric Carcinoma	FYN (6):	--3-- |  435_C-75_GDSC1(2) |  1185_KU-60019_GDSC1(3) |  1054_Palbociclib_GDSC2(3) | Gastric Carcinoma	GAB1 (3):	--1-- |  294_MPS-1-IN-1_GDSC1(3) | Gastric Carcinoma	GAB2 (4):	--2-- |  1614_WZ4003_GDSC2(2) |  2047_Ulixertinib_GDSC2(3) | Gastric Carcinoma	GNA12 (9):	--2-- |  221_TAK-715_GDSC1(6) |  303_PIK-93_GDSC1(6) | Gastric Carcinoma	GNAQ (7):	--3-- |  308_Foretinib_GDSC1(3) |  1062_Selumetinib_GDSC2(4) |  1511_Epirubicin_GDSC2(3) | Gastric Carcinoma	GNAS (16):	--3-- |  226_GSK1070916_GDSC1(9) |  436_CAP-232, TT-232, TLN-232_GDSC1(9) |  1494_SN-38_GDSC2(10) | Gastric Carcinoma	GNB1 (7):	--2-- |  199_Pazopanib_GDSC1(5) |  208_Ispinesib Mesylate_GDSC1(5) | Gastric Carcinoma	GSK3B (8):	--2-- |  225_Genentech Cpd 10_GDSC1(5) |  1558_Lapatinib_GDSC2(5) | Gastric Carcinoma	GTF2I (6):	--2-- |  1430_IGFR_3801_GDSC1(5) |  1561_Taselisib_GDSC2(3) | Gastric Carcinoma	HDAC1 (3):	--2-- |  175_PAC-1_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	HDAC7 (9):	--3-- |  317_WYE-125132_GDSC1(5) |  1453_RAF_9304_GDSC1(7) |  1464_TTK_3146_GDSC1(6) | Gastric Carcinoma	HMGA1 (8):	--3-- |  474_ARRY-520_GDSC1(4) |  1527_Pictilisib_GDSC1(3) |  1578_Leflunomide_GDSC2(5) | Gastric Carcinoma	IDH1 (3):	--2-- |  1449_AZD1208_GDSC1(2) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(2) | Gastric Carcinoma	IDH2 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1005_Cisplatin_GDSC2(2) | Gastric Carcinoma	IGF1R (5):	--3-- |  252_WZ3105_GDSC1(2) |  1232_I-BET-151_GDSC1(2) |  1430_IGFR_3801_GDSC1(3) | Gastric Carcinoma	IKBKE (5):	--1-- |  1720_AZD5991_GDSC2(5) | Gastric Carcinoma	IL3 (4):	--2-- |  261_TL-1-85_GDSC1(2) |  1461_TANK_1366_GDSC1(2) | Gastric Carcinoma	IL6ST (8):	--2-- |  264_ACY-1215_GDSC1(5) |  1918_AZD8186_GDSC2(5) | Gastric Carcinoma	IL7R (3):	--1-- |  1192_GSK269962A_GDSC1(3) | Gastric Carcinoma	INSR (14):	--3-- |  1006_Cytarabine_GDSC1(4) |  1578_Leflunomide_GDSC2(7) |  2156_5-azacytidine_GDSC2(9) | Gastric Carcinoma	IRS1 (8):	--2-- |  177_GSK650394_GDSC1(4) |  1021_Axitinib_GDSC2(5) | Gastric Carcinoma	JAK2 (12):	--4-- |  1232_I-BET-151_GDSC1(5) |  1239_YK-4-279_GDSC1(4) |  1427_AZD5582_GDSC1(7) |  1804_Acetalax_GDSC2(5) | Gastric Carcinoma	JAK3 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(3) |  1057_Dactolisib_GDSC2(3) | Gastric Carcinoma	KDM5A (7):	--2-- |  1183_CRT0160829_GDSC1(6) |  1057_Dactolisib_GDSC2(4) | Gastric Carcinoma	KDR (4):	--2-- |  1059_AZD8055_GDSC1(3) |  1059_AZD8055_GDSC2(2) | Gastric Carcinoma	KSR2 (14):	--3-- |  184_BMS-754807_GDSC1(6) |  1232_I-BET-151_GDSC1(7) |  1922_Cediranib_GDSC2(7) | Gastric Carcinoma	LMO1 (8):	--3-- |  375_Voxtalisib_GDSC1(5) |  474_ARRY-520_GDSC1(4) |  1427_AZD5582_GDSC1(4) | Gastric Carcinoma	LTK (8):	--2-- |  1019_Bosutinib_GDSC1(4) |  1494_SN-38_GDSC1(6) | Gastric Carcinoma	MAP2K2 (5):	--2-- |  1066_AZD6482_GDSC1(4) |  1005_Cisplatin_GDSC2(2) | Gastric Carcinoma	MAP3K13 (12):	--2-- |  1135_AZD4547_GDSC1(7) |  1578_Leflunomide_GDSC2(7) | Gastric Carcinoma	MAP4K4 (11):	--2-- |  474_ARRY-520_GDSC1(7) |  1011_Navitoclax_GDSC1(6) | Gastric Carcinoma	MDM2 (5):	--3-- |  1248_Daporinad_GDSC1(1) |  1373_Dabrafenib_GDSC1(2) |  1997_WEHI-539_GDSC2(2) | Gastric Carcinoma	MECOM (13):	--2-- |  1135_AZD4547_GDSC1(8) |  135_Gemcitabine_GDSC1(7) | Gastric Carcinoma	MEF2D (4):	--2-- |  1047_Nutlin-3a (-)_GDSC2(3) |  1736_Selumetinib_GDSC2(3) | Gastric Carcinoma	MET (5):	--2-- |  1187_CCT245232_GDSC1(4) |  1091_BMS-536924_GDSC2(3) | Gastric Carcinoma	MGAM (13):	--3-- |  207_AS601245_GDSC1(9) |  474_ARRY-520_GDSC1(7) |  1249_BMS-345541_GDSC2(6) | Gastric Carcinoma	MKI67 (9):	--4-- |  1434_JAK3_7406_GDSC1(6) |  1464_TTK_3146_GDSC1(6) |  1835_Elephantin_GDSC2(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Gastric Carcinoma	MLLT3 (10):	--2-- |  474_ARRY-520_GDSC1(6) |  1453_RAF_9304_GDSC1(7) | Gastric Carcinoma	MPL (3):	--2-- |  376_Brivanib, BMS-540215_GDSC1(2) |  1129_PF-4708671_GDSC1(2) | Gastric Carcinoma	MSI1 (3):	--2-- |  1248_Daporinad_GDSC1(1) |  1373_Dabrafenib_GDSC1(2) | Gastric Carcinoma	MSI2 (6):	--3-- |  299_OSI-027_GDSC1(3) |  1449_AZD1208_GDSC1(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Gastric Carcinoma	MTOR (12):	--3-- |  1008_Methotrexate_GDSC2(9) |  1578_Leflunomide_GDSC2(7) |  2172_JQ1_GDSC2(5) | Gastric Carcinoma	NADK (4):	--3-- |  1058_Pictilisib_GDSC1(1) |  1266_ICL1100013_GDSC1(2) |  1372_Trametinib_GDSC1(1) | Gastric Carcinoma	NCSTN (5):	--1-- |  287_KIN001-244_GDSC1(5) | Gastric Carcinoma	NSD2 (15):	--4-- |  299_OSI-027_GDSC1(6) |  1453_RAF_9304_GDSC1(8) |  1190_Gemcitabine_GDSC2(10) |  1578_Leflunomide_GDSC2(8) | Gastric Carcinoma	NT5C2 (9):	--3-- |  317_WYE-125132_GDSC1(6) |  1199_Tamoxifen_GDSC2(3) |  1847_BEN_GDSC2(5) | Gastric Carcinoma	NTRK1 (13):	--3-- |  153_Midostaurin_GDSC1(6) |  310_YM201636_GDSC1(7) |  1426_AZD7969_GDSC1(6) | Gastric Carcinoma	NTRK2 (8):	--2-- |  310_YM201636_GDSC1(5) |  1183_CRT0160829_GDSC1(5) | Gastric Carcinoma	NTRK3 (14):	--3-- |  476_SB505124_GDSC1(10) |  1190_Gemcitabine_GDSC2(9) |  1511_Epirubicin_GDSC2(8) | Gastric Carcinoma	NUP214 (10):	--3-- |  179_5-Fluorouracil_GDSC1(6) |  1553_Uprosertib_GDSC2(6) |  1593_Entinostat_GDSC2(3) | Gastric Carcinoma	NUP98 (12):	--3-- |  171_AKT inhibitor VIII_GDSC1(5) |  310_YM201636_GDSC1(7) |  1553_Uprosertib_GDSC2(7) | Gastric Carcinoma	PAK5 (7):	--2-- |  1261_rTRAIL_GDSC1(4) |  1560_Alpelisib_GDSC2(5) | Gastric Carcinoma	PDCD1LG2 (4):	--2-- |  156_AZD6482_GDSC1(3) |  326_GSK690693_GDSC1(3) | Gastric Carcinoma	PDGFRA (11):	--4-- |  224_AS605240_GDSC1(6) |  1031_Elesclomol_GDSC1(4) |  1236_UNC0638_GDSC1(3) |  1007_Docetaxel_GDSC2(3) | Gastric Carcinoma	PDGFRB (5):	--2-- |  474_ARRY-520_GDSC1(2) |  1005_Cisplatin_GDSC1(4) | Gastric Carcinoma	PGR (4):	--2-- |  176_IPA-3_GDSC1(3) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	PIK3CA (12):	--3-- |  303_PIK-93_GDSC1(7) |  1445_AZD8835_GDSC1(6) |  1553_Uprosertib_GDSC2(8) | Gastric Carcinoma	PIK3CB (9):	--2-- |  301_PHA-793887_GDSC1(6) |  1261_rTRAIL_GDSC1(4) | Gastric Carcinoma	PIK3CD (9):	--2-- |  1249_BMS-345541_GDSC2(4) |  1432_AZD1480_GDSC1(6) | Gastric Carcinoma	PLCG1 (6):	--2-- |  284_JNJ38877605_GDSC1(5) |  2111_VE821_GDSC2(3) | Gastric Carcinoma	PLCG2 (10):	--3-- |  310_YM201636_GDSC1(7) |  356_AT7867_GDSC1(8) |  1407_Dyrk1b_0191_GDSC1(3) | Gastric Carcinoma	PRKACA (9):	--3-- |  165_DMOG_GDSC1(3) |  285_SU11274_GDSC1(5) |  1187_CCT245232_GDSC1(4) | Gastric Carcinoma	PTPN11 (2):	--1-- |  576_RU-SKI 43_GDSC1(2) | Gastric Carcinoma	RAC1 (8):	--3-- |  155_Ponatinib_GDSC1(4) |  171_AKT inhibitor VIII_GDSC1(4) |  1444_AZD8186_GDSC1(4) | Gastric Carcinoma	RAF1 (6):	--3-- |  153_Midostaurin_GDSC1(4) |  1185_KU-60019_GDSC1(3) |  1022_AZD7762_GDSC2(4) | Gastric Carcinoma	RET (12):	--5-- |  252_WZ3105_GDSC1(7) |  1024_Lestaurtinib_GDSC1(5) |  1026_Tanespimycin_GDSC2(5) |  1912_Afuresertib_GDSC2(4) |  1917_AZD6738_GDSC2(5) | Gastric Carcinoma	REV3L (9):	--2-- |  1453_RAF_9304_GDSC1(7) |  1463_AZD1332_GDSC2(5) | Gastric Carcinoma	RHOA (8):	--3-- |  135_Gemcitabine_GDSC1(4) |  1036_PLX-4720_GDSC2(3) |  1510_Linsitinib_GDSC2(3) | Gastric Carcinoma	RICTOR (10):	--2-- |  317_WYE-125132_GDSC1(6) |  1032_Afatinib_GDSC1(5) | Gastric Carcinoma	ROS1 (11):	--3-- |  1016_Temsirolimus_GDSC1(4) |  1847_BEN_GDSC2(6) |  2171_BMS-754807_GDSC2(4) | Gastric Carcinoma	RPS6KB2 (3):	--1-- |  1188_CCT245467_GDSC1(3) | Gastric Carcinoma	RPTOR (16):	--3-- |  356_AT7867_GDSC1(10) |  1407_Dyrk1b_0191_GDSC1(7) |  1460_PARP_9482_GDSC1(7) | Gastric Carcinoma	RRAGC (3):	--2-- |  255_CP724714_GDSC1(2) |  344_THZ-2-49_GDSC1(2) | Gastric Carcinoma	RUNX1T1 (6):	--2-- |  1047_Nutlin-3a (-)_GDSC1(4) |  1445_AZD8835_GDSC1(5) | Gastric Carcinoma	SET (4):	--2-- |  261_TL-1-85_GDSC1(2) |  1720_AZD5991_GDSC2(3) | Gastric Carcinoma	SETBP1 (8):	--4-- |  284_JNJ38877605_GDSC1(5) |  1142_HG-5-113-01_GDSC1(1) |  1236_UNC0638_GDSC1(2) |  1086_BI-2536_GDSC2(4) | Gastric Carcinoma	SETD1A (3):	--2-- |  474_ARRY-520_GDSC1(1) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	SF3B1 (8):	--2-- |  1261_rTRAIL_GDSC1(4) |  1131_PRIMA-1MET_GDSC2(4) | Gastric Carcinoma	SGK1 (8):	--2-- |  260_NG-25_GDSC1(5) |  1062_Selumetinib_GDSC1(3) | Gastric Carcinoma	SHOC2 (3):	--2-- |  252_WZ3105_GDSC1(2) |  1430_IGFR_3801_GDSC1(2) | Gastric Carcinoma	SMO (9):	--2-- |  303_PIK-93_GDSC1(7) |  1847_BEN_GDSC2(6) | Gastric Carcinoma	SMYD3 (10):	--3-- |  310_YM201636_GDSC1(7) |  1058_Pictilisib_GDSC1(6) |  1249_BMS-345541_GDSC2(5) | Gastric Carcinoma	SOS1 (11):	--2-- |  1453_RAF_9304_GDSC1(7) |  1553_Uprosertib_GDSC2(7) | Gastric Carcinoma	SS18 (3):	--1-- |  1168_Erlotinib_GDSC2(3) | Gastric Carcinoma	STAT3 (6):	--3-- |  300_CX-5461_GDSC1(3) |  344_THZ-2-49_GDSC1(3) |  1011_Navitoclax_GDSC1(4) | Gastric Carcinoma	STAT5B (5):	--2-- |  1243_Piperlongumine_GDSC1(2) |  1179_MK-1775_GDSC2(3) | Gastric Carcinoma	SYK (7):	--2-- |  1249_BMS-345541_GDSC2(5) |  1835_Elephantin_GDSC2(3) | Gastric Carcinoma	TLX1 (2):	--1-- |  1403_AZD6094_GDSC1(2) | Gastric Carcinoma	TRIM27 (3):	--2-- |  1168_Erlotinib_GDSC2(2) |  1840_630600_GDSC2(2) | Gastric Carcinoma	TSHR (11):	--3-- |  1053_MK-2206_GDSC1(3) |  1372_Trametinib_GDSC1(7) |  1016_Temsirolimus_GDSC2(5) | Gastric Carcinoma	TYK2 (6):	--2-- |  1019_Bosutinib_GDSC1(4) |  1910_ABT737_GDSC2(3) | Gastric Carcinoma	UBR5 (12):	--2-- |  303_PIK-93_GDSC1(8) |  1419_FEN1_3940_GDSC1(7) | Gastric Carcinoma	VAV1 (9):	--2-- |  1060_PD0325901_GDSC1(6) |  1197_ZL049_GDSC1(6) | Gastric Carcinoma	VAV2 (14):	--4-- |  171_AKT inhibitor VIII_GDSC1(5) |  476_SB505124_GDSC1(9) |  1046_Wee1 Inhibitor_GDSC2(4) |  1917_AZD6738_GDSC2(6) | Gastric Carcinoma	VEGFA (6):	--3-- |  272_AR-42_GDSC1(1) |  1068_Obatoclax Mesylate_GDSC2(3) |  1191_Bortezomib_GDSC2(3) | Gastric Carcinoma	XBP1 (7):	--3-- |  1242_(5Z)-7-Oxozeaenol_GDSC1(3) |  1578_Leflunomide_GDSC2(5) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Gastric Carcinoma	XPO1 (5):	--2-- |  173_FH535_GDSC1(3) |  1259_Talazoparib_GDSC2(3) | Gastric Carcinoma	YES1 (3):	--2-- |  344_THZ-2-49_GDSC1(2) |  1430_IGFR_3801_GDSC1(1) | Glioblastoma	ABL1 (7):	--2-- |  328_SNX-2112_GDSC1(4) |  1494_SN-38_GDSC1(5) | Glioblastoma	ABL2 (6):	--2-- |  190_Bleomycin_GDSC1(5) |  1164_XMD8-92_GDSC1(3) | Glioblastoma	ACVR1 (3):	--2-- |  326_GSK690693_GDSC1(2) |  2046_MK-8776_GDSC2(2) | Glioblastoma	ADHFE1 (5):	--2-- |  159_HG6-64-1_GDSC1(4) |  269_NSC-207895_GDSC1(3) | Glioblastoma	AFF4 (4):	--2-- |  186_Bexarotene_GDSC1(2) |  1009_Tretinoin_GDSC1(3) | Glioblastoma	AGO1 (5):	--2-- |  159_HG6-64-1_GDSC1(4) |  269_NSC-207895_GDSC1(3) | Glioblastoma	AKT2 (3):	--1-- |  1008_Methotrexate_GDSC2(3) | Glioblastoma	AKT3 (7):	--3-- |  186_Bexarotene_GDSC1(3) |  208_Ispinesib Mesylate_GDSC1(5) |  1049_PD173074_GDSC1(2) | Glioblastoma	ALK (8):	--2-- |  407_kb NB 142-70_GDSC1(5) |  1847_BEN_GDSC2(5) | Glioblastoma	AR (3):	--2-- |  428_Pemetrexed_GDSC1(2) |  1197_ZL049_GDSC1(2) | Glioblastoma	ARHGEF28 (11):	--2-- |  1007_Docetaxel_GDSC1(10) |  1011_Navitoclax_GDSC1(5) | Glioblastoma	AXL (3):	--2-- |  1016_Temsirolimus_GDSC1(2) |  1873_Buparlisib_GDSC2(2) | Glioblastoma	BAALC (3):	--2-- |  1008_Methotrexate_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | Glioblastoma	BCL2 (3):	--2-- |  110_Seliciclib_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(2) | Glioblastoma	BCL3 (3):	--2-- |  294_MPS-1-IN-1_GDSC1(2) |  2096_VX-11e_GDSC2(2) | Glioblastoma	BCL6 (3):	--2-- |  256_JW-7-24-1_GDSC1(2) |  1024_Lestaurtinib_GDSC1(1) | Glioblastoma	BCR (8):	--2-- |  226_GSK1070916_GDSC1(6) |  1845_Schweinfurthin A_GDSC2(6) | Glioblastoma	BRAF (5):	--1-- |  1024_Lestaurtinib_GDSC1(5) | Glioblastoma	BRD3 (4):	--2-- |  342_Tenovin-6_GDSC1(2) |  1016_Temsirolimus_GDSC1(2) | Glioblastoma	BTK (11):	--3-- |  295_NVP-BHG712_GDSC1(3) |  415_CPI-613_GDSC1(7) |  1232_I-BET-151_GDSC1(6) | Glioblastoma	CARD11 (15):	--2-- |  302_PI-103_GDSC1(11) |  1926_GNE-317_GDSC2(12) | Glioblastoma	CCNB3 (3):	--2-- |  331_QL-X-138_GDSC1(2) |  1812_Bleomycin_GDSC2(2) | Glioblastoma	CCND2 (5):	--3-- |  51_Dasatinib_GDSC1(2) |  1011_Navitoclax_GDSC2(3) |  1089_Oxaliplatin_GDSC2(2) | Glioblastoma	CD274 (6):	--2-- |  252_WZ3105_GDSC1(2) |  1052_RO-3306_GDSC2(4) | Glioblastoma	CDC42 (3):	--2-- |  1197_ZL049_GDSC1(2) |  2096_VX-11e_GDSC2(2) | Glioblastoma	CDK8 (3):	--1-- |  159_HG6-64-1_GDSC1(3) | Glioblastoma	COP1 (7):	--2-- |  1451_PLK_6522_GDSC1(5) |  1372_Trametinib_GDSC2(4) | Glioblastoma	CSF3R (8):	--2-- |  35_NVP-TAE684_GDSC1(6) |  249_Cabozantinib_GDSC1(6) | Glioblastoma	CTNNB1 (3):	--2-- |  1367_BAY-HDAC11_4_GDSC1(2) |  1558_Lapatinib_GDSC2(2) | Glioblastoma	CYP19A1 (3):	--2-- |  262_VX-11e_GDSC1(2) |  1177_Niraparib_GDSC2(2) | Glioblastoma	DCUN1D1 (6):	--2-- |  223_ZSTK474_GDSC1(4) |  1409_AZD4877_GDSC1(5) | Glioblastoma	DNMT1 (14):	--3-- |  1250_AZ960_GDSC2(9) |  1372_Trametinib_GDSC1(6) |  342_Tenovin-6_GDSC1(10) | Glioblastoma	DOT1L (9):	--2-- |  301_PHA-793887_GDSC1(7) |  381_AST-1306_GDSC1(8) | Glioblastoma	EGFL7 (11):	--3-- |  156_AZD6482_GDSC1(4) |  299_OSI-027_GDSC1(7) |  1024_Lestaurtinib_GDSC1(7) | Glioblastoma	EGFR (13):	--2-- |  299_OSI-027_GDSC1(10) |  415_CPI-613_GDSC1(9) | Glioblastoma	EIF4A2 (6):	--2-- |  1005_Cisplatin_GDSC1(4) |  1409_AZD4877_GDSC1(4) | Glioblastoma	ERBB2 (8):	--3-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1190_Gemcitabine_GDSC2(5) |  2040_Foretinib_GDSC2(5) | Glioblastoma	ERBB3 (6):	--3-- |  180_Thapsigargin_GDSC1(4) |  299_OSI-027_GDSC1(3) |  1527_Pictilisib_GDSC1(2) | Glioblastoma	ERBB4 (10):	--3-- |  262_VX-11e_GDSC1(3) |  1243_Piperlongumine_GDSC1(7) |  1060_PD0325901_GDSC2(3) | Glioblastoma	ERG (9):	--2-- |  235_QL-XII-47_GDSC1(6) |  1051_Alisertib_GDSC2(5) | Glioblastoma	FGFR1 (5):	--2-- |  546_FTY-720_GDSC1(4) |  1047_Nutlin-3a (-)_GDSC1(4) | Glioblastoma	FGFR2 (4):	--2-- |  1036_PLX-4720_GDSC1(2) |  1464_TTK_3146_GDSC1(3) | Glioblastoma	FGFR3 (7):	--2-- |  269_NSC-207895_GDSC1(3) |  1409_AZD4877_GDSC1(5) | Glioblastoma	FGFR4 (4):	--1-- |  1083_Crizotinib_GDSC2(4) | Glioblastoma	FLI1 (5):	--2-- |  1008_Methotrexate_GDSC1(2) |  1060_PD0325901_GDSC2(3) | Glioblastoma	FLT3 (6):	--2-- |  1444_AZD8186_GDSC1(4) |  1049_PD173074_GDSC2(3) | Glioblastoma	FLT4 (10):	--3-- |  245_UNC0638_GDSC1(5) |  1432_AZD1480_GDSC1(6) |  1013_Nilotinib_GDSC2(5) | Glioblastoma	FURIN (5):	--2-- |  1050_ZM447439_GDSC1(4) |  1445_AZD8835_GDSC1(4) | Glioblastoma	FYN (3):	--1-- |  1083_Crizotinib_GDSC2(3) | Glioblastoma	GAB1 (2):	--1-- |  197_Bryostatin 1_GDSC1(2) | Glioblastoma	GAB2 (3):	--2-- |  344_THZ-2-49_GDSC1(2) |  449_CD532_GDSC1(2) | Glioblastoma	GATA2 (4):	--2-- |  1031_Elesclomol_GDSC1(3) |  1557_LCL161_GDSC2(2) | Glioblastoma	GLI1 (4):	--1-- |  299_OSI-027_GDSC1(4) | Glioblastoma	GNA11 (7):	--3-- |  1429_IAP_7638_GDSC1(3) |  1085_Sorafenib_GDSC2(5) |  1812_Bleomycin_GDSC2(2) | Glioblastoma	GNA12 (5):	--1-- |  546_FTY-720_GDSC1(5) | Glioblastoma	GNAS (5):	--2-- |  1001_AICA Ribonucleotide_GDSC1(4) |  1197_ZL049_GDSC1(3) | Glioblastoma	GSK3B (9):	--2-- |  178_BAY-61-3606_GDSC1(7) |  2109_AZ6102_GDSC2(7) | Glioblastoma	HDAC1 (4):	--2-- |  257_NPK76-II-72-1_GDSC1(3) |  1089_Oxaliplatin_GDSC2(2) | Glioblastoma	HDAC7 (5):	--3-- |  1175_Rucaparib_GDSC1(2) |  1428_IAP_5620_GDSC1(3) |  1460_PARP_9482_GDSC1(3) | Glioblastoma	HGF (6):	--2-- |  342_Tenovin-6_GDSC1(5) |  432_Flavopiridol_GDSC1(5) | Glioblastoma	HMGA1 (8):	--2-- |  208_Ispinesib Mesylate_GDSC1(6) |  1617_AZD5582_GDSC2(5) | Glioblastoma	IDH2 (3):	--2-- |  1030_KU-55933_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | Glioblastoma	IGF1 (3):	--2-- |  1197_ZL049_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | Glioblastoma	IGF1R (8):	--2-- |  299_OSI-027_GDSC1(7) |  331_QL-X-138_GDSC1(6) | Glioblastoma	IKBKE (8):	--3-- |  197_Bryostatin 1_GDSC1(2) |  1022_AZD7762_GDSC2(3) |  1084_Rapamycin_GDSC2(5) | Glioblastoma	INSR (7):	--2-- |  208_Ispinesib Mesylate_GDSC1(6) |  1011_Navitoclax_GDSC2(4) | Glioblastoma	JAK2 (7):	--3-- |  5_Sunitinib_GDSC1(5) |  54_CGP-082996_GDSC1(5) |  1829_667880_GDSC2(4) | Glioblastoma	JAK3 (5):	--1-- |  299_OSI-027_GDSC1(5) | Glioblastoma	JUN (2):	--1-- |  1261_rTRAIL_GDSC1(2) | Glioblastoma	KDM5A (9):	--2-- |  449_CD532_GDSC1(5) |  1232_I-BET-151_GDSC1(5) | Glioblastoma	KDR (7):	--2-- |  152_CP466722_GDSC1(4) |  1422_FGFR_3831_GDSC1(6) | Glioblastoma	KIT (5):	--2-- |  1371_PLX-4720_GDSC1(3) |  1008_Methotrexate_GDSC2(3) | Glioblastoma	KSR2 (15):	--3-- |  291_KIN001-266_GDSC1(9) |  1001_AICA Ribonucleotide_GDSC1(6) |  1407_Dyrk1b_0191_GDSC1(8) | Glioblastoma	LGR5 (3):	--2-- |  1732_TAF1_5496_GDSC2(2) |  2145_PBD-288_GDSC2(1) | Glioblastoma	LRP6 (6):	--2-- |  249_Cabozantinib_GDSC1(5) |  372_Pilaralisib_GDSC1(4) | Glioblastoma	LTK (5):	--2-- |  1393_Gemcitabine_GDSC1(3) |  1714_ERK_6604_GDSC2(2) | Glioblastoma	LYN (3):	--2-- |  256_JW-7-24-1_GDSC1(2) |  381_AST-1306_GDSC1(2) | Glioblastoma	MAP2K1 (5):	--3-- |  59_WZ-1-84_GDSC1(2) |  1009_Tretinoin_GDSC1(2) |  1564_SCH772984_GDSC2(3) | Glioblastoma	MAP3K13 (6):	--2-- |  151_QS11_GDSC1(3) |  304_SB52334_GDSC1(4) | Glioblastoma	MAP4K4 (10):	--3-- |  252_WZ3105_GDSC1(6) |  304_SB52334_GDSC1(5) |  1261_rTRAIL_GDSC1(4) | Glioblastoma	MECOM (11):	--3-- |  381_AST-1306_GDSC1(8) |  1009_Tretinoin_GDSC1(3) |  1564_SCH772984_GDSC2(5) | Glioblastoma	MEF2D (4):	--2-- |  1248_Daporinad_GDSC1(3) |  1026_Tanespimycin_GDSC2(3) | Glioblastoma	MET (7):	--2-- |  1170_CCT-018159_GDSC1(5) |  1190_Gemcitabine_GDSC2(5) | Glioblastoma	MGAM (15):	--2-- |  226_GSK1070916_GDSC1(9) |  415_CPI-613_GDSC1(12) | Glioblastoma	MKI67 (11):	--3-- |  133_Doxorubicin_GDSC1(7) |  172_Embelin_GDSC1(8) |  302_PI-103_GDSC1(7) | Glioblastoma	MLLT10 (6):	--1-- |  194_Luminespib_GDSC1(6) | Glioblastoma	MLLT3 (2):	--1-- |  1089_Oxaliplatin_GDSC2(2) | Glioblastoma	MSI1 (4):	--2-- |  546_FTY-720_GDSC1(3) |  1250_AZ960_GDSC2(2) | Glioblastoma	MSI2 (11):	--2-- |  176_IPA-3_GDSC1(8) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(7) | Glioblastoma	MST1R (5):	--2-- |  252_WZ3105_GDSC1(2) |  372_Pilaralisib_GDSC1(4) | Glioblastoma	MTOR (12):	--3-- |  366_TWS119_GDSC1(6) |  1011_Navitoclax_GDSC2(5) |  1051_Alisertib_GDSC2(6) | Glioblastoma	MYBL1 (4):	--2-- |  275_I-BET-762_GDSC1(3) |  1129_PF-4708671_GDSC1(2) | Glioblastoma	MYD88 (2):	--1-- |  1557_LCL161_GDSC2(2) | Glioblastoma	NADK (6):	--2-- |  346_THZ-2-102-1_GDSC1(4) |  1128_FS106_GDSC1(4) | Glioblastoma	NCSTN (6):	--2-- |  294_MPS-1-IN-1_GDSC1(3) |  1393_Gemcitabine_GDSC1(4) | Glioblastoma	NR4A3 (6):	--2-- |  256_JW-7-24-1_GDSC1(5) |  1031_Elesclomol_GDSC1(5) | Glioblastoma	NRAS (2):	--1-- |  185_Linsitinib_GDSC1(2) | Glioblastoma	NRG1 (12):	--3-- |  156_AZD6482_GDSC1(5) |  249_Cabozantinib_GDSC1(7) |  1393_Gemcitabine_GDSC1(8) | Glioblastoma	NT5C2 (7):	--2-- |  1011_Navitoclax_GDSC1(4) |  1266_ICL1100013_GDSC1(4) | Glioblastoma	NTRK3 (13):	--2-- |  152_CP466722_GDSC1(8) |  1372_Trametinib_GDSC1(8) | Glioblastoma	NUF2 (4):	--2-- |  1136_Capivasertib_GDSC1(2) |  1373_Dabrafenib_GDSC2(2) | Glioblastoma	NUP214 (14):	--3-- |  342_Tenovin-6_GDSC1(10) |  1365_BAY-HDAC11_2_GDSC1(5) |  1459_PARP_0108_GDSC1(6) | Glioblastoma	PAK1 (4):	--2-- |  245_UNC0638_GDSC1(2) |  1031_Elesclomol_GDSC1(3) | Glioblastoma	PAK5 (6):	--2-- |  303_PIK-93_GDSC1(3) |  1378_Bleomycin (50 uM)_GDSC1(5) | Glioblastoma	PDGFB (3):	--2-- |  294_MPS-1-IN-1_GDSC1(2) |  1803_Acetalax_GDSC2(2) | Glioblastoma	PDGFRA (4):	--2-- |  185_Linsitinib_GDSC1(2) |  197_Bryostatin 1_GDSC1(2) | Glioblastoma	PDGFRB (5):	--2-- |  262_VX-11e_GDSC1(3) |  372_Pilaralisib_GDSC1(4) | Glioblastoma	PIK3CA (2):	--1-- |  190_Bleomycin_GDSC1(2) | Glioblastoma	PIK3CB (6):	--2-- |  230_GSK429286A_GDSC1(5) |  269_NSC-207895_GDSC1(4) | Glioblastoma	PIK3CG (5):	--2-- |  295_NVP-BHG712_GDSC1(2) |  1052_RO-3306_GDSC2(3) | Glioblastoma	PLCG1 (8):	--2-- |  1363_BAY AKT1_GDSC1(5) |  1047_Nutlin-3a (-)_GDSC2(3) | Glioblastoma	PLCG2 (12):	--3-- |  156_AZD6482_GDSC1(6) |  304_SB52334_GDSC1(5) |  1016_Temsirolimus_GDSC1(10) | Glioblastoma	PPM1D (4):	--2-- |  330_XMD13-2_GDSC1(3) |  1049_PD173074_GDSC2(3) | Glioblastoma	PRKCI (9):	--4-- |  331_QL-X-138_GDSC1(5) |  432_Flavopiridol_GDSC1(6) |  1142_HG-5-113-01_GDSC1(1) |  1393_Gemcitabine_GDSC1(4) | Glioblastoma	PSMB2 (4):	--2-- |  372_Pilaralisib_GDSC1(3) |  1803_Acetalax_GDSC2(2) | Glioblastoma	PTPN11 (5):	--2-- |  11_Paclitaxel_GDSC1(1) |  1008_Methotrexate_GDSC2(4) | Glioblastoma	RAB35 (4):	--2-- |  89_Parthenolide_GDSC1(2) |  1031_Elesclomol_GDSC1(3) | Glioblastoma	RAC1 (5):	--2-- |  230_GSK429286A_GDSC1(3) |  304_SB52334_GDSC1(3) | Glioblastoma	RAC2 (3):	--2-- |  17_Cyclopamine_GDSC1(2) |  1031_Elesclomol_GDSC1(2) | Glioblastoma	REL (3):	--1-- |  151_QS11_GDSC1(3) | Glioblastoma	RET (5):	--2-- |  295_NVP-BHG712_GDSC1(3) |  1557_LCL161_GDSC2(2) | Glioblastoma	REV3L (3):	--1-- |  1451_PLK_6522_GDSC1(3) | Glioblastoma	RHOA (4):	--2-- |  230_GSK429286A_GDSC1(3) |  269_NSC-207895_GDSC1(3) | Glioblastoma	RICTOR (11):	--2-- |  299_OSI-027_GDSC1(8) |  1463_AZD1332_GDSC1(8) | Glioblastoma	ROS1 (6):	--1-- |  1191_Bortezomib_GDSC2(6) | Glioblastoma	RPTOR (6):	--2-- |  1009_Tretinoin_GDSC1(3) |  1829_667880_GDSC2(4) | Glioblastoma	SETBP1 (5):	--2-- |  172_Embelin_GDSC1(2) |  1096_Tozasertib_GDSC2(4) | Glioblastoma	SETD1A (6):	--2-- |  159_HG6-64-1_GDSC1(4) |  1180_Dinaciclib_GDSC2(4) | Glioblastoma	SF3B1 (4):	--2-- |  1421_FGFR_0939_GDSC1(2) |  1932_NVP-ADW742_GDSC2(3) | Glioblastoma	SGK1 (6):	--2-- |  1197_ZL049_GDSC1(3) |  1847_BEN_GDSC2(5) | Glioblastoma	SMO (5):	--1-- |  1494_SN-38_GDSC1(5) | Glioblastoma	SMYD3 (9):	--2-- |  344_THZ-2-49_GDSC1(6) |  1498_Selumetinib_GDSC1(5) | Glioblastoma	SOS1 (13):	--2-- |  363_PF-00299804_GDSC1(10) |  1011_Navitoclax_GDSC1(5) | Glioblastoma	SQSTM1 (5):	--3-- |  51_Dasatinib_GDSC1(1) |  1232_I-BET-151_GDSC1(2) |  1011_Navitoclax_GDSC2(3) | Glioblastoma	SRC (8):	--2-- |  54_CGP-082996_GDSC1(5) |  1820_123829_GDSC2(5) | Glioblastoma	SS18 (4):	--1-- |  1594_OSI-027_GDSC2(4) | Glioblastoma	STAT3 (6):	--3-- |  328_SNX-2112_GDSC1(3) |  432_Flavopiridol_GDSC1(3) |  461_NSC319726_GDSC1(3) | Glioblastoma	STAT6 (5):	--2-- |  136_Mitomycin-C_GDSC1(3) |  1047_Nutlin-3a (-)_GDSC1(4) | Glioblastoma	TERT (9):	--2-- |  330_XMD13-2_GDSC1(4) |  1407_Dyrk1b_0191_GDSC1(7) | Glioblastoma	TSHR (8):	--3-- |  1494_SN-38_GDSC1(6) |  1250_AZ960_GDSC2(4) |  1804_Acetalax_GDSC2(3) | Glioblastoma	TYK2 (5):	--3-- |  151_QS11_GDSC1(3) |  197_Bryostatin 1_GDSC1(2) |  1557_LCL161_GDSC2(2) | Glioblastoma	UBR5 (9):	--2-- |  1052_RO-3306_GDSC2(5) |  1910_ABT737_GDSC2(6) | Glioblastoma	USP8 (11):	--3-- |  140_Vinorelbine_GDSC1(6) |  1016_Temsirolimus_GDSC1(7) |  1250_AZ960_GDSC2(7) | Glioblastoma	VAV1 (8):	--3-- |  295_NVP-BHG712_GDSC1(3) |  476_SB505124_GDSC1(5) |  1564_SCH772984_GDSC2(4) | Glioblastoma	VAV2 (13):	--4-- |  64_CMK_GDSC1(7) |  208_Ispinesib Mesylate_GDSC1(7) |  1005_Cisplatin_GDSC1(6) |  1011_Navitoclax_GDSC2(5) | Glioblastoma	WWP1 (7):	--2-- |  186_Bexarotene_GDSC1(3) |  1553_Uprosertib_GDSC2(5) | Glioblastoma	WWTR1 (5):	--2-- |  1026_Tanespimycin_GDSC1(3) |  1136_Capivasertib_GDSC1(3) | Glioblastoma	YAP1 (5):	--2-- |  196_Phenformin_GDSC1(4) |  476_SB505124_GDSC1(4) | Glioma	BRAF (4):	--2-- |  260_NG-25_GDSC1(3) |  1016_Temsirolimus_GDSC2(1) | Glioma	DNMT1 (4):	--2-- |  1498_Selumetinib_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC2(1) | Glioma	RPTOR (3):	--1-- |  1432_AZD1480_GDSC1(3) | Glioma	TSHR (2):	--2-- |  164_JQ12_GDSC1(1) |  273_CUDC-101_GDSC1(1) | Head and Neck Carcinoma	ARHGEF28 (7):	--3-- |  163_JQ1_GDSC1(3) |  184_BMS-754807_GDSC1(4) |  1070_CRT0105950_GDSC1(3) | Head and Neck Carcinoma	AXL (8):	--2-- |  171_AKT inhibitor VIII_GDSC1(5) |  372_Pilaralisib_GDSC1(4) | Head and Neck Carcinoma	BCR (9):	--3-- |  167_OSU-03012_GDSC1(5) |  299_OSI-027_GDSC1(3) |  1070_CRT0105950_GDSC1(5) | Head and Neck Carcinoma	BRAF (3):	--2-- |  135_Gemcitabine_GDSC1(1) |  1444_AZD8186_GDSC1(2) | Head and Neck Carcinoma	CCNE1 (2):	--1-- |  190_Bleomycin_GDSC1(2) | Head and Neck Carcinoma	CSF3R (4):	--2-- |  135_Gemcitabine_GDSC1(1) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	DOT1L (3):	--2-- |  249_Cabozantinib_GDSC1(2) |  1242_(5Z)-7-Oxozeaenol_GDSC1(1) | Head and Neck Carcinoma	EGFR (7):	--1-- |  1053_MK-2206_GDSC1(7) | Head and Neck Carcinoma	EIF4A2 (2):	--1-- |  1373_Dabrafenib_GDSC1(2) | Head and Neck Carcinoma	ERBB3 (4):	--2-- |  1129_PF-4708671_GDSC1(3) |  1232_I-BET-151_GDSC1(1) | Head and Neck Carcinoma	ERBB4 (3):	--2-- |  1015_CI-1040_GDSC1(1) |  1407_Dyrk1b_0191_GDSC1(2) | Head and Neck Carcinoma	FGFR1 (4):	--2-- |  1249_BMS-345541_GDSC2(3) |  1915_AZD3759_GDSC2(3) | Head and Neck Carcinoma	FLT4 (3):	--2-- |  1428_IAP_5620_GDSC1(2) |  1495_Olaparib_GDSC1(2) | Head and Neck Carcinoma	FUS (3):	--2-- |  1407_Dyrk1b_0191_GDSC1(2) |  1372_Trametinib_GDSC2(1) | Head and Neck Carcinoma	GLI1 (3):	--1-- |  175_PAC-1_GDSC1(3) | Head and Neck Carcinoma	GNAS (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  260_NG-25_GDSC1(3) | Head and Neck Carcinoma	HDAC1 (3):	--1-- |  171_AKT inhibitor VIII_GDSC1(3) | Head and Neck Carcinoma	IGF1R (3):	--1-- |  175_PAC-1_GDSC1(3) | Head and Neck Carcinoma	JAK2 (6):	--3-- |  185_Linsitinib_GDSC1(4) |  1005_Cisplatin_GDSC1(2) |  1066_AZD6482_GDSC1(4) | Head and Neck Carcinoma	KDM5A (4):	--2-- |  133_Doxorubicin_GDSC1(1) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	LGR5 (2):	--1-- |  1393_Gemcitabine_GDSC1(2) | Head and Neck Carcinoma	MAP3K13 (3):	--2-- |  1008_Methotrexate_GDSC2(2) |  2044_Pyridostatin_GDSC2(2) | Head and Neck Carcinoma	MEF2D (2):	--2-- |  1407_Dyrk1b_0191_GDSC1(1) |  1086_BI-2536_GDSC2(1) | Head and Neck Carcinoma	MGAM (3):	--2-- |  184_BMS-754807_GDSC1(1) |  1407_Dyrk1b_0191_GDSC1(2) | Head and Neck Carcinoma	MLLT10 (2):	--2-- |  163_JQ1_GDSC1(1) |  276_CAY10603_GDSC1(1) | Head and Neck Carcinoma	MSI2 (4):	--2-- |  184_BMS-754807_GDSC1(2) |  439_LCL161_GDSC1(3) | Head and Neck Carcinoma	MTOR (4):	--3-- |  140_Vinorelbine_GDSC1(2) |  223_ZSTK474_GDSC1(1) |  235_QL-XII-47_GDSC1(1) | Head and Neck Carcinoma	NFE2L2 (2):	--1-- |  1071_CRT0105446_GDSC1(2) | Head and Neck Carcinoma	NRG1 (4):	--2-- |  171_AKT inhibitor VIII_GDSC1(3) |  1421_FGFR_0939_GDSC1(2) | Head and Neck Carcinoma	NTRK2 (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  1382_AZD3514_GDSC1(3) | Head and Neck Carcinoma	PDGFB (1):	--1-- |  276_CAY10603_GDSC1(1) | Head and Neck Carcinoma	PLCG1 (4):	--3-- |  249_Cabozantinib_GDSC1(2) |  1428_IAP_5620_GDSC1(2) |  1495_Olaparib_GDSC1(2) | Head and Neck Carcinoma	PLCG2 (7):	--2-- |  1422_FGFR_3831_GDSC1(5) |  1720_AZD5991_GDSC2(3) | Head and Neck Carcinoma	PPM1D (4):	--2-- |  1382_AZD3514_GDSC1(3) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	PRKACA (4):	--2-- |  275_I-BET-762_GDSC1(3) |  375_Voxtalisib_GDSC1(3) | Head and Neck Carcinoma	REV3L (4):	--2-- |  194_Luminespib_GDSC1(2) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	RICTOR (6):	--2-- |  1026_Tanespimycin_GDSC1(3) |  1425_BPTES_GDSC1(4) | Head and Neck Carcinoma	ROS1 (7):	--2-- |  1236_UNC0638_GDSC1(6) |  1553_Uprosertib_GDSC2(2) | Head and Neck Carcinoma	RPTOR (6):	--3-- |  272_AR-42_GDSC1(3) |  382_Apitolisib_GDSC1(2) |  1445_AZD8835_GDSC1(2) | Head and Neck Carcinoma	SET (2):	--2-- |  180_Thapsigargin_GDSC1(1) |  474_ARRY-520_GDSC1(1) | Head and Neck Carcinoma	SMO (3):	--1-- |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	STAT5A (2):	--1-- |  1373_Dabrafenib_GDSC1(2) | Head and Neck Carcinoma	TERT (3):	--1-- |  1382_AZD3514_GDSC1(3) | Head and Neck Carcinoma	WWP1 (3):	--1-- |  1249_BMS-345541_GDSC2(3) | Head and Neck Carcinoma	WWTR1 (3):	--2-- |  1407_Dyrk1b_0191_GDSC1(2) |  1058_Pictilisib_GDSC2(1) | Head and Neck Carcinoma	YES1 (2):	--1-- |  249_Cabozantinib_GDSC1(2) | Hepatocellular Carcinoma	ABL2 (5):	--2-- |  179_5-Fluorouracil_GDSC1(4) |  1808_Topotecan_GDSC2(4) | Hepatocellular Carcinoma	AFF4 (2):	--1-- |  159_HG6-64-1_GDSC1(2) | Hepatocellular Carcinoma	AKT3 (2):	--1-- |  159_HG6-64-1_GDSC1(2) | Hepatocellular Carcinoma	ARID3B (3):	--2-- |  375_Voxtalisib_GDSC1(2) |  2172_JQ1_GDSC2(2) | Hepatocellular Carcinoma	ATXN7 (3):	--1-- |  293_Amuvatinib_GDSC1(3) | Hepatocellular Carcinoma	BRD3 (4):	--2-- |  1183_CRT0160829_GDSC1(3) |  1219_PFI-1_GDSC1(3) | Hepatocellular Carcinoma	CALR (4):	--2-- |  1026_Tanespimycin_GDSC2(3) |  1060_PD0325901_GDSC2(3) | Hepatocellular Carcinoma	CCND2 (3):	--2-- |  175_PAC-1_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	CYP19A1 (5):	--2-- |  380_BIBF-1120_GDSC1(1) |  1810_Mitoxantrone_GDSC2(4) | Hepatocellular Carcinoma	DDX4 (3):	--1-- |  1185_KU-60019_GDSC1(3) | Hepatocellular Carcinoma	DNMT1 (3):	--2-- |  1706_AZD5153_GDSC2(2) |  1819_Docetaxel_GDSC2(2) | Hepatocellular Carcinoma	DOT1L (6):	--2-- |  1011_Navitoclax_GDSC2(5) |  1713_ERK_2440_GDSC2(5) | Hepatocellular Carcinoma	EGFL7 (7):	--2-- |  155_Ponatinib_GDSC1(5) |  305_TPCA-1_GDSC1(5) | Hepatocellular Carcinoma	EGFR (5):	--2-- |  446_MIM1_GDSC1(4) |  1135_AZD4547_GDSC1(4) | Hepatocellular Carcinoma	ERBB3 (6):	--2-- |  1192_GSK269962A_GDSC1(2) |  1416_AZD8931_GDSC1(5) | Hepatocellular Carcinoma	ERBB4 (7):	--2-- |  1561_Taselisib_GDSC2(5) |  1713_ERK_2440_GDSC2(5) | Hepatocellular Carcinoma	FGFR1 (3):	--1-- |  1426_AZD7969_GDSC1(3) | Hepatocellular Carcinoma	FGFR2 (6):	--2-- |  1086_BI-2536_GDSC2(4) |  1091_BMS-536924_GDSC2(5) | Hepatocellular Carcinoma	GLI1 (4):	--1-- |  153_Midostaurin_GDSC1(4) | Hepatocellular Carcinoma	GNA12 (4):	--2-- |  301_PHA-793887_GDSC1(3) |  1714_ERK_6604_GDSC2(3) | Hepatocellular Carcinoma	GNAQ (5):	--1-- |  196_Phenformin_GDSC1(5) | Hepatocellular Carcinoma	GNAS (4):	--2-- |  1011_Navitoclax_GDSC1(3) |  1188_CCT245467_GDSC1(3) | Hepatocellular Carcinoma	GTF2I (4):	--2-- |  1835_Elephantin_GDSC2(3) |  1910_ABT737_GDSC2(3) | Hepatocellular Carcinoma	IDH2 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	IGF1R (5):	--2-- |  476_SB505124_GDSC1(4) |  1706_AZD5153_GDSC2(2) | Hepatocellular Carcinoma	IGF2 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	JAK2 (4):	--2-- |  249_Cabozantinib_GDSC1(3) |  415_CPI-613_GDSC1(2) | Hepatocellular Carcinoma	LMO2 (3):	--2-- |  375_Voxtalisib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	MAP4K4 (5):	--2-- |  1026_Tanespimycin_GDSC1(4) |  1236_UNC0638_GDSC1(2) | Hepatocellular Carcinoma	MEF2D (1):	--1-- |  407_kb NB 142-70_GDSC1(1) | Hepatocellular Carcinoma	MSI2 (7):	--2-- |  203_BMS-345541_GDSC1(5) |  1617_AZD5582_GDSC2(4) | Hepatocellular Carcinoma	NCOA3 (2):	--1-- |  283_Omipalisib_GDSC1(2) | Hepatocellular Carcinoma	NCSTN (4):	--2-- |  285_SU11274_GDSC1(3) |  1021_Axitinib_GDSC1(2) | Hepatocellular Carcinoma	NFE2L2 (4):	--1-- |  446_MIM1_GDSC1(4) | Hepatocellular Carcinoma	NTRK3 (5):	--2-- |  1054_Palbociclib_GDSC1(4) |  1926_GNE-317_GDSC2(2) | Hepatocellular Carcinoma	NUP98 (4):	--2-- |  176_IPA-3_GDSC1(3) |  1188_CCT245467_GDSC1(3) | Hepatocellular Carcinoma	PDCD1LG2 (5):	--2-- |  208_Ispinesib Mesylate_GDSC1(3) |  224_AS605240_GDSC1(4) | Hepatocellular Carcinoma	PIK3CD (3):	--1-- |  1026_Tanespimycin_GDSC2(3) | Hepatocellular Carcinoma	RAC1 (5):	--2-- |  269_NSC-207895_GDSC1(4) |  1808_Topotecan_GDSC2(4) | Hepatocellular Carcinoma	REV3L (6):	--2-- |  225_Genentech Cpd 10_GDSC1(2) |  1024_Lestaurtinib_GDSC2(4) | Hepatocellular Carcinoma	SF3B1 (4):	--2-- |  208_Ispinesib Mesylate_GDSC1(3) |  476_SB505124_GDSC1(3) | Hepatocellular Carcinoma	SGK1 (4):	--1-- |  1259_Talazoparib_GDSC1(4) | Hepatocellular Carcinoma	TERT (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	USP8 (7):	--2-- |  287_KIN001-244_GDSC1(5) |  1086_BI-2536_GDSC2(4) | Kidney Carcinoma	ABL1 (2):	--1-- |  284_JNJ38877605_GDSC1(2) | Kidney Carcinoma	ABL2 (6):	--2-- |  221_TAK-715_GDSC1(4) |  1364_BAY-HDAC11_1_GDSC1(5) | Kidney Carcinoma	AFF4 (5):	--2-- |  1084_Rapamycin_GDSC2(3) |  1085_Sorafenib_GDSC2(3) | Kidney Carcinoma	AGO1 (5):	--2-- |  261_TL-1-85_GDSC1(3) |  2048_Vinorelbine_GDSC2(4) | Kidney Carcinoma	AKT2 (7):	--2-- |  362_CI-1033_GDSC1(5) |  1026_Tanespimycin_GDSC1(4) | Kidney Carcinoma	AKT3 (2):	--1-- |  1030_KU-55933_GDSC1(2) | Kidney Carcinoma	ALK (7):	--1-- |  308_Foretinib_GDSC1(7) | Kidney Carcinoma	ARHGEF28 (9):	--2-- |  245_UNC0638_GDSC1(5) |  1416_AZD8931_GDSC1(7) | Kidney Carcinoma	ARID3B (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1049_PD173074_GDSC2(3) | Kidney Carcinoma	ATXN7 (5):	--3-- |  1432_AZD1480_GDSC1(3) |  1047_Nutlin-3a (-)_GDSC2(3) |  1168_Erlotinib_GDSC2(3) | Kidney Carcinoma	AXL (3):	--2-- |  225_Genentech Cpd 10_GDSC1(2) |  299_OSI-027_GDSC1(2) | Kidney Carcinoma	BAALC (5):	--2-- |  261_TL-1-85_GDSC1(3) |  1085_Sorafenib_GDSC2(3) | Kidney Carcinoma	BCL6 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	BCL9 (1):	--1-- |  283_Omipalisib_GDSC1(1) | Kidney Carcinoma	BCR (11):	--2-- |  245_UNC0638_GDSC1(6) |  1426_AZD7969_GDSC1(8) | Kidney Carcinoma	BRAF (4):	--2-- |  256_JW-7-24-1_GDSC1(2) |  366_TWS119_GDSC1(2) | Kidney Carcinoma	BRD3 (5):	--2-- |  256_JW-7-24-1_GDSC1(2) |  1085_Sorafenib_GDSC2(3) | Kidney Carcinoma	BRD4 (6):	--2-- |  1022_AZD7762_GDSC1(4) |  1378_Bleomycin (50 uM)_GDSC1(4) | Kidney Carcinoma	CCNB3 (5):	--2-- |  173_FH535_GDSC1(2) |  245_UNC0638_GDSC1(4) | Kidney Carcinoma	CCND1 (3):	--3-- |  159_HG6-64-1_GDSC1(1) |  1012_Vorinostat_GDSC1(1) |  2040_Foretinib_GDSC2(1) | Kidney Carcinoma	CCND2 (5):	--2-- |  282_Pelitinib_GDSC1(3) |  1066_AZD6482_GDSC1(3) | Kidney Carcinoma	CD28 (2):	--1-- |  1624_I-BET-762_GDSC2(2) | Kidney Carcinoma	CDK6 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1096_Tozasertib_GDSC2(2) | Kidney Carcinoma	CDK8 (5):	--2-- |  175_PAC-1_GDSC1(3) |  1011_Navitoclax_GDSC2(4) | Kidney Carcinoma	COP1 (8):	--2-- |  1197_ZL049_GDSC1(3) |  1080_Paclitaxel_GDSC2(5) | Kidney Carcinoma	CSF3R (5):	--2-- |  1422_FGFR_3831_GDSC1(4) |  1049_PD173074_GDSC2(3) | Kidney Carcinoma	DDR2 (4):	--2-- |  134_Etoposide_GDSC1(1) |  1432_AZD1480_GDSC1(3) | Kidney Carcinoma	DDX4 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1038_NU7441_GDSC2(4) | Kidney Carcinoma	DNMT1 (11):	--3-- |  1183_CRT0160829_GDSC1(3) |  1392_Bleomycin (10 uM)_GDSC1(5) |  1179_MK-1775_GDSC2(6) | Kidney Carcinoma	DOT1L (10):	--2-- |  1446_PI3Ka_4409_GDSC1(6) |  1866_BDP-00009066_GDSC2(6) | Kidney Carcinoma	EGFL7 (5):	--2-- |  152_CP466722_GDSC1(2) |  2048_Vinorelbine_GDSC2(4) | Kidney Carcinoma	EGFR (7):	--2-- |  172_Embelin_GDSC1(3) |  1014_Refametinib_GDSC2(6) | Kidney Carcinoma	ERBB2 (6):	--2-- |  1490_SN-38_GDSC1(4) |  1037_BX795_GDSC2(3) | Kidney Carcinoma	ERBB3 (9):	--3-- |  224_AS605240_GDSC1(6) |  303_PIK-93_GDSC1(7) |  1593_Entinostat_GDSC2(6) | Kidney Carcinoma	ERBB4 (6):	--2-- |  228_AKT inhibitor VIII_GDSC1(4) |  1372_Trametinib_GDSC1(4) | Kidney Carcinoma	ESR1 (3):	--2-- |  362_CI-1033_GDSC1(2) |  1052_RO-3306_GDSC1(2) | Kidney Carcinoma	ETV1 (6):	--2-- |  152_CP466722_GDSC1(2) |  1378_Bleomycin (50 uM)_GDSC1(5) | Kidney Carcinoma	EWSR1 (3):	--2-- |  1197_ZL049_GDSC1(2) |  1360_993-D2_GDSC1(2) | Kidney Carcinoma	FGFR2 (6):	--3-- |  1054_Palbociclib_GDSC1(2) |  1085_Sorafenib_GDSC2(4) |  1932_NVP-ADW742_GDSC2(4) | Kidney Carcinoma	FGFR3 (3):	--2-- |  1416_AZD8931_GDSC1(2) |  1079_Dasatinib_GDSC2(1) | Kidney Carcinoma	FGFR4 (5):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(3) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	FLI1 (4):	--2-- |  1170_CCT-018159_GDSC1(2) |  1060_PD0325901_GDSC2(2) | Kidney Carcinoma	FLT3 (4):	--2-- |  1084_Rapamycin_GDSC2(3) |  1578_Leflunomide_GDSC2(2) | Kidney Carcinoma	FLT4 (8):	--3-- |  261_TL-1-85_GDSC1(4) |  1236_UNC0638_GDSC1(6) |  1712_Eg5_9814_GDSC2(4) | Kidney Carcinoma	FYN (3):	--1-- |  1011_Navitoclax_GDSC1(3) | Kidney Carcinoma	GAB1 (5):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(3) |  1038_NU7441_GDSC2(4) | Kidney Carcinoma	GLI1 (2):	--2-- |  1407_Dyrk1b_0191_GDSC1(1) |  2055_Mycophenolic acid_GDSC2(1) | Kidney Carcinoma	GNA12 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	GNAS (6):	--2-- |  245_UNC0638_GDSC1(5) |  295_NVP-BHG712_GDSC1(3) | Kidney Carcinoma	GSK3B (3):	--2-- |  1031_Elesclomol_GDSC1(1) |  1060_PD0325901_GDSC2(2) | Kidney Carcinoma	GTF2I (5):	--2-- |  261_TL-1-85_GDSC1(3) |  1184_AZ20_GDSC1(3) | Kidney Carcinoma	HDAC7 (10):	--3-- |  133_Doxorubicin_GDSC1(4) |  449_CD532_GDSC1(5) |  1416_AZD8931_GDSC1(7) | Kidney Carcinoma	HGF (3):	--1-- |  1011_Navitoclax_GDSC1(3) | Kidney Carcinoma	HMGA1 (2):	--1-- |  309_Y-39983_GDSC1(2) | Kidney Carcinoma	IGF1R (5):	--3-- |  134_Etoposide_GDSC1(1) |  299_OSI-027_GDSC1(2) |  1997_WEHI-539_GDSC2(3) | Kidney Carcinoma	IL7R (3):	--1-- |  1461_TANK_1366_GDSC1(3) | Kidney Carcinoma	INSR (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	JAK2 (9):	--2-- |  1062_Selumetinib_GDSC1(6) |  1079_Dasatinib_GDSC2(5) | Kidney Carcinoma	JAK3 (7):	--2-- |  380_BIBF-1120_GDSC1(4) |  449_CD532_GDSC1(4) | Kidney Carcinoma	KDM5A (8):	--4-- |  163_JQ1_GDSC1(2) |  258_STF-62247_GDSC1(4) |  261_TL-1-85_GDSC1(4) |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(2) | Kidney Carcinoma	KDR (5):	--2-- |  284_JNJ38877605_GDSC1(3) |  1080_Paclitaxel_GDSC2(4) | Kidney Carcinoma	KLF5 (3):	--1-- |  1378_Bleomycin (50 uM)_GDSC1(3) | Kidney Carcinoma	KSR2 (5):	--2-- |  439_LCL161_GDSC1(3) |  1394_AZD6738_GDSC1(4) | Kidney Carcinoma	LRP6 (9):	--3-- |  225_Genentech Cpd 10_GDSC1(4) |  276_CAY10603_GDSC1(5) |  1136_Capivasertib_GDSC1(3) | Kidney Carcinoma	MAP2K1 (4):	--2-- |  304_SB52334_GDSC1(2) |  439_LCL161_GDSC1(3) | Kidney Carcinoma	MAP3K13 (6):	--2-- |  203_BMS-345541_GDSC1(4) |  1038_NU7441_GDSC2(5) | Kidney Carcinoma	MAP4K4 (7):	--2-- |  1026_Tanespimycin_GDSC1(5) |  1908_Ulixertinib_GDSC2(3) | Kidney Carcinoma	MAPK1 (3):	--2-- |  308_Foretinib_GDSC1(2) |  1184_AZ20_GDSC1(1) | Kidney Carcinoma	MECOM (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1416_AZD8931_GDSC1(4) | Kidney Carcinoma	MEF2B (2):	--1-- |  283_Omipalisib_GDSC1(2) | Kidney Carcinoma	MGAM (13):	--2-- |  203_BMS-345541_GDSC1(7) |  1559_Luminespib_GDSC2(10) | Kidney Carcinoma	MLLT10 (5):	--2-- |  1047_Nutlin-3a (-)_GDSC2(4) |  1073_5-Fluorouracil_GDSC2(4) | Kidney Carcinoma	MPL (4):	--2-- |  1490_SN-38_GDSC1(2) |  1037_BX795_GDSC2(3) | Kidney Carcinoma	MSI2 (5):	--2-- |  133_Doxorubicin_GDSC1(1) |  1378_Bleomycin (50 uM)_GDSC1(4) | Kidney Carcinoma	MTOR (12):	--3-- |  226_GSK1070916_GDSC1(4) |  1527_Pictilisib_GDSC1(9) |  1031_Elesclomol_GDSC2(5) | Kidney Carcinoma	NCOA3 (5):	--3-- |  228_AKT inhibitor VIII_GDSC1(3) |  261_TL-1-85_GDSC1(3) |  287_KIN001-244_GDSC1(3) | Kidney Carcinoma	NR4A3 (4):	--2-- |  1578_Leflunomide_GDSC2(2) |  2096_VX-11e_GDSC2(3) | Kidney Carcinoma	NRG1 (4):	--2-- |  152_CP466722_GDSC1(2) |  1024_Lestaurtinib_GDSC1(3) | Kidney Carcinoma	NT5C2 (8):	--2-- |  256_JW-7-24-1_GDSC1(4) |  268_Sepantronium bromide_GDSC1(5) | Kidney Carcinoma	NTRK1 (8):	--2-- |  1008_Methotrexate_GDSC2(4) |  1932_NVP-ADW742_GDSC2(5) | Kidney Carcinoma	NTRK2 (8):	--3-- |  1066_AZD6482_GDSC1(4) |  1372_Trametinib_GDSC1(4) |  1808_Topotecan_GDSC2(1) | Kidney Carcinoma	NTRK3 (9):	--3-- |  245_UNC0638_GDSC1(5) |  1422_FGFR_3831_GDSC1(4) |  1446_PI3Ka_4409_GDSC1(6) | Kidney Carcinoma	NUF2 (5):	--2-- |  1012_Vorinostat_GDSC1(4) |  1364_BAY-HDAC11_1_GDSC1(4) | Kidney Carcinoma	NUP214 (10):	--3-- |  1026_Tanespimycin_GDSC1(4) |  1038_NU7441_GDSC2(6) |  1048_Mirin_GDSC2(5) | Kidney Carcinoma	NUP98 (7):	--2-- |  382_Apitolisib_GDSC1(5) |  1012_Vorinostat_GDSC1(4) | Kidney Carcinoma	PAK5 (5):	--3-- |  135_Gemcitabine_GDSC1(1) |  1463_AZD1332_GDSC1(2) |  1179_MK-1775_GDSC2(2) | Kidney Carcinoma	PDGFB (4):	--2-- |  362_CI-1033_GDSC1(2) |  1426_AZD7969_GDSC1(2) | Kidney Carcinoma	PDGFRA (9):	--2-- |  165_DMOG_GDSC1(5) |  264_ACY-1215_GDSC1(4) | Kidney Carcinoma	PDGFRB (6):	--2-- |  1197_ZL049_GDSC1(3) |  1008_Methotrexate_GDSC2(4) | Kidney Carcinoma	PIK3CB (6):	--2-- |  154_CHIR-99021_GDSC1(3) |  1022_AZD7762_GDSC1(4) | Kidney Carcinoma	PIK3CD (6):	--3-- |  1378_Bleomycin (50 uM)_GDSC1(3) |  1422_FGFR_3831_GDSC1(3) |  1048_Mirin_GDSC2(4) | Kidney Carcinoma	PLCG1 (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  2171_BMS-754807_GDSC2(5) | Kidney Carcinoma	PLCG2 (14):	--3-- |  258_STF-62247_GDSC1(5) |  1444_AZD8186_GDSC1(8) |  1593_Entinostat_GDSC2(8) | Kidney Carcinoma	PTPN11 (4):	--1-- |  2171_BMS-754807_GDSC2(4) | Kidney Carcinoma	RAC2 (2):	--1-- |  1432_AZD1480_GDSC1(2) | Kidney Carcinoma	REL (4):	--2-- |  285_SU11274_GDSC1(3) |  1364_BAY-HDAC11_1_GDSC1(3) | Kidney Carcinoma	RET (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1422_FGFR_3831_GDSC1(4) | Kidney Carcinoma	REV3L (8):	--2-- |  208_Ispinesib Mesylate_GDSC1(4) |  1048_Mirin_GDSC2(5) | Kidney Carcinoma	RHEB (6):	--2-- |  282_Pelitinib_GDSC1(3) |  2040_Foretinib_GDSC2(4) | Kidney Carcinoma	RICTOR (7):	--2-- |  282_Pelitinib_GDSC1(5) |  1048_Mirin_GDSC2(5) | Kidney Carcinoma	ROS1 (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1490_SN-38_GDSC1(5) | Kidney Carcinoma	RPTOR (11):	--3-- |  273_CUDC-101_GDSC1(5) |  1394_AZD6738_GDSC1(8) |  1012_Vorinostat_GDSC2(6) | Kidney Carcinoma	SETD1A (8):	--2-- |  1048_Mirin_GDSC1(5) |  2171_BMS-754807_GDSC2(5) | Kidney Carcinoma	SF3B1 (4):	--2-- |  1184_AZ20_GDSC1(2) |  1426_AZD7969_GDSC1(2) | Kidney Carcinoma	SGK1 (6):	--3-- |  1052_RO-3306_GDSC1(2) |  1038_NU7441_GDSC2(4) |  1593_Entinostat_GDSC2(4) | Kidney Carcinoma	SHOC2 (2):	--1-- |  1416_AZD8931_GDSC1(2) | Kidney Carcinoma	SMO (5):	--2-- |  285_SU11274_GDSC1(3) |  1908_Ulixertinib_GDSC2(2) | Kidney Carcinoma	SMYD3 (5):	--2-- |  256_JW-7-24-1_GDSC1(2) |  2171_BMS-754807_GDSC2(4) | Kidney Carcinoma	SOS1 (6):	--2-- |  1038_NU7441_GDSC1(2) |  1219_PFI-1_GDSC1(5) | Kidney Carcinoma	STAT5A (4):	--2-- |  285_SU11274_GDSC1(2) |  1378_Bleomycin (50 uM)_GDSC1(3) | Kidney Carcinoma	STAT5B (1):	--1-- |  1407_Dyrk1b_0191_GDSC1(1) | Kidney Carcinoma	STAT6 (4):	--2-- |  1038_NU7441_GDSC1(2) |  1490_SN-38_GDSC1(3) | Kidney Carcinoma	SYK (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1432_AZD1480_GDSC1(2) | Kidney Carcinoma	TERT (3):	--2-- |  204_Tipifarnib_GDSC1(2) |  265_Tubastatin A_GDSC1(2) | Kidney Carcinoma	TSHR (6):	--3-- |  203_BMS-345541_GDSC1(4) |  258_STF-62247_GDSC1(3) |  261_TL-1-85_GDSC1(3) | Kidney Carcinoma	UBR5 (9):	--2-- |  1014_Refametinib_GDSC2(7) |  2169_AZD6482_GDSC2(5) | Kidney Carcinoma	USP8 (9):	--3-- |  245_UNC0638_GDSC1(5) |  1446_PI3Ka_4409_GDSC1(6) |  1079_Dasatinib_GDSC2(6) | Kidney Carcinoma	VAV1 (11):	--2-- |  223_ZSTK474_GDSC1(7) |  1179_MK-1775_GDSC2(7) | Kidney Carcinoma	VAV2 (10):	--2-- |  245_UNC0638_GDSC1(6) |  1416_AZD8931_GDSC1(8) | Kidney Carcinoma	VEGFA (2):	--1-- |  285_SU11274_GDSC1(2) | Kidney Carcinoma	WWP1 (12):	--2-- |  272_AR-42_GDSC1(8) |  1407_Dyrk1b_0191_GDSC1(9) | Kidney Carcinoma	XIAP (3):	--2-- |  268_Sepantronium bromide_GDSC1(1) |  1197_ZL049_GDSC1(2) | Kidney Carcinoma	XPO1 (7):	--2-- |  282_Pelitinib_GDSC1(4) |  1012_Vorinostat_GDSC1(5) | Kidney Carcinoma	YES1 (3):	--2-- |  268_Sepantronium bromide_GDSC1(1) |  1197_ZL049_GDSC1(2) | Melanoma	ABL1 (8):	--3-- |  165_DMOG_GDSC1(4) |  300_CX-5461_GDSC1(4) |  1738_IGF1R_3801_GDSC2(4) | Melanoma	ABL2 (12):	--2-- |  362_CI-1033_GDSC1(8) |  1004_Vinblastine_GDSC1(9) | Melanoma	ACVR1 (4):	--2-- |  284_JNJ38877605_GDSC1(2) |  308_Foretinib_GDSC1(3) | Melanoma	ADHFE1 (7):	--2-- |  1183_CRT0160829_GDSC1(4) |  1259_Talazoparib_GDSC2(4) | Melanoma	AFF4 (11):	--3-- |  1022_AZD7762_GDSC1(5) |  1416_AZD8931_GDSC1(5) |  1559_Luminespib_GDSC2(7) | Melanoma	AGO1 (15):	--3-- |  163_JQ1_GDSC1(7) |  172_Embelin_GDSC1(12) |  1559_Luminespib_GDSC2(8) | Melanoma	AKT1 (6):	--3-- |  1066_AZD6482_GDSC1(3) |  1014_Refametinib_GDSC2(3) |  1069_EHT-1864_GDSC2(2) | Melanoma	AKT2 (13):	--3-- |  64_CMK_GDSC1(3) |  1451_PLK_6522_GDSC1(9) |  1560_Alpelisib_GDSC2(3) | Melanoma	AKT3 (8):	--3-- |  54_CGP-082996_GDSC1(3) |  228_AKT inhibitor VIII_GDSC1(5) |  1008_Methotrexate_GDSC2(5) | Melanoma	ALK (25):	--3-- |  151_QS11_GDSC1(13) |  207_AS601245_GDSC1(16) |  2109_AZ6102_GDSC2(17) | Melanoma	AR (4):	--1-- |  1559_Luminespib_GDSC2(4) | Melanoma	ARHGEF28 (9):	--2-- |  1197_ZL049_GDSC1(6) |  1932_NVP-ADW742_GDSC2(7) | Melanoma	ARID3B (6):	--2-- |  284_JNJ38877605_GDSC1(2) |  308_Foretinib_GDSC1(5) | Melanoma	ATXN7 (8):	--2-- |  293_Amuvatinib_GDSC1(4) |  1008_Methotrexate_GDSC2(5) | Melanoma	AURKA (3):	--2-- |  263_FR-180204_GDSC1(2) |  1004_Vinblastine_GDSC1(2) | Melanoma	AURKB (4):	--2-- |  1197_ZL049_GDSC1(3) |  2046_MK-8776_GDSC2(3) | Melanoma	AXL (10):	--2-- |  305_TPCA-1_GDSC1(8) |  1022_AZD7762_GDSC1(5) | Melanoma	BAALC (6):	--2-- |  173_FH535_GDSC1(4) |  308_Foretinib_GDSC1(3) | Melanoma	BCL2 (3):	--3-- |  190_Bleomycin_GDSC1(1) |  1024_Lestaurtinib_GDSC1(1) |  1184_AZ20_GDSC1(1) | Melanoma	BCL9 (7):	--2-- |  362_CI-1033_GDSC1(6) |  1197_ZL049_GDSC1(5) | Melanoma	BCR (18):	--2-- |  208_Ispinesib Mesylate_GDSC1(12) |  225_Genentech Cpd 10_GDSC1(14) | Melanoma	BRAF (37):	--4-- |  1061_SB590885_GDSC1(21) |  1368_BAY-MPS1_GDSC1(13) |  1036_PLX-4720_GDSC2(24) |  1912_Afuresertib_GDSC2(17) | Melanoma	BRD4 (8):	--2-- |  228_AKT inhibitor VIII_GDSC1(5) |  1008_Methotrexate_GDSC2(5) | Melanoma	BTK (8):	--2-- |  158_PF-562271_GDSC1(4) |  1016_Temsirolimus_GDSC2(4) | Melanoma	CARD11 (18):	--4-- |  257_NPK76-II-72-1_GDSC1(4) |  416_CAY10566_GDSC1(4) |  1131_PRIMA-1MET_GDSC2(12) |  1239_YK-4-279_GDSC2(14) | Melanoma	CCND1 (3):	--2-- |  1049_PD173074_GDSC2(2) |  1375_Temozolomide_GDSC2(2) | Melanoma	CCND2 (3):	--2-- |  1186_FS112_GDSC1(1) |  1425_BPTES_GDSC1(2) | Melanoma	CCND3 (4):	--2-- |  172_Embelin_GDSC1(2) |  1560_Alpelisib_GDSC2(2) | Melanoma	CD276 (3):	--2-- |  147_NSC-87877_GDSC1(2) |  155_Ponatinib_GDSC1(2) | Melanoma	CDK6 (2):	--1-- |  165_DMOG_GDSC1(2) | Melanoma	CDK8 (4):	--2-- |  1038_NU7441_GDSC2(3) |  1560_Alpelisib_GDSC2(2) | Melanoma	COP1 (7):	--3-- |  416_CAY10566_GDSC1(3) |  1197_ZL049_GDSC1(4) |  1382_AZD3514_GDSC1(3) | Melanoma	CRKL (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  576_RU-SKI 43_GDSC1(2) | Melanoma	CTNNB1 (2):	--2-- |  172_Embelin_GDSC1(1) |  194_Luminespib_GDSC1(1) | Melanoma	CYP19A1 (13):	--3-- |  199_Pazopanib_GDSC1(7) |  264_ACY-1215_GDSC1(9) |  1011_Navitoclax_GDSC1(5) | Melanoma	DCUN1D1 (4):	--1-- |  308_Foretinib_GDSC1(4) | Melanoma	DDR2 (5):	--2-- |  432_Flavopiridol_GDSC1(3) |  1372_Trametinib_GDSC2(4) | Melanoma	DDX4 (9):	--2-- |  264_ACY-1215_GDSC1(8) |  362_CI-1033_GDSC1(8) | Melanoma	DEK (3):	--2-- |  416_CAY10566_GDSC1(2) |  2111_VE821_GDSC2(2) | Melanoma	DNMT1 (12):	--4-- |  1059_AZD8055_GDSC1(7) |  1143_HG-5-88-01_GDSC1(4) |  1407_Dyrk1b_0191_GDSC1(6) |  1427_AZD5582_GDSC1(8) | Melanoma	DOT1L (15):	--3-- |  292_Masitinib_GDSC1(10) |  1091_BMS-536924_GDSC1(8) |  1464_TTK_3146_GDSC1(10) | Melanoma	EGFL7 (3):	--2-- |  341_Selisistat_GDSC1(2) |  2438_ascorbate (vitamin C)_GDSC2(2) | Melanoma	EGFR (18):	--3-- |  180_Thapsigargin_GDSC1(15) |  1058_Pictilisib_GDSC1(11) |  1713_ERK_2440_GDSC2(7) | Melanoma	EIF4A2 (3):	--2-- |  180_Thapsigargin_GDSC1(2) |  1168_Erlotinib_GDSC2(2) | Melanoma	EIF4E (3):	--2-- |  147_NSC-87877_GDSC1(2) |  194_Luminespib_GDSC1(1) | Melanoma	EPOR (14):	--3-- |  179_5-Fluorouracil_GDSC1(9) |  228_AKT inhibitor VIII_GDSC1(8) |  476_SB505124_GDSC1(9) | Melanoma	ERBB3 (13):	--3-- |  152_CP466722_GDSC1(5) |  245_UNC0638_GDSC1(7) |  363_PF-00299804_GDSC1(5) | Melanoma	ERBB4 (22):	--4-- |  133_Doxorubicin_GDSC1(17) |  151_QS11_GDSC1(12) |  1011_Navitoclax_GDSC2(7) |  2148_POMHEX_GDSC2(11) | Melanoma	ERG (12):	--3-- |  1129_PF-4708671_GDSC1(4) |  1183_CRT0160829_GDSC1(9) |  1449_AZD1208_GDSC1(4) | Melanoma	ESR1 (6):	--3-- |  263_FR-180204_GDSC1(2) |  264_ACY-1215_GDSC1(4) |  415_CPI-613_GDSC1(3) | Melanoma	ETV1 (3):	--2-- |  263_FR-180204_GDSC1(2) |  265_Tubastatin A_GDSC1(2) | Melanoma	ETV5 (5):	--3-- |  1050_ZM447439_GDSC1(3) |  1203_QL-XII-61_GDSC1(2) |  1558_Lapatinib_GDSC2(3) | Melanoma	EWSR1 (6):	--2-- |  416_CAY10566_GDSC1(3) |  1004_Vinblastine_GDSC1(4) | Melanoma	EZH1 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1164_XMD8-92_GDSC1(3) | Melanoma	FGF3 (4):	--2-- |  147_NSC-87877_GDSC1(2) |  180_Thapsigargin_GDSC1(2) | Melanoma	FGFR1 (6):	--2-- |  341_Selisistat_GDSC1(2) |  1427_AZD5582_GDSC1(4) | Melanoma	FGFR2 (17):	--2-- |  157_JNK-9L_GDSC1(13) |  1559_Luminespib_GDSC2(10) | Melanoma	FGFR3 (7):	--2-- |  179_5-Fluorouracil_GDSC1(4) |  1614_WZ4003_GDSC2(4) | Melanoma	FGFR4 (3):	--2-- |  180_Thapsigargin_GDSC1(2) |  342_Tenovin-6_GDSC1(2) | Melanoma	FLI1 (9):	--3-- |  416_CAY10566_GDSC1(4) |  1042_Doramapimod_GDSC2(5) |  1553_Uprosertib_GDSC2(6) | Melanoma	FLT1 (20):	--3-- |  157_JNK-9L_GDSC1(16) |  300_CX-5461_GDSC1(8) |  1219_PFI-1_GDSC1(13) | Melanoma	FLT3 (9):	--3-- |  275_I-BET-762_GDSC1(5) |  1072_Avagacestat_GDSC1(2) |  1185_KU-60019_GDSC1(6) | Melanoma	FLT4 (19):	--2-- |  157_JNK-9L_GDSC1(15) |  1559_Luminespib_GDSC2(11) | Melanoma	FURIN (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  308_Foretinib_GDSC1(3) | Melanoma	FUS (7):	--2-- |  406_LIMK1 inhibitor BMS4_GDSC1(5) |  1445_AZD8835_GDSC1(6) | Melanoma	FYN (11):	--4-- |  265_Tubastatin A_GDSC1(3) |  330_XMD13-2_GDSC1(3) |  1135_AZD4547_GDSC1(6) |  1464_TTK_3146_GDSC1(7) | Melanoma	GAB1 (3):	--1-- |  180_Thapsigargin_GDSC1(3) | Melanoma	GAB2 (10):	--2-- |  1511_Epirubicin_GDSC2(9) |  1873_Buparlisib_GDSC2(7) | Melanoma	GLI1 (6):	--4-- |  133_Doxorubicin_GDSC1(2) |  342_Tenovin-6_GDSC1(3) |  362_CI-1033_GDSC1(2) |  1186_FS112_GDSC1(3) | Melanoma	GNA11 (3):	--1-- |  275_I-BET-762_GDSC1(3) | Melanoma	GNA12 (6):	--2-- |  1088_Irinotecan_GDSC2(4) |  1564_SCH772984_GDSC2(3) | Melanoma	GNAS (12):	--3-- |  30_Sorafenib_GDSC1(3) |  1022_AZD7762_GDSC1(6) |  1490_SN-38_GDSC1(6) | Melanoma	GSK3B (11):	--1-- |  317_WYE-125132_GDSC1(11) | Melanoma	GTF2I (13):	--3-- |  362_CI-1033_GDSC1(9) |  1392_Bleomycin (10 uM)_GDSC1(6) |  1559_Luminespib_GDSC2(7) | Melanoma	HDAC1 (4):	--2-- |  1030_KU-55933_GDSC1(2) |  1084_Rapamycin_GDSC2(3) | Melanoma	HDAC7 (12):	--3-- |  228_AKT inhibitor VIII_GDSC1(6) |  1190_Gemcitabine_GDSC2(7) |  1529_Pevonedistat_GDSC2(5) | Melanoma	HGF (15):	--3-- |  163_JQ1_GDSC1(7) |  1427_AZD5582_GDSC1(7) |  1085_Sorafenib_GDSC2(9) | Melanoma	HMGA2 (9):	--2-- |  407_kb NB 142-70_GDSC1(4) |  1378_Bleomycin (50 uM)_GDSC1(6) | Melanoma	IDH1 (1):	--1-- |  1012_Vorinostat_GDSC1(1) | Melanoma	IDH2 (5):	--3-- |  285_SU11274_GDSC1(3) |  1458_PARP_9495_GDSC1(3) |  1051_Alisertib_GDSC2(3) | Melanoma	IGF1 (9):	--4-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  439_LCL161_GDSC1(4) |  1185_KU-60019_GDSC1(4) |  1011_Navitoclax_GDSC2(4) | Melanoma	IGF1R (17):	--3-- |  1261_rTRAIL_GDSC1(8) |  1529_Pevonedistat_GDSC1(9) |  1032_Afatinib_GDSC2(11) | Melanoma	IGF2 (3):	--1-- |  175_PAC-1_GDSC1(3) | Melanoma	IKBKE (7):	--3-- |  179_5-Fluorouracil_GDSC1(5) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1613_VE-822_GDSC2(4) | Melanoma	IL6ST (4):	--1-- |  306_Fedratinib_GDSC1(4) | Melanoma	IL7R (10):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1511_Epirubicin_GDSC2(9) | Melanoma	INSR (13):	--3-- |  269_NSC-207895_GDSC1(8) |  294_MPS-1-IN-1_GDSC1(10) |  1053_MK-2206_GDSC1(6) | Melanoma	IRS1 (3):	--1-- |  1430_IGFR_3801_GDSC1(3) | Melanoma	JAK2 (9):	--3-- |  164_JQ12_GDSC1(5) |  285_SU11274_GDSC1(5) |  328_SNX-2112_GDSC1(5) | Melanoma	JAK3 (15):	--2-- |  1190_Gemcitabine_GDSC2(9) |  194_Luminespib_GDSC1(10) | Melanoma	KDM5A (21):	--3-- |  252_WZ3105_GDSC1(15) |  406_LIMK1 inhibitor BMS4_GDSC1(9) |  1179_MK-1775_GDSC2(11) | Melanoma	KDR (11):	--3-- |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(8) |  1425_BPTES_GDSC1(4) |  1096_Tozasertib_GDSC2(3) | Melanoma	KIT (11):	--3-- |  300_CX-5461_GDSC1(6) |  1066_AZD6482_GDSC1(5) |  1427_AZD5582_GDSC1(8) | Melanoma	KRAS (2):	--1-- |  45_Z-LLNle-CHO_GDSC1(2) | Melanoma	KSR2 (12):	--3-- |  1714_ERK_6604_GDSC2(8) |  1808_Topotecan_GDSC2(6) |  1825_Podophyllotoxin bromide_GDSC2(6) | Melanoma	LCK (4):	--2-- |  172_Embelin_GDSC1(2) |  1069_EHT-1864_GDSC1(2) | Melanoma	LGR5 (10):	--3-- |  1019_Bosutinib_GDSC1(6) |  1430_IGFR_3801_GDSC1(8) |  1089_Oxaliplatin_GDSC2(3) | Melanoma	LMO1 (3):	--1-- |  1011_Navitoclax_GDSC2(3) | Melanoma	LMO2 (5):	--2-- |  1031_Elesclomol_GDSC1(3) |  1511_Epirubicin_GDSC2(4) | Melanoma	LRP6 (14):	--4-- |  1059_AZD8055_GDSC1(7) |  1239_YK-4-279_GDSC1(9) |  1430_IGFR_3801_GDSC1(9) |  1553_Uprosertib_GDSC2(6) | Melanoma	LTK (8):	--2-- |  199_Pazopanib_GDSC1(5) |  264_ACY-1215_GDSC1(5) | Melanoma	LYN (10):	--4-- |  293_Amuvatinib_GDSC1(6) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1129_PF-4708671_GDSC1(3) |  1011_Navitoclax_GDSC2(4) | Melanoma	MAP2K1 (7):	--2-- |  1614_WZ4003_GDSC2(4) |  2171_BMS-754807_GDSC2(4) | Melanoma	MAP2K2 (4):	--2-- |  173_FH535_GDSC1(3) |  197_Bryostatin 1_GDSC1(2) | Melanoma	MAP3K13 (5):	--1-- |  1613_VE-822_GDSC2(5) | Melanoma	MAP4K4 (14):	--3-- |  1036_PLX-4720_GDSC1(8) |  1617_AZD5582_GDSC2(6) |  1713_ERK_2440_GDSC2(6) | Melanoma	MAPK1 (3):	--2-- |  147_NSC-87877_GDSC1(2) |  180_Thapsigargin_GDSC1(1) | Melanoma	MAPK3 (7):	--2-- |  194_Luminespib_GDSC1(5) |  308_Foretinib_GDSC1(5) | Melanoma	MDM2 (5):	--3-- |  140_Vinorelbine_GDSC1(2) |  238_Idelalisib_GDSC1(2) |  1560_Alpelisib_GDSC2(2) | Melanoma	MDM4 (7):	--2-- |  264_ACY-1215_GDSC1(5) |  363_PF-00299804_GDSC1(3) | Melanoma	MECOM (25):	--4-- |  185_Linsitinib_GDSC1(8) |  362_CI-1033_GDSC1(19) |  1036_PLX-4720_GDSC1(12) |  1136_Capivasertib_GDSC1(12) | Melanoma	MEF2D (7):	--2-- |  170_Shikonin_GDSC1(6) |  1720_AZD5991_GDSC2(4) | Melanoma	MET (13):	--2-- |  245_UNC0638_GDSC1(9) |  342_Tenovin-6_GDSC1(11) | Melanoma	MGAM (37):	--5-- |  163_JQ1_GDSC1(25) |  201_Epothilone B_GDSC1(25) |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(16) |  1529_Pevonedistat_GDSC1(14) |  1007_Docetaxel_GDSC2(17) | Melanoma	MKI67 (8):	--1-- |  1511_Epirubicin_GDSC2(8) | Melanoma	MLLT10 (10):	--3-- |  185_Linsitinib_GDSC1(5) |  428_Pemetrexed_GDSC1(4) |  1007_Docetaxel_GDSC2(6) | Melanoma	MLLT3 (4):	--2-- |  288_WHI-P97_GDSC1(2) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) | Melanoma	MPL (4):	--2-- |  185_Linsitinib_GDSC1(3) |  308_Foretinib_GDSC1(3) | Melanoma	MSI1 (7):	--3-- |  185_Linsitinib_GDSC1(4) |  1019_Bosutinib_GDSC1(4) |  1241_CHIR-99021_GDSC1(4) | Melanoma	MSI2 (19):	--4-- |  1494_SN-38_GDSC2(7) |  127_GSK269962A_GDSC1(3) |  1394_AZD6738_GDSC1(9) |  2096_VX-11e_GDSC2(11) | Melanoma	MST1R (6):	--3-- |  265_Tubastatin A_GDSC1(2) |  1031_Elesclomol_GDSC1(3) |  1042_Doramapimod_GDSC2(3) | Melanoma	MTOR (23):	--4-- |  163_JQ1_GDSC1(11) |  223_ZSTK474_GDSC1(15) |  1058_Pictilisib_GDSC1(11) |  1367_BAY-HDAC11_4_GDSC1(8) | Melanoma	MYBL1 (6):	--3-- |  221_TAK-715_GDSC1(2) |  1014_Refametinib_GDSC2(3) |  1069_EHT-1864_GDSC2(2) | Melanoma	MYC (5):	--2-- |  173_FH535_GDSC1(4) |  1011_Navitoclax_GDSC1(4) | Melanoma	NADK (13):	--4-- |  199_Pazopanib_GDSC1(7) |  292_Masitinib_GDSC1(9) |  293_Amuvatinib_GDSC1(6) |  1016_Temsirolimus_GDSC2(6) | Melanoma	NCOA3 (10):	--4-- |  228_AKT inhibitor VIII_GDSC1(6) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1203_QL-XII-61_GDSC1(2) |  1908_Ulixertinib_GDSC2(5) | Melanoma	NCSTN (9):	--3-- |  264_ACY-1215_GDSC1(5) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1614_WZ4003_GDSC2(5) | Melanoma	NFE2 (3):	--2-- |  263_FR-180204_GDSC1(2) |  283_Omipalisib_GDSC1(2) | Melanoma	NFE2L2 (5):	--2-- |  275_I-BET-762_GDSC1(3) |  1011_Navitoclax_GDSC2(3) | Melanoma	NR4A3 (6):	--2-- |  342_Tenovin-6_GDSC1(5) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) | Melanoma	NRAS (12):	--3-- |  164_JQ12_GDSC1(5) |  1036_PLX-4720_GDSC1(4) |  1254_GSK-J4_GDSC1(7) | Melanoma	NRG1 (17):	--3-- |  1016_Temsirolimus_GDSC1(11) |  1042_Doramapimod_GDSC2(7) |  1249_BMS-345541_GDSC2(8) | Melanoma	NSD2 (10):	--2-- |  228_AKT inhibitor VIII_GDSC1(8) |  1529_Pevonedistat_GDSC2(6) | Melanoma	NT5C2 (7):	--3-- |  285_SU11274_GDSC1(5) |  288_WHI-P97_GDSC1(2) |  310_YM201636_GDSC1(5) | Melanoma	NTRK1 (12):	--3-- |  163_JQ1_GDSC1(6) |  261_TL-1-85_GDSC1(8) |  1008_Methotrexate_GDSC2(7) | Melanoma	NTRK2 (15):	--3-- |  1593_Entinostat_GDSC2(7) |  1713_ERK_2440_GDSC2(7) |  2148_POMHEX_GDSC2(6) | Melanoma	NTRK3 (22):	--2-- |  362_CI-1033_GDSC1(16) |  1930_Telomerase Inhibitor IX_GDSC2(18) | Melanoma	NUP214 (20):	--3-- |  276_CAY10603_GDSC1(14) |  362_CI-1033_GDSC1(14) |  1365_BAY-HDAC11_2_GDSC1(7) | Melanoma	NUP98 (16):	--3-- |  167_OSU-03012_GDSC1(9) |  184_BMS-754807_GDSC1(7) |  256_JW-7-24-1_GDSC1(7) | Melanoma	PAK1 (7):	--3-- |  224_AS605240_GDSC1(3) |  428_Pemetrexed_GDSC1(4) |  1624_I-BET-762_GDSC2(4) | Melanoma	PAK5 (16):	--2-- |  165_DMOG_GDSC1(12) |  264_ACY-1215_GDSC1(11) | Melanoma	PDCD1 (4):	--2-- |  1069_EHT-1864_GDSC1(2) |  1089_Oxaliplatin_GDSC2(2) | Melanoma	PDCD1LG2 (5):	--2-- |  238_Idelalisib_GDSC1(2) |  1066_AZD6482_GDSC1(4) | Melanoma	PDGFB (6):	--2-- |  300_CX-5461_GDSC1(4) |  306_Fedratinib_GDSC1(4) | Melanoma	PDGFRA (13):	--2-- |  180_Thapsigargin_GDSC1(11) |  1371_PLX-4720_GDSC1(5) | Melanoma	PDGFRB (13):	--2-- |  179_5-Fluorouracil_GDSC1(7) |  2040_Foretinib_GDSC2(11) | Melanoma	PGR (9):	--3-- |  185_Linsitinib_GDSC1(5) |  257_NPK76-II-72-1_GDSC1(3) |  264_ACY-1215_GDSC1(7) | Melanoma	PIK3CA (3):	--2-- |  172_Embelin_GDSC1(1) |  1069_EHT-1864_GDSC1(2) | Melanoma	PIK3CB (11):	--3-- |  133_Doxorubicin_GDSC1(6) |  190_Bleomycin_GDSC1(6) |  264_ACY-1215_GDSC1(6) | Melanoma	PIK3CG (9):	--2-- |  177_GSK650394_GDSC1(6) |  1053_MK-2206_GDSC2(5) | Melanoma	PLCG1 (6):	--2-- |  172_Embelin_GDSC1(4) |  1069_EHT-1864_GDSC1(2) | Melanoma	PLCG2 (14):	--4-- |  1373_Dabrafenib_GDSC1(6) |  1451_PLK_6522_GDSC1(9) |  1024_Lestaurtinib_GDSC2(6) |  1179_MK-1775_GDSC2(7) | Melanoma	PPARG (5):	--2-- |  285_SU11274_GDSC1(3) |  428_Pemetrexed_GDSC1(3) | Melanoma	PPM1D (4):	--1-- |  342_Tenovin-6_GDSC1(4) | Melanoma	PRKACA (8):	--3-- |  147_NSC-87877_GDSC1(3) |  1564_SCH772984_GDSC2(4) |  1997_WEHI-539_GDSC2(2) | Melanoma	PRKCI (10):	--2-- |  292_Masitinib_GDSC1(7) |  294_MPS-1-IN-1_GDSC1(7) | Melanoma	PTPN11 (6):	--2-- |  170_Shikonin_GDSC1(4) |  330_XMD13-2_GDSC1(2) | Melanoma	RAC1 (3):	--2-- |  221_TAK-715_GDSC1(2) |  576_RU-SKI 43_GDSC1(2) | Melanoma	RAF1 (8):	--2-- |  432_Flavopiridol_GDSC1(6) |  1012_Vorinostat_GDSC1(6) | Melanoma	REV3L (11):	--3-- |  265_Tubastatin A_GDSC1(3) |  330_XMD13-2_GDSC1(3) |  1015_CI-1040_GDSC1(7) | Melanoma	RHEB (9):	--2-- |  177_GSK650394_GDSC1(6) |  1014_Refametinib_GDSC2(6) | Melanoma	RHOA (2):	--1-- |  157_JNK-9L_GDSC1(2) | Melanoma	RICTOR (7):	--2-- |  173_FH535_GDSC1(5) |  1511_Epirubicin_GDSC2(6) | Melanoma	RIT1 (3):	--1-- |  306_Fedratinib_GDSC1(3) | Melanoma	ROS1 (20):	--3-- |  157_JNK-9L_GDSC1(16) |  1427_AZD5582_GDSC1(12) |  1733_ULK1_4989_GDSC2(5) | Melanoma	RPTOR (23):	--3-- |  1136_Capivasertib_GDSC1(12) |  1184_AZ20_GDSC1(20) |  1494_SN-38_GDSC2(10) | Melanoma	RRAGC (5):	--3-- |  238_Idelalisib_GDSC1(2) |  265_Tubastatin A_GDSC1(2) |  1720_AZD5991_GDSC2(2) | Melanoma	RUNX1T1 (10):	--3-- |  300_CX-5461_GDSC1(5) |  1015_CI-1040_GDSC1(6) |  1164_XMD8-92_GDSC1(4) | Melanoma	SET (7):	--2-- |  170_Shikonin_GDSC1(5) |  293_Amuvatinib_GDSC1(4) | Melanoma	SETBP1 (9):	--3-- |  264_ACY-1215_GDSC1(7) |  1071_CRT0105446_GDSC1(4) |  1069_EHT-1864_GDSC2(2) | Melanoma	SETD1A (9):	--2-- |  362_CI-1033_GDSC1(6) |  1004_Vinblastine_GDSC1(6) | Melanoma	SF3B1 (10):	--2-- |  196_Phenformin_GDSC1(8) |  224_AS605240_GDSC1(6) | Melanoma	SGK1 (12):	--3-- |  1019_Bosutinib_GDSC1(5) |  1032_Afatinib_GDSC2(8) |  1714_ERK_6604_GDSC2(5) | Melanoma	SMO (7):	--2-- |  153_Midostaurin_GDSC1(4) |  1183_CRT0160829_GDSC1(4) | Melanoma	SMYD3 (17):	--3-- |  304_SB52334_GDSC1(9) |  1062_Selumetinib_GDSC2(10) |  1873_Buparlisib_GDSC2(12) | Melanoma	SOS1 (9):	--2-- |  133_Doxorubicin_GDSC1(7) |  293_Amuvatinib_GDSC1(5) | Melanoma	SRC (8):	--1-- |  1184_AZ20_GDSC1(8) | Melanoma	SS18 (6):	--2-- |  308_Foretinib_GDSC1(5) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) | Melanoma	STAT3 (6):	--2-- |  342_Tenovin-6_GDSC1(5) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) | Melanoma	STAT5A (6):	--2-- |  219_AT-7519_GDSC1(4) |  362_CI-1033_GDSC1(5) | Melanoma	STAT5B (4):	--2-- |  342_Tenovin-6_GDSC1(3) |  1734_VSP34_8731_GDSC2(2) | Melanoma	STAT6 (9):	--3-- |  147_NSC-87877_GDSC1(3) |  157_JNK-9L_GDSC1(7) |  288_WHI-P97_GDSC1(2) | Melanoma	SYK (6):	--3-- |  1030_KU-55933_GDSC1(2) |  1444_AZD8186_GDSC1(4) |  1069_EHT-1864_GDSC2(2) | Melanoma	TAL1 (5):	--2-- |  179_5-Fluorouracil_GDSC1(4) |  1559_Luminespib_GDSC2(3) | Melanoma	TSHR (8):	--2-- |  111_Salubrinal_GDSC1(3) |  1011_Navitoclax_GDSC2(6) | Melanoma	TYK2 (7):	--2-- |  308_Foretinib_GDSC1(5) |  1011_Navitoclax_GDSC1(4) | Melanoma	UBR5 (21):	--3-- |  164_JQ12_GDSC1(12) |  305_TPCA-1_GDSC1(13) |  2172_JQ1_GDSC2(14) | Melanoma	USP8 (9):	--3-- |  1036_PLX-4720_GDSC1(4) |  1161_ZG-10_GDSC1(4) |  1427_AZD5582_GDSC1(5) | Melanoma	VAV1 (16):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(11) |  1133_Serdemetan_GDSC1(12) | Melanoma	VAV2 (11):	--3-- |  1407_Dyrk1b_0191_GDSC1(5) |  1446_PI3Ka_4409_GDSC1(7) |  1449_AZD1208_GDSC1(4) | Melanoma	WWP1 (9):	--2-- |  151_QS11_GDSC1(6) |  406_LIMK1 inhibitor BMS4_GDSC1(5) | Melanoma	WWTR1 (10):	--3-- |  196_Phenformin_GDSC1(6) |  228_AKT inhibitor VIII_GDSC1(6) |  1036_PLX-4720_GDSC1(4) | Melanoma	XIAP (4):	--1-- |  342_Tenovin-6_GDSC1(4) | Melanoma	XPO1 (8):	--2-- |  185_Linsitinib_GDSC1(4) |  362_CI-1033_GDSC1(6) | Melanoma	YES1 (5):	--2-- |  185_Linsitinib_GDSC1(3) |  308_Foretinib_GDSC1(4) | Mesothelioma	ABL2 (3):	--1-- |  1049_PD173074_GDSC1(3) | Mesothelioma	AKT2 (4):	--2-- |  439_LCL161_GDSC1(2) |  1011_Navitoclax_GDSC1(2) | Mesothelioma	ALK (9):	--2-- |  1070_CRT0105950_GDSC1(7) |  1419_FEN1_3940_GDSC1(2) | Mesothelioma	ARHGEF28 (5):	--2-- |  1037_BX795_GDSC1(3) |  1049_PD173074_GDSC2(4) | Mesothelioma	ATXN7 (2):	--1-- |  439_LCL161_GDSC1(2) | Mesothelioma	BRD3 (2):	--1-- |  1128_FS106_GDSC1(2) | Mesothelioma	BTK (4):	--2-- |  269_NSC-207895_GDSC1(2) |  1926_GNE-317_GDSC2(3) | Mesothelioma	CALR (3):	--2-- |  439_LCL161_GDSC1(2) |  1032_Afatinib_GDSC1(2) | Mesothelioma	COP1 (2):	--2-- |  342_Tenovin-6_GDSC1(1) |  1180_Dinaciclib_GDSC2(1) | Mesothelioma	DNMT1 (4):	--2-- |  228_AKT inhibitor VIII_GDSC1(2) |  1847_BEN_GDSC2(3) | Mesothelioma	E2F3 (2):	--2-- |  1031_Elesclomol_GDSC1(1) |  1187_CCT245232_GDSC1(1) | Mesothelioma	EGFR (6):	--2-- |  1032_Afatinib_GDSC2(5) |  1626_OTX015_GDSC2(4) | Mesothelioma	EIF4A2 (3):	--2-- |  176_IPA-3_GDSC1(2) |  177_GSK650394_GDSC1(2) | Mesothelioma	EPOR (2):	--1-- |  203_BMS-345541_GDSC1(2) | Mesothelioma	ETV1 (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  1037_BX795_GDSC1(3) | Mesothelioma	EWSR1 (2):	--2-- |  1031_Elesclomol_GDSC1(1) |  1180_Dinaciclib_GDSC2(1) | Mesothelioma	EZH1 (4):	--2-- |  1187_CCT245232_GDSC1(3) |  1511_Epirubicin_GDSC2(3) | Mesothelioma	FGFR1 (4):	--2-- |  170_Shikonin_GDSC1(2) |  1088_Irinotecan_GDSC2(3) | Mesothelioma	FGFR3 (2):	--2-- |  342_Tenovin-6_GDSC1(1) |  1031_Elesclomol_GDSC1(1) | Mesothelioma	FLT1 (5):	--3-- |  273_CUDC-101_GDSC1(1) |  1142_HG-5-113-01_GDSC1(1) |  1926_GNE-317_GDSC2(3) | Mesothelioma	GAB2 (4):	--2-- |  439_LCL161_GDSC1(2) |  1007_Docetaxel_GDSC2(2) | Mesothelioma	GLI1 (3):	--1-- |  328_SNX-2112_GDSC1(3) | Mesothelioma	GNA11 (3):	--2-- |  1460_PARP_9482_GDSC1(1) |  1053_MK-2206_GDSC2(2) | Mesothelioma	GNAS (10):	--3-- |  152_CP466722_GDSC1(7) |  303_PIK-93_GDSC1(4) |  2172_JQ1_GDSC2(6) | Mesothelioma	HDAC1 (2):	--1-- |  1011_Navitoclax_GDSC2(2) | Mesothelioma	IGF1R (3):	--2-- |  1186_FS112_GDSC1(1) |  1243_Piperlongumine_GDSC1(2) | Mesothelioma	KDM5A (2):	--1-- |  1001_AICA Ribonucleotide_GDSC1(2) | Mesothelioma	KIT (5):	--2-- |  461_NSC319726_GDSC1(2) |  1427_AZD5582_GDSC1(4) | Mesothelioma	KSR2 (6):	--2-- |  1042_Doramapimod_GDSC1(4) |  1024_Lestaurtinib_GDSC2(2) | Mesothelioma	LGR5 (4):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1015_CI-1040_GDSC1(3) | Mesothelioma	LTK (3):	--2-- |  1011_Navitoclax_GDSC1(2) |  1060_PD0325901_GDSC1(2) | Mesothelioma	MAP4K4 (4):	--1-- |  1015_CI-1040_GDSC1(4) | Mesothelioma	MDM2 (3):	--2-- |  293_Amuvatinib_GDSC1(2) |  1377_Afatinib_GDSC1(2) | Mesothelioma	MEF2B (4):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1015_CI-1040_GDSC1(3) | Mesothelioma	MEF2D (4):	--2-- |  229_Enzastaurin_GDSC1(3) |  1186_FS112_GDSC1(1) | Mesothelioma	MET (4):	--2-- |  261_TL-1-85_GDSC1(3) |  302_PI-103_GDSC1(3) | Mesothelioma	MLLT10 (5):	--2-- |  283_Omipalisib_GDSC1(3) |  1373_Dabrafenib_GDSC1(3) | Mesothelioma	MLLT3 (6):	--2-- |  1458_PARP_9495_GDSC1(4) |  1829_667880_GDSC2(5) | Mesothelioma	MSI2 (7):	--3-- |  133_Doxorubicin_GDSC1(3) |  172_Embelin_GDSC1(2) |  1459_PARP_0108_GDSC1(3) | Mesothelioma	MTOR (6):	--2-- |  1042_Doramapimod_GDSC1(4) |  1494_SN-38_GDSC1(5) | Mesothelioma	NRG1 (6):	--2-- |  1014_Refametinib_GDSC1(4) |  1453_RAF_9304_GDSC1(4) | Mesothelioma	NSD2 (4):	--2-- |  1015_CI-1040_GDSC1(3) |  1049_PD173074_GDSC1(3) | Mesothelioma	NTRK1 (4):	--2-- |  1007_Docetaxel_GDSC2(2) |  1786_AZD4547_GDSC2(3) | Mesothelioma	NTRK3 (2):	--1-- |  439_LCL161_GDSC1(2) | Mesothelioma	NUP98 (5):	--2-- |  1037_BX795_GDSC1(3) |  1049_PD173074_GDSC2(3) | Mesothelioma	PGR (4):	--2-- |  135_Gemcitabine_GDSC1(1) |  1932_NVP-ADW742_GDSC2(3) | Mesothelioma	PLCG1 (4):	--2-- |  164_JQ12_GDSC1(3) |  203_BMS-345541_GDSC1(2) | Mesothelioma	PLCG2 (3):	--1-- |  1037_BX795_GDSC1(3) | Mesothelioma	PRKACA (3):	--2-- |  1197_ZL049_GDSC1(2) |  1425_BPTES_GDSC1(2) | Mesothelioma	RAC1 (2):	--1-- |  1425_BPTES_GDSC1(2) | Mesothelioma	RAC2 (3):	--2-- |  439_LCL161_GDSC1(2) |  1032_Afatinib_GDSC1(2) | Mesothelioma	RHEB (4):	--1-- |  331_QL-X-138_GDSC1(4) | Mesothelioma	RICTOR (8):	--3-- |  363_PF-00299804_GDSC1(5) |  1003_Camptothecin_GDSC2(5) |  1917_AZD6738_GDSC2(3) | Mesothelioma	ROS1 (2):	--1-- |  1001_AICA Ribonucleotide_GDSC1(2) | Mesothelioma	SETBP1 (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(2) |  1011_Navitoclax_GDSC2(3) | Mesothelioma	SF3B1 (4):	--2-- |  301_PHA-793887_GDSC1(3) |  1142_HG-5-113-01_GDSC1(1) | Mesothelioma	SHOC2 (3):	--2-- |  293_Amuvatinib_GDSC1(2) |  1377_Afatinib_GDSC1(2) | Mesothelioma	SMYD3 (4):	--2-- |  1023_GW441756_GDSC1(3) |  1042_Doramapimod_GDSC1(3) | Mesothelioma	SOS1 (3):	--2-- |  439_LCL161_GDSC1(2) |  1446_PI3Ka_4409_GDSC1(2) | Mesothelioma	SQSTM1 (3):	--2-- |  203_BMS-345541_GDSC1(2) |  1011_Navitoclax_GDSC2(2) | Mesothelioma	STAT6 (3):	--1-- |  1188_CCT245467_GDSC1(3) | Mesothelioma	TERT (4):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1015_CI-1040_GDSC1(3) | Mesothelioma	TYK2 (3):	--1-- |  1023_GW441756_GDSC1(3) | Mesothelioma	USP8 (5):	--2-- |  1432_AZD1480_GDSC1(4) |  1809_Teniposide_GDSC2(4) | Mesothelioma	VAV1 (3):	--2-- |  439_LCL161_GDSC1(2) |  1446_PI3Ka_4409_GDSC1(2) | Mesothelioma	VAV2 (4):	--2-- |  1451_PLK_6522_GDSC1(2) |  1511_Epirubicin_GDSC2(3) | Mesothelioma	VEGFA (3):	--2-- |  273_CUDC-101_GDSC1(1) |  439_LCL161_GDSC1(2) | Mesothelioma	WWTR1 (3):	--2-- |  190_Bleomycin_GDSC1(1) |  293_Amuvatinib_GDSC1(2) | Mesothelioma	XPO1 (4):	--2-- |  1446_PI3Ka_4409_GDSC1(3) |  1191_Bortezomib_GDSC2(2) | Mesothelioma	YES1 (4):	--2-- |  269_NSC-207895_GDSC1(2) |  1425_BPTES_GDSC1(2) | Neuroblastoma	ACVR1 (3):	--1-- |  1050_ZM447439_GDSC2(3) | Neuroblastoma	AFF4 (3):	--2-- |  281_Alectinib_GDSC1(2) |  1013_Nilotinib_GDSC2(2) | Neuroblastoma	AGO1 (5):	--3-- |  302_PI-103_GDSC1(3) |  1062_Selumetinib_GDSC1(3) |  1084_Rapamycin_GDSC2(2) | Neuroblastoma	AKT2 (3):	--2-- |  38_Saracatinib_GDSC1(2) |  1079_Dasatinib_GDSC2(2) | Neuroblastoma	AKT3 (5):	--3-- |  63_BMS-509744_GDSC1(2) |  199_Pazopanib_GDSC1(2) |  230_GSK429286A_GDSC1(3) | Neuroblastoma	ALK (16):	--4-- |  30_Sorafenib_GDSC1(6) |  219_AT-7519_GDSC1(8) |  252_WZ3105_GDSC1(10) |  2172_JQ1_GDSC2(10) | Neuroblastoma	ARHGEF28 (15):	--4-- |  261_TL-1-85_GDSC1(10) |  1241_CHIR-99021_GDSC1(4) |  2096_VX-11e_GDSC2(8) |  2111_VE821_GDSC2(5) | Neuroblastoma	ATF1 (3):	--2-- |  342_Tenovin-6_GDSC1(2) |  563_Kobe2602_GDSC1(2) | Neuroblastoma	ATXN7 (6):	--2-- |  163_JQ1_GDSC1(3) |  1062_Selumetinib_GDSC2(4) | Neuroblastoma	AXL (8):	--3-- |  30_Sorafenib_GDSC1(4) |  1062_Selumetinib_GDSC1(3) |  1259_Talazoparib_GDSC2(3) | Neuroblastoma	BCL2 (2):	--1-- |  1046_Wee1 Inhibitor_GDSC1(2) | Neuroblastoma	BCL9 (7):	--2-- |  415_CPI-613_GDSC1(4) |  2171_BMS-754807_GDSC2(5) | Neuroblastoma	BCR (13):	--2-- |  261_TL-1-85_GDSC1(10) |  435_C-75_GDSC1(11) | Neuroblastoma	BRAF (6):	--2-- |  356_AT7867_GDSC1(3) |  1241_CHIR-99021_GDSC1(3) | Neuroblastoma	BRD3 (4):	--1-- |  344_THZ-2-49_GDSC1(4) | Neuroblastoma	BRD4 (5):	--3-- |  273_CUDC-101_GDSC1(3) |  281_Alectinib_GDSC1(2) |  431_Alisertib_GDSC1(2) | Neuroblastoma	BTK (2):	--2-- |  1031_Elesclomol_GDSC1(1) |  1250_AZ960_GDSC2(1) | Neuroblastoma	CALR (6):	--2-- |  1005_Cisplatin_GDSC1(4) |  2111_VE821_GDSC2(4) | Neuroblastoma	CARD11 (7):	--2-- |  1186_FS112_GDSC1(4) |  1624_I-BET-762_GDSC2(4) | Neuroblastoma	CD28 (4):	--2-- |  1032_Afatinib_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | Neuroblastoma	CD79B (3):	--2-- |  253_XMD14-99_GDSC1(2) |  1066_AZD6482_GDSC1(2) | Neuroblastoma	CDC42 (3):	--2-- |  167_OSU-03012_GDSC1(1) |  1203_QL-XII-61_GDSC1(2) | Neuroblastoma	CDK4 (3):	--2-- |  262_VX-11e_GDSC1(2) |  1032_Afatinib_GDSC1(2) | Neuroblastoma	CDK8 (2):	--2-- |  1003_Camptothecin_GDSC2(1) |  1922_Cediranib_GDSC2(1) | Neuroblastoma	CYP19A1 (3):	--1-- |  5_Sunitinib_GDSC1(3) | Neuroblastoma	DCUN1D1 (5):	--1-- |  1080_Paclitaxel_GDSC2(5) | Neuroblastoma	DDR2 (3):	--2-- |  1036_PLX-4720_GDSC1(2) |  1052_RO-3306_GDSC1(2) | Neuroblastoma	DDX4 (3):	--2-- |  342_Tenovin-6_GDSC1(2) |  380_BIBF-1120_GDSC1(2) | Neuroblastoma	DNMT1 (5):	--3-- |  37_Crizotinib_GDSC1(2) |  576_RU-SKI 43_GDSC1(3) |  1922_Cediranib_GDSC2(3) | Neuroblastoma	DOT1L (6):	--2-- |  1916_AZD5363_GDSC2(4) |  2109_AZ6102_GDSC2(3) | Neuroblastoma	EGFL7 (10):	--3-- |  11_Paclitaxel_GDSC1(6) |  30_Sorafenib_GDSC1(6) |  1093_GSK1904529A_GDSC2(3) | Neuroblastoma	EGFR (6):	--2-- |  30_Sorafenib_GDSC1(4) |  151_QS11_GDSC1(5) | Neuroblastoma	EIF4A2 (4):	--2-- |  412_Venotoclax_GDSC1(3) |  1401_AZD5438_GDSC1(3) | Neuroblastoma	ERBB2 (6):	--2-- |  1197_ZL049_GDSC1(3) |  1564_SCH772984_GDSC2(4) | Neuroblastoma	ERBB3 (5):	--2-- |  30_Sorafenib_GDSC1(4) |  1084_Rapamycin_GDSC2(2) | Neuroblastoma	ERBB4 (9):	--2-- |  134_Etoposide_GDSC1(5) |  380_BIBF-1120_GDSC1(7) | Neuroblastoma	ERG (10):	--2-- |  1446_PI3Ka_4409_GDSC1(6) |  1910_ABT737_GDSC2(6) | Neuroblastoma	ESR1 (3):	--2-- |  37_Crizotinib_GDSC1(2) |  1712_Eg5_9814_GDSC2(1) | Neuroblastoma	ETV1 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1241_CHIR-99021_GDSC1(3) | Neuroblastoma	EWSR1 (7):	--2-- |  226_GSK1070916_GDSC1(4) |  1367_BAY-HDAC11_4_GDSC1(5) | Neuroblastoma	EZH1 (5):	--2-- |  1069_EHT-1864_GDSC1(2) |  1241_CHIR-99021_GDSC1(3) | Neuroblastoma	FGFR1 (6):	--3-- |  1242_(5Z)-7-Oxozeaenol_GDSC1(4) |  1036_PLX-4720_GDSC2(2) |  1048_Mirin_GDSC2(2) | Neuroblastoma	FGFR2 (10):	--3-- |  173_FH535_GDSC1(6) |  302_PI-103_GDSC1(4) |  2111_VE821_GDSC2(4) | Neuroblastoma	FGFR3 (6):	--2-- |  412_Venotoclax_GDSC1(3) |  1093_GSK1904529A_GDSC2(3) | Neuroblastoma	FGFR4 (6):	--3-- |  152_CP466722_GDSC1(2) |  1241_CHIR-99021_GDSC1(3) |  1085_Sorafenib_GDSC2(3) | Neuroblastoma	FLT1 (6):	--2-- |  228_AKT inhibitor VIII_GDSC1(5) |  1490_SN-38_GDSC1(4) | Neuroblastoma	FLT3 (3):	--2-- |  380_BIBF-1120_GDSC1(2) |  2171_BMS-754807_GDSC2(2) | Neuroblastoma	FLT4 (8):	--4-- |  190_Bleomycin_GDSC1(3) |  199_Pazopanib_GDSC1(3) |  1007_Docetaxel_GDSC2(3) |  1932_NVP-ADW742_GDSC2(4) | Neuroblastoma	FURIN (3):	--2-- |  51_Dasatinib_GDSC1(2) |  63_BMS-509744_GDSC1(2) | Neuroblastoma	FYN (3):	--2-- |  268_Sepantronium bromide_GDSC1(2) |  1195_FY026_GDSC1(1) | Neuroblastoma	GAB1 (6):	--2-- |  412_Venotoclax_GDSC1(3) |  576_RU-SKI 43_GDSC1(4) | Neuroblastoma	GNA13 (2):	--1-- |  329_QL-XI-92_GDSC1(2) | Neuroblastoma	GNAQ (3):	--1-- |  177_GSK650394_GDSC1(3) | Neuroblastoma	GNAS (7):	--3-- |  224_AS605240_GDSC1(4) |  1241_CHIR-99021_GDSC1(3) |  1084_Rapamycin_GDSC2(2) | Neuroblastoma	GTF2I (3):	--2-- |  281_Alectinib_GDSC1(2) |  1013_Nilotinib_GDSC2(2) | Neuroblastoma	HDAC7 (4):	--2-- |  167_OSU-03012_GDSC1(2) |  268_Sepantronium bromide_GDSC1(3) | Neuroblastoma	HGF (5):	--2-- |  273_CUDC-101_GDSC1(4) |  281_Alectinib_GDSC1(2) | Neuroblastoma	HMGA2 (6):	--2-- |  5_Sunitinib_GDSC1(3) |  1062_Selumetinib_GDSC1(3) | Neuroblastoma	IDH1 (3):	--1-- |  576_RU-SKI 43_GDSC1(3) | Neuroblastoma	IDH2 (6):	--4-- |  152_CP466722_GDSC1(2) |  226_GSK1070916_GDSC1(3) |  282_Pelitinib_GDSC1(2) |  431_Alisertib_GDSC1(3) | Neuroblastoma	IGF1 (5):	--2-- |  177_GSK650394_GDSC1(3) |  1008_Methotrexate_GDSC1(3) | Neuroblastoma	IKBKE (7):	--2-- |  269_NSC-207895_GDSC1(5) |  1133_Serdemetan_GDSC2(4) | Neuroblastoma	IL6ST (2):	--1-- |  1036_PLX-4720_GDSC2(2) | Neuroblastoma	INSR (9):	--4-- |  5_Sunitinib_GDSC1(4) |  252_WZ3105_GDSC1(3) |  1057_Dactolisib_GDSC1(5) |  1093_GSK1904529A_GDSC2(3) | Neuroblastoma	IRS1 (5):	--2-- |  37_Crizotinib_GDSC1(2) |  56_WH-4-023_GDSC1(3) | Neuroblastoma	JAK3 (8):	--2-- |  330_XMD13-2_GDSC1(4) |  1026_Tanespimycin_GDSC2(5) | Neuroblastoma	KDR (9):	--2-- |  309_Y-39983_GDSC1(7) |  1080_Paclitaxel_GDSC2(6) | Neuroblastoma	KIT (7):	--3-- |  1008_Methotrexate_GDSC1(4) |  1026_Tanespimycin_GDSC2(4) |  1806_Oxaliplatin_GDSC2(2) | Neuroblastoma	KLF5 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | Neuroblastoma	KRAS (3):	--2-- |  155_Ponatinib_GDSC1(2) |  1490_SN-38_GDSC1(2) | Neuroblastoma	KSR2 (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  342_Tenovin-6_GDSC1(3) | Neuroblastoma	LCK (2):	--1-- |  199_Pazopanib_GDSC1(2) | Neuroblastoma	LGR5 (3):	--2-- |  3_Rapamycin_GDSC1(2) |  563_Kobe2602_GDSC1(2) | Neuroblastoma	LMO1 (2):	--1-- |  1377_Afatinib_GDSC1(2) | Neuroblastoma	LRP6 (9):	--2-- |  29_AZ628_GDSC1(6) |  1997_WEHI-539_GDSC2(6) | Neuroblastoma	LTK (6):	--2-- |  1241_CHIR-99021_GDSC1(3) |  1080_Paclitaxel_GDSC2(5) | Neuroblastoma	LYN (5):	--2-- |  127_GSK269962A_GDSC1(2) |  1003_Camptothecin_GDSC2(3) | Neuroblastoma	MAP3K13 (7):	--2-- |  152_CP466722_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(5) | Neuroblastoma	MDM4 (6):	--2-- |  190_Bleomycin_GDSC1(3) |  1070_CRT0105950_GDSC1(3) | Neuroblastoma	MECOM (10):	--2-- |  62_BMS-536924_GDSC1(6) |  1026_Tanespimycin_GDSC1(6) | Neuroblastoma	MEF2D (4):	--2-- |  152_CP466722_GDSC1(2) |  1187_CCT245232_GDSC1(3) | Neuroblastoma	MET (6):	--3-- |  53_CGP-60474_GDSC1(3) |  344_THZ-2-49_GDSC1(4) |  356_AT7867_GDSC1(3) | Neuroblastoma	MGAM (19):	--5-- |  64_CMK_GDSC1(8) |  140_Vinorelbine_GDSC1(8) |  204_Tipifarnib_GDSC1(9) |  331_QL-X-138_GDSC1(10) |  1840_630600_GDSC2(6) | Neuroblastoma	MLLT3 (3):	--2-- |  1248_Daporinad_GDSC1(1) |  1553_Uprosertib_GDSC2(2) | Neuroblastoma	MST1R (3):	--2-- |  1032_Afatinib_GDSC1(2) |  1084_Rapamycin_GDSC2(2) | Neuroblastoma	MTOR (7):	--2-- |  1062_Selumetinib_GDSC2(4) |  1933_P22077_GDSC2(3) | Neuroblastoma	MYD88 (2):	--1-- |  156_AZD6482_GDSC1(2) | Neuroblastoma	NCOA3 (10):	--3-- |  64_CMK_GDSC1(6) |  380_BIBF-1120_GDSC1(6) |  476_SB505124_GDSC1(4) | Neuroblastoma	NCSTN (5):	--3-- |  576_RU-SKI 43_GDSC1(3) |  1250_AZ960_GDSC2(2) |  1932_NVP-ADW742_GDSC2(2) | Neuroblastoma	NR4A3 (8):	--3-- |  273_CUDC-101_GDSC1(4) |  1242_(5Z)-7-Oxozeaenol_GDSC1(4) |  1080_Paclitaxel_GDSC2(6) | Neuroblastoma	NRAS (5):	--2-- |  346_THZ-2-102-1_GDSC1(4) |  1241_CHIR-99021_GDSC1(3) | Neuroblastoma	NRG1 (6):	--2-- |  290_KIN001-260_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(4) | Neuroblastoma	NSD2 (3):	--2-- |  3_Rapamycin_GDSC1(2) |  37_Crizotinib_GDSC1(2) | Neuroblastoma	NT5C2 (7):	--2-- |  1070_CRT0105950_GDSC1(4) |  1494_SN-38_GDSC1(6) | Neuroblastoma	NTRK1 (6):	--2-- |  412_Venotoclax_GDSC1(3) |  1409_AZD4877_GDSC1(4) | Neuroblastoma	NTRK2 (6):	--2-- |  32_Tozasertib_GDSC1(5) |  88_Entinostat_GDSC1(4) | Neuroblastoma	NTRK3 (11):	--3-- |  152_CP466722_GDSC1(4) |  256_JW-7-24-1_GDSC1(7) |  1232_I-BET-151_GDSC1(4) | Neuroblastoma	NUF2 (4):	--1-- |  1026_Tanespimycin_GDSC1(4) | Neuroblastoma	NUP214 (13):	--3-- |  208_Ispinesib Mesylate_GDSC1(4) |  1053_MK-2206_GDSC2(7) |  2046_MK-8776_GDSC2(9) | Neuroblastoma	NUP98 (9):	--3-- |  64_CMK_GDSC1(6) |  152_CP466722_GDSC1(3) |  163_JQ1_GDSC1(4) | Neuroblastoma	PAK1 (4):	--2-- |  127_GSK269962A_GDSC1(2) |  1170_CCT-018159_GDSC1(3) | Neuroblastoma	PDCD1 (3):	--2-- |  175_PAC-1_GDSC1(2) |  1004_Vinblastine_GDSC1(1) | Neuroblastoma	PDGFRA (2):	--2-- |  1180_Dinaciclib_GDSC2(1) |  1922_Cediranib_GDSC2(1) | Neuroblastoma	PDGFRB (5):	--2-- |  163_JQ1_GDSC1(3) |  1093_GSK1904529A_GDSC2(3) | Neuroblastoma	PIK3CA (4):	--2-- |  1008_Methotrexate_GDSC1(3) |  1185_KU-60019_GDSC1(3) | Neuroblastoma	PIK3CB (6):	--3-- |  133_Doxorubicin_GDSC1(3) |  1241_CHIR-99021_GDSC1(3) |  1199_Tamoxifen_GDSC2(3) | Neuroblastoma	PLCG1 (8):	--2-- |  228_AKT inhibitor VIII_GDSC1(5) |  366_TWS119_GDSC1(5) | Neuroblastoma	PLCG2 (8):	--2-- |  1161_ZG-10_GDSC1(4) |  1526_Refametinib_GDSC1(6) | Neuroblastoma	PRKACA (7):	--2-- |  88_Entinostat_GDSC1(3) |  330_XMD13-2_GDSC1(5) | Neuroblastoma	PRKCI (1):	--1-- |  299_OSI-027_GDSC1(1) | Neuroblastoma	RAC2 (6):	--2-- |  152_CP466722_GDSC1(3) |  1187_CCT245232_GDSC1(4) | Neuroblastoma	RAF1 (6):	--2-- |  306_Fedratinib_GDSC1(3) |  1188_CCT245467_GDSC1(5) | Neuroblastoma	RET (2):	--1-- |  342_Tenovin-6_GDSC1(2) | Neuroblastoma	REV3L (6):	--2-- |  342_Tenovin-6_GDSC1(4) |  1409_AZD4877_GDSC1(4) | Neuroblastoma	RHEB (3):	--1-- |  1241_CHIR-99021_GDSC1(3) | Neuroblastoma	RICTOR (9):	--2-- |  309_Y-39983_GDSC1(7) |  1997_WEHI-539_GDSC2(6) | Neuroblastoma	RNASEH2A (2):	--1-- |  194_Luminespib_GDSC1(2) | Neuroblastoma	RPTOR (13):	--3-- |  62_BMS-536924_GDSC1(7) |  304_SB52334_GDSC1(5) |  2109_AZ6102_GDSC2(6) | Neuroblastoma	SET (3):	--1-- |  1594_OSI-027_GDSC2(3) | Neuroblastoma	SETD1A (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1377_Afatinib_GDSC1(2) | Neuroblastoma	SMO (3):	--1-- |  1401_AZD5438_GDSC1(3) | Neuroblastoma	SMYD3 (11):	--3-- |  32_Tozasertib_GDSC1(6) |  203_BMS-345541_GDSC1(6) |  1617_AZD5582_GDSC2(5) | Neuroblastoma	SOS1 (12):	--2-- |  64_CMK_GDSC1(6) |  1873_Buparlisib_GDSC2(9) | Neuroblastoma	SQSTM1 (8):	--3-- |  38_Saracatinib_GDSC1(2) |  1241_CHIR-99021_GDSC1(4) |  2057_Remodelin_GDSC2(3) | Neuroblastoma	SRC (6):	--2-- |  151_QS11_GDSC1(5) |  476_SB505124_GDSC1(2) | Neuroblastoma	STAT3 (5):	--3-- |  38_Saracatinib_GDSC1(2) |  1032_Afatinib_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | Neuroblastoma	STAT5B (5):	--2-- |  1170_CCT-018159_GDSC1(3) |  1549_Sapitinib_GDSC2(2) | Neuroblastoma	STAT6 (3):	--2-- |  1046_Wee1 Inhibitor_GDSC1(2) |  1449_AZD1208_GDSC1(2) | Neuroblastoma	SYK (2):	--1-- |  1046_Wee1 Inhibitor_GDSC1(2) | Neuroblastoma	TRIM27 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1933_P22077_GDSC2(2) | Neuroblastoma	TSHR (6):	--2-- |  5_Sunitinib_GDSC1(3) |  2044_Pyridostatin_GDSC2(3) | Neuroblastoma	UBR5 (13):	--4-- |  86_A-443654_GDSC1(3) |  164_JQ12_GDSC1(7) |  252_WZ3105_GDSC1(6) |  256_JW-7-24-1_GDSC1(8) | Neuroblastoma	USP8 (3):	--2-- |  37_Crizotinib_GDSC1(2) |  1922_Cediranib_GDSC2(2) | Neuroblastoma	VAV1 (7):	--3-- |  152_CP466722_GDSC1(3) |  372_Pilaralisib_GDSC1(3) |  1241_CHIR-99021_GDSC1(3) | Neuroblastoma	VAV2 (10):	--3-- |  224_AS605240_GDSC1(5) |  372_Pilaralisib_GDSC1(5) |  1001_AICA Ribonucleotide_GDSC1(6) | Neuroblastoma	XPO1 (5):	--2-- |  412_Venotoclax_GDSC1(4) |  1071_CRT0105446_GDSC1(3) | Neuroblastoma	YES1 (3):	--1-- |  1046_Wee1 Inhibitor_GDSC1(3) | Non-Small Cell Lung Carcinoma	ABL1 (16):	--2-- |  374_GSK1059615_GDSC1(13) |  1190_Gemcitabine_GDSC2(8) | Non-Small Cell Lung Carcinoma	ABL2 (23):	--3-- |  294_MPS-1-IN-1_GDSC1(10) |  1060_PD0325901_GDSC1(15) |  1128_FS106_GDSC1(14) | Non-Small Cell Lung Carcinoma	ACVR1 (12):	--3-- |  170_Shikonin_GDSC1(9) |  1058_Pictilisib_GDSC2(7) |  1919_Osimertinib_GDSC2(4) | Non-Small Cell Lung Carcinoma	ADHFE1 (9):	--3-- |  1168_Erlotinib_GDSC2(6) |  211_TL-2-105_GDSC1(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Non-Small Cell Lung Carcinoma	AFF4 (19):	--4-- |  303_PIK-93_GDSC1(11) |  1164_XMD8-92_GDSC1(3) |  1529_Pevonedistat_GDSC1(9) |  2057_Remodelin_GDSC2(3) | Non-Small Cell Lung Carcinoma	AGO1 (16):	--4-- |  59_WZ-1-84_GDSC1(2) |  185_Linsitinib_GDSC1(7) |  1060_PD0325901_GDSC1(10) |  1464_TTK_3146_GDSC1(8) | Non-Small Cell Lung Carcinoma	AKT1 (16):	--2-- |  268_Sepantronium bromide_GDSC1(12) |  1057_Dactolisib_GDSC1(13) | Non-Small Cell Lung Carcinoma	AKT2 (15):	--3-- |  119_Lapatinib_GDSC1(2) |  1187_CCT245232_GDSC1(12) |  1559_Luminespib_GDSC2(10) | Non-Small Cell Lung Carcinoma	AKT3 (15):	--2-- |  170_Shikonin_GDSC1(13) |  346_THZ-2-102-1_GDSC1(12) | Non-Small Cell Lung Carcinoma	ALK (53):	--5-- |  152_CP466722_GDSC1(35) |  163_JQ1_GDSC1(27) |  1060_PD0325901_GDSC1(39) |  1232_I-BET-151_GDSC1(27) |  1829_667880_GDSC2(19) | Non-Small Cell Lung Carcinoma	AR (13):	--3-- |  180_Thapsigargin_GDSC1(10) |  437_Trichostatin A_GDSC1(9) |  1060_PD0325901_GDSC1(7) | Non-Small Cell Lung Carcinoma	ARAF (3):	--2-- |  249_Cabozantinib_GDSC1(2) |  258_STF-62247_GDSC1(1) | Non-Small Cell Lung Carcinoma	ARHGEF28 (22):	--3-- |  176_IPA-3_GDSC1(12) |  294_MPS-1-IN-1_GDSC1(11) |  449_CD532_GDSC1(19) | Non-Small Cell Lung Carcinoma	ARID3B (7):	--2-- |  300_CX-5461_GDSC1(5) |  431_Alisertib_GDSC1(4) | Non-Small Cell Lung Carcinoma	ATF1 (8):	--3-- |  170_Shikonin_GDSC1(5) |  1386_Doxorubicin_GDSC1(6) |  2057_Remodelin_GDSC2(2) | Non-Small Cell Lung Carcinoma	ATXN7 (10):	--3-- |  151_QS11_GDSC1(5) |  1011_Navitoclax_GDSC1(4) |  1032_Afatinib_GDSC1(4) | Non-Small Cell Lung Carcinoma	AURKB (5):	--3-- |  1401_AZD5438_GDSC1(3) |  1461_TANK_1366_GDSC1(2) |  1179_MK-1775_GDSC2(2) | Non-Small Cell Lung Carcinoma	AXL (17):	--2-- |  346_THZ-2-102-1_GDSC1(13) |  374_GSK1059615_GDSC1(15) | Non-Small Cell Lung Carcinoma	BAALC (5):	--2-- |  1143_HG-5-88-01_GDSC1(4) |  1560_Alpelisib_GDSC2(3) | Non-Small Cell Lung Carcinoma	BCL2 (8):	--3-- |  257_NPK76-II-72-1_GDSC1(6) |  262_VX-11e_GDSC1(4) |  1367_BAY-HDAC11_4_GDSC1(2) | Non-Small Cell Lung Carcinoma	BCL3 (11):	--4-- |  1143_HG-5-88-01_GDSC1(4) |  1197_ZL049_GDSC1(4) |  1594_OSI-027_GDSC2(6) |  1734_VSP34_8731_GDSC2(4) | Non-Small Cell Lung Carcinoma	BCL6 (9):	--2-- |  180_Thapsigargin_GDSC1(5) |  1379_ZL109_GDSC1(7) | Non-Small Cell Lung Carcinoma	BCL9 (10):	--2-- |  1364_BAY-HDAC11_1_GDSC1(9) |  1622_Wnt-C59_GDSC2(2) | Non-Small Cell Lung Carcinoma	BCR (37):	--4-- |  1242_(5Z)-7-Oxozeaenol_GDSC1(27) |  1248_Daporinad_GDSC1(16) |  1372_Trametinib_GDSC2(16) |  1926_GNE-317_GDSC2(29) | Non-Small Cell Lung Carcinoma	BRAF (23):	--4-- |  134_Etoposide_GDSC1(14) |  140_Vinorelbine_GDSC1(16) |  362_CI-1033_GDSC1(11) |  1161_ZG-10_GDSC1(8) | Non-Small Cell Lung Carcinoma	BRD3 (14):	--4-- |  71_Pyrimethamine_GDSC1(3) |  288_WHI-P97_GDSC1(4) |  1133_Serdemetan_GDSC1(8) |  1529_Pevonedistat_GDSC1(9) | Non-Small Cell Lung Carcinoma	BRD4 (13):	--3-- |  173_FH535_GDSC1(9) |  1128_FS106_GDSC1(6) |  1594_OSI-027_GDSC2(6) | Non-Small Cell Lung Carcinoma	BTK (9):	--1-- |  478_LDN-193189_GDSC1(9) | Non-Small Cell Lung Carcinoma	CARD11 (30):	--3-- |  140_Vinorelbine_GDSC1(21) |  170_Shikonin_GDSC1(25) |  1378_Bleomycin (50 uM)_GDSC1(22) | Non-Small Cell Lung Carcinoma	CCNB3 (15):	--2-- |  328_SNX-2112_GDSC1(7) |  374_GSK1059615_GDSC1(12) | Non-Small Cell Lung Carcinoma	CCND1 (7):	--3-- |  170_Shikonin_GDSC1(4) |  196_Phenformin_GDSC1(3) |  273_CUDC-101_GDSC1(4) | Non-Small Cell Lung Carcinoma	CCND2 (4):	--2-- |  1149_TW 37_GDSC1(3) |  1359_965-D2_GDSC1(2) | Non-Small Cell Lung Carcinoma	CCND3 (19):	--2-- |  170_Shikonin_GDSC1(16) |  229_Enzastaurin_GDSC1(12) | Non-Small Cell Lung Carcinoma	CCNE1 (6):	--2-- |  1912_Afuresertib_GDSC2(5) |  1996_MIM1_GDSC2(2) | Non-Small Cell Lung Carcinoma	CD274 (10):	--2-- |  170_Shikonin_GDSC1(8) |  283_Omipalisib_GDSC1(8) | Non-Small Cell Lung Carcinoma	CD276 (9):	--4-- |  279_BIX02189_GDSC1(2) |  1050_ZM447439_GDSC1(4) |  1085_Sorafenib_GDSC2(5) |  1557_LCL161_GDSC2(2) | Non-Small Cell Lung Carcinoma	CD28 (4):	--1-- |  1428_IAP_5620_GDSC1(4) | Non-Small Cell Lung Carcinoma	CD79B (5):	--2-- |  194_Luminespib_GDSC1(2) |  374_GSK1059615_GDSC1(4) | Non-Small Cell Lung Carcinoma	CDC42 (7):	--2-- |  196_Phenformin_GDSC1(4) |  1918_AZD8186_GDSC2(5) | Non-Small Cell Lung Carcinoma	CDK6 (11):	--3-- |  170_Shikonin_GDSC1(8) |  173_FH535_GDSC1(7) |  1386_Doxorubicin_GDSC1(9) | Non-Small Cell Lung Carcinoma	CDK8 (16):	--3-- |  294_MPS-1-IN-1_GDSC1(9) |  1060_PD0325901_GDSC1(10) |  1058_Pictilisib_GDSC2(8) | Non-Small Cell Lung Carcinoma	COP1 (19):	--4-- |  201_Epothilone B_GDSC1(11) |  252_WZ3105_GDSC1(11) |  276_CAY10603_GDSC1(13) |  1197_ZL049_GDSC1(4) | Non-Small Cell Lung Carcinoma	CREB1 (6):	--3-- |  300_CX-5461_GDSC1(4) |  1038_NU7441_GDSC1(2) |  2159_UNC0379_GDSC2(3) | Non-Small Cell Lung Carcinoma	CRKL (5):	--1-- |  1911_Dactinomycin_GDSC2(5) | Non-Small Cell Lung Carcinoma	CSF3R (14):	--2-- |  1463_AZD1332_GDSC1(10) |  1803_Acetalax_GDSC2(5) | Non-Small Cell Lung Carcinoma	CTLA4 (4):	--2-- |  261_TL-1-85_GDSC1(2) |  371_Torin 2_GDSC1(3) | Non-Small Cell Lung Carcinoma	CTNNB1 (10):	--3-- |  151_QS11_GDSC1(6) |  176_IPA-3_GDSC1(7) |  199_Pazopanib_GDSC1(4) | Non-Small Cell Lung Carcinoma	CXCR4 (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  1022_AZD7762_GDSC2(3) | Non-Small Cell Lung Carcinoma	CYP19A1 (16):	--2-- |  262_VX-11e_GDSC1(5) |  1379_ZL109_GDSC1(14) | Non-Small Cell Lung Carcinoma	DCUN1D1 (8):	--2-- |  135_Gemcitabine_GDSC1(4) |  374_GSK1059615_GDSC1(6) | Non-Small Cell Lung Carcinoma	DDR2 (25):	--2-- |  170_Shikonin_GDSC1(19) |  1184_AZ20_GDSC1(18) | Non-Small Cell Lung Carcinoma	DDX4 (9):	--3-- |  170_Shikonin_GDSC1(6) |  284_JNJ38877605_GDSC1(5) |  1179_MK-1775_GDSC2(5) | Non-Small Cell Lung Carcinoma	DEK (7):	--2-- |  432_Flavopiridol_GDSC1(5) |  1911_Dactinomycin_GDSC2(5) | Non-Small Cell Lung Carcinoma	DNMT1 (30):	--5-- |  288_WHI-P97_GDSC1(6) |  294_MPS-1-IN-1_GDSC1(12) |  1259_Talazoparib_GDSC1(18) |  1829_667880_GDSC2(13) |  1912_Afuresertib_GDSC2(13) | Non-Small Cell Lung Carcinoma	DOT1L (30):	--3-- |  203_BMS-345541_GDSC1(17) |  546_FTY-720_GDSC1(23) |  1003_Camptothecin_GDSC2(16) | Non-Small Cell Lung Carcinoma	E2F3 (12):	--3-- |  185_Linsitinib_GDSC1(6) |  264_ACY-1215_GDSC1(6) |  2109_AZ6102_GDSC2(7) | Non-Small Cell Lung Carcinoma	EGFL7 (12):	--2-- |  1058_Pictilisib_GDSC2(8) |  1085_Sorafenib_GDSC2(7) | Non-Small Cell Lung Carcinoma	EGFR (37):	--3-- |  1407_Dyrk1b_0191_GDSC1(17) |  170_Shikonin_GDSC1(31) |  1372_Trametinib_GDSC2(16) | Non-Small Cell Lung Carcinoma	EIF4A2 (13):	--2-- |  374_GSK1059615_GDSC1(10) |  1031_Elesclomol_GDSC1(7) | Non-Small Cell Lung Carcinoma	EIF4E (11):	--3-- |  140_Vinorelbine_GDSC1(6) |  1032_Afatinib_GDSC1(5) |  1553_Uprosertib_GDSC2(5) | Non-Small Cell Lung Carcinoma	EPOR (6):	--2-- |  275_I-BET-762_GDSC1(4) |  1732_TAF1_5496_GDSC2(3) | Non-Small Cell Lung Carcinoma	ERBB3 (14):	--3-- |  196_Phenformin_GDSC1(9) |  1003_Camptothecin_GDSC2(10) |  1827_Dihydrorotenone_GDSC2(5) | Non-Small Cell Lung Carcinoma	ERBB4 (43):	--4-- |  276_CAY10603_GDSC1(37) |  1032_Afatinib_GDSC1(11) |  1453_RAF_9304_GDSC1(23) |  1060_PD0325901_GDSC2(26) | Non-Small Cell Lung Carcinoma	ERG (18):	--2-- |  170_Shikonin_GDSC1(14) |  1187_CCT245232_GDSC1(12) | Non-Small Cell Lung Carcinoma	ESR1 (12):	--3-- |  32_Tozasertib_GDSC1(3) |  1005_Cisplatin_GDSC1(8) |  1085_Sorafenib_GDSC2(8) | Non-Small Cell Lung Carcinoma	ETV1 (24):	--3-- |  194_Luminespib_GDSC1(17) |  1060_PD0325901_GDSC1(15) |  1401_AZD5438_GDSC1(19) | Non-Small Cell Lung Carcinoma	ETV4 (11):	--4-- |  294_MPS-1-IN-1_GDSC1(6) |  1048_Mirin_GDSC1(6) |  1114_Cetuximab_GDSC1(4) |  1833_741909_GDSC2(2) | Non-Small Cell Lung Carcinoma	ETV5 (10):	--3-- |  1032_Afatinib_GDSC1(5) |  1494_SN-38_GDSC1(6) |  1833_741909_GDSC2(2) | Non-Small Cell Lung Carcinoma	EWSR1 (9):	--3-- |  269_NSC-207895_GDSC1(4) |  294_MPS-1-IN-1_GDSC1(6) |  1714_ERK_6604_GDSC2(4) | Non-Small Cell Lung Carcinoma	EZH1 (11):	--2-- |  291_KIN001-266_GDSC1(7) |  1011_Navitoclax_GDSC2(7) | Non-Small Cell Lung Carcinoma	FGF3 (10):	--3-- |  416_CAY10566_GDSC1(2) |  1170_CCT-018159_GDSC1(6) |  1261_rTRAIL_GDSC1(5) | Non-Small Cell Lung Carcinoma	FGF4 (8):	--2-- |  190_Bleomycin_GDSC1(5) |  1911_Dactinomycin_GDSC2(5) | Non-Small Cell Lung Carcinoma	FGFR1 (17):	--2-- |  196_Phenformin_GDSC1(11) |  374_GSK1059615_GDSC1(14) | Non-Small Cell Lung Carcinoma	FGFR2 (33):	--3-- |  1149_TW 37_GDSC1(29) |  1409_AZD4877_GDSC1(27) |  1062_Selumetinib_GDSC2(11) | Non-Small Cell Lung Carcinoma	FGFR3 (13):	--3-- |  1060_PD0325901_GDSC1(7) |  1128_FS106_GDSC1(8) |  1866_BDP-00009066_GDSC2(7) | Non-Small Cell Lung Carcinoma	FGFR4 (10):	--2-- |  194_Luminespib_GDSC1(6) |  1594_OSI-027_GDSC2(5) | Non-Small Cell Lung Carcinoma	FLI1 (18):	--4-- |  170_Shikonin_GDSC1(14) |  185_Linsitinib_GDSC1(9) |  229_Enzastaurin_GDSC1(11) |  1401_AZD5438_GDSC2(7) | Non-Small Cell Lung Carcinoma	FLT1 (23):	--2-- |  273_CUDC-101_GDSC1(16) |  1058_Pictilisib_GDSC2(12) | Non-Small Cell Lung Carcinoma	FLT3 (23):	--4-- |  245_UNC0638_GDSC1(11) |  546_FTY-720_GDSC1(16) |  1032_Afatinib_GDSC1(7) |  1827_Dihydrorotenone_GDSC2(10) | Non-Small Cell Lung Carcinoma	FLT4 (31):	--4-- |  176_IPA-3_GDSC1(13) |  1060_PD0325901_GDSC1(21) |  1083_Crizotinib_GDSC2(13) |  1827_Dihydrorotenone_GDSC2(9) | Non-Small Cell Lung Carcinoma	FURIN (9):	--3-- |  288_WHI-P97_GDSC1(4) |  1058_Pictilisib_GDSC2(6) |  1622_Wnt-C59_GDSC2(2) | Non-Small Cell Lung Carcinoma	FUS (20):	--4-- |  287_KIN001-244_GDSC1(8) |  294_MPS-1-IN-1_GDSC1(9) |  1038_NU7441_GDSC2(8) |  1564_SCH772984_GDSC2(11) | Non-Small Cell Lung Carcinoma	FYN (18):	--3-- |  1066_AZD6482_GDSC1(7) |  346_THZ-2-102-1_GDSC1(13) |  182_Obatoclax Mesylate_GDSC1(14) | Non-Small Cell Lung Carcinoma	GAB1 (13):	--3-- |  249_Cabozantinib_GDSC1(3) |  546_FTY-720_GDSC1(10) |  1177_Niraparib_GDSC2(3) | Non-Small Cell Lung Carcinoma	GAB2 (23):	--5-- |  294_MPS-1-IN-1_GDSC1(9) |  1011_Navitoclax_GDSC1(6) |  1024_Lestaurtinib_GDSC1(10) |  1128_FS106_GDSC1(14) |  1187_CCT245232_GDSC1(15) | Non-Small Cell Lung Carcinoma	GATA2 (8):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1912_Afuresertib_GDSC2(6) | Non-Small Cell Lung Carcinoma	GLI1 (18):	--3-- |  310_YM201636_GDSC1(7) |  372_Pilaralisib_GDSC1(8) |  1364_BAY-HDAC11_1_GDSC1(11) | Non-Small Cell Lung Carcinoma	GNA11 (6):	--3-- |  1072_Avagacestat_GDSC1(2) |  1428_IAP_5620_GDSC1(4) |  2170_AT13148_GDSC2(3) | Non-Small Cell Lung Carcinoma	GNA12 (18):	--4-- |  170_Shikonin_GDSC1(15) |  330_XMD13-2_GDSC1(4) |  1072_Avagacestat_GDSC1(3) |  1594_OSI-027_GDSC2(8) | Non-Small Cell Lung Carcinoma	GNAQ (13):	--2-- |  1183_CRT0160829_GDSC1(8) |  1242_(5Z)-7-Oxozeaenol_GDSC1(10) | Non-Small Cell Lung Carcinoma	GNAS (19):	--3-- |  294_MPS-1-IN-1_GDSC1(10) |  476_SB505124_GDSC1(10) |  1578_Leflunomide_GDSC2(6) | Non-Small Cell Lung Carcinoma	GNB1 (11):	--3-- |  186_Bexarotene_GDSC1(4) |  362_CI-1033_GDSC1(5) |  1873_Buparlisib_GDSC2(7) | Non-Small Cell Lung Carcinoma	GREM1 (3):	--2-- |  269_NSC-207895_GDSC1(2) |  288_WHI-P97_GDSC1(2) | Non-Small Cell Lung Carcinoma	GSK3B (20):	--2-- |  163_JQ1_GDSC1(9) |  374_GSK1059615_GDSC1(17) | Non-Small Cell Lung Carcinoma	GTF2I (15):	--3-- |  1059_AZD8055_GDSC1(8) |  1003_Camptothecin_GDSC2(10) |  1558_Lapatinib_GDSC2(8) | Non-Small Cell Lung Carcinoma	H1-4 (6):	--2-- |  262_VX-11e_GDSC1(3) |  304_SB52334_GDSC1(3) | Non-Small Cell Lung Carcinoma	HDAC1 (6):	--2-- |  170_Shikonin_GDSC1(4) |  317_WYE-125132_GDSC1(4) | Non-Small Cell Lung Carcinoma	HDAC7 (12):	--4-- |  1164_XMD8-92_GDSC1(3) |  1248_Daporinad_GDSC2(4) |  1730_PAK_5339_GDSC2(6) |  1933_P22077_GDSC2(2) | Non-Small Cell Lung Carcinoma	HGF (30):	--2-- |  1060_PD0325901_GDSC1(23) |  2040_Foretinib_GDSC2(21) | Non-Small Cell Lung Carcinoma	HIF1A (8):	--2-- |  1184_AZ20_GDSC1(6) |  1242_(5Z)-7-Oxozeaenol_GDSC1(6) | Non-Small Cell Lung Carcinoma	HMGA2 (11):	--2-- |  1558_Lapatinib_GDSC2(7) |  2106_Uprosertib_GDSC2(7) | Non-Small Cell Lung Carcinoma	IDH1 (5):	--2-- |  1434_JAK3_7406_GDSC1(4) |  1915_AZD3759_GDSC2(2) | Non-Small Cell Lung Carcinoma	IDH2 (6):	--2-- |  1161_ZG-10_GDSC1(2) |  1038_NU7441_GDSC2(4) | Non-Small Cell Lung Carcinoma	IGF1 (2):	--1-- |  1069_EHT-1864_GDSC2(2) | Non-Small Cell Lung Carcinoma	IGF1R (24):	--5-- |  64_CMK_GDSC1(3) |  294_MPS-1-IN-1_GDSC1(10) |  1006_Cytarabine_GDSC1(11) |  1248_Daporinad_GDSC1(12) |  1364_BAY-HDAC11_1_GDSC1(18) | Non-Small Cell Lung Carcinoma	IGF2 (12):	--3-- |  252_WZ3105_GDSC1(8) |  346_THZ-2-102-1_GDSC1(10) |  1359_965-D2_GDSC1(4) | Non-Small Cell Lung Carcinoma	IKBKE (16):	--3-- |  374_GSK1059615_GDSC1(14) |  1133_Serdemetan_GDSC1(9) |  1048_Mirin_GDSC2(9) | Non-Small Cell Lung Carcinoma	IL3 (5):	--2-- |  173_FH535_GDSC1(4) |  1188_CCT245467_GDSC1(4) | Non-Small Cell Lung Carcinoma	IL6ST (12):	--3-- |  375_Voxtalisib_GDSC1(3) |  1584_BDOCA000347a_GDSC2(2) |  1912_Afuresertib_GDSC2(8) | Non-Small Cell Lung Carcinoma	IL7R (22):	--2-- |  374_GSK1059615_GDSC1(17) |  1386_Doxorubicin_GDSC1(19) | Non-Small Cell Lung Carcinoma	INSR (25):	--4-- |  179_5-Fluorouracil_GDSC1(14) |  1136_Capivasertib_GDSC1(14) |  1007_Docetaxel_GDSC2(16) |  2096_VX-11e_GDSC2(16) | Non-Small Cell Lung Carcinoma	IRS1 (5):	--1-- |  1259_Talazoparib_GDSC2(5) | Non-Small Cell Lung Carcinoma	IRS2 (6):	--3-- |  329_QL-XI-92_GDSC1(2) |  1496_Cisplatin_GDSC1(3) |  1177_Niraparib_GDSC2(2) | Non-Small Cell Lung Carcinoma	JAK2 (23):	--4-- |  356_AT7867_GDSC1(9) |  476_SB505124_GDSC1(9) |  1011_Navitoclax_GDSC2(14) |  1866_BDP-00009066_GDSC2(11) | Non-Small Cell Lung Carcinoma	JAK3 (19):	--3-- |  476_SB505124_GDSC1(8) |  1011_Navitoclax_GDSC2(11) |  1091_BMS-536924_GDSC2(9) | Non-Small Cell Lung Carcinoma	KDM5A (26):	--5-- |  199_Pazopanib_GDSC1(7) |  294_MPS-1-IN-1_GDSC1(12) |  1032_Afatinib_GDSC2(13) |  1529_Pevonedistat_GDSC2(14) |  1803_Acetalax_GDSC2(8) | Non-Small Cell Lung Carcinoma	KDR (30):	--5-- |  151_QS11_GDSC1(12) |  153_Midostaurin_GDSC1(18) |  293_Amuvatinib_GDSC1(12) |  1529_Pevonedistat_GDSC1(13) |  1131_PRIMA-1MET_GDSC2(9) | Non-Small Cell Lung Carcinoma	KIT (18):	--2-- |  170_Shikonin_GDSC1(17) |  1248_Daporinad_GDSC1(9) | Non-Small Cell Lung Carcinoma	KLF5 (4):	--2-- |  170_Shikonin_GDSC1(2) |  2057_Remodelin_GDSC2(2) | Non-Small Cell Lung Carcinoma	KRAS (31):	--5-- |  186_Bexarotene_GDSC1(7) |  1060_PD0325901_GDSC2(19) |  1458_PARP_9495_GDSC1(16) |  1188_CCT245467_GDSC1(11) |  1062_Selumetinib_GDSC1(11) | Non-Small Cell Lung Carcinoma	KSR2 (30):	--4-- |  291_KIN001-266_GDSC1(15) |  1133_Serdemetan_GDSC1(15) |  1232_I-BET-151_GDSC1(13) |  1058_Pictilisib_GDSC2(18) | Non-Small Cell Lung Carcinoma	LCK (8):	--2-- |  252_WZ3105_GDSC1(4) |  1409_AZD4877_GDSC1(6) | Non-Small Cell Lung Carcinoma	LGR5 (31):	--2-- |  374_GSK1059615_GDSC1(26) |  1386_Doxorubicin_GDSC1(28) | Non-Small Cell Lung Carcinoma	LMO1 (7):	--2-- |  1031_Elesclomol_GDSC1(5) |  1062_Selumetinib_GDSC1(4) | Non-Small Cell Lung Carcinoma	LMO2 (7):	--2-- |  1022_AZD7762_GDSC1(4) |  1827_Dihydrorotenone_GDSC2(4) | Non-Small Cell Lung Carcinoma	LRP6 (21):	--3-- |  207_AS601245_GDSC1(11) |  1248_Daporinad_GDSC1(11) |  2040_Foretinib_GDSC2(16) | Non-Small Cell Lung Carcinoma	LTK (12):	--3-- |  546_FTY-720_GDSC1(7) |  1926_GNE-317_GDSC2(9) |  2109_AZ6102_GDSC2(7) | Non-Small Cell Lung Carcinoma	LYN (19):	--2-- |  194_Luminespib_GDSC1(14) |  371_Torin 2_GDSC1(13) | Non-Small Cell Lung Carcinoma	MAP2K1 (12):	--3-- |  170_Shikonin_GDSC1(9) |  1183_CRT0160829_GDSC1(7) |  1085_Sorafenib_GDSC2(6) | Non-Small Cell Lung Carcinoma	MAP2K2 (8):	--3-- |  257_NPK76-II-72-1_GDSC1(5) |  287_KIN001-244_GDSC1(6) |  1367_BAY-HDAC11_4_GDSC1(2) | Non-Small Cell Lung Carcinoma	MAP3K13 (20):	--4-- |  170_Shikonin_GDSC1(17) |  134_Etoposide_GDSC1(12) |  252_WZ3105_GDSC1(12) |  1007_Docetaxel_GDSC1(10) | Non-Small Cell Lung Carcinoma	MAPK1 (5):	--2-- |  1011_Navitoclax_GDSC1(4) |  1038_NU7441_GDSC2(4) | Non-Small Cell Lung Carcinoma	MAPK3 (10):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(5) |  1085_Sorafenib_GDSC2(6) | Non-Small Cell Lung Carcinoma	MCL1 (8):	--2-- |  196_Phenformin_GDSC1(4) |  1184_AZ20_GDSC1(5) | Non-Small Cell Lung Carcinoma	MDM2 (12):	--2-- |  219_AT-7519_GDSC1(4) |  374_GSK1059615_GDSC1(10) | Non-Small Cell Lung Carcinoma	MDM4 (23):	--4-- |  294_MPS-1-IN-1_GDSC1(10) |  295_NVP-BHG712_GDSC1(6) |  476_SB505124_GDSC1(9) |  1058_Pictilisib_GDSC2(13) | Non-Small Cell Lung Carcinoma	MECOM (35):	--4-- |  294_MPS-1-IN-1_GDSC1(12) |  1187_CCT245232_GDSC1(25) |  1401_AZD5438_GDSC1(28) |  1624_I-BET-762_GDSC2(8) | Non-Small Cell Lung Carcinoma	MEF2B (11):	--3-- |  310_YM201636_GDSC1(6) |  1136_Capivasertib_GDSC1(8) |  1495_Olaparib_GDSC1(3) | Non-Small Cell Lung Carcinoma	MEF2D (17):	--2-- |  1441_AZD2014_GDSC1(15) |  1058_Pictilisib_GDSC2(8) | Non-Small Cell Lung Carcinoma	MET (25):	--2-- |  165_DMOG_GDSC1(21) |  371_Torin 2_GDSC1(18) | Non-Small Cell Lung Carcinoma	MGAM (64):	--4-- |  449_CD532_GDSC1(48) |  1242_(5Z)-7-Oxozeaenol_GDSC1(49) |  1059_AZD8055_GDSC2(24) |  1593_Entinostat_GDSC2(29) | Non-Small Cell Lung Carcinoma	MKI67 (26):	--2-- |  371_Torin 2_GDSC1(19) |  1386_Doxorubicin_GDSC1(23) | Non-Small Cell Lung Carcinoma	MLLT10 (21):	--3-- |  1070_CRT0105950_GDSC1(11) |  1363_BAY AKT1_GDSC1(9) |  1080_Paclitaxel_GDSC2(10) | Non-Small Cell Lung Carcinoma	MLLT3 (15):	--2-- |  165_DMOG_GDSC1(12) |  1441_AZD2014_GDSC1(13) | Non-Small Cell Lung Carcinoma	MPL (10):	--2-- |  185_Linsitinib_GDSC1(5) |  442_IMD-0354_GDSC1(7) | Non-Small Cell Lung Carcinoma	MSI1 (7):	--2-- |  222_BX-912_GDSC1(5) |  1036_PLX-4720_GDSC1(2) | Non-Small Cell Lung Carcinoma	MSI2 (33):	--4-- |  331_QL-X-138_GDSC1(16) |  1803_Acetalax_GDSC2(7) |  1866_BDP-00009066_GDSC2(12) |  1910_ABT737_GDSC2(19) | Non-Small Cell Lung Carcinoma	MST1R (5):	--2-- |  1266_ICL1100013_GDSC1(4) |  1006_Cytarabine_GDSC2(4) | Non-Small Cell Lung Carcinoma	MTOR (30):	--6-- |  185_Linsitinib_GDSC1(11) |  476_SB505124_GDSC1(12) |  1032_Afatinib_GDSC1(9) |  1048_Mirin_GDSC1(14) |  1091_BMS-536924_GDSC1(14) |  1804_Acetalax_GDSC2(6) | Non-Small Cell Lung Carcinoma	MYBL1 (17):	--3-- |  291_KIN001-266_GDSC1(11) |  446_MIM1_GDSC1(11) |  1032_Afatinib_GDSC1(6) | Non-Small Cell Lung Carcinoma	MYC (10):	--3-- |  156_AZD6482_GDSC1(5) |  1066_AZD6482_GDSC1(6) |  1560_Alpelisib_GDSC2(3) | Non-Small Cell Lung Carcinoma	MYCL (3):	--2-- |  211_TL-2-105_GDSC1(2) |  288_WHI-P97_GDSC1(2) | Non-Small Cell Lung Carcinoma	MYCN (3):	--2-- |  186_Bexarotene_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(2) | Non-Small Cell Lung Carcinoma	MYD88 (2):	--1-- |  1052_RO-3306_GDSC1(2) | Non-Small Cell Lung Carcinoma	NADK (12):	--3-- |  1416_AZD8931_GDSC1(5) |  1430_IGFR_3801_GDSC1(9) |  1926_GNE-317_GDSC2(7) | Non-Small Cell Lung Carcinoma	NCOA3 (27):	--4-- |  449_CD532_GDSC1(21) |  1001_AICA Ribonucleotide_GDSC1(14) |  1131_PRIMA-1MET_GDSC2(8) |  1817_Romidepsin_GDSC2(10) | Non-Small Cell Lung Carcinoma	NCSTN (14):	--3-- |  310_YM201636_GDSC1(6) |  461_NSC319726_GDSC1(10) |  1047_Nutlin-3a (-)_GDSC1(4) | Non-Small Cell Lung Carcinoma	NFE2 (2):	--1-- |  1011_Navitoclax_GDSC1(2) | Non-Small Cell Lung Carcinoma	NFE2L2 (10):	--3-- |  171_AKT inhibitor VIII_GDSC1(4) |  272_AR-42_GDSC1(6) |  1428_IAP_5620_GDSC2(2) | Non-Small Cell Lung Carcinoma	NR4A3 (6):	--2-- |  173_FH535_GDSC1(4) |  346_THZ-2-102-1_GDSC1(5) | Non-Small Cell Lung Carcinoma	NRAS (12):	--2-- |  194_Luminespib_GDSC1(8) |  374_GSK1059615_GDSC1(10) | Non-Small Cell Lung Carcinoma	NRG1 (30):	--3-- |  196_Phenformin_GDSC1(21) |  442_IMD-0354_GDSC1(21) |  1133_Serdemetan_GDSC1(12) | Non-Small Cell Lung Carcinoma	NSD2 (31):	--3-- |  264_ACY-1215_GDSC1(22) |  273_CUDC-101_GDSC1(25) |  1259_Talazoparib_GDSC1(20) | Non-Small Cell Lung Carcinoma	NT5C2 (9):	--2-- |  170_Shikonin_GDSC1(8) |  1080_Paclitaxel_GDSC2(6) | Non-Small Cell Lung Carcinoma	NTRK1 (21):	--4-- |  1183_CRT0160829_GDSC1(10) |  1219_PFI-1_GDSC1(10) |  1453_RAF_9304_GDSC1(13) |  1732_TAF1_5496_GDSC2(5) | Non-Small Cell Lung Carcinoma	NTRK2 (24):	--5-- |  71_Pyrimethamine_GDSC1(3) |  431_Alisertib_GDSC1(6) |  1133_Serdemetan_GDSC1(10) |  1428_IAP_5620_GDSC1(8) |  1003_Camptothecin_GDSC2(13) | Non-Small Cell Lung Carcinoma	NTRK3 (51):	--3-- |  176_IPA-3_GDSC1(20) |  274_Belinostat_GDSC1(46) |  1022_AZD7762_GDSC1(35) | Non-Small Cell Lung Carcinoma	NUF2 (13):	--2-- |  176_IPA-3_GDSC1(7) |  1402_AZD7762_GDSC1(11) | Non-Small Cell Lung Carcinoma	NUP214 (32):	--3-- |  158_PF-562271_GDSC1(6) |  308_Foretinib_GDSC1(24) |  442_IMD-0354_GDSC1(26) | Non-Small Cell Lung Carcinoma	NUP98 (24):	--4-- |  106_XMD8-85_GDSC1(3) |  1133_Serdemetan_GDSC1(13) |  1022_AZD7762_GDSC2(19) |  1810_Mitoxantrone_GDSC2(11) | Non-Small Cell Lung Carcinoma	PAK1 (13):	--3-- |  294_MPS-1-IN-1_GDSC1(8) |  1060_PD0325901_GDSC1(8) |  1128_FS106_GDSC1(7) | Non-Small Cell Lung Carcinoma	PAK5 (25):	--5-- |  29_AZ628_GDSC1(4) |  366_TWS119_GDSC1(10) |  1232_I-BET-151_GDSC1(11) |  1058_Pictilisib_GDSC2(13) |  1179_MK-1775_GDSC2(16) | Non-Small Cell Lung Carcinoma	PAX8 (9):	--4-- |  119_Lapatinib_GDSC1(2) |  294_MPS-1-IN-1_GDSC1(4) |  1022_AZD7762_GDSC1(4) |  1128_FS106_GDSC1(4) | Non-Small Cell Lung Carcinoma	PDCD1 (7):	--3-- |  53_CGP-60474_GDSC1(1) |  300_CX-5461_GDSC1(5) |  428_Pemetrexed_GDSC1(4) | Non-Small Cell Lung Carcinoma	PDCD1LG2 (10):	--2-- |  134_Etoposide_GDSC1(6) |  170_Shikonin_GDSC1(9) | Non-Small Cell Lung Carcinoma	PDGFB (5):	--2-- |  356_AT7867_GDSC1(3) |  374_GSK1059615_GDSC1(4) | Non-Small Cell Lung Carcinoma	PDGFRA (28):	--3-- |  170_Shikonin_GDSC1(25) |  185_Linsitinib_GDSC1(11) |  273_CUDC-101_GDSC1(21) | Non-Small Cell Lung Carcinoma	PDGFRB (25):	--3-- |  1494_SN-38_GDSC2(12) |  1037_BX795_GDSC1(14) |  229_Enzastaurin_GDSC1(13) | Non-Small Cell Lung Carcinoma	PGR (18):	--2-- |  170_Shikonin_GDSC1(15) |  1409_AZD4877_GDSC1(16) | Non-Small Cell Lung Carcinoma	PIK3CA (16):	--4-- |  1016_Temsirolimus_GDSC2(6) |  1083_Crizotinib_GDSC2(10) |  1401_AZD5438_GDSC2(8) |  1820_123829_GDSC2(6) | Non-Small Cell Lung Carcinoma	PIK3CB (10):	--2-- |  268_Sepantronium bromide_GDSC1(8) |  1266_ICL1100013_GDSC1(4) | Non-Small Cell Lung Carcinoma	PIK3CD (10):	--3-- |  170_Shikonin_GDSC1(5) |  268_Sepantronium bromide_GDSC1(8) |  1359_965-D2_GDSC1(3) | Non-Small Cell Lung Carcinoma	PIK3CG (14):	--3-- |  294_MPS-1-IN-1_GDSC1(7) |  356_AT7867_GDSC1(5) |  1184_AZ20_GDSC1(10) | Non-Small Cell Lung Carcinoma	PLCG1 (13):	--4-- |  211_TL-2-105_GDSC1(4) |  291_KIN001-266_GDSC1(8) |  1058_Pictilisib_GDSC2(6) |  1088_Irinotecan_GDSC2(7) | Non-Small Cell Lung Carcinoma	PLCG2 (38):	--4-- |  173_FH535_GDSC1(29) |  1372_Trametinib_GDSC1(23) |  1378_Bleomycin (50 uM)_GDSC1(25) |  1091_BMS-536924_GDSC2(20) | Non-Small Cell Lung Carcinoma	PPM1D (6):	--1-- |  274_Belinostat_GDSC1(6) | Non-Small Cell Lung Carcinoma	PRKACA (7):	--2-- |  135_Gemcitabine_GDSC1(5) |  1197_ZL049_GDSC1(3) | Non-Small Cell Lung Carcinoma	PTPN11 (9):	--3-- |  1196_FY069_GDSC1(2) |  1496_Cisplatin_GDSC1(5) |  2148_POMHEX_GDSC2(4) | Non-Small Cell Lung Carcinoma	RAC1 (10):	--2-- |  1714_ERK_6604_GDSC2(5) |  1386_Doxorubicin_GDSC1(8) | Non-Small Cell Lung Carcinoma	RAC2 (12):	--3-- |  158_PF-562271_GDSC1(4) |  1011_Navitoclax_GDSC1(5) |  1922_Cediranib_GDSC2(9) | Non-Small Cell Lung Carcinoma	RAF1 (10):	--2-- |  170_Shikonin_GDSC1(6) |  442_IMD-0354_GDSC1(8) | Non-Small Cell Lung Carcinoma	REL (10):	--3-- |  294_MPS-1-IN-1_GDSC1(6) |  1085_Sorafenib_GDSC2(6) |  1833_741909_GDSC2(2) | Non-Small Cell Lung Carcinoma	RET (23):	--2-- |  374_GSK1059615_GDSC1(20) |  1022_AZD7762_GDSC1(13) | Non-Small Cell Lung Carcinoma	REV3L (21):	--3-- |  264_ACY-1215_GDSC1(12) |  301_PHA-793887_GDSC1(13) |  1060_PD0325901_GDSC1(15) | Non-Small Cell Lung Carcinoma	RHEB (17):	--2-- |  371_Torin 2_GDSC1(11) |  1057_Dactolisib_GDSC1(14) | Non-Small Cell Lung Carcinoma	RHOA (5):	--2-- |  173_FH535_GDSC1(4) |  252_WZ3105_GDSC1(3) | Non-Small Cell Lung Carcinoma	RICTOR (18):	--3-- |  356_AT7867_GDSC1(7) |  1133_Serdemetan_GDSC1(11) |  1168_Erlotinib_GDSC2(8) | Non-Small Cell Lung Carcinoma	RNASEH2A (4):	--2-- |  1362_BAY ACCi_GDSC1(1) |  1786_AZD4547_GDSC2(3) | Non-Small Cell Lung Carcinoma	ROS1 (17):	--2-- |  203_BMS-345541_GDSC1(14) |  293_Amuvatinib_GDSC1(9) | Non-Small Cell Lung Carcinoma	RPS6KA4 (6):	--2-- |  356_AT7867_GDSC1(3) |  1803_Acetalax_GDSC2(3) | Non-Small Cell Lung Carcinoma	RPS6KB2 (2):	--1-- |  1011_Navitoclax_GDSC1(2) | Non-Small Cell Lung Carcinoma	RPTOR (45):	--3-- |  159_HG6-64-1_GDSC1(22) |  272_AR-42_GDSC1(34) |  1184_AZ20_GDSC1(37) | Non-Small Cell Lung Carcinoma	RRAGC (8):	--3-- |  310_YM201636_GDSC1(4) |  374_GSK1059615_GDSC1(5) |  1428_IAP_5620_GDSC1(4) | Non-Small Cell Lung Carcinoma	RUNX1T1 (25):	--3-- |  294_MPS-1-IN-1_GDSC1(10) |  1242_(5Z)-7-Oxozeaenol_GDSC1(16) |  1386_Doxorubicin_GDSC1(22) | Non-Small Cell Lung Carcinoma	SCG5 (6):	--2-- |  1149_TW 37_GDSC1(5) |  1444_AZD8186_GDSC1(4) | Non-Small Cell Lung Carcinoma	SET (6):	--2-- |  171_AKT inhibitor VIII_GDSC1(4) |  1062_Selumetinib_GDSC1(3) | Non-Small Cell Lung Carcinoma	SETBP1 (32):	--2-- |  1128_FS106_GDSC1(24) |  1911_Dactinomycin_GDSC2(31) | Non-Small Cell Lung Carcinoma	SETD1A (18):	--4-- |  185_Linsitinib_GDSC1(8) |  476_SB505124_GDSC1(7) |  1091_BMS-536924_GDSC1(9) |  1997_WEHI-539_GDSC2(4) | Non-Small Cell Lung Carcinoma	SF3B1 (23):	--4-- |  29_AZ628_GDSC1(5) |  1266_ICL1100013_GDSC1(14) |  1180_Dinaciclib_GDSC2(13) |  2148_POMHEX_GDSC2(10) | Non-Small Cell Lung Carcinoma	SGK1 (15):	--3-- |  1011_Navitoclax_GDSC1(7) |  1364_BAY-HDAC11_1_GDSC1(10) |  2047_Ulixertinib_GDSC2(4) | Non-Small Cell Lung Carcinoma	SHOC2 (13):	--3-- |  257_NPK76-II-72-1_GDSC1(7) |  1812_Bleomycin_GDSC2(3) |  1558_Lapatinib_GDSC2(6) | Non-Small Cell Lung Carcinoma	SMO (18):	--2-- |  170_Shikonin_GDSC1(14) |  1401_AZD5438_GDSC1(15) | Non-Small Cell Lung Carcinoma	SMYD3 (36):	--3-- |  133_Doxorubicin_GDSC1(29) |  1022_AZD7762_GDSC1(22) |  1594_OSI-027_GDSC2(12) | Non-Small Cell Lung Carcinoma	SOS1 (22):	--4-- |  264_ACY-1215_GDSC1(12) |  1048_Mirin_GDSC1(11) |  1088_Irinotecan_GDSC2(9) |  2106_Uprosertib_GDSC2(9) | Non-Small Cell Lung Carcinoma	SQSTM1 (11):	--3-- |  310_YM201636_GDSC1(5) |  1062_Selumetinib_GDSC1(5) |  1187_CCT245232_GDSC1(7) | Non-Small Cell Lung Carcinoma	SRC (12):	--3-- |  1058_Pictilisib_GDSC2(7) |  1494_SN-38_GDSC2(8) |  1845_Schweinfurthin A_GDSC2(3) | Non-Small Cell Lung Carcinoma	SS18 (4):	--2-- |  416_CAY10566_GDSC1(2) |  1131_PRIMA-1MET_GDSC2(3) | Non-Small Cell Lung Carcinoma	STAT3 (19):	--2-- |  260_NG-25_GDSC1(7) |  374_GSK1059615_GDSC1(17) | Non-Small Cell Lung Carcinoma	STAT5A (10):	--3-- |  431_Alisertib_GDSC1(4) |  1021_Axitinib_GDSC1(3) |  1032_Afatinib_GDSC1(4) | Non-Small Cell Lung Carcinoma	STAT5B (12):	--2-- |  157_JNK-9L_GDSC1(9) |  1494_SN-38_GDSC2(7) | Non-Small Cell Lung Carcinoma	STAT6 (22):	--5-- |  185_Linsitinib_GDSC1(9) |  1432_AZD1480_GDSC1(8) |  1050_ZM447439_GDSC2(11) |  1866_BDP-00009066_GDSC2(9) |  1912_Afuresertib_GDSC2(11) | Non-Small Cell Lung Carcinoma	STK19 (8):	--3-- |  196_Phenformin_GDSC1(4) |  1129_PF-4708671_GDSC1(2) |  1549_Sapitinib_GDSC2(4) | Non-Small Cell Lung Carcinoma	SYK (12):	--2-- |  157_JNK-9L_GDSC1(11) |  294_MPS-1-IN-1_GDSC1(7) | Non-Small Cell Lung Carcinoma	TCL1A (8):	--2-- |  135_Gemcitabine_GDSC1(5) |  284_JNJ38877605_GDSC1(4) | Non-Small Cell Lung Carcinoma	TCL1B (7):	--2-- |  170_Shikonin_GDSC1(5) |  1128_FS106_GDSC1(4) | Non-Small Cell Lung Carcinoma	TERT (21):	--2-- |  170_Shikonin_GDSC1(16) |  371_Torin 2_GDSC1(17) | Non-Small Cell Lung Carcinoma	TLX3 (4):	--2-- |  261_TL-1-85_GDSC1(2) |  1185_KU-60019_GDSC1(3) | Non-Small Cell Lung Carcinoma	TSHR (32):	--5-- |  203_BMS-345541_GDSC1(18) |  293_Amuvatinib_GDSC1(12) |  356_AT7867_GDSC1(10) |  476_SB505124_GDSC1(12) |  1133_Serdemetan_GDSC1(16) | Non-Small Cell Lung Carcinoma	TYK2 (13):	--3-- |  185_Linsitinib_GDSC1(6) |  294_MPS-1-IN-1_GDSC1(9) |  1184_AZ20_GDSC1(9) | Non-Small Cell Lung Carcinoma	UBR5 (46):	--4-- |  173_FH535_GDSC1(32) |  207_AS601245_GDSC1(20) |  252_WZ3105_GDSC1(31) |  1022_AZD7762_GDSC1(29) | Non-Small Cell Lung Carcinoma	USP8 (22):	--4-- |  1401_AZD5438_GDSC2(10) |  1527_Pictilisib_GDSC1(10) |  1072_Avagacestat_GDSC1(4) |  2170_AT13148_GDSC2(7) | Non-Small Cell Lung Carcinoma	VAV1 (24):	--5-- |  1232_I-BET-151_GDSC1(11) |  1248_Daporinad_GDSC1(10) |  1026_Tanespimycin_GDSC2(11) |  1248_Daporinad_GDSC2(9) |  1827_Dihydrorotenone_GDSC2(8) | Non-Small Cell Lung Carcinoma	VAV2 (33):	--3-- |  1060_PD0325901_GDSC1(23) |  1022_AZD7762_GDSC2(23) |  1593_Entinostat_GDSC2(17) | Non-Small Cell Lung Carcinoma	VEGFA (6):	--2-- |  134_Etoposide_GDSC1(3) |  374_GSK1059615_GDSC1(5) | Non-Small Cell Lung Carcinoma	WWP1 (15):	--2-- |  1709_CDK9_5038_GDSC2(10) |  1908_Ulixertinib_GDSC2(11) | Non-Small Cell Lung Carcinoma	WWTR1 (15):	--2-- |  294_MPS-1-IN-1_GDSC1(8) |  1379_ZL109_GDSC1(13) | Non-Small Cell Lung Carcinoma	XBP1 (4):	--2-- |  287_KIN001-244_GDSC1(3) |  1496_Cisplatin_GDSC1(3) | Non-Small Cell Lung Carcinoma	XIAP (5):	--3-- |  194_Luminespib_GDSC1(3) |  356_AT7867_GDSC1(3) |  436_CAP-232, TT-232, TLN-232_GDSC1(3) | Non-Small Cell Lung Carcinoma	XPO1 (11):	--2-- |  302_PI-103_GDSC1(7) |  1529_Pevonedistat_GDSC1(7) | Non-Small Cell Lung Carcinoma	YAP1 (6):	--3-- |  32_Tozasertib_GDSC1(2) |  1359_965-D2_GDSC1(3) |  1510_Linsitinib_GDSC2(2) | Non-Small Cell Lung Carcinoma	YES1 (9):	--2-- |  170_Shikonin_GDSC1(7) |  310_YM201636_GDSC1(5) | Oral Cavity Carcinoma	ADHFE1 (6):	--2-- |  272_AR-42_GDSC1(4) |  1135_AZD4547_GDSC1(3) | Oral Cavity Carcinoma	AFF4 (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	AGO1 (4):	--2-- |  356_AT7867_GDSC1(2) |  1131_PRIMA-1MET_GDSC2(3) | Oral Cavity Carcinoma	AKT2 (2):	--1-- |  1378_Bleomycin (50 uM)_GDSC2(2) | Oral Cavity Carcinoma	ARAF (4):	--1-- |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	ARHGEF28 (6):	--2-- |  151_QS11_GDSC1(4) |  1168_Erlotinib_GDSC2(5) | Oral Cavity Carcinoma	BCR (12):	--2-- |  177_GSK650394_GDSC1(9) |  1498_Selumetinib_GDSC1(5) | Oral Cavity Carcinoma	BRAF (10):	--3-- |  151_QS11_GDSC1(5) |  1367_BAY-HDAC11_4_GDSC1(4) |  1085_Sorafenib_GDSC2(8) | Oral Cavity Carcinoma	BRD4 (8):	--3-- |  180_Thapsigargin_GDSC1(5) |  1135_AZD4547_GDSC1(3) |  1799_Ibrutinib_GDSC2(5) | Oral Cavity Carcinoma	BTK (3):	--1-- |  1021_Axitinib_GDSC2(3) | Oral Cavity Carcinoma	CARD11 (8):	--1-- |  177_GSK650394_GDSC1(8) | Oral Cavity Carcinoma	CCND2 (4):	--2-- |  449_CD532_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Oral Cavity Carcinoma	CCND3 (8):	--2-- |  363_PF-00299804_GDSC1(5) |  1046_Wee1 Inhibitor_GDSC1(5) | Oral Cavity Carcinoma	CDK6 (3):	--2-- |  1194_SB505124_GDSC1(2) |  1016_Temsirolimus_GDSC2(2) | Oral Cavity Carcinoma	CSF3R (4):	--2-- |  1614_WZ4003_GDSC2(2) |  1629_ML323_GDSC2(2) | Oral Cavity Carcinoma	CTNNB1 (2):	--1-- |  1194_SB505124_GDSC1(2) | Oral Cavity Carcinoma	CYP19A1 (2):	--1-- |  1188_CCT245467_GDSC1(2) | Oral Cavity Carcinoma	DNMT1 (8):	--2-- |  151_QS11_GDSC1(5) |  1498_Selumetinib_GDSC1(4) | Oral Cavity Carcinoma	DOT1L (7):	--2-- |  178_BAY-61-3606_GDSC1(5) |  291_KIN001-266_GDSC1(4) | Oral Cavity Carcinoma	EGFL7 (3):	--1-- |  1421_FGFR_0939_GDSC1(3) | Oral Cavity Carcinoma	EGFR (6):	--2-- |  219_AT-7519_GDSC1(4) |  1560_Alpelisib_GDSC2(4) | Oral Cavity Carcinoma	EIF4A2 (5):	--2-- |  1053_MK-2206_GDSC2(4) |  1428_IAP_5620_GDSC2(2) | Oral Cavity Carcinoma	ERBB3 (2):	--1-- |  1421_FGFR_0939_GDSC1(2) | Oral Cavity Carcinoma	ERBB4 (7):	--2-- |  1197_ZL049_GDSC1(5) |  1446_PI3Ka_4409_GDSC1(4) | Oral Cavity Carcinoma	ESR1 (4):	--1-- |  1429_IAP_7638_GDSC1(4) | Oral Cavity Carcinoma	ETV1 (5):	--2-- |  1135_AZD4547_GDSC1(3) |  1631_PRT062607_GDSC2(3) | Oral Cavity Carcinoma	EZH1 (5):	--2-- |  449_CD532_GDSC1(3) |  1021_Axitinib_GDSC1(2) | Oral Cavity Carcinoma	FGFR1 (6):	--2-- |  1236_UNC0638_GDSC1(5) |  1434_JAK3_7406_GDSC1(5) | Oral Cavity Carcinoma	FGFR2 (3):	--1-- |  1428_IAP_5620_GDSC1(3) | Oral Cavity Carcinoma	FLT3 (4):	--2-- |  190_Bleomycin_GDSC1(1) |  1578_Leflunomide_GDSC2(3) | Oral Cavity Carcinoma	FLT4 (8):	--3-- |  371_Torin 2_GDSC1(5) |  1434_JAK3_7406_GDSC1(5) |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	GAB2 (4):	--2-- |  1593_Entinostat_GDSC2(3) |  1918_AZD8186_GDSC2(3) | Oral Cavity Carcinoma	GNA12 (4):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1084_Rapamycin_GDSC2(2) | Oral Cavity Carcinoma	GNAQ (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1236_UNC0638_GDSC1(4) | Oral Cavity Carcinoma	GNAS (4):	--2-- |  300_CX-5461_GDSC1(3) |  1069_EHT-1864_GDSC2(2) | Oral Cavity Carcinoma	GTF2I (3):	--1-- |  344_THZ-2-49_GDSC1(3) | Oral Cavity Carcinoma	HDAC7 (8):	--2-- |  163_JQ1_GDSC1(4) |  1080_Paclitaxel_GDSC2(7) | Oral Cavity Carcinoma	HGF (5):	--2-- |  1009_Tretinoin_GDSC1(4) |  1026_Tanespimycin_GDSC1(3) | Oral Cavity Carcinoma	HIF1A (3):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1360_993-D2_GDSC1(2) | Oral Cavity Carcinoma	IGF1R (7):	--2-- |  228_AKT inhibitor VIII_GDSC1(4) |  1014_Refametinib_GDSC1(4) | Oral Cavity Carcinoma	IL7R (3):	--2-- |  372_Pilaralisib_GDSC1(2) |  1853_OF-1_GDSC2(2) | Oral Cavity Carcinoma	INSR (8):	--3-- |  179_5-Fluorouracil_GDSC1(5) |  300_CX-5461_GDSC1(4) |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	JAK2 (3):	--2-- |  371_Torin 2_GDSC1(1) |  1069_EHT-1864_GDSC2(2) | Oral Cavity Carcinoma	JAK3 (7):	--2-- |  1593_Entinostat_GDSC2(4) |  1853_OF-1_GDSC2(3) | Oral Cavity Carcinoma	KDM5A (8):	--2-- |  1429_IAP_7638_GDSC1(5) |  1553_Uprosertib_GDSC2(4) | Oral Cavity Carcinoma	KDR (3):	--2-- |  1194_SB505124_GDSC1(2) |  1005_Cisplatin_GDSC2(2) | Oral Cavity Carcinoma	KSR2 (11):	--2-- |  303_PIK-93_GDSC1(6) |  1197_ZL049_GDSC1(6) | Oral Cavity Carcinoma	LGR5 (3):	--1-- |  1185_KU-60019_GDSC1(3) | Oral Cavity Carcinoma	LRP6 (7):	--2-- |  158_PF-562271_GDSC1(4) |  178_BAY-61-3606_GDSC1(6) | Oral Cavity Carcinoma	MAP2K2 (3):	--2-- |  1008_Methotrexate_GDSC1(2) |  1188_CCT245467_GDSC1(2) | Oral Cavity Carcinoma	MAP3K13 (5):	--3-- |  477_A-83-01_GDSC1(2) |  1446_PI3Ka_4409_GDSC1(3) |  1919_Osimertinib_GDSC2(3) | Oral Cavity Carcinoma	MAP4K4 (5):	--2-- |  446_MIM1_GDSC1(3) |  1847_BEN_GDSC2(3) | Oral Cavity Carcinoma	MDM4 (5):	--2-- |  1421_FGFR_0939_GDSC1(3) |  1498_Selumetinib_GDSC1(2) | Oral Cavity Carcinoma	MECOM (7):	--2-- |  178_BAY-61-3606_GDSC1(5) |  1853_OF-1_GDSC2(3) | Oral Cavity Carcinoma	MET (4):	--2-- |  1038_NU7441_GDSC2(3) |  1630_Entospletinib_GDSC2(2) | Oral Cavity Carcinoma	MGAM (13):	--3-- |  203_BMS-345541_GDSC1(7) |  1164_XMD8-92_GDSC1(4) |  1593_Entinostat_GDSC2(5) | Oral Cavity Carcinoma	MLLT10 (5):	--2-- |  293_Amuvatinib_GDSC1(2) |  1009_Tretinoin_GDSC1(3) | Oral Cavity Carcinoma	MLLT3 (6):	--2-- |  272_AR-42_GDSC1(4) |  1135_AZD4547_GDSC1(3) | Oral Cavity Carcinoma	MPL (4):	--1-- |  1425_BPTES_GDSC1(4) | Oral Cavity Carcinoma	MSI2 (5):	--2-- |  446_MIM1_GDSC1(3) |  1919_Osimertinib_GDSC2(3) | Oral Cavity Carcinoma	MYBL1 (9):	--2-- |  252_WZ3105_GDSC1(6) |  1046_Wee1 Inhibitor_GDSC1(5) | Oral Cavity Carcinoma	NADK (3):	--2-- |  173_FH535_GDSC1(1) |  477_A-83-01_GDSC1(2) | Oral Cavity Carcinoma	NCOA3 (7):	--2-- |  1032_Afatinib_GDSC2(3) |  2109_AZ6102_GDSC2(4) | Oral Cavity Carcinoma	NRG1 (4):	--2-- |  228_AKT inhibitor VIII_GDSC1(3) |  576_RU-SKI 43_GDSC1(3) | Oral Cavity Carcinoma	NT5C2 (5):	--2-- |  1011_Navitoclax_GDSC1(3) |  1429_IAP_7638_GDSC1(4) | Oral Cavity Carcinoma	NTRK2 (6):	--2-- |  291_KIN001-266_GDSC1(4) |  1421_FGFR_0939_GDSC1(3) | Oral Cavity Carcinoma	NTRK3 (6):	--3-- |  1054_Palbociclib_GDSC1(2) |  1058_Pictilisib_GDSC1(3) |  1446_PI3Ka_4409_GDSC1(4) | Oral Cavity Carcinoma	NUF2 (3):	--1-- |  1031_Elesclomol_GDSC1(3) | Oral Cavity Carcinoma	NUP214 (4):	--2-- |  1236_UNC0638_GDSC1(3) |  1428_IAP_5620_GDSC2(2) | Oral Cavity Carcinoma	PDCD1LG2 (4):	--2-- |  449_CD532_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Oral Cavity Carcinoma	PDGFB (3):	--1-- |  1079_Dasatinib_GDSC2(3) | Oral Cavity Carcinoma	PDGFRA (3):	--2-- |  356_AT7867_GDSC1(2) |  1918_AZD8186_GDSC2(2) | Oral Cavity Carcinoma	PIK3CA (9):	--3-- |  303_PIK-93_GDSC1(6) |  1016_Temsirolimus_GDSC1(6) |  1498_Selumetinib_GDSC1(5) | Oral Cavity Carcinoma	PIK3CD (4):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1131_PRIMA-1MET_GDSC2(3) | Oral Cavity Carcinoma	PLCG1 (5):	--2-- |  1021_Axitinib_GDSC2(3) |  1038_NU7441_GDSC2(3) | Oral Cavity Carcinoma	PLCG2 (10):	--2-- |  382_Apitolisib_GDSC1(5) |  1496_Cisplatin_GDSC1(7) | Oral Cavity Carcinoma	PTPN11 (3):	--2-- |  282_Pelitinib_GDSC1(1) |  1188_CCT245467_GDSC1(2) | Oral Cavity Carcinoma	RAB35 (3):	--1-- |  1428_IAP_5620_GDSC1(3) | Oral Cavity Carcinoma	RAC1 (5):	--2-- |  249_Cabozantinib_GDSC1(2) |  1490_SN-38_GDSC1(3) | Oral Cavity Carcinoma	RET (3):	--1-- |  257_NPK76-II-72-1_GDSC1(3) | Oral Cavity Carcinoma	REV3L (4):	--2-- |  330_XMD13-2_GDSC1(3) |  1826_50869_GDSC2(3) | Oral Cavity Carcinoma	RHEB (3):	--2-- |  1421_FGFR_0939_GDSC1(2) |  1614_WZ4003_GDSC2(2) | Oral Cavity Carcinoma	RICTOR (7):	--2-- |  1009_Tretinoin_GDSC1(4) |  1853_OF-1_GDSC2(3) | Oral Cavity Carcinoma	ROS1 (11):	--3-- |  140_Vinorelbine_GDSC1(7) |  300_CX-5461_GDSC1(5) |  435_C-75_GDSC1(7) | Oral Cavity Carcinoma	RPTOR (10):	--2-- |  151_QS11_GDSC1(5) |  203_BMS-345541_GDSC1(7) | Oral Cavity Carcinoma	RUNX1T1 (4):	--1-- |  1236_UNC0638_GDSC1(4) | Oral Cavity Carcinoma	SETD1A (4):	--2-- |  1919_Osimertinib_GDSC2(3) |  2170_AT13148_GDSC2(3) | Oral Cavity Carcinoma	SMYD3 (5):	--2-- |  576_RU-SKI 43_GDSC1(4) |  1219_PFI-1_GDSC1(2) | Oral Cavity Carcinoma	SOS1 (5):	--1-- |  151_QS11_GDSC1(5) | Oral Cavity Carcinoma	SRC (5):	--2-- |  151_QS11_GDSC1(4) |  1526_Refametinib_GDSC1(2) | Oral Cavity Carcinoma	STAT3 (3):	--2-- |  1059_AZD8055_GDSC1(1) |  1360_993-D2_GDSC1(2) | Oral Cavity Carcinoma	STAT5B (2):	--1-- |  1194_SB505124_GDSC1(2) | Oral Cavity Carcinoma	TLX1 (2):	--1-- |  1432_AZD1480_GDSC1(2) | Oral Cavity Carcinoma	TSHR (5):	--2-- |  1498_Selumetinib_GDSC1(2) |  1038_NU7441_GDSC2(3) | Oral Cavity Carcinoma	TYK2 (3):	--2-- |  1194_SB505124_GDSC1(2) |  1432_AZD1480_GDSC1(2) | Oral Cavity Carcinoma	UBR5 (10):	--2-- |  152_CP466722_GDSC1(8) |  303_PIK-93_GDSC1(7) | Oral Cavity Carcinoma	USP8 (7):	--2-- |  153_Midostaurin_GDSC1(5) |  1908_Ulixertinib_GDSC2(4) | Oral Cavity Carcinoma	VAV2 (5):	--2-- |  140_Vinorelbine_GDSC1(2) |  1429_IAP_7638_GDSC1(4) | Oral Cavity Carcinoma	VEGFA (4):	--2-- |  260_NG-25_GDSC1(2) |  344_THZ-2-49_GDSC1(3) | Oral Cavity Carcinoma	WWP1 (3):	--2-- |  135_Gemcitabine_GDSC1(2) |  1461_TANK_1366_GDSC1(2) | Oral Cavity Carcinoma	WWTR1 (8):	--3-- |  282_Pelitinib_GDSC1(5) |  1188_CCT245467_GDSC1(3) |  1498_Selumetinib_GDSC1(3) | Oral Cavity Carcinoma	XBP1 (3):	--2-- |  223_ZSTK474_GDSC1(1) |  1021_Axitinib_GDSC1(2) | Osteosarcoma	AFF4 (2):	--2-- |  1527_Pictilisib_GDSC1(1) |  1008_Methotrexate_GDSC2(1) | Osteosarcoma	BCL2 (3):	--1-- |  2010_HKMTI-1-005_GDSC2(3) | Osteosarcoma	CDK6 (3):	--1-- |  1526_Refametinib_GDSC1(3) | Osteosarcoma	COP1 (5):	--1-- |  1003_Camptothecin_GDSC2(5) | Osteosarcoma	DDR2 (4):	--1-- |  1014_Refametinib_GDSC1(4) | Osteosarcoma	DDX4 (4):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1526_Refametinib_GDSC1(3) | Osteosarcoma	EGFR (5):	--2-- |  1051_Alisertib_GDSC2(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	ERBB3 (4):	--2-- |  223_ZSTK474_GDSC1(1) |  2170_AT13148_GDSC2(3) | Osteosarcoma	ETV1 (5):	--2-- |  219_AT-7519_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	FLT1 (3):	--1-- |  2010_HKMTI-1-005_GDSC2(3) | Osteosarcoma	IGF1R (3):	--3-- |  476_SB505124_GDSC1(1) |  1416_AZD8931_GDSC1(1) |  1419_FEN1_3940_GDSC1(1) | Osteosarcoma	LRP6 (3):	--1-- |  185_Linsitinib_GDSC1(3) | Osteosarcoma	LYN (4):	--2-- |  1526_Refametinib_GDSC1(3) |  1786_AZD4547_GDSC2(3) | Osteosarcoma	MAP2K1 (2):	--2-- |  1427_AZD5582_GDSC1(1) |  1932_NVP-ADW742_GDSC2(1) | Osteosarcoma	MECOM (5):	--2-- |  219_AT-7519_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	MKI67 (3):	--1-- |  1497_AZD4547_GDSC1(3) | Osteosarcoma	MSI2 (5):	--2-- |  135_Gemcitabine_GDSC1(4) |  178_BAY-61-3606_GDSC1(4) | Osteosarcoma	NTRK2 (4):	--2-- |  133_Doxorubicin_GDSC1(1) |  1009_Tretinoin_GDSC1(3) | Osteosarcoma	PPM1D (6):	--2-- |  219_AT-7519_GDSC1(4) |  1593_Entinostat_GDSC2(4) | Osteosarcoma	RAC2 (3):	--1-- |  1526_Refametinib_GDSC1(3) | Osteosarcoma	RPTOR (5):	--2-- |  219_AT-7519_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	SOS1 (5):	--2-- |  208_Ispinesib Mesylate_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	UBR5 (6):	--2-- |  256_JW-7-24-1_GDSC1(5) |  1079_Dasatinib_GDSC2(5) | Osteosarcoma	VAV1 (3):	--1-- |  2010_HKMTI-1-005_GDSC2(3) | Osteosarcoma	XPO1 (4):	--2-- |  293_Amuvatinib_GDSC1(3) |  1939_UMI-77_GDSC2(3) | Other Sarcomas	ABL1 (1):	--1-- |  1734_VSP34_8731_GDSC2(1) | Other Sarcomas	ACVR1 (3):	--1-- |  476_SB505124_GDSC1(3) | Other Sarcomas	AFF4 (5):	--2-- |  155_Ponatinib_GDSC1(4) |  435_C-75_GDSC1(3) | Other Sarcomas	AGO1 (3):	--3-- |  153_Midostaurin_GDSC1(1) |  272_AR-42_GDSC1(1) |  1005_Cisplatin_GDSC1(1) | Other Sarcomas	BCR (4):	--3-- |  1005_Cisplatin_GDSC1(2) |  1372_Trametinib_GDSC1(2) |  1088_Irinotecan_GDSC2(1) | Other Sarcomas	BRD4 (4):	--2-- |  184_BMS-754807_GDSC1(2) |  1183_CRT0160829_GDSC1(2) | Other Sarcomas	CARD11 (1):	--1-- |  1004_Vinblastine_GDSC2(1) | Other Sarcomas	CCNB3 (4):	--2-- |  428_Pemetrexed_GDSC1(3) |  2109_AZ6102_GDSC2(3) | Other Sarcomas	CYP19A1 (2):	--2-- |  159_HG6-64-1_GDSC1(1) |  1059_AZD8055_GDSC2(1) | Other Sarcomas	DDX4 (2):	--2-- |  159_HG6-64-1_GDSC1(1) |  346_THZ-2-102-1_GDSC1(1) | Other Sarcomas	DEK (1):	--1-- |  256_JW-7-24-1_GDSC1(1) | Other Sarcomas	DOT1L (2):	--2-- |  159_HG6-64-1_GDSC1(1) |  1059_AZD8055_GDSC2(1) | Other Sarcomas	EGFR (2):	--2-- |  272_AR-42_GDSC1(1) |  1037_BX795_GDSC1(1) | Other Sarcomas	ERG (1):	--1-- |  256_JW-7-24-1_GDSC1(1) | Other Sarcomas	ETV1 (2):	--1-- |  2046_MK-8776_GDSC2(2) | Other Sarcomas	ETV4 (2):	--2-- |  256_JW-7-24-1_GDSC1(1) |  1004_Vinblastine_GDSC2(1) | Other Sarcomas	FGFR2 (3):	--2-- |  372_Pilaralisib_GDSC1(1) |  1529_Pevonedistat_GDSC2(2) | Other Sarcomas	FGFR3 (2):	--2-- |  159_HG6-64-1_GDSC1(1) |  1004_Vinblastine_GDSC2(1) | Other Sarcomas	FGFR4 (2):	--2-- |  272_AR-42_GDSC1(1) |  1037_BX795_GDSC1(1) | Other Sarcomas	FLT1 (2):	--2-- |  272_AR-42_GDSC1(1) |  1037_BX795_GDSC1(1) | Other Sarcomas	FLT3 (3):	--3-- |  177_GSK650394_GDSC1(1) |  1037_BX795_GDSC1(1) |  1734_VSP34_8731_GDSC2(1) | Other Sarcomas	FLT4 (7):	--2-- |  199_Pazopanib_GDSC1(4) |  1363_BAY AKT1_GDSC1(4) | Other Sarcomas	GLI1 (4):	--1-- |  156_AZD6482_GDSC1(4) | Other Sarcomas	GSK3B (3):	--2-- |  273_CUDC-101_GDSC1(2) |  1527_Pictilisib_GDSC1(2) | Other Sarcomas	HIF1A (2):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1004_Vinblastine_GDSC2(1) | Other Sarcomas	HMGA2 (1):	--1-- |  1004_Vinblastine_GDSC2(1) | Other Sarcomas	IDH1 (2):	--1-- |  1021_Axitinib_GDSC2(2) | Other Sarcomas	IGF1R (5):	--2-- |  306_Fedratinib_GDSC1(4) |  1368_BAY-MPS1_GDSC1(2) | Other Sarcomas	IGF2 (1):	--1-- |  1734_VSP34_8731_GDSC2(1) | Other Sarcomas	IL3 (2):	--2-- |  415_CPI-613_GDSC1(1) |  1004_Vinblastine_GDSC2(1) | Other Sarcomas	IRS1 (2):	--1-- |  2046_MK-8776_GDSC2(2) | Other Sarcomas	JAK3 (3):	--3-- |  153_Midostaurin_GDSC1(1) |  272_AR-42_GDSC1(1) |  1005_Cisplatin_GDSC1(1) | Other Sarcomas	KDM5A (3):	--3-- |  299_OSI-027_GDSC1(1) |  1037_BX795_GDSC1(1) |  1053_MK-2206_GDSC1(1) | Other Sarcomas	KDR (2):	--2-- |  256_JW-7-24-1_GDSC1(1) |  346_THZ-2-102-1_GDSC1(1) | Other Sarcomas	KIT (2):	--2-- |  1006_Cytarabine_GDSC1(1) |  1734_VSP34_8731_GDSC2(1) | Other Sarcomas	KRAS (2):	--1-- |  262_VX-11e_GDSC1(2) | Other Sarcomas	KSR2 (4):	--2-- |  1012_Vorinostat_GDSC2(2) |  1561_Taselisib_GDSC2(2) | Other Sarcomas	LMO1 (2):	--1-- |  292_Masitinib_GDSC1(2) | Other Sarcomas	MAP4K4 (3):	--1-- |  428_Pemetrexed_GDSC1(3) | Other Sarcomas	MDM2 (2):	--2-- |  272_AR-42_GDSC1(1) |  1037_BX795_GDSC1(1) | Other Sarcomas	MECOM (2):	--2-- |  1183_CRT0160829_GDSC1(1) |  1427_AZD5582_GDSC1(1) | Other Sarcomas	MET (2):	--1-- |  177_GSK650394_GDSC1(2) | Other Sarcomas	MKI67 (2):	--1-- |  2046_MK-8776_GDSC2(2) | Other Sarcomas	NCOA3 (1):	--1-- |  276_CAY10603_GDSC1(1) | Other Sarcomas	NFE2L2 (2):	--1-- |  1912_Afuresertib_GDSC2(2) | Other Sarcomas	NRG1 (4):	--2-- |  1054_Palbociclib_GDSC1(2) |  1368_BAY-MPS1_GDSC1(2) | Other Sarcomas	NTRK3 (1):	--1-- |  272_AR-42_GDSC1(1) | Other Sarcomas	NUP214 (2):	--2-- |  153_Midostaurin_GDSC1(1) |  1026_Tanespimycin_GDSC2(1) | Other Sarcomas	PAK1 (4):	--2-- |  1015_CI-1040_GDSC1(2) |  1529_Pevonedistat_GDSC2(2) | Other Sarcomas	PDGFB (1):	--1-- |  276_CAY10603_GDSC1(1) | Other Sarcomas	PDGFRB (4):	--3-- |  153_Midostaurin_GDSC1(2) |  273_CUDC-101_GDSC1(2) |  1005_Cisplatin_GDSC1(2) | Other Sarcomas	PGR (1):	--1-- |  159_HG6-64-1_GDSC1(1) | Other Sarcomas	PIK3CG (2):	--2-- |  256_JW-7-24-1_GDSC1(1) |  346_THZ-2-102-1_GDSC1(1) | Other Sarcomas	PLCG2 (4):	--3-- |  273_CUDC-101_GDSC1(2) |  328_SNX-2112_GDSC1(1) |  1372_Trametinib_GDSC1(2) | Other Sarcomas	PPARG (1):	--1-- |  256_JW-7-24-1_GDSC1(1) | Other Sarcomas	RAF1 (3):	--3-- |  1070_CRT0105950_GDSC1(1) |  1183_CRT0160829_GDSC1(1) |  1529_Pevonedistat_GDSC2(1) | Other Sarcomas	REV3L (2):	--1-- |  2046_MK-8776_GDSC2(2) | Other Sarcomas	ROS1 (3):	--3-- |  153_Midostaurin_GDSC1(1) |  1037_BX795_GDSC1(1) |  1070_CRT0105950_GDSC1(1) | Other Sarcomas	RPS6KA4 (2):	--1-- |  576_RU-SKI 43_GDSC1(2) | Other Sarcomas	RPTOR (3):	--2-- |  1014_Refametinib_GDSC1(1) |  1053_MK-2206_GDSC1(2) | Other Sarcomas	RUNX1T1 (1):	--1-- |  256_JW-7-24-1_GDSC1(1) | Other Sarcomas	SGK1 (4):	--2-- |  306_Fedratinib_GDSC1(3) |  310_YM201636_GDSC1(3) | Other Sarcomas	SMYD3 (3):	--3-- |  1053_MK-2206_GDSC1(1) |  1070_CRT0105950_GDSC1(1) |  1003_Camptothecin_GDSC2(1) | Other Sarcomas	TSHR (4):	--3-- |  184_BMS-754807_GDSC1(2) |  1048_Mirin_GDSC1(1) |  1149_TW 37_GDSC2(1) | Other Sarcomas	UBR5 (1):	--1-- |  1734_VSP34_8731_GDSC2(1) | Other Sarcomas	USP8 (5):	--3-- |  272_AR-42_GDSC1(2) |  1037_BX795_GDSC1(2) |  1054_Palbociclib_GDSC1(2) | Other Sarcomas	VAV1 (2):	--1-- |  292_Masitinib_GDSC1(2) | Other Sarcomas	VAV2 (3):	--2-- |  184_BMS-754807_GDSC1(2) |  1005_Cisplatin_GDSC1(2) | Other Solid Cancers	ABL1 (5):	--2-- |  86_A-443654_GDSC1(1) |  1463_AZD1332_GDSC2(4) | Other Solid Cancers	ADHFE1 (6):	--2-- |  375_Voxtalisib_GDSC1(3) |  439_LCL161_GDSC1(4) | Other Solid Cancers	AFF4 (2):	--1-- |  1175_Rucaparib_GDSC1(2) | Other Solid Cancers	AGO1 (4):	--2-- |  329_QL-XI-92_GDSC1(3) |  1451_PLK_6522_GDSC1(2) | Other Solid Cancers	AKT2 (3):	--2-- |  221_TAK-715_GDSC1(2) |  326_GSK690693_GDSC1(2) | Other Solid Cancers	AKT3 (7):	--2-- |  199_Pazopanib_GDSC1(4) |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	ALK (11):	--2-- |  1048_Mirin_GDSC1(7) |  1427_AZD5582_GDSC1(7) | Other Solid Cancers	ARHGEF28 (7):	--2-- |  29_AZ628_GDSC1(4) |  1624_I-BET-762_GDSC2(4) | Other Solid Cancers	ATXN7 (2):	--1-- |  326_GSK690693_GDSC1(2) | Other Solid Cancers	AXL (5):	--2-- |  294_MPS-1-IN-1_GDSC1(4) |  1016_Temsirolimus_GDSC2(4) | Other Solid Cancers	BCL9 (5):	--2-- |  342_Tenovin-6_GDSC1(4) |  439_LCL161_GDSC1(4) | Other Solid Cancers	BCR (10):	--3-- |  262_VX-11e_GDSC1(5) |  366_TWS119_GDSC1(6) |  1026_Tanespimycin_GDSC1(3) | Other Solid Cancers	BRAF (6):	--2-- |  262_VX-11e_GDSC1(4) |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	BRD4 (5):	--3-- |  276_CAY10603_GDSC1(3) |  1180_Dinaciclib_GDSC2(3) |  1825_Podophyllotoxin bromide_GDSC2(1) | Other Solid Cancers	BTK (6):	--2-- |  1019_Bosutinib_GDSC1(3) |  1054_Palbociclib_GDSC1(4) | Other Solid Cancers	CARD11 (14):	--3-- |  1427_AZD5582_GDSC1(5) |  1007_Docetaxel_GDSC2(10) |  1372_Trametinib_GDSC2(9) | Other Solid Cancers	CCND1 (1):	--1-- |  1004_Vinblastine_GDSC1(1) | Other Solid Cancers	CCND3 (4):	--1-- |  1004_Vinblastine_GDSC1(4) | Other Solid Cancers	CD79B (2):	--1-- |  2173_PFI-1_GDSC2(2) | Other Solid Cancers	CREB1 (2):	--2-- |  1012_Vorinostat_GDSC1(1) |  1511_Epirubicin_GDSC2(1) | Other Solid Cancers	CYP19A1 (2):	--1-- |  196_Phenformin_GDSC1(2) | Other Solid Cancers	DCUN1D1 (1):	--1-- |  1004_Vinblastine_GDSC1(1) | Other Solid Cancers	DDR2 (4):	--1-- |  2170_AT13148_GDSC2(4) | Other Solid Cancers	DNMT1 (9):	--4-- |  29_AZ628_GDSC1(4) |  89_Parthenolide_GDSC1(3) |  1048_Mirin_GDSC1(3) |  1261_rTRAIL_GDSC1(3) | Other Solid Cancers	DOT1L (7):	--3-- |  223_ZSTK474_GDSC1(3) |  435_C-75_GDSC1(5) |  1813_Fludarabine_GDSC2(2) | Other Solid Cancers	EGFR (10):	--3-- |  292_Masitinib_GDSC1(6) |  1464_TTK_3146_GDSC1(8) |  1016_Temsirolimus_GDSC2(4) | Other Solid Cancers	EIF4A2 (2):	--1-- |  38_Saracatinib_GDSC1(2) | Other Solid Cancers	EPOR (2):	--2-- |  11_Paclitaxel_GDSC1(1) |  157_JNK-9L_GDSC1(1) | Other Solid Cancers	ERBB3 (4):	--2-- |  1021_Axitinib_GDSC1(2) |  1016_Temsirolimus_GDSC2(3) | Other Solid Cancers	ERBB4 (9):	--2-- |  111_Salubrinal_GDSC1(4) |  1908_Ulixertinib_GDSC2(6) | Other Solid Cancers	ERG (2):	--1-- |  186_Bexarotene_GDSC1(2) | Other Solid Cancers	ESR1 (7):	--2-- |  1194_SB505124_GDSC1(3) |  1578_Leflunomide_GDSC2(5) | Other Solid Cancers	ETV1 (6):	--3-- |  576_RU-SKI 43_GDSC1(2) |  1013_Nilotinib_GDSC2(3) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	EZH1 (2):	--1-- |  1194_SB505124_GDSC1(2) | Other Solid Cancers	FGFR1 (5):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1933_P22077_GDSC2(3) | Other Solid Cancers	FGFR3 (4):	--2-- |  272_AR-42_GDSC1(2) |  1180_Dinaciclib_GDSC2(3) | Other Solid Cancers	FGFR4 (4):	--2-- |  51_Dasatinib_GDSC1(1) |  157_JNK-9L_GDSC1(3) | Other Solid Cancers	FLI1 (6):	--2-- |  223_ZSTK474_GDSC1(4) |  435_C-75_GDSC1(5) | Other Solid Cancers	FLT3 (3):	--2-- |  135_Gemcitabine_GDSC1(1) |  1511_Epirubicin_GDSC2(2) | Other Solid Cancers	FLT4 (8):	--4-- |  175_PAC-1_GDSC1(3) |  275_I-BET-762_GDSC1(4) |  1419_FEN1_3940_GDSC1(4) |  1933_P22077_GDSC2(4) | Other Solid Cancers	FURIN (3):	--2-- |  1059_AZD8055_GDSC2(1) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	FYN (6):	--3-- |  3_Rapamycin_GDSC1(3) |  157_JNK-9L_GDSC1(3) |  1924_Ipatasertib_GDSC2(4) | Other Solid Cancers	GLI1 (4):	--2-- |  1243_Piperlongumine_GDSC1(2) |  1559_Luminespib_GDSC2(3) | Other Solid Cancers	GNA12 (4):	--1-- |  1135_AZD4547_GDSC1(4) | Other Solid Cancers	GNAQ (3):	--1-- |  1004_Vinblastine_GDSC1(3) | Other Solid Cancers	GNAS (8):	--2-- |  223_ZSTK474_GDSC1(4) |  435_C-75_GDSC1(5) | Other Solid Cancers	GSK3B (5):	--2-- |  1527_Pictilisib_GDSC1(2) |  2044_Pyridostatin_GDSC2(4) | Other Solid Cancers	HDAC7 (4):	--2-- |  342_Tenovin-6_GDSC1(3) |  1004_Vinblastine_GDSC1(3) | Other Solid Cancers	HGF (8):	--3-- |  262_VX-11e_GDSC1(5) |  1026_Tanespimycin_GDSC1(3) |  1419_FEN1_3940_GDSC1(5) | Other Solid Cancers	HMGA2 (8):	--3-- |  89_Parthenolide_GDSC1(3) |  310_YM201636_GDSC1(5) |  1933_P22077_GDSC2(4) | Other Solid Cancers	IDH2 (3):	--1-- |  1004_Vinblastine_GDSC1(3) | Other Solid Cancers	IGF1 (3):	--2-- |  172_Embelin_GDSC1(1) |  1180_Dinaciclib_GDSC2(2) | Other Solid Cancers	IGF1R (8):	--3-- |  204_Tipifarnib_GDSC1(3) |  1012_Vorinostat_GDSC1(5) |  1511_Epirubicin_GDSC2(5) | Other Solid Cancers	IL6ST (3):	--2-- |  326_GSK690693_GDSC1(2) |  2173_PFI-1_GDSC2(2) | Other Solid Cancers	IL7R (3):	--2-- |  221_TAK-715_GDSC1(2) |  1449_AZD1208_GDSC1(2) | Other Solid Cancers	INSR (9):	--2-- |  1413_EphB4_9721_GDSC1(4) |  1008_Methotrexate_GDSC2(7) | Other Solid Cancers	IRS1 (4):	--2-- |  158_PF-562271_GDSC1(3) |  1013_Nilotinib_GDSC2(3) | Other Solid Cancers	KDM5A (15):	--3-- |  199_Pazopanib_GDSC1(6) |  372_Pilaralisib_GDSC1(12) |  1933_P22077_GDSC2(5) | Other Solid Cancers	KIT (4):	--2-- |  342_Tenovin-6_GDSC1(3) |  1813_Fludarabine_GDSC2(2) | Other Solid Cancers	KRAS (4):	--2-- |  175_PAC-1_GDSC1(2) |  474_ARRY-520_GDSC1(2) | Other Solid Cancers	KSR2 (6):	--2-- |  1446_PI3Ka_4409_GDSC1(3) |  2044_Pyridostatin_GDSC2(5) | Other Solid Cancers	LGR5 (4):	--2-- |  1038_NU7441_GDSC1(2) |  1062_Selumetinib_GDSC1(3) | Other Solid Cancers	LRP6 (13):	--3-- |  184_BMS-754807_GDSC1(7) |  328_SNX-2112_GDSC1(8) |  2170_AT13148_GDSC2(6) | Other Solid Cancers	MAP2K2 (3):	--2-- |  326_GSK690693_GDSC1(2) |  1004_Vinblastine_GDSC1(2) | Other Solid Cancers	MAP3K13 (7):	--3-- |  89_Parthenolide_GDSC1(3) |  285_SU11274_GDSC1(4) |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	MAP4K4 (8):	--3-- |  262_VX-11e_GDSC1(4) |  330_XMD13-2_GDSC1(4) |  2148_POMHEX_GDSC2(3) | Other Solid Cancers	MAPK3 (4):	--2-- |  264_ACY-1215_GDSC1(3) |  1714_ERK_6604_GDSC2(2) | Other Solid Cancers	MDM2 (6):	--2-- |  1445_AZD8835_GDSC1(4) |  1924_Ipatasertib_GDSC2(4) | Other Solid Cancers	MDM4 (5):	--3-- |  380_BIBF-1120_GDSC1(2) |  1593_Entinostat_GDSC2(2) |  1817_Romidepsin_GDSC2(1) | Other Solid Cancers	MECOM (8):	--2-- |  294_MPS-1-IN-1_GDSC1(5) |  1453_RAF_9304_GDSC1(7) | Other Solid Cancers	MET (6):	--2-- |  175_PAC-1_GDSC1(2) |  474_ARRY-520_GDSC1(4) | Other Solid Cancers	MGAM (10):	--1-- |  1393_Gemcitabine_GDSC1(10) | Other Solid Cancers	MKI67 (4):	--2-- |  62_BMS-536924_GDSC1(1) |  245_UNC0638_GDSC1(3) | Other Solid Cancers	MLLT10 (4):	--2-- |  1016_Temsirolimus_GDSC2(3) |  1618_GSK2606414_GDSC2(2) | Other Solid Cancers	MLLT3 (6):	--3-- |  54_CGP-082996_GDSC1(2) |  1804_Acetalax_GDSC2(3) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	MPL (3):	--2-- |  342_Tenovin-6_GDSC1(2) |  1128_FS106_GDSC1(1) | Other Solid Cancers	MSI2 (15):	--3-- |  366_TWS119_GDSC1(10) |  1187_CCT245232_GDSC1(8) |  1254_GSK-J4_GDSC1(9) | Other Solid Cancers	MST1R (3):	--2-- |  326_GSK690693_GDSC1(2) |  1084_Rapamycin_GDSC2(2) | Other Solid Cancers	MTOR (8):	--3-- |  135_Gemcitabine_GDSC1(5) |  1494_SN-38_GDSC2(5) |  1866_BDP-00009066_GDSC2(2) | Other Solid Cancers	NCOA3 (6):	--2-- |  175_PAC-1_GDSC1(3) |  474_ARRY-520_GDSC1(4) | Other Solid Cancers	NFE2L2 (3):	--2-- |  1614_WZ4003_GDSC2(2) |  1630_Entospletinib_GDSC2(2) | Other Solid Cancers	NRG1 (7):	--3-- |  380_BIBF-1120_GDSC1(3) |  1419_FEN1_3940_GDSC1(5) |  1738_IGF1R_3801_GDSC2(2) | Other Solid Cancers	NSD2 (4):	--2-- |  83_JW-7-52-1_GDSC1(1) |  1091_BMS-536924_GDSC1(3) | Other Solid Cancers	NTRK1 (5):	--2-- |  304_SB52334_GDSC1(3) |  1827_Dihydrorotenone_GDSC2(3) | Other Solid Cancers	NTRK2 (2):	--1-- |  1529_Pevonedistat_GDSC2(2) | Other Solid Cancers	NTRK3 (13):	--2-- |  229_Enzastaurin_GDSC1(8) |  1451_PLK_6522_GDSC1(9) | Other Solid Cancers	NUF2 (3):	--1-- |  1196_FY069_GDSC1(3) | Other Solid Cancers	NUP214 (10):	--2-- |  151_QS11_GDSC1(6) |  1498_Selumetinib_GDSC1(6) | Other Solid Cancers	NUP98 (7):	--2-- |  1434_JAK3_7406_GDSC1(6) |  1578_Leflunomide_GDSC2(4) | Other Solid Cancers	PAK1 (4):	--3-- |  1004_Vinblastine_GDSC1(1) |  1012_Vorinostat_GDSC1(1) |  1511_Epirubicin_GDSC2(2) | Other Solid Cancers	PAK5 (2):	--1-- |  1511_Epirubicin_GDSC2(2) | Other Solid Cancers	PDCD1 (2):	--1-- |  326_GSK690693_GDSC1(2) | Other Solid Cancers	PDGFRA (4):	--2-- |  196_Phenformin_GDSC1(1) |  1933_P22077_GDSC2(3) | Other Solid Cancers	PDGFRB (5):	--2-- |  185_Linsitinib_GDSC1(3) |  1084_Rapamycin_GDSC2(3) | Other Solid Cancers	PIK3CA (2):	--1-- |  290_KIN001-260_GDSC1(2) | Other Solid Cancers	PIK3CB (3):	--2-- |  175_PAC-1_GDSC1(2) |  1511_Epirubicin_GDSC2(2) | Other Solid Cancers	PIK3CD (5):	--2-- |  264_ACY-1215_GDSC1(4) |  356_AT7867_GDSC1(2) | Other Solid Cancers	PIK3CG (3):	--1-- |  221_TAK-715_GDSC1(3) | Other Solid Cancers	PLCG1 (6):	--2-- |  1084_Rapamycin_GDSC2(3) |  1924_Ipatasertib_GDSC2(5) | Other Solid Cancers	PLCG2 (11):	--4-- |  245_UNC0638_GDSC1(3) |  1059_AZD8055_GDSC1(6) |  1186_FS112_GDSC1(5) |  1922_Cediranib_GDSC2(4) | Other Solid Cancers	PRKACA (9):	--4-- |  151_QS11_GDSC1(5) |  1494_SN-38_GDSC2(3) |  1529_Pevonedistat_GDSC2(5) |  1924_Ipatasertib_GDSC2(5) | Other Solid Cancers	PRKCI (6):	--2-- |  1012_Vorinostat_GDSC1(5) |  1069_EHT-1864_GDSC2(3) | Other Solid Cancers	RAB35 (2):	--1-- |  1049_PD173074_GDSC1(2) | Other Solid Cancers	RAC1 (3):	--2-- |  86_A-443654_GDSC1(1) |  376_Brivanib, BMS-540215_GDSC1(2) | Other Solid Cancers	RAC2 (2):	--1-- |  221_TAK-715_GDSC1(2) | Other Solid Cancers	RAF1 (4):	--1-- |  29_AZ628_GDSC1(4) | Other Solid Cancers	REV3L (7):	--3-- |  1194_SB505124_GDSC1(3) |  1248_Daporinad_GDSC1(3) |  1428_IAP_5620_GDSC1(3) | Other Solid Cancers	RHEB (3):	--1-- |  158_PF-562271_GDSC1(3) | Other Solid Cancers	RICTOR (6):	--2-- |  249_Cabozantinib_GDSC1(4) |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	ROS1 (8):	--2-- |  262_VX-11e_GDSC1(5) |  1249_BMS-345541_GDSC2(6) | Other Solid Cancers	RPTOR (15):	--2-- |  299_OSI-027_GDSC1(9) |  1031_Elesclomol_GDSC1(8) | Other Solid Cancers	RUNX1T1 (2):	--1-- |  221_TAK-715_GDSC1(2) | Other Solid Cancers	SET (2):	--1-- |  221_TAK-715_GDSC1(2) | Other Solid Cancers	SETBP1 (6):	--2-- |  199_Pazopanib_GDSC1(5) |  375_Voxtalisib_GDSC1(3) | Other Solid Cancers	SETD1A (4):	--2-- |  111_Salubrinal_GDSC1(3) |  1069_EHT-1864_GDSC2(3) | Other Solid Cancers	SF3B1 (6):	--2-- |  329_QL-XI-92_GDSC1(3) |  563_Kobe2602_GDSC1(3) | Other Solid Cancers	SGK1 (6):	--2-- |  152_CP466722_GDSC1(2) |  2170_AT13148_GDSC2(5) | Other Solid Cancers	SMO (4):	--1-- |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	SMYD3 (7):	--2-- |  59_WZ-1-84_GDSC1(5) |  156_AZD6482_GDSC1(5) | Other Solid Cancers	SOS1 (7):	--2-- |  295_NVP-BHG712_GDSC1(3) |  1079_Dasatinib_GDSC2(6) | Other Solid Cancers	SRC (3):	--2-- |  1007_Docetaxel_GDSC2(2) |  1239_YK-4-279_GDSC2(2) | Other Solid Cancers	STAT3 (3):	--2-- |  295_NVP-BHG712_GDSC1(2) |  1004_Vinblastine_GDSC1(2) | Other Solid Cancers	STAT5A (3):	--1-- |  1089_Oxaliplatin_GDSC2(3) | Other Solid Cancers	STAT5B (4):	--2-- |  1004_Vinblastine_GDSC1(3) |  1401_AZD5438_GDSC1(3) | Other Solid Cancers	STAT6 (5):	--3-- |  261_TL-1-85_GDSC1(3) |  474_ARRY-520_GDSC1(3) |  1069_EHT-1864_GDSC2(3) | Other Solid Cancers	SYK (3):	--2-- |  295_NVP-BHG712_GDSC1(2) |  1004_Vinblastine_GDSC1(2) | Other Solid Cancers	TAL1 (2):	--1-- |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	TCL1B (3):	--2-- |  54_CGP-082996_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Other Solid Cancers	TSHR (7):	--2-- |  111_Salubrinal_GDSC1(4) |  199_Pazopanib_GDSC1(5) | Other Solid Cancers	UBR5 (14):	--3-- |  223_ZSTK474_GDSC1(9) |  435_C-75_GDSC1(7) |  1840_630600_GDSC2(3) | Other Solid Cancers	USP8 (5):	--1-- |  1008_Methotrexate_GDSC1(5) | Other Solid Cancers	VAV1 (7):	--3-- |  366_TWS119_GDSC1(3) |  1128_FS106_GDSC1(3) |  1180_Dinaciclib_GDSC2(3) | Other Solid Cancers	VEGFA (6):	--3-- |  1004_Vinblastine_GDSC1(4) |  1732_TAF1_5496_GDSC2(3) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	XPO1 (5):	--3-- |  89_Parthenolide_GDSC1(3) |  1630_Entospletinib_GDSC2(2) |  2173_PFI-1_GDSC2(2) | Other Solid Cancers	YAP1 (3):	--2-- |  221_TAK-715_GDSC1(2) |  1428_IAP_5620_GDSC1(2) | Ovarian Carcinoma	ABL1 (9):	--3-- |  1999_N25720-51-A1_GDSC2(3) |  1924_Ipatasertib_GDSC2(5) |  1149_TW 37_GDSC2(4) | Ovarian Carcinoma	ABL2 (8):	--2-- |  1005_Cisplatin_GDSC1(6) |  1185_KU-60019_GDSC1(4) | Ovarian Carcinoma	ACVR1 (9):	--2-- |  428_Pemetrexed_GDSC1(6) |  1019_Bosutinib_GDSC1(8) | Ovarian Carcinoma	ADHFE1 (8):	--3-- |  326_GSK690693_GDSC1(4) |  1422_FGFR_3831_GDSC1(6) |  1999_N25720-51-A1_GDSC2(3) | Ovarian Carcinoma	AFF4 (12):	--2-- |  272_AR-42_GDSC1(8) |  1091_BMS-536924_GDSC2(8) | Ovarian Carcinoma	AGO1 (8):	--3-- |  326_GSK690693_GDSC1(4) |  1010_Gefitinib_GDSC1(3) |  1849_Sabutoclax_GDSC2(5) | Ovarian Carcinoma	AKT3 (4):	--2-- |  1142_HG-5-113-01_GDSC1(2) |  1393_Gemcitabine_GDSC1(3) | Ovarian Carcinoma	ALK (12):	--3-- |  1188_CCT245467_GDSC1(8) |  1259_Talazoparib_GDSC1(8) |  1131_PRIMA-1MET_GDSC2(7) | Ovarian Carcinoma	AR (4):	--2-- |  272_AR-42_GDSC1(3) |  1999_N25720-51-A1_GDSC2(2) | Ovarian Carcinoma	ARHGEF28 (14):	--4-- |  222_BX-912_GDSC1(6) |  261_TL-1-85_GDSC1(5) |  381_AST-1306_GDSC1(11) |  1368_BAY-MPS1_GDSC1(8) | Ovarian Carcinoma	ARID3B (6):	--3-- |  171_AKT inhibitor VIII_GDSC1(2) |  1494_SN-38_GDSC1(3) |  1168_Erlotinib_GDSC2(3) | Ovarian Carcinoma	ATXN7 (4):	--2-- |  1170_CCT-018159_GDSC1(3) |  1924_Ipatasertib_GDSC2(3) | Ovarian Carcinoma	BCL2 (3):	--2-- |  1036_PLX-4720_GDSC2(2) |  1997_WEHI-539_GDSC2(2) | Ovarian Carcinoma	BCL6 (3):	--2-- |  1261_rTRAIL_GDSC1(2) |  1425_BPTES_GDSC1(2) | Ovarian Carcinoma	BCL9 (5):	--2-- |  326_GSK690693_GDSC1(3) |  1168_Erlotinib_GDSC2(4) | Ovarian Carcinoma	BCR (14):	--4-- |  1924_Ipatasertib_GDSC2(5) |  1070_CRT0105950_GDSC1(8) |  1048_Mirin_GDSC2(7) |  1250_AZ960_GDSC2(9) | Ovarian Carcinoma	BRAF (15):	--3-- |  179_5-Fluorouracil_GDSC1(10) |  1062_Selumetinib_GDSC2(7) |  1053_MK-2206_GDSC2(7) | Ovarian Carcinoma	BRD3 (9):	--2-- |  1916_AZD5363_GDSC2(5) |  1558_Lapatinib_GDSC2(5) | Ovarian Carcinoma	BRD4 (6):	--2-- |  356_AT7867_GDSC1(4) |  1047_Nutlin-3a (-)_GDSC1(3) | Ovarian Carcinoma	BTK (14):	--3-- |  156_AZD6482_GDSC1(6) |  1066_AZD6482_GDSC1(7) |  1091_BMS-536924_GDSC2(10) | Ovarian Carcinoma	CALR (4):	--2-- |  1012_Vorinostat_GDSC1(3) |  1036_PLX-4720_GDSC2(2) | Ovarian Carcinoma	CARD11 (12):	--3-- |  1070_CRT0105950_GDSC1(6) |  1444_AZD8186_GDSC1(6) |  1073_5-Fluorouracil_GDSC2(4) | Ovarian Carcinoma	CCNB3 (8):	--2-- |  272_AR-42_GDSC1(4) |  1441_AZD2014_GDSC1(6) | Ovarian Carcinoma	CCND1 (2):	--1-- |  1021_Axitinib_GDSC1(2) | Ovarian Carcinoma	CCND2 (4):	--3-- |  223_ZSTK474_GDSC1(1) |  273_CUDC-101_GDSC1(2) |  1425_BPTES_GDSC1(2) | Ovarian Carcinoma	CCND3 (3):	--1-- |  1114_Cetuximab_GDSC1(3) | Ovarian Carcinoma	CCNE1 (10):	--4-- |  135_Gemcitabine_GDSC1(4) |  151_QS11_GDSC1(4) |  1058_Pictilisib_GDSC2(5) |  1190_Gemcitabine_GDSC2(6) | Ovarian Carcinoma	CD274 (5):	--3-- |  326_GSK690693_GDSC1(3) |  1005_Cisplatin_GDSC2(3) |  1016_Temsirolimus_GDSC2(3) | Ovarian Carcinoma	CD276 (4):	--2-- |  1799_Ibrutinib_GDSC2(2) |  1999_N25720-51-A1_GDSC2(2) | Ovarian Carcinoma	CD28 (3):	--2-- |  1021_Axitinib_GDSC1(2) |  1460_PARP_9482_GDSC1(2) | Ovarian Carcinoma	CDK6 (5):	--2-- |  283_Omipalisib_GDSC1(3) |  1434_JAK3_7406_GDSC1(3) | Ovarian Carcinoma	CDK8 (5):	--2-- |  182_Obatoclax Mesylate_GDSC1(2) |  1441_AZD2014_GDSC1(4) | Ovarian Carcinoma	COP1 (7):	--2-- |  1377_Afatinib_GDSC1(4) |  1073_5-Fluorouracil_GDSC2(3) | Ovarian Carcinoma	CRKL (3):	--2-- |  1230_IOX2_GDSC1(2) |  1409_AZD4877_GDSC1(2) | Ovarian Carcinoma	CSF3R (9):	--3-- |  272_AR-42_GDSC1(5) |  1460_PARP_9482_GDSC1(5) |  1058_Pictilisib_GDSC2(5) | Ovarian Carcinoma	CTLA4 (3):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1164_XMD8-92_GDSC1(2) | Ovarian Carcinoma	CTNNB1 (7):	--2-- |  151_QS11_GDSC1(4) |  1835_Elephantin_GDSC2(5) | Ovarian Carcinoma	CYSLTR2 (3):	--2-- |  230_GSK429286A_GDSC1(2) |  1203_QL-XII-61_GDSC1(2) | Ovarian Carcinoma	DCUN1D1 (6):	--2-- |  269_NSC-207895_GDSC1(3) |  1924_Ipatasertib_GDSC2(3) | Ovarian Carcinoma	DDR2 (6):	--2-- |  442_IMD-0354_GDSC1(5) |  1062_Selumetinib_GDSC2(4) | Ovarian Carcinoma	DDX4 (6):	--3-- |  1135_AZD4547_GDSC1(4) |  1230_IOX2_GDSC1(3) |  1036_PLX-4720_GDSC2(2) | Ovarian Carcinoma	DNMT1 (17):	--3-- |  272_AR-42_GDSC1(13) |  1005_Cisplatin_GDSC1(9) |  1070_CRT0105950_GDSC1(8) | Ovarian Carcinoma	DOT1L (12):	--2-- |  228_AKT inhibitor VIII_GDSC1(9) |  1444_AZD8186_GDSC1(7) | Ovarian Carcinoma	E2F3 (5):	--2-- |  1195_FY026_GDSC1(2) |  1940_WIKI4_GDSC2(3) | Ovarian Carcinoma	EGFL7 (6):	--2-- |  1168_Erlotinib_GDSC2(3) |  1820_123829_GDSC2(3) | Ovarian Carcinoma	EGFR (11):	--2-- |  223_ZSTK474_GDSC1(7) |  1183_CRT0160829_GDSC1(6) | Ovarian Carcinoma	EIF4A2 (8):	--2-- |  442_IMD-0354_GDSC1(6) |  1441_AZD2014_GDSC1(6) | Ovarian Carcinoma	EPOR (6):	--2-- |  1820_123829_GDSC2(3) |  1066_AZD6482_GDSC1(4) | Ovarian Carcinoma	ERBB2 (8):	--3-- |  299_OSI-027_GDSC1(4) |  1464_TTK_3146_GDSC1(5) |  1930_Telomerase Inhibitor IX_GDSC2(5) | Ovarian Carcinoma	ERBB3 (9):	--2-- |  1019_Bosutinib_GDSC1(7) |  1192_GSK269962A_GDSC1(7) | Ovarian Carcinoma	ERBB4 (9):	--2-- |  1441_AZD2014_GDSC1(7) |  310_YM201636_GDSC1(4) | Ovarian Carcinoma	ERG (4):	--2-- |  186_Bexarotene_GDSC1(2) |  1463_AZD1332_GDSC2(3) | Ovarian Carcinoma	ESR1 (6):	--2-- |  1441_AZD2014_GDSC1(4) |  310_YM201636_GDSC1(3) | Ovarian Carcinoma	ETV1 (7):	--2-- |  223_ZSTK474_GDSC1(4) |  1188_CCT245467_GDSC1(5) | Ovarian Carcinoma	ETV4 (6):	--2-- |  295_NVP-BHG712_GDSC1(4) |  1425_BPTES_GDSC1(3) | Ovarian Carcinoma	ETV5 (3):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | Ovarian Carcinoma	EWSR1 (8):	--2-- |  273_CUDC-101_GDSC1(5) |  1066_AZD6482_GDSC1(5) | Ovarian Carcinoma	EZH1 (4):	--2-- |  273_CUDC-101_GDSC1(3) |  363_PF-00299804_GDSC1(3) | Ovarian Carcinoma	FGF3 (2):	--1-- |  1560_Alpelisib_GDSC2(2) | Ovarian Carcinoma	FGF4 (2):	--1-- |  1425_BPTES_GDSC1(2) | Ovarian Carcinoma	FGFR1 (11):	--3-- |  1054_Palbociclib_GDSC2(4) |  1230_IOX2_GDSC1(3) |  1912_Afuresertib_GDSC2(7) | Ovarian Carcinoma	FGFR2 (11):	--3-- |  273_CUDC-101_GDSC1(7) |  428_Pemetrexed_GDSC1(6) |  1939_UMI-77_GDSC2(5) | Ovarian Carcinoma	FGFR3 (7):	--4-- |  182_Obatoclax Mesylate_GDSC1(2) |  272_AR-42_GDSC1(3) |  1036_PLX-4720_GDSC2(2) |  1916_AZD5363_GDSC2(4) | Ovarian Carcinoma	FGFR4 (13):	--3-- |  260_NG-25_GDSC1(7) |  381_AST-1306_GDSC1(10) |  1011_Navitoclax_GDSC1(6) | Ovarian Carcinoma	FLI1 (11):	--3-- |  272_AR-42_GDSC1(7) |  1490_SN-38_GDSC1(4) |  1014_Refametinib_GDSC2(4) | Ovarian Carcinoma	FLT1 (12):	--2-- |  1242_(5Z)-7-Oxozeaenol_GDSC1(9) |  1091_BMS-536924_GDSC2(8) | Ovarian Carcinoma	FLT3 (10):	--2-- |  208_Ispinesib Mesylate_GDSC1(7) |  1005_Cisplatin_GDSC1(7) | Ovarian Carcinoma	FLT4 (6):	--2-- |  1114_Cetuximab_GDSC1(3) |  1135_AZD4547_GDSC1(4) | Ovarian Carcinoma	FURIN (4):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1434_JAK3_7406_GDSC1(3) | Ovarian Carcinoma	FYN (3):	--2-- |  279_BIX02189_GDSC1(2) |  1919_Osimertinib_GDSC2(2) | Ovarian Carcinoma	GAB1 (4):	--2-- |  431_Alisertib_GDSC1(3) |  1624_I-BET-762_GDSC2(3) | Ovarian Carcinoma	GAB2 (9):	--3-- |  1070_CRT0105950_GDSC1(6) |  1188_CCT245467_GDSC1(6) |  1460_PARP_9482_GDSC1(6) | Ovarian Carcinoma	GATA2 (6):	--2-- |  1031_Elesclomol_GDSC1(5) |  1377_Afatinib_GDSC1(4) | Ovarian Carcinoma	GLI1 (8):	--2-- |  1441_AZD2014_GDSC1(7) |  1007_Docetaxel_GDSC2(6) | Ovarian Carcinoma	GNA12 (5):	--2-- |  309_Y-39983_GDSC1(3) |  436_CAP-232, TT-232, TLN-232_GDSC1(2) | Ovarian Carcinoma	GNAQ (3):	--1-- |  1135_AZD4547_GDSC1(3) | Ovarian Carcinoma	GNAS (16):	--3-- |  295_NVP-BHG712_GDSC1(6) |  1378_Bleomycin (50 uM)_GDSC1(10) |  1091_BMS-536924_GDSC2(10) | Ovarian Carcinoma	GSK3B (7):	--3-- |  223_ZSTK474_GDSC1(4) |  1135_AZD4547_GDSC1(4) |  1062_Selumetinib_GDSC2(4) | Ovarian Carcinoma	GTF2I (11):	--3-- |  342_Tenovin-6_GDSC1(6) |  1062_Selumetinib_GDSC2(6) |  1912_Afuresertib_GDSC2(7) | Ovarian Carcinoma	HDAC7 (8):	--2-- |  1549_Sapitinib_GDSC2(4) |  1070_CRT0105950_GDSC1(6) | Ovarian Carcinoma	HGF (4):	--2-- |  288_WHI-P97_GDSC1(2) |  1135_AZD4547_GDSC1(3) | Ovarian Carcinoma	HIF1A (5):	--2-- |  1021_Axitinib_GDSC1(2) |  1185_KU-60019_GDSC1(3) | Ovarian Carcinoma	HMGA1 (3):	--2-- |  1230_IOX2_GDSC1(2) |  1409_AZD4877_GDSC1(2) | Ovarian Carcinoma	HMGA2 (9):	--3-- |  272_AR-42_GDSC1(6) |  1529_Pevonedistat_GDSC2(4) |  1999_N25720-51-A1_GDSC2(3) | Ovarian Carcinoma	IDH1 (3):	--1-- |  1008_Methotrexate_GDSC1(3) | Ovarian Carcinoma	IDH2 (4):	--2-- |  273_CUDC-101_GDSC1(3) |  299_OSI-027_GDSC1(2) | Ovarian Carcinoma	IGF1R (10):	--2-- |  381_AST-1306_GDSC1(8) |  1409_AZD4877_GDSC1(8) | Ovarian Carcinoma	IL3 (2):	--1-- |  1021_Axitinib_GDSC1(2) | Ovarian Carcinoma	IL6ST (6):	--2-- |  1463_AZD1332_GDSC2(3) |  222_BX-912_GDSC1(4) | Ovarian Carcinoma	IL7R (5):	--2-- |  1393_Gemcitabine_GDSC1(3) |  1999_N25720-51-A1_GDSC2(3) | Ovarian Carcinoma	INSR (13):	--3-- |  1142_HG-5-113-01_GDSC1(7) |  1239_YK-4-279_GDSC1(6) |  1463_AZD1332_GDSC1(9) | Ovarian Carcinoma	IRS1 (8):	--4-- |  326_GSK690693_GDSC1(4) |  1135_AZD4547_GDSC1(4) |  1249_BMS-345541_GDSC2(2) |  1847_BEN_GDSC2(3) | Ovarian Carcinoma	IRS2 (4):	--2-- |  1021_Axitinib_GDSC1(2) |  1919_Osimertinib_GDSC2(2) | Ovarian Carcinoma	JAK2 (14):	--3-- |  178_BAY-61-3606_GDSC1(6) |  1835_Elephantin_GDSC2(6) |  1498_Selumetinib_GDSC1(8) | Ovarian Carcinoma	JAK3 (14):	--2-- |  1091_BMS-536924_GDSC2(9) |  1426_AZD7969_GDSC1(10) | Ovarian Carcinoma	KDM5A (11):	--3-- |  1047_Nutlin-3a (-)_GDSC1(5) |  1050_ZM447439_GDSC1(6) |  1170_CCT-018159_GDSC1(5) | Ovarian Carcinoma	KDR (11):	--2-- |  356_AT7867_GDSC1(5) |  1444_AZD8186_GDSC1(7) | Ovarian Carcinoma	KIT (10):	--3-- |  1131_PRIMA-1MET_GDSC2(5) |  1425_BPTES_GDSC1(5) |  310_YM201636_GDSC1(4) | Ovarian Carcinoma	KLF5 (4):	--2-- |  1434_JAK3_7406_GDSC1(3) |  1428_IAP_5620_GDSC2(2) | Ovarian Carcinoma	KRAS (7):	--3-- |  300_CX-5461_GDSC1(5) |  309_Y-39983_GDSC1(3) |  1001_AICA Ribonucleotide_GDSC1(4) | Ovarian Carcinoma	KSR2 (14):	--5-- |  135_Gemcitabine_GDSC1(7) |  201_Epothilone B_GDSC1(6) |  238_Idelalisib_GDSC1(3) |  1070_CRT0105950_GDSC1(7) |  1131_PRIMA-1MET_GDSC2(6) | Ovarian Carcinoma	LCK (4):	--2-- |  288_WHI-P97_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Ovarian Carcinoma	LGR5 (10):	--3-- |  235_QL-XII-47_GDSC1(5) |  1377_Afatinib_GDSC1(5) |  1803_Acetalax_GDSC2(4) | Ovarian Carcinoma	LMO1 (6):	--2-- |  1630_Entospletinib_GDSC2(4) |  1005_Cisplatin_GDSC2(3) | Ovarian Carcinoma	LMO2 (3):	--1-- |  1021_Axitinib_GDSC1(3) | Ovarian Carcinoma	LRP6 (16):	--3-- |  179_5-Fluorouracil_GDSC1(10) |  415_CPI-613_GDSC1(6) |  1032_Afatinib_GDSC1(7) | Ovarian Carcinoma	LTK (8):	--3-- |  134_Etoposide_GDSC1(2) |  287_KIN001-244_GDSC1(5) |  1529_Pevonedistat_GDSC1(4) | Ovarian Carcinoma	LYN (7):	--2-- |  1739_JAK_8517_GDSC2(3) |  1549_Sapitinib_GDSC2(5) | Ovarian Carcinoma	MAP2K1 (2):	--1-- |  249_Cabozantinib_GDSC1(2) | Ovarian Carcinoma	MAP2K2 (7):	--2-- |  1114_Cetuximab_GDSC1(3) |  1188_CCT245467_GDSC1(5) | Ovarian Carcinoma	MAP3K13 (11):	--3-- |  229_Enzastaurin_GDSC1(4) |  1032_Afatinib_GDSC1(5) |  1494_SN-38_GDSC2(7) | Ovarian Carcinoma	MAP4K4 (13):	--3-- |  223_ZSTK474_GDSC1(8) |  1377_Afatinib_GDSC1(6) |  1373_Dabrafenib_GDSC1(7) | Ovarian Carcinoma	MAPK1 (6):	--3-- |  222_BX-912_GDSC1(3) |  326_GSK690693_GDSC1(3) |  1924_Ipatasertib_GDSC2(3) | Ovarian Carcinoma	MAPK3 (4):	--2-- |  230_GSK429286A_GDSC1(2) |  262_VX-11e_GDSC1(3) | Ovarian Carcinoma	MCL1 (2):	--1-- |  1230_IOX2_GDSC1(2) | Ovarian Carcinoma	MDM2 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1461_TANK_1366_GDSC1(2) | Ovarian Carcinoma	MDM4 (8):	--2-- |  1549_Sapitinib_GDSC2(4) |  1849_Sabutoclax_GDSC2(5) | Ovarian Carcinoma	MECOM (12):	--3-- |  1490_SN-38_GDSC1(5) |  1190_Gemcitabine_GDSC2(7) |  1844_776928_GDSC2(4) | Ovarian Carcinoma	MEF2B (3):	--2-- |  1261_rTRAIL_GDSC1(2) |  1005_Cisplatin_GDSC2(2) | Ovarian Carcinoma	MEF2D (6):	--2-- |  223_ZSTK474_GDSC1(4) |  1036_PLX-4720_GDSC1(3) | Ovarian Carcinoma	MET (8):	--2-- |  1847_BEN_GDSC2(4) |  1422_FGFR_3831_GDSC1(6) | Ovarian Carcinoma	MGAM (26):	--4-- |  260_NG-25_GDSC1(12) |  1015_CI-1040_GDSC1(11) |  1413_EphB4_9721_GDSC1(14) |  1617_AZD5582_GDSC2(12) | Ovarian Carcinoma	MKI67 (13):	--3-- |  331_QL-X-138_GDSC1(6) |  1219_PFI-1_GDSC1(9) |  1190_Gemcitabine_GDSC2(9) | Ovarian Carcinoma	MLLT10 (9):	--3-- |  1135_AZD4547_GDSC1(6) |  1422_FGFR_3831_GDSC1(7) |  1464_TTK_3146_GDSC1(6) | Ovarian Carcinoma	MLLT3 (4):	--2-- |  1016_Temsirolimus_GDSC2(3) |  1799_Ibrutinib_GDSC2(2) | Ovarian Carcinoma	MSI1 (6):	--2-- |  1195_FY026_GDSC1(4) |  1382_AZD3514_GDSC1(3) | Ovarian Carcinoma	MSI2 (13):	--2-- |  228_AKT inhibitor VIII_GDSC1(10) |  1459_PARP_0108_GDSC1(8) | Ovarian Carcinoma	MST1R (5):	--2-- |  1434_JAK3_7406_GDSC1(3) |  1038_NU7441_GDSC2(3) | Ovarian Carcinoma	MTOR (11):	--3-- |  1409_AZD4877_GDSC1(8) |  1430_IGFR_3801_GDSC1(7) |  1073_5-Fluorouracil_GDSC2(4) | Ovarian Carcinoma	MYBL1 (7):	--2-- |  303_PIK-93_GDSC1(3) |  1084_Rapamycin_GDSC2(4) | Ovarian Carcinoma	MYC (3):	--1-- |  1463_AZD1332_GDSC2(3) | Ovarian Carcinoma	NADK (6):	--2-- |  304_SB52334_GDSC1(3) |  1031_Elesclomol_GDSC1(5) | Ovarian Carcinoma	NCOA3 (9):	--2-- |  272_AR-42_GDSC1(6) |  299_OSI-027_GDSC1(6) | Ovarian Carcinoma	NCSTN (8):	--3-- |  151_QS11_GDSC1(3) |  1066_AZD6482_GDSC1(6) |  252_WZ3105_GDSC1(3) | Ovarian Carcinoma	NFE2L2 (6):	--2-- |  317_WYE-125132_GDSC1(4) |  1031_Elesclomol_GDSC1(4) | Ovarian Carcinoma	NR4A3 (5):	--2-- |  223_ZSTK474_GDSC1(2) |  363_PF-00299804_GDSC1(3) | Ovarian Carcinoma	NRAS (5):	--2-- |  223_ZSTK474_GDSC1(3) |  1135_AZD4547_GDSC1(4) | Ovarian Carcinoma	NRG1 (6):	--3-- |  372_Pilaralisib_GDSC1(4) |  1720_AZD5991_GDSC2(3) |  1845_Schweinfurthin A_GDSC2(3) | Ovarian Carcinoma	NSD2 (6):	--1-- |  1188_CCT245467_GDSC1(6) | Ovarian Carcinoma	NT5C2 (9):	--2-- |  331_QL-X-138_GDSC1(3) |  1031_Elesclomol_GDSC1(7) | Ovarian Carcinoma	NTRK1 (8):	--2-- |  1008_Methotrexate_GDSC1(3) |  1011_Navitoclax_GDSC2(5) | Ovarian Carcinoma	NTRK2 (7):	--2-- |  304_SB52334_GDSC1(3) |  1031_Elesclomol_GDSC1(6) | Ovarian Carcinoma	NTRK3 (13):	--2-- |  1393_Gemcitabine_GDSC1(8) |  276_CAY10603_GDSC1(8) | Ovarian Carcinoma	NUP214 (12):	--3-- |  1463_AZD1332_GDSC2(5) |  1053_MK-2206_GDSC2(6) |  208_Ispinesib Mesylate_GDSC1(7) | Ovarian Carcinoma	NUP98 (17):	--4-- |  177_GSK650394_GDSC1(6) |  1026_Tanespimycin_GDSC2(12) |  1219_PFI-1_GDSC1(10) |  310_YM201636_GDSC1(5) | Ovarian Carcinoma	PAK5 (5):	--2-- |  1057_Dactolisib_GDSC1(3) |  1933_P22077_GDSC2(2) | Ovarian Carcinoma	PAX8 (5):	--2-- |  1021_Axitinib_GDSC1(2) |  1463_AZD1332_GDSC2(4) | Ovarian Carcinoma	PDCD1LG2 (5):	--3-- |  249_Cabozantinib_GDSC1(2) |  1010_Gefitinib_GDSC1(2) |  1434_JAK3_7406_GDSC1(3) | Ovarian Carcinoma	PDGFRA (9):	--2-- |  1070_CRT0105950_GDSC1(5) |  1444_AZD8186_GDSC1(6) | Ovarian Carcinoma	PDGFRB (8):	--3-- |  151_QS11_GDSC1(3) |  1008_Methotrexate_GDSC1(3) |  1131_PRIMA-1MET_GDSC2(5) | Ovarian Carcinoma	PGR (3):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1421_FGFR_0939_GDSC1(2) | Ovarian Carcinoma	PIK3CA (11):	--4-- |  176_IPA-3_GDSC1(5) |  1422_FGFR_3831_GDSC1(6) |  1053_MK-2206_GDSC2(6) |  1618_GSK2606414_GDSC2(3) | Ovarian Carcinoma	PIK3CB (8):	--2-- |  1001_AICA Ribonucleotide_GDSC1(4) |  1422_FGFR_3831_GDSC1(5) | Ovarian Carcinoma	PIK3CD (9):	--2-- |  1434_JAK3_7406_GDSC1(5) |  1085_Sorafenib_GDSC2(6) | Ovarian Carcinoma	PIK3CG (3):	--1-- |  222_BX-912_GDSC1(3) | Ovarian Carcinoma	PLCG1 (6):	--2-- |  155_Ponatinib_GDSC1(3) |  1050_ZM447439_GDSC2(4) | Ovarian Carcinoma	PLCG2 (18):	--4-- |  1053_MK-2206_GDSC1(6) |  1062_Selumetinib_GDSC1(7) |  1183_CRT0160829_GDSC1(10) |  1529_Pevonedistat_GDSC2(10) | Ovarian Carcinoma	PPARG (7):	--3-- |  223_ZSTK474_GDSC1(4) |  272_AR-42_GDSC1(4) |  1188_CCT245467_GDSC1(4) | Ovarian Carcinoma	PPM1D (3):	--2-- |  133_Doxorubicin_GDSC1(1) |  363_PF-00299804_GDSC1(2) | Ovarian Carcinoma	PRKACA (9):	--2-- |  252_WZ3105_GDSC1(4) |  1031_Elesclomol_GDSC1(7) | Ovarian Carcinoma	PRKCI (12):	--3-- |  1924_Ipatasertib_GDSC2(5) |  1999_N25720-51-A1_GDSC2(3) |  1377_Afatinib_GDSC1(6) | Ovarian Carcinoma	PSMB2 (2):	--1-- |  1425_BPTES_GDSC1(2) | Ovarian Carcinoma	REL (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  1736_Selumetinib_GDSC2(2) | Ovarian Carcinoma	RET (10):	--2-- |  1422_FGFR_3831_GDSC1(6) |  1008_Methotrexate_GDSC2(6) | Ovarian Carcinoma	REV3L (12):	--3-- |  155_Ponatinib_GDSC1(4) |  265_Tubastatin A_GDSC1(4) |  1131_PRIMA-1MET_GDSC2(6) | Ovarian Carcinoma	RHEB (5):	--2-- |  1021_Axitinib_GDSC1(2) |  1940_WIKI4_GDSC2(3) | Ovarian Carcinoma	RHOA (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  1010_Gefitinib_GDSC1(2) | Ovarian Carcinoma	RICTOR (15):	--3-- |  1019_Bosutinib_GDSC1(8) |  1022_AZD7762_GDSC2(11) |  1131_PRIMA-1MET_GDSC2(7) | Ovarian Carcinoma	RNASEH2A (3):	--2-- |  1249_BMS-345541_GDSC2(2) |  1560_Alpelisib_GDSC2(2) | Ovarian Carcinoma	ROS1 (15):	--3-- |  1873_Buparlisib_GDSC2(9) |  415_CPI-613_GDSC1(5) |  1459_PARP_0108_GDSC1(7) | Ovarian Carcinoma	RPTOR (18):	--3-- |  1091_BMS-536924_GDSC2(11) |  1135_AZD4547_GDSC1(6) |  179_5-Fluorouracil_GDSC1(10) | Ovarian Carcinoma	RRAS (3):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1421_FGFR_0939_GDSC1(2) | Ovarian Carcinoma	RUNX1T1 (3):	--2-- |  167_OSU-03012_GDSC1(2) |  1436_MCT1_6447_GDSC1(2) | Ovarian Carcinoma	SET (5):	--3-- |  171_AKT inhibitor VIII_GDSC1(2) |  1916_AZD5363_GDSC2(3) |  1714_ERK_6604_GDSC2(3) | Ovarian Carcinoma	SETBP1 (2):	--1-- |  135_Gemcitabine_GDSC1(2) | Ovarian Carcinoma	SETD1A (8):	--3-- |  186_Bexarotene_GDSC1(2) |  1007_Docetaxel_GDSC2(5) |  1549_Sapitinib_GDSC2(4) | Ovarian Carcinoma	SF3B1 (10):	--2-- |  1037_BX795_GDSC1(6) |  1066_AZD6482_GDSC1(7) | Ovarian Carcinoma	SGK1 (6):	--3-- |  326_GSK690693_GDSC1(3) |  1010_Gefitinib_GDSC1(2) |  1849_Sabutoclax_GDSC2(4) | Ovarian Carcinoma	SHOC2 (1):	--1-- |  272_AR-42_GDSC1(1) | Ovarian Carcinoma	SMO (5):	--3-- |  173_FH535_GDSC1(3) |  372_Pilaralisib_GDSC1(3) |  1021_Axitinib_GDSC1(2) | Ovarian Carcinoma	SMYD3 (11):	--4-- |  229_Enzastaurin_GDSC1(4) |  1232_I-BET-151_GDSC1(5) |  1083_Crizotinib_GDSC2(4) |  1712_Eg5_9814_GDSC2(5) | Ovarian Carcinoma	SOS1 (8):	--2-- |  256_JW-7-24-1_GDSC1(5) |  1032_Afatinib_GDSC2(4) | Ovarian Carcinoma	SQSTM1 (8):	--2-- |  431_Alisertib_GDSC1(4) |  1908_Ulixertinib_GDSC2(6) | Ovarian Carcinoma	SRC (11):	--2-- |  223_ZSTK474_GDSC1(7) |  1460_PARP_9482_GDSC1(5) | Ovarian Carcinoma	SS18 (3):	--1-- |  1463_AZD1332_GDSC2(3) | Ovarian Carcinoma	STAT3 (7):	--2-- |  301_PHA-793887_GDSC1(5) |  1031_Elesclomol_GDSC1(6) | Ovarian Carcinoma	STAT5A (4):	--1-- |  1062_Selumetinib_GDSC2(4) | Ovarian Carcinoma	STAT5B (8):	--2-- |  1053_MK-2206_GDSC2(5) |  1558_Lapatinib_GDSC2(6) | Ovarian Carcinoma	STAT6 (5):	--2-- |  223_ZSTK474_GDSC1(3) |  1066_AZD6482_GDSC1(4) | Ovarian Carcinoma	SYK (3):	--2-- |  1091_BMS-536924_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(2) | Ovarian Carcinoma	TCL1A (3):	--2-- |  1008_Methotrexate_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(2) | Ovarian Carcinoma	TERT (10):	--3-- |  1066_AZD6482_GDSC1(6) |  1444_AZD8186_GDSC1(6) |  1736_Selumetinib_GDSC2(3) | Ovarian Carcinoma	TFE3 (6):	--2-- |  1919_Osimertinib_GDSC2(2) |  292_Masitinib_GDSC1(4) | Ovarian Carcinoma	TSHR (10):	--2-- |  363_PF-00299804_GDSC1(8) |  1012_Vorinostat_GDSC1(6) | Ovarian Carcinoma	TYK2 (10):	--2-- |  275_I-BET-762_GDSC1(6) |  1019_Bosutinib_GDSC1(6) | Ovarian Carcinoma	UBR5 (13):	--3-- |  1091_BMS-536924_GDSC2(8) |  1409_AZD4877_GDSC1(10) |  310_YM201636_GDSC1(4) | Ovarian Carcinoma	USP8 (13):	--4-- |  436_CAP-232, TT-232, TLN-232_GDSC1(3) |  1070_CRT0105950_GDSC1(7) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(7) |  1050_ZM447439_GDSC2(6) | Ovarian Carcinoma	VAV1 (14):	--3-- |  366_TWS119_GDSC1(7) |  1091_BMS-536924_GDSC2(9) |  1835_Elephantin_GDSC2(7) | Ovarian Carcinoma	VAV2 (13):	--3-- |  326_GSK690693_GDSC1(5) |  1032_Afatinib_GDSC1(8) |  1131_PRIMA-1MET_GDSC2(7) | Ovarian Carcinoma	VEGFA (7):	--2-- |  292_Masitinib_GDSC1(5) |  1464_TTK_3146_GDSC1(5) | Ovarian Carcinoma	WWP1 (7):	--3-- |  222_BX-912_GDSC1(4) |  304_SB52334_GDSC1(3) |  1421_FGFR_0939_GDSC1(2) | Ovarian Carcinoma	XPO1 (6):	--2-- |  1032_Afatinib_GDSC1(4) |  1434_JAK3_7406_GDSC1(4) | Ovarian Carcinoma	YAP1 (4):	--3-- |  223_ZSTK474_GDSC1(2) |  249_Cabozantinib_GDSC1(2) |  1161_ZG-10_GDSC1(2) | Ovarian Carcinoma	YES1 (7):	--2-- |  1549_Sapitinib_GDSC2(4) |  1849_Sabutoclax_GDSC2(5) | Pancreatic Carcinoma	ABL1 (6):	--2-- |  306_Fedratinib_GDSC1(5) |  1184_AZ20_GDSC1(4) | Pancreatic Carcinoma	ABL2 (4):	--2-- |  225_Genentech Cpd 10_GDSC1(3) |  1712_Eg5_9814_GDSC2(3) | Pancreatic Carcinoma	ADHFE1 (6):	--2-- |  476_SB505124_GDSC1(4) |  1086_BI-2536_GDSC2(4) | Pancreatic Carcinoma	AFF4 (5):	--2-- |  1446_PI3Ka_4409_GDSC1(2) |  1490_SN-38_GDSC1(3) | Pancreatic Carcinoma	AGO1 (4):	--2-- |  260_NG-25_GDSC1(3) |  1261_rTRAIL_GDSC1(3) | Pancreatic Carcinoma	AKT1 (5):	--3-- |  356_AT7867_GDSC1(2) |  1011_Navitoclax_GDSC1(2) |  1136_Capivasertib_GDSC1(3) | Pancreatic Carcinoma	AKT2 (1):	--1-- |  437_Trichostatin A_GDSC1(1) | Pancreatic Carcinoma	AKT3 (2):	--1-- |  1739_JAK_8517_GDSC2(2) | Pancreatic Carcinoma	ALK (8):	--3-- |  284_JNJ38877605_GDSC1(3) |  1453_RAF_9304_GDSC1(4) |  1190_Gemcitabine_GDSC2(5) | Pancreatic Carcinoma	ARHGEF28 (6):	--2-- |  546_FTY-720_GDSC1(2) |  1070_CRT0105950_GDSC1(4) | Pancreatic Carcinoma	ATF1 (2):	--2-- |  165_DMOG_GDSC1(1) |  371_Torin 2_GDSC1(1) | Pancreatic Carcinoma	ATXN7 (3):	--2-- |  172_Embelin_GDSC1(2) |  224_AS605240_GDSC1(2) | Pancreatic Carcinoma	BCL9 (1):	--1-- |  1128_FS106_GDSC1(1) | Pancreatic Carcinoma	BRAF (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  1192_GSK269962A_GDSC1(2) | Pancreatic Carcinoma	CARD11 (5):	--2-- |  172_Embelin_GDSC1(2) |  1926_GNE-317_GDSC2(3) | Pancreatic Carcinoma	COP1 (5):	--3-- |  449_CD532_GDSC1(2) |  1026_Tanespimycin_GDSC1(2) |  1434_JAK3_7406_GDSC1(3) | Pancreatic Carcinoma	CSF3R (5):	--2-- |  225_Genentech Cpd 10_GDSC1(4) |  1037_BX795_GDSC1(4) | Pancreatic Carcinoma	DNMT1 (7):	--2-- |  306_Fedratinib_GDSC1(5) |  1058_Pictilisib_GDSC2(3) | Pancreatic Carcinoma	EGFL7 (3):	--1-- |  265_Tubastatin A_GDSC1(3) | Pancreatic Carcinoma	EIF4A2 (3):	--1-- |  249_Cabozantinib_GDSC1(3) | Pancreatic Carcinoma	EIF4E (4):	--2-- |  194_Luminespib_GDSC1(3) |  279_BIX02189_GDSC1(2) | Pancreatic Carcinoma	ERBB2 (4):	--2-- |  1072_Avagacestat_GDSC1(2) |  1149_TW 37_GDSC1(2) | Pancreatic Carcinoma	ERBB3 (6):	--2-- |  170_Shikonin_GDSC1(4) |  1496_Cisplatin_GDSC1(4) | Pancreatic Carcinoma	ERBB4 (8):	--3-- |  317_WYE-125132_GDSC1(3) |  1378_Bleomycin (50 uM)_GDSC1(4) |  1463_AZD1332_GDSC1(5) | Pancreatic Carcinoma	ESR1 (3):	--2-- |  155_Ponatinib_GDSC1(2) |  1926_GNE-317_GDSC2(2) | Pancreatic Carcinoma	ETV1 (7):	--2-- |  1004_Vinblastine_GDSC1(4) |  2171_BMS-754807_GDSC2(5) | Pancreatic Carcinoma	FLI1 (2):	--1-- |  432_Flavopiridol_GDSC1(2) | Pancreatic Carcinoma	FLT1 (7):	--2-- |  140_Vinorelbine_GDSC1(4) |  1930_Telomerase Inhibitor IX_GDSC2(3) | Pancreatic Carcinoma	FLT3 (6):	--2-- |  1192_GSK269962A_GDSC1(2) |  1011_Navitoclax_GDSC2(4) | Pancreatic Carcinoma	FURIN (3):	--2-- |  432_Flavopiridol_GDSC1(2) |  1739_JAK_8517_GDSC2(2) | Pancreatic Carcinoma	FYN (2):	--2-- |  371_Torin 2_GDSC1(1) |  442_IMD-0354_GDSC1(1) | Pancreatic Carcinoma	GATA2 (4):	--2-- |  275_I-BET-762_GDSC1(3) |  439_LCL161_GDSC1(3) | Pancreatic Carcinoma	GLI1 (4):	--2-- |  175_PAC-1_GDSC1(3) |  1188_CCT245467_GDSC1(3) | Pancreatic Carcinoma	GNA12 (4):	--2-- |  1197_ZL049_GDSC1(2) |  1401_AZD5438_GDSC2(3) | Pancreatic Carcinoma	GNAQ (2):	--2-- |  371_Torin 2_GDSC1(1) |  1068_Obatoclax Mesylate_GDSC2(1) | Pancreatic Carcinoma	GNAS (6):	--2-- |  175_PAC-1_GDSC1(4) |  225_Genentech Cpd 10_GDSC1(5) | Pancreatic Carcinoma	GTF2I (4):	--1-- |  1219_PFI-1_GDSC1(4) | Pancreatic Carcinoma	HDAC7 (5):	--2-- |  133_Doxorubicin_GDSC1(3) |  1932_NVP-ADW742_GDSC2(2) | Pancreatic Carcinoma	HIF1A (5):	--2-- |  194_Luminespib_GDSC1(3) |  1128_FS106_GDSC1(3) | Pancreatic Carcinoma	HMGA2 (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1932_NVP-ADW742_GDSC2(2) | Pancreatic Carcinoma	IGF1R (6):	--3-- |  363_PF-00299804_GDSC1(2) |  1091_BMS-536924_GDSC1(4) |  1022_AZD7762_GDSC2(2) | Pancreatic Carcinoma	INSR (4):	--2-- |  175_PAC-1_GDSC1(3) |  1070_CRT0105950_GDSC1(3) | Pancreatic Carcinoma	JAK2 (5):	--3-- |  301_PHA-793887_GDSC1(2) |  1232_I-BET-151_GDSC1(2) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(2) | Pancreatic Carcinoma	JAK3 (4):	--2-- |  363_PF-00299804_GDSC1(2) |  371_Torin 2_GDSC1(3) | Pancreatic Carcinoma	KDM5A (3):	--2-- |  1007_Docetaxel_GDSC1(2) |  1490_SN-38_GDSC1(2) | Pancreatic Carcinoma	KDR (5):	--2-- |  1188_CCT245467_GDSC1(3) |  1624_I-BET-762_GDSC2(3) | Pancreatic Carcinoma	KSR2 (8):	--3-- |  284_JNJ38877605_GDSC1(3) |  1070_CRT0105950_GDSC1(4) |  1085_Sorafenib_GDSC2(4) | Pancreatic Carcinoma	LGR5 (5):	--2-- |  235_QL-XII-47_GDSC1(3) |  1007_Docetaxel_GDSC2(3) | Pancreatic Carcinoma	LTK (5):	--2-- |  1011_Navitoclax_GDSC1(2) |  1259_Talazoparib_GDSC2(3) | Pancreatic Carcinoma	MAP4K4 (6):	--2-- |  228_AKT inhibitor VIII_GDSC1(4) |  1136_Capivasertib_GDSC1(3) | Pancreatic Carcinoma	MCL1 (3):	--2-- |  1011_Navitoclax_GDSC1(2) |  1250_AZ960_GDSC2(2) | Pancreatic Carcinoma	MDM2 (3):	--1-- |  175_PAC-1_GDSC1(3) | Pancreatic Carcinoma	MDM4 (6):	--2-- |  170_Shikonin_GDSC1(4) |  416_CAY10566_GDSC1(2) | Pancreatic Carcinoma	MECOM (8):	--2-- |  222_BX-912_GDSC1(5) |  1003_Camptothecin_GDSC2(5) | Pancreatic Carcinoma	MET (7):	--3-- |  317_WYE-125132_GDSC1(4) |  442_IMD-0354_GDSC1(4) |  1527_Pictilisib_GDSC1(2) | Pancreatic Carcinoma	MGAM (5):	--2-- |  1564_SCH772984_GDSC2(4) |  1817_Romidepsin_GDSC2(2) | Pancreatic Carcinoma	MTOR (5):	--2-- |  449_CD532_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Pancreatic Carcinoma	NCOA3 (3):	--1-- |  1714_ERK_6604_GDSC2(3) | Pancreatic Carcinoma	NCSTN (4):	--2-- |  330_XMD13-2_GDSC1(2) |  1070_CRT0105950_GDSC1(3) | Pancreatic Carcinoma	NRG1 (5):	--2-- |  371_Torin 2_GDSC1(3) |  1734_VSP34_8731_GDSC2(2) | Pancreatic Carcinoma	NSD2 (3):	--2-- |  292_Masitinib_GDSC1(2) |  1188_CCT245467_GDSC1(2) | Pancreatic Carcinoma	NT5C2 (4):	--2-- |  287_KIN001-244_GDSC1(3) |  1008_Methotrexate_GDSC1(2) | Pancreatic Carcinoma	NTRK2 (4):	--2-- |  1007_Docetaxel_GDSC1(2) |  1128_FS106_GDSC1(3) | Pancreatic Carcinoma	NTRK3 (8):	--2-- |  177_GSK650394_GDSC1(3) |  1006_Cytarabine_GDSC1(7) | Pancreatic Carcinoma	NUP214 (5):	--2-- |  224_AS605240_GDSC1(2) |  1373_Dabrafenib_GDSC1(3) | Pancreatic Carcinoma	NUP98 (4):	--3-- |  330_XMD13-2_GDSC1(2) |  356_AT7867_GDSC1(2) |  1011_Navitoclax_GDSC1(2) | Pancreatic Carcinoma	PDGFRA (5):	--3-- |  261_TL-1-85_GDSC1(3) |  1058_Pictilisib_GDSC2(2) |  1930_Telomerase Inhibitor IX_GDSC2(2) | Pancreatic Carcinoma	PDGFRB (3):	--1-- |  249_Cabozantinib_GDSC1(3) | Pancreatic Carcinoma	PIK3CA (3):	--2-- |  284_JNJ38877605_GDSC1(2) |  1050_ZM447439_GDSC2(2) | Pancreatic Carcinoma	PLCG2 (6):	--2-- |  546_FTY-720_GDSC1(3) |  1529_Pevonedistat_GDSC2(5) | Pancreatic Carcinoma	PRKACA (5):	--3-- |  184_BMS-754807_GDSC1(2) |  374_GSK1059615_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC1(2) | Pancreatic Carcinoma	PRKCI (3):	--1-- |  371_Torin 2_GDSC1(3) | Pancreatic Carcinoma	RAC1 (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1085_Sorafenib_GDSC2(3) | Pancreatic Carcinoma	REV3L (7):	--2-- |  167_OSU-03012_GDSC1(5) |  1441_AZD2014_GDSC2(5) | Pancreatic Carcinoma	RICTOR (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1932_NVP-ADW742_GDSC2(2) | Pancreatic Carcinoma	ROS1 (5):	--2-- |  176_IPA-3_GDSC1(4) |  1062_Selumetinib_GDSC2(3) | Pancreatic Carcinoma	RPTOR (5):	--2-- |  1188_CCT245467_GDSC1(3) |  1714_ERK_6604_GDSC2(4) | Pancreatic Carcinoma	SETD1A (2):	--1-- |  1170_CCT-018159_GDSC1(2) | Pancreatic Carcinoma	SF3B1 (3):	--1-- |  1239_YK-4-279_GDSC2(3) | Pancreatic Carcinoma	SGK1 (4):	--2-- |  175_PAC-1_GDSC1(3) |  225_Genentech Cpd 10_GDSC1(3) | Pancreatic Carcinoma	SMO (7):	--2-- |  262_VX-11e_GDSC1(4) |  306_Fedratinib_GDSC1(5) | Pancreatic Carcinoma	SMYD3 (6):	--2-- |  140_Vinorelbine_GDSC1(4) |  1059_AZD8055_GDSC1(4) | Pancreatic Carcinoma	SOS1 (6):	--2-- |  257_NPK76-II-72-1_GDSC1(4) |  439_LCL161_GDSC1(4) | Pancreatic Carcinoma	SQSTM1 (5):	--2-- |  194_Luminespib_GDSC1(3) |  1407_Dyrk1b_0191_GDSC1(2) | Pancreatic Carcinoma	STAT3 (5):	--2-- |  1091_BMS-536924_GDSC1(4) |  1197_ZL049_GDSC1(2) | Pancreatic Carcinoma	STAT5B (6):	--3-- |  1239_YK-4-279_GDSC1(2) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(1) |  1709_CDK9_5038_GDSC2(3) | Pancreatic Carcinoma	STK19 (2):	--1-- |  284_JNJ38877605_GDSC1(2) | Pancreatic Carcinoma	TSHR (8):	--3-- |  446_MIM1_GDSC1(5) |  1464_TTK_3146_GDSC1(6) |  1050_ZM447439_GDSC2(3) | Pancreatic Carcinoma	UBR5 (12):	--3-- |  175_PAC-1_GDSC1(5) |  407_kb NB 142-70_GDSC1(7) |  1058_Pictilisib_GDSC2(6) | Pancreatic Carcinoma	USP8 (2):	--2-- |  172_Embelin_GDSC1(1) |  1059_AZD8055_GDSC1(1) | Pancreatic Carcinoma	VAV2 (11):	--3-- |  449_CD532_GDSC1(6) |  1526_Refametinib_GDSC1(4) |  1190_Gemcitabine_GDSC2(7) | Pancreatic Carcinoma	WWTR1 (2):	--2-- |  1184_AZ20_GDSC1(1) |  1266_ICL1100013_GDSC1(1) | Plasma Cell Myeloma	ABL2 (5):	--2-- |  279_BIX02189_GDSC1(3) |  1778_GSK2110183B_GDSC2(4) | Plasma Cell Myeloma	AFF4 (4):	--2-- |  1020_Lenalidomide_GDSC1(3) |  1054_Palbociclib_GDSC1(3) | Plasma Cell Myeloma	AGO1 (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	ARHGEF28 (6):	--2-- |  366_TWS119_GDSC1(3) |  1007_Docetaxel_GDSC1(4) | Plasma Cell Myeloma	ARID3B (2):	--1-- |  1786_AZD4547_GDSC2(2) | Plasma Cell Myeloma	ATXN7 (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	AXL (2):	--1-- |  184_BMS-754807_GDSC1(2) | Plasma Cell Myeloma	BCL6 (4):	--2-- |  158_PF-562271_GDSC1(3) |  1053_MK-2206_GDSC1(2) | Plasma Cell Myeloma	BCR (7):	--2-- |  310_YM201636_GDSC1(3) |  1133_Serdemetan_GDSC1(5) | Plasma Cell Myeloma	BRAF (6):	--2-- |  71_Pyrimethamine_GDSC1(3) |  2173_PFI-1_GDSC2(4) | Plasma Cell Myeloma	BRD3 (4):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1060_PD0325901_GDSC2(3) | Plasma Cell Myeloma	BRD4 (2):	--1-- |  55_A-770041_GDSC1(2) | Plasma Cell Myeloma	CCNB3 (3):	--2-- |  416_CAY10566_GDSC1(2) |  1630_Entospletinib_GDSC2(2) | Plasma Cell Myeloma	CCND1 (5):	--2-- |  269_NSC-207895_GDSC1(4) |  1021_Axitinib_GDSC2(4) | Plasma Cell Myeloma	CCND3 (4):	--1-- |  1005_Cisplatin_GDSC2(4) | Plasma Cell Myeloma	COP1 (2):	--1-- |  1259_Talazoparib_GDSC1(2) | Plasma Cell Myeloma	CTLA4 (2):	--1-- |  281_Alectinib_GDSC1(2) | Plasma Cell Myeloma	DDR2 (5):	--2-- |  1259_Talazoparib_GDSC2(3) |  2046_MK-8776_GDSC2(4) | Plasma Cell Myeloma	DOT1L (6):	--2-- |  1261_rTRAIL_GDSC1(5) |  1080_Paclitaxel_GDSC2(2) | Plasma Cell Myeloma	EGFL7 (4):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1558_Lapatinib_GDSC2(3) | Plasma Cell Myeloma	ERBB2 (3):	--2-- |  1630_Entospletinib_GDSC2(2) |  1833_741909_GDSC2(2) | Plasma Cell Myeloma	ERG (3):	--1-- |  1050_ZM447439_GDSC1(3) | Plasma Cell Myeloma	FGFR2 (6):	--2-- |  428_Pemetrexed_GDSC1(5) |  1005_Cisplatin_GDSC2(4) | Plasma Cell Myeloma	FLT4 (4):	--2-- |  262_VX-11e_GDSC1(2) |  1129_PF-4708671_GDSC1(2) | Plasma Cell Myeloma	FURIN (4):	--2-- |  416_CAY10566_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(3) | Plasma Cell Myeloma	FUS (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	GNAS (6):	--2-- |  175_PAC-1_GDSC1(3) |  1026_Tanespimycin_GDSC1(4) | Plasma Cell Myeloma	IGF1R (6):	--2-- |  1050_ZM447439_GDSC1(4) |  1133_Serdemetan_GDSC1(5) | Plasma Cell Myeloma	IL7R (3):	--2-- |  293_Amuvatinib_GDSC1(1) |  1058_Pictilisib_GDSC1(2) | Plasma Cell Myeloma	INSR (5):	--1-- |  2173_PFI-1_GDSC2(5) | Plasma Cell Myeloma	JAK3 (6):	--2-- |  366_TWS119_GDSC1(1) |  2046_MK-8776_GDSC2(5) | Plasma Cell Myeloma	KDR (1):	--1-- |  41_S-Trityl-L-cysteine_GDSC1(1) | Plasma Cell Myeloma	KRAS (5):	--2-- |  1218_JQ1_GDSC1(4) |  1526_Refametinib_GDSC1(4) | Plasma Cell Myeloma	KSR2 (5):	--2-- |  329_QL-XI-92_GDSC1(4) |  1052_RO-3306_GDSC2(4) | Plasma Cell Myeloma	LRP6 (5):	--2-- |  285_SU11274_GDSC1(3) |  1054_Palbociclib_GDSC1(3) | Plasma Cell Myeloma	LYN (3):	--2-- |  51_Dasatinib_GDSC1(2) |  1259_Talazoparib_GDSC1(2) | Plasma Cell Myeloma	MAP3K13 (3):	--1-- |  1050_ZM447439_GDSC1(3) | Plasma Cell Myeloma	MDM4 (4):	--2-- |  439_LCL161_GDSC1(3) |  1617_AZD5582_GDSC2(2) | Plasma Cell Myeloma	MECOM (3):	--1-- |  1718_JAK1_8709_GDSC2(3) | Plasma Cell Myeloma	MGAM (5):	--3-- |  1053_MK-2206_GDSC1(3) |  1445_AZD8835_GDSC1(2) |  1829_667880_GDSC2(3) | Plasma Cell Myeloma	MLLT10 (4):	--2-- |  184_BMS-754807_GDSC1(2) |  1023_GW441756_GDSC1(3) | Plasma Cell Myeloma	MLLT3 (3):	--2-- |  225_Genentech Cpd 10_GDSC1(1) |  1058_Pictilisib_GDSC1(2) | Plasma Cell Myeloma	MPL (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	MSI2 (2):	--1-- |  262_VX-11e_GDSC1(2) | Plasma Cell Myeloma	MTOR (6):	--2-- |  439_LCL161_GDSC1(3) |  1020_Lenalidomide_GDSC1(4) | Plasma Cell Myeloma	NRG1 (3):	--2-- |  178_BAY-61-3606_GDSC1(1) |  415_CPI-613_GDSC1(2) | Plasma Cell Myeloma	NSD2 (4):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Plasma Cell Myeloma	NTRK2 (5):	--2-- |  1133_Serdemetan_GDSC2(4) |  1598_LGK974_GDSC2(3) | Plasma Cell Myeloma	NUF2 (4):	--2-- |  1019_Bosutinib_GDSC1(3) |  1020_Lenalidomide_GDSC1(3) | Plasma Cell Myeloma	NUP98 (8):	--2-- |  1736_Selumetinib_GDSC2(4) |  1916_AZD5363_GDSC2(6) | Plasma Cell Myeloma	PDCD1LG2 (3):	--3-- |  204_Tipifarnib_GDSC1(1) |  293_Amuvatinib_GDSC1(1) |  1999_N25720-51-A1_GDSC2(1) | Plasma Cell Myeloma	PDGFRA (2):	--2-- |  204_Tipifarnib_GDSC1(1) |  229_Enzastaurin_GDSC1(1) | Plasma Cell Myeloma	PIK3CA (6):	--2-- |  1054_Palbociclib_GDSC1(3) |  1052_RO-3306_GDSC2(4) | Plasma Cell Myeloma	PLCG2 (9):	--2-- |  309_Y-39983_GDSC1(6) |  1016_Temsirolimus_GDSC2(7) | Plasma Cell Myeloma	PRKACA (5):	--2-- |  158_PF-562271_GDSC1(3) |  1827_Dihydrorotenone_GDSC2(2) | Plasma Cell Myeloma	RAF1 (3):	--1-- |  1718_JAK1_8709_GDSC2(3) | Plasma Cell Myeloma	REL (3):	--2-- |  260_NG-25_GDSC1(1) |  1062_Selumetinib_GDSC1(2) | Plasma Cell Myeloma	RET (4):	--1-- |  1359_965-D2_GDSC1(4) | Plasma Cell Myeloma	REV3L (4):	--1-- |  1918_AZD8186_GDSC2(4) | Plasma Cell Myeloma	ROS1 (7):	--2-- |  1426_AZD7969_GDSC1(4) |  1806_Oxaliplatin_GDSC2(5) | Plasma Cell Myeloma	RPS6KA4 (3):	--2-- |  1049_PD173074_GDSC1(2) |  1630_Entospletinib_GDSC2(2) | Plasma Cell Myeloma	RPTOR (9):	--2-- |  428_Pemetrexed_GDSC1(6) |  1806_Oxaliplatin_GDSC2(6) | Plasma Cell Myeloma	SETBP1 (2):	--1-- |  1463_AZD1332_GDSC2(2) | Plasma Cell Myeloma	SGK1 (6):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1133_Serdemetan_GDSC2(5) | Plasma Cell Myeloma	SHOC2 (4):	--2-- |  1069_EHT-1864_GDSC2(3) |  1089_Oxaliplatin_GDSC2(3) | Plasma Cell Myeloma	SMYD3 (5):	--1-- |  1713_ERK_2440_GDSC2(5) | Plasma Cell Myeloma	SOS1 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  1598_LGK974_GDSC2(3) | Plasma Cell Myeloma	SQSTM1 (4):	--2-- |  293_Amuvatinib_GDSC1(1) |  1463_AZD1332_GDSC1(3) | Plasma Cell Myeloma	STAT3 (4):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1629_ML323_GDSC2(3) | Plasma Cell Myeloma	STAT5B (4):	--2-- |  1629_ML323_GDSC2(3) |  1826_50869_GDSC2(3) | Plasma Cell Myeloma	TERT (3):	--1-- |  71_Pyrimethamine_GDSC1(3) | Plasma Cell Myeloma	TYK2 (4):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1598_LGK974_GDSC2(3) | Plasma Cell Myeloma	UBR5 (6):	--2-- |  269_NSC-207895_GDSC1(5) |  1007_Docetaxel_GDSC1(2) | Plasma Cell Myeloma	VAV1 (5):	--2-- |  1463_AZD1332_GDSC1(3) |  1718_JAK1_8709_GDSC2(3) | Plasma Cell Myeloma	XPO1 (6):	--2-- |  1713_ERK_2440_GDSC2(5) |  2111_VE821_GDSC2(3) | Small Cell Lung Carcinoma	ABL2 (10):	--3-- |  211_TL-2-105_GDSC1(4) |  1012_Vorinostat_GDSC1(7) |  1149_TW 37_GDSC1(7) | Small Cell Lung Carcinoma	ACVR1 (5):	--2-- |  1057_Dactolisib_GDSC1(4) |  1170_CCT-018159_GDSC1(3) | Small Cell Lung Carcinoma	ADHFE1 (7):	--2-- |  1175_Rucaparib_GDSC1(2) |  1089_Oxaliplatin_GDSC2(6) | Small Cell Lung Carcinoma	AFF4 (8):	--3-- |  223_ZSTK474_GDSC1(4) |  317_WYE-125132_GDSC1(5) |  1039_SL0101_GDSC1(2) | Small Cell Lung Carcinoma	AGO1 (8):	--3-- |  223_ZSTK474_GDSC1(2) |  1386_Doxorubicin_GDSC1(3) |  1012_Vorinostat_GDSC2(5) | Small Cell Lung Carcinoma	AKT1 (9):	--2-- |  245_UNC0638_GDSC1(6) |  1069_EHT-1864_GDSC2(4) | Small Cell Lung Carcinoma	AKT2 (10):	--4-- |  1071_CRT0105446_GDSC1(3) |  1024_Lestaurtinib_GDSC2(5) |  1086_BI-2536_GDSC2(5) |  1250_AZ960_GDSC2(4) | Small Cell Lung Carcinoma	AKT3 (12):	--3-- |  178_BAY-61-3606_GDSC1(7) |  1053_MK-2206_GDSC1(7) |  1091_BMS-536924_GDSC2(7) | Small Cell Lung Carcinoma	ALK (28):	--4-- |  326_GSK690693_GDSC1(10) |  1070_CRT0105950_GDSC1(13) |  1249_BMS-345541_GDSC2(12) |  1594_OSI-027_GDSC2(11) | Small Cell Lung Carcinoma	AR (4):	--2-- |  1170_CCT-018159_GDSC1(3) |  1622_Wnt-C59_GDSC2(2) | Small Cell Lung Carcinoma	ARAF (4):	--2-- |  89_Parthenolide_GDSC1(2) |  284_JNJ38877605_GDSC1(2) | Small Cell Lung Carcinoma	ARHGEF28 (14):	--2-- |  257_NPK76-II-72-1_GDSC1(5) |  1180_Dinaciclib_GDSC2(12) | Small Cell Lung Carcinoma	ATF1 (3):	--2-- |  284_JNJ38877605_GDSC1(2) |  1918_AZD8186_GDSC2(2) | Small Cell Lung Carcinoma	ATXN7 (4):	--2-- |  478_LDN-193189_GDSC1(2) |  1038_NU7441_GDSC2(3) | Small Cell Lung Carcinoma	AURKA (3):	--2-- |  331_QL-X-138_GDSC1(2) |  2011_ICL-SIRT078_GDSC2(2) | Small Cell Lung Carcinoma	AXL (17):	--4-- |  1529_Pevonedistat_GDSC2(10) |  363_PF-00299804_GDSC1(11) |  302_PI-103_GDSC1(10) |  439_LCL161_GDSC1(7) | Small Cell Lung Carcinoma	BAALC (6):	--3-- |  235_QL-XII-47_GDSC1(3) |  1005_Cisplatin_GDSC1(4) |  1598_LGK974_GDSC2(2) | Small Cell Lung Carcinoma	BCL6 (4):	--2-- |  110_Seliciclib_GDSC1(2) |  1510_Linsitinib_GDSC2(3) | Small Cell Lung Carcinoma	BCL9 (3):	--2-- |  1188_CCT245467_GDSC1(2) |  1382_AZD3514_GDSC1(2) | Small Cell Lung Carcinoma	BCR (15):	--3-- |  62_BMS-536924_GDSC1(5) |  1393_Gemcitabine_GDSC1(9) |  1910_ABT737_GDSC2(8) | Small Cell Lung Carcinoma	BRAF (16):	--4-- |  1006_Cytarabine_GDSC2(7) |  310_YM201636_GDSC1(9) |  304_SB52334_GDSC1(9) |  2106_Uprosertib_GDSC2(8) | Small Cell Lung Carcinoma	BRD3 (8):	--3-- |  223_ZSTK474_GDSC1(4) |  317_WYE-125132_GDSC1(4) |  1720_AZD5991_GDSC2(4) | Small Cell Lung Carcinoma	BRD4 (13):	--4-- |  88_Entinostat_GDSC1(4) |  159_HG6-64-1_GDSC1(6) |  1060_PD0325901_GDSC1(8) |  1046_Wee1 Inhibitor_GDSC2(6) | Small Cell Lung Carcinoma	BTK (6):	--2-- |  1066_AZD6482_GDSC1(3) |  1426_AZD7969_GDSC1(5) | Small Cell Lung Carcinoma	CALR (6):	--3-- |  1446_PI3Ka_4409_GDSC1(4) |  1918_AZD8186_GDSC2(3) |  2148_POMHEX_GDSC2(3) | Small Cell Lung Carcinoma	CARD11 (23):	--3-- |  363_PF-00299804_GDSC1(18) |  1046_Wee1 Inhibitor_GDSC1(4) |  1191_Bortezomib_GDSC2(14) | Small Cell Lung Carcinoma	CCNB3 (14):	--4-- |  304_SB52334_GDSC1(8) |  1368_BAY-MPS1_GDSC1(6) |  1392_Bleomycin (10 uM)_GDSC1(5) |  1016_Temsirolimus_GDSC2(6) | Small Cell Lung Carcinoma	CCND2 (8):	--3-- |  258_STF-62247_GDSC1(2) |  261_TL-1-85_GDSC1(3) |  1918_AZD8186_GDSC2(3) | Small Cell Lung Carcinoma	CCND3 (7):	--3-- |  151_QS11_GDSC1(3) |  196_Phenformin_GDSC1(4) |  1175_Rucaparib_GDSC1(2) | Small Cell Lung Carcinoma	CCNE1 (6):	--1-- |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(6) | Small Cell Lung Carcinoma	CD274 (2):	--1-- |  165_DMOG_GDSC1(2) | Small Cell Lung Carcinoma	CD276 (3):	--2-- |  86_A-443654_GDSC1(2) |  1441_AZD2014_GDSC1(2) | Small Cell Lung Carcinoma	CD79B (3):	--2-- |  151_QS11_GDSC1(2) |  175_PAC-1_GDSC1(2) | Small Cell Lung Carcinoma	CDK6 (2):	--1-- |  1004_Vinblastine_GDSC2(2) | Small Cell Lung Carcinoma	CDK8 (5):	--2-- |  1386_Doxorubicin_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(2) | Small Cell Lung Carcinoma	COP1 (13):	--2-- |  219_AT-7519_GDSC1(11) |  306_Fedratinib_GDSC1(7) | Small Cell Lung Carcinoma	CSF3R (9):	--3-- |  1026_Tanespimycin_GDSC1(6) |  1016_Temsirolimus_GDSC2(4) |  1042_Doramapimod_GDSC2(2) | Small Cell Lung Carcinoma	CTLA4 (3):	--1-- |  1496_Cisplatin_GDSC1(3) | Small Cell Lung Carcinoma	CYP19A1 (7):	--2-- |  474_ARRY-520_GDSC1(5) |  1511_Epirubicin_GDSC2(6) | Small Cell Lung Carcinoma	DCUN1D1 (8):	--3-- |  329_QL-XI-92_GDSC1(5) |  1402_AZD7762_GDSC1(3) |  1084_Rapamycin_GDSC2(4) | Small Cell Lung Carcinoma	DDR2 (10):	--3-- |  55_A-770041_GDSC1(4) |  279_BIX02189_GDSC1(3) |  1416_AZD8931_GDSC1(7) | Small Cell Lung Carcinoma	DDX4 (6):	--2-- |  435_C-75_GDSC1(3) |  1445_AZD8835_GDSC1(4) | Small Cell Lung Carcinoma	DEK (3):	--1-- |  230_GSK429286A_GDSC1(3) | Small Cell Lung Carcinoma	DNMT1 (20):	--2-- |  274_Belinostat_GDSC1(14) |  1997_WEHI-539_GDSC2(12) | Small Cell Lung Carcinoma	DOT1L (7):	--2-- |  1192_GSK269962A_GDSC1(5) |  1496_Cisplatin_GDSC1(3) | Small Cell Lung Carcinoma	E2F3 (5):	--3-- |  87_GW843682X_GDSC1(3) |  151_QS11_GDSC1(3) |  1248_Daporinad_GDSC2(3) | Small Cell Lung Carcinoma	EGFL7 (5):	--2-- |  151_QS11_GDSC1(3) |  1409_AZD4877_GDSC1(4) | Small Cell Lung Carcinoma	EGFR (20):	--2-- |  157_JNK-9L_GDSC1(14) |  1012_Vorinostat_GDSC2(16) | Small Cell Lung Carcinoma	EIF4E (5):	--2-- |  196_Phenformin_GDSC1(4) |  1170_CCT-018159_GDSC1(3) | Small Cell Lung Carcinoma	EPOR (6):	--3-- |  64_CMK_GDSC1(3) |  89_Parthenolide_GDSC1(2) |  1363_BAY AKT1_GDSC1(3) | Small Cell Lung Carcinoma	ERBB2 (7):	--2-- |  328_SNX-2112_GDSC1(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(5) | Small Cell Lung Carcinoma	ERBB3 (12):	--4-- |  159_HG6-64-1_GDSC1(6) |  294_MPS-1-IN-1_GDSC1(6) |  1006_Cytarabine_GDSC1(6) |  1026_Tanespimycin_GDSC1(6) | Small Cell Lung Carcinoma	ERBB4 (22):	--3-- |  1873_Buparlisib_GDSC2(15) |  1529_Pevonedistat_GDSC2(13) |  317_WYE-125132_GDSC1(13) | Small Cell Lung Carcinoma	ERG (4):	--2-- |  1015_CI-1040_GDSC1(2) |  1042_Doramapimod_GDSC2(2) | Small Cell Lung Carcinoma	ESR1 (9):	--3-- |  342_Tenovin-6_GDSC1(4) |  1016_Temsirolimus_GDSC1(6) |  1177_Niraparib_GDSC2(5) | Small Cell Lung Carcinoma	ETV1 (11):	--5-- |  86_A-443654_GDSC1(2) |  87_GW843682X_GDSC1(2) |  279_BIX02189_GDSC1(3) |  1407_Dyrk1b_0191_GDSC1(5) |  1248_Daporinad_GDSC2(4) | Small Cell Lung Carcinoma	EWSR1 (5):	--3-- |  1021_Axitinib_GDSC1(2) |  1413_EphB4_9721_GDSC1(2) |  1817_Romidepsin_GDSC2(3) | Small Cell Lung Carcinoma	FGFR1 (10):	--2-- |  260_NG-25_GDSC1(6) |  1091_BMS-536924_GDSC2(6) | Small Cell Lung Carcinoma	FGFR2 (15):	--3-- |  178_BAY-61-3606_GDSC1(8) |  1016_Temsirolimus_GDSC1(6) |  1593_Entinostat_GDSC2(9) | Small Cell Lung Carcinoma	FGFR3 (4):	--1-- |  1177_Niraparib_GDSC2(4) | Small Cell Lung Carcinoma	FGFR4 (7):	--3-- |  86_A-443654_GDSC1(2) |  317_WYE-125132_GDSC1(3) |  1180_Dinaciclib_GDSC2(4) | Small Cell Lung Carcinoma	FLI1 (13):	--4-- |  87_GW843682X_GDSC1(5) |  1057_Dactolisib_GDSC1(8) |  1089_Oxaliplatin_GDSC2(7) |  1918_AZD8186_GDSC2(5) | Small Cell Lung Carcinoma	FLT1 (14):	--3-- |  362_CI-1033_GDSC1(8) |  1024_Lestaurtinib_GDSC1(6) |  1553_Uprosertib_GDSC2(6) | Small Cell Lung Carcinoma	FLT3 (22):	--3-- |  219_AT-7519_GDSC1(15) |  272_AR-42_GDSC1(15) |  1187_CCT245232_GDSC1(14) | Small Cell Lung Carcinoma	FLT4 (13):	--2-- |  1441_AZD2014_GDSC1(5) |  1012_Vorinostat_GDSC2(10) | Small Cell Lung Carcinoma	FURIN (5):	--2-- |  1069_EHT-1864_GDSC2(2) |  1933_P22077_GDSC2(3) | Small Cell Lung Carcinoma	FUS (6):	--3-- |  86_A-443654_GDSC1(2) |  1170_CCT-018159_GDSC1(3) |  1372_Trametinib_GDSC1(2) | Small Cell Lung Carcinoma	FYN (9):	--2-- |  268_Sepantronium bromide_GDSC1(7) |  1016_Temsirolimus_GDSC1(4) | Small Cell Lung Carcinoma	GAB1 (12):	--4-- |  1049_PD173074_GDSC1(3) |  1058_Pictilisib_GDSC1(6) |  1188_CCT245467_GDSC1(3) |  1037_BX795_GDSC2(5) | Small Cell Lung Carcinoma	GAB2 (5):	--2-- |  175_PAC-1_GDSC1(3) |  279_BIX02189_GDSC1(2) | Small Cell Lung Carcinoma	GATA2 (3):	--2-- |  1015_CI-1040_GDSC1(2) |  1175_Rucaparib_GDSC1(2) | Small Cell Lung Carcinoma	GLI1 (13):	--4-- |  279_BIX02189_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC2(6) |  1190_Gemcitabine_GDSC2(9) | Small Cell Lung Carcinoma	GNA11 (4):	--2-- |  127_GSK269962A_GDSC1(3) |  1170_CCT-018159_GDSC1(2) | Small Cell Lung Carcinoma	GNA12 (9):	--2-- |  224_AS605240_GDSC1(5) |  1910_ABT737_GDSC2(4) | Small Cell Lung Carcinoma	GNA13 (3):	--1-- |  1073_5-Fluorouracil_GDSC2(3) | Small Cell Lung Carcinoma	GNAQ (10):	--2-- |  178_BAY-61-3606_GDSC1(7) |  474_ARRY-520_GDSC1(7) | Small Cell Lung Carcinoma	GNAS (14):	--3-- |  230_GSK429286A_GDSC1(5) |  310_YM201636_GDSC1(9) |  1022_AZD7762_GDSC2(10) | Small Cell Lung Carcinoma	GNB1 (6):	--2-- |  170_Shikonin_GDSC1(4) |  1432_AZD1480_GDSC1(4) | Small Cell Lung Carcinoma	GSK3B (6):	--2-- |  439_LCL161_GDSC1(5) |  1066_AZD6482_GDSC1(3) | Small Cell Lung Carcinoma	GTF2I (6):	--2-- |  157_JNK-9L_GDSC1(5) |  328_SNX-2112_GDSC1(3) | Small Cell Lung Carcinoma	HGF (13):	--4-- |  86_A-443654_GDSC1(4) |  140_Vinorelbine_GDSC1(6) |  224_AS605240_GDSC1(7) |  1490_SN-38_GDSC1(6) | Small Cell Lung Carcinoma	HIF1A (9):	--2-- |  268_Sepantronium bromide_GDSC1(7) |  1133_Serdemetan_GDSC1(3) | Small Cell Lung Carcinoma	HMGA2 (4):	--2-- |  175_PAC-1_GDSC1(2) |  230_GSK429286A_GDSC1(2) | Small Cell Lung Carcinoma	IDH1 (3):	--2-- |  87_GW843682X_GDSC1(2) |  256_JW-7-24-1_GDSC1(2) | Small Cell Lung Carcinoma	IDH2 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  1170_CCT-018159_GDSC1(3) | Small Cell Lung Carcinoma	IGF1 (6):	--3-- |  64_CMK_GDSC1(3) |  1084_Rapamycin_GDSC2(3) |  1613_VE-822_GDSC2(3) | Small Cell Lung Carcinoma	IGF1R (23):	--3-- |  363_PF-00299804_GDSC1(17) |  1007_Docetaxel_GDSC1(12) |  1593_Entinostat_GDSC2(16) | Small Cell Lung Carcinoma	IGF2 (7):	--2-- |  1006_Cytarabine_GDSC1(5) |  1135_AZD4547_GDSC1(5) | Small Cell Lung Carcinoma	IKBKE (10):	--2-- |  1149_TW 37_GDSC1(7) |  1084_Rapamycin_GDSC2(4) | Small Cell Lung Carcinoma	IL3 (7):	--2-- |  407_kb NB 142-70_GDSC1(5) |  1066_AZD6482_GDSC1(3) | Small Cell Lung Carcinoma	IL6ST (7):	--3-- |  283_Omipalisib_GDSC1(4) |  342_Tenovin-6_GDSC1(3) |  1733_ULK1_4989_GDSC2(2) | Small Cell Lung Carcinoma	IL7R (8):	--2-- |  1012_Vorinostat_GDSC1(7) |  1510_Linsitinib_GDSC2(4) | Small Cell Lung Carcinoma	INSR (19):	--3-- |  178_BAY-61-3606_GDSC1(12) |  474_ARRY-520_GDSC1(13) |  1186_FS112_GDSC1(11) | Small Cell Lung Carcinoma	IRS2 (2):	--1-- |  1049_PD173074_GDSC1(2) | Small Cell Lung Carcinoma	JAK2 (17):	--3-- |  1026_Tanespimycin_GDSC2(11) |  224_AS605240_GDSC1(8) |  1038_NU7441_GDSC2(6) | Small Cell Lung Carcinoma	JAK3 (11):	--4-- |  106_XMD8-85_GDSC1(2) |  439_LCL161_GDSC1(6) |  1188_CCT245467_GDSC1(3) |  1446_PI3Ka_4409_GDSC1(5) | Small Cell Lung Carcinoma	KDM5A (21):	--4-- |  163_JQ1_GDSC1(14) |  287_KIN001-244_GDSC1(11) |  1026_Tanespimycin_GDSC1(9) |  1918_AZD8186_GDSC2(5) | Small Cell Lung Carcinoma	KDR (18):	--4-- |  1197_ZL049_GDSC1(8) |  1402_AZD7762_GDSC1(12) |  1046_Wee1 Inhibitor_GDSC2(9) |  1733_ULK1_4989_GDSC2(9) | Small Cell Lung Carcinoma	KIT (9):	--2-- |  1016_Temsirolimus_GDSC1(5) |  1631_PRT062607_GDSC2(6) | Small Cell Lung Carcinoma	KRAS (4):	--2-- |  478_LDN-193189_GDSC1(3) |  2111_VE821_GDSC2(2) | Small Cell Lung Carcinoma	KSR2 (15):	--2-- |  1052_RO-3306_GDSC2(10) |  1709_CDK9_5038_GDSC2(8) | Small Cell Lung Carcinoma	LCK (2):	--1-- |  1164_XMD8-92_GDSC1(2) | Small Cell Lung Carcinoma	LGR5 (12):	--4-- |  176_IPA-3_GDSC1(5) |  260_NG-25_GDSC1(6) |  295_NVP-BHG712_GDSC1(6) |  1918_AZD8186_GDSC2(4) | Small Cell Lung Carcinoma	LMO2 (7):	--3-- |  328_SNX-2112_GDSC1(3) |  1071_CRT0105446_GDSC1(2) |  1089_Oxaliplatin_GDSC2(4) | Small Cell Lung Carcinoma	LRP6 (12):	--3-- |  83_JW-7-52-1_GDSC1(4) |  275_I-BET-762_GDSC1(9) |  1015_CI-1040_GDSC1(3) | Small Cell Lung Carcinoma	LTK (6):	--3-- |  1004_Vinblastine_GDSC2(2) |  1060_PD0325901_GDSC2(2) |  1073_5-Fluorouracil_GDSC2(3) | Small Cell Lung Carcinoma	MAP2K1 (5):	--3-- |  196_Phenformin_GDSC1(3) |  1170_CCT-018159_GDSC1(3) |  1175_Rucaparib_GDSC1(2) | Small Cell Lung Carcinoma	MAP2K2 (4):	--2-- |  1496_Cisplatin_GDSC1(3) |  1023_GW441756_GDSC2(2) | Small Cell Lung Carcinoma	MAP3K13 (10):	--2-- |  363_PF-00299804_GDSC1(7) |  1930_Telomerase Inhibitor IX_GDSC2(9) | Small Cell Lung Carcinoma	MAP4K4 (9):	--3-- |  412_Venotoclax_GDSC1(3) |  1014_Refametinib_GDSC1(4) |  1529_Pevonedistat_GDSC1(6) | Small Cell Lung Carcinoma	MAPK3 (5):	--2-- |  1015_CI-1040_GDSC1(2) |  1016_Temsirolimus_GDSC1(4) | Small Cell Lung Carcinoma	MCL1 (4):	--3-- |  253_XMD14-99_GDSC1(2) |  1049_PD173074_GDSC1(2) |  1908_Ulixertinib_GDSC2(2) | Small Cell Lung Carcinoma	MDM2 (8):	--3-- |  86_A-443654_GDSC1(3) |  1084_Rapamycin_GDSC2(4) |  1909_Venetoclax_GDSC2(5) | Small Cell Lung Carcinoma	MDM4 (16):	--3-- |  273_CUDC-101_GDSC1(12) |  1050_ZM447439_GDSC1(7) |  1187_CCT245232_GDSC1(9) | Small Cell Lung Carcinoma	MECOM (14):	--3-- |  45_Z-LLNle-CHO_GDSC1(7) |  196_Phenformin_GDSC1(10) |  1709_CDK9_5038_GDSC2(7) | Small Cell Lung Carcinoma	MEF2B (4):	--3-- |  111_Salubrinal_GDSC1(2) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1042_Doramapimod_GDSC2(2) | Small Cell Lung Carcinoma	MEF2D (7):	--2-- |  176_IPA-3_GDSC1(5) |  256_JW-7-24-1_GDSC1(4) | Small Cell Lung Carcinoma	MET (16):	--2-- |  165_DMOG_GDSC1(13) |  1617_AZD5582_GDSC2(10) | Small Cell Lung Carcinoma	MGAM (34):	--4-- |  86_A-443654_GDSC1(15) |  257_NPK76-II-72-1_GDSC1(17) |  1048_Mirin_GDSC1(12) |  1021_Axitinib_GDSC2(18) | Small Cell Lung Carcinoma	MKI67 (15):	--3-- |  299_OSI-027_GDSC1(11) |  317_WYE-125132_GDSC1(9) |  381_AST-1306_GDSC1(8) | Small Cell Lung Carcinoma	MLLT3 (7):	--2-- |  256_JW-7-24-1_GDSC1(5) |  1037_BX795_GDSC2(5) | Small Cell Lung Carcinoma	MSI1 (3):	--1-- |  1017_Olaparib_GDSC2(3) | Small Cell Lung Carcinoma	MSI2 (13):	--5-- |  3_Rapamycin_GDSC1(5) |  111_Salubrinal_GDSC1(3) |  284_JNJ38877605_GDSC1(3) |  304_SB52334_GDSC1(8) |  428_Pemetrexed_GDSC1(8) | Small Cell Lung Carcinoma	MST1R (9):	--2-- |  1393_Gemcitabine_GDSC1(6) |  1017_Olaparib_GDSC2(4) | Small Cell Lung Carcinoma	MTOR (14):	--3-- |  53_CGP-60474_GDSC1(7) |  2044_Pyridostatin_GDSC2(9) |  2047_Ulixertinib_GDSC2(4) | Small Cell Lung Carcinoma	MYBL1 (5):	--1-- |  474_ARRY-520_GDSC1(5) | Small Cell Lung Carcinoma	MYCN (3):	--2-- |  1017_Olaparib_GDSC2(2) |  1133_Serdemetan_GDSC2(2) | Small Cell Lung Carcinoma	NADK (7):	--3-- |  223_ZSTK474_GDSC1(3) |  1386_Doxorubicin_GDSC1(4) |  1918_AZD8186_GDSC2(3) | Small Cell Lung Carcinoma	NCSTN (5):	--2-- |  151_QS11_GDSC1(3) |  1386_Doxorubicin_GDSC1(4) | Small Cell Lung Carcinoma	NFE2L2 (5):	--2-- |  439_LCL161_GDSC1(4) |  1621_PCI-34051_GDSC2(2) | Small Cell Lung Carcinoma	NR4A3 (4):	--2-- |  165_DMOG_GDSC1(3) |  331_QL-X-138_GDSC1(2) | Small Cell Lung Carcinoma	NRAS (5):	--2-- |  279_BIX02189_GDSC1(2) |  1012_Vorinostat_GDSC2(3) | Small Cell Lung Carcinoma	NRG1 (21):	--4-- |  272_AR-42_GDSC1(17) |  1054_Palbociclib_GDSC1(4) |  1016_Temsirolimus_GDSC2(6) |  1017_Olaparib_GDSC2(6) | Small Cell Lung Carcinoma	NSD2 (10):	--2-- |  177_GSK650394_GDSC1(7) |  1133_Serdemetan_GDSC2(3) | Small Cell Lung Carcinoma	NT5C2 (5):	--2-- |  1073_5-Fluorouracil_GDSC2(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(4) | Small Cell Lung Carcinoma	NTRK1 (13):	--3-- |  344_THZ-2-49_GDSC1(8) |  1494_SN-38_GDSC2(7) |  1809_Teniposide_GDSC2(3) | Small Cell Lung Carcinoma	NTRK2 (23):	--3-- |  60_BI-2536_GDSC1(8) |  219_AT-7519_GDSC1(17) |  1511_Epirubicin_GDSC2(15) | Small Cell Lung Carcinoma	NTRK3 (22):	--3-- |  86_A-443654_GDSC1(9) |  222_BX-912_GDSC1(8) |  1511_Epirubicin_GDSC2(15) | Small Cell Lung Carcinoma	NUF2 (4):	--3-- |  1012_Vorinostat_GDSC1(1) |  2040_Foretinib_GDSC2(2) |  2145_PBD-288_GDSC2(1) | Small Cell Lung Carcinoma	NUP214 (10):	--2-- |  1053_MK-2206_GDSC1(8) |  1933_P22077_GDSC2(6) | Small Cell Lung Carcinoma	NUP98 (14):	--4-- |  1005_Cisplatin_GDSC1(6) |  1026_Tanespimycin_GDSC1(8) |  1183_CRT0160829_GDSC1(8) |  1853_OF-1_GDSC2(4) | Small Cell Lung Carcinoma	PAK1 (14):	--4-- |  35_NVP-TAE684_GDSC1(5) |  223_ZSTK474_GDSC1(7) |  1909_Venetoclax_GDSC2(8) |  1926_GNE-317_GDSC2(6) | Small Cell Lung Carcinoma	PAK5 (15):	--3-- |  1007_Docetaxel_GDSC2(8) |  1734_VSP34_8731_GDSC2(5) |  1909_Venetoclax_GDSC2(8) | Small Cell Lung Carcinoma	PAX8 (8):	--3-- |  1012_Vorinostat_GDSC1(5) |  1402_AZD7762_GDSC1(4) |  1930_Telomerase Inhibitor IX_GDSC2(6) | Small Cell Lung Carcinoma	PDCD1 (4):	--2-- |  110_Seliciclib_GDSC1(2) |  1413_EphB4_9721_GDSC1(2) | Small Cell Lung Carcinoma	PDGFRA (7):	--2-- |  55_A-770041_GDSC1(4) |  2055_Mycophenolic acid_GDSC2(4) | Small Cell Lung Carcinoma	PDGFRB (13):	--3-- |  328_SNX-2112_GDSC1(7) |  1128_FS106_GDSC1(6) |  1022_AZD7762_GDSC2(7) | Small Cell Lung Carcinoma	PGR (10):	--4-- |  229_Enzastaurin_GDSC1(5) |  1050_ZM447439_GDSC1(5) |  1368_BAY-MPS1_GDSC1(5) |  1416_AZD8931_GDSC1(5) | Small Cell Lung Carcinoma	PIK3CA (8):	--2-- |  1170_CCT-018159_GDSC1(4) |  1052_RO-3306_GDSC2(6) | Small Cell Lung Carcinoma	PIK3CB (12):	--3-- |  153_Midostaurin_GDSC1(3) |  1050_ZM447439_GDSC1(7) |  1249_BMS-345541_GDSC2(7) | Small Cell Lung Carcinoma	PIK3CD (6):	--2-- |  1402_AZD7762_GDSC1(4) |  1042_Doramapimod_GDSC2(2) | Small Cell Lung Carcinoma	PLCG1 (6):	--2-- |  110_Seliciclib_GDSC1(2) |  159_HG6-64-1_GDSC1(4) | Small Cell Lung Carcinoma	PLCG2 (24):	--4-- |  342_Tenovin-6_GDSC1(14) |  546_FTY-720_GDSC1(8) |  1053_MK-2206_GDSC1(10) |  1997_WEHI-539_GDSC2(13) | Small Cell Lung Carcinoma	PPARG (5):	--2-- |  1149_TW 37_GDSC1(4) |  1511_Epirubicin_GDSC2(3) | Small Cell Lung Carcinoma	PPM1D (3):	--2-- |  1458_PARP_9495_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Small Cell Lung Carcinoma	PRKACA (11):	--5-- |  71_Pyrimethamine_GDSC1(4) |  127_GSK269962A_GDSC1(4) |  1453_RAF_9304_GDSC1(3) |  1464_TTK_3146_GDSC1(4) |  1510_Linsitinib_GDSC2(5) | Small Cell Lung Carcinoma	PRKCI (3):	--1-- |  1453_RAF_9304_GDSC1(3) | Small Cell Lung Carcinoma	PTPN11 (6):	--2-- |  1017_Olaparib_GDSC2(3) |  1084_Rapamycin_GDSC2(3) | Small Cell Lung Carcinoma	RAB35 (4):	--2-- |  230_GSK429286A_GDSC1(2) |  1581_Bromosporine_GDSC2(2) | Small Cell Lung Carcinoma	RAC1 (6):	--2-- |  157_JNK-9L_GDSC1(4) |  1427_AZD5582_GDSC1(2) | Small Cell Lung Carcinoma	RAC2 (4):	--2-- |  1066_AZD6482_GDSC1(2) |  1023_GW441756_GDSC2(2) | Small Cell Lung Carcinoma	RET (8):	--3-- |  1005_Cisplatin_GDSC1(4) |  1016_Temsirolimus_GDSC1(4) |  1613_VE-822_GDSC2(4) | Small Cell Lung Carcinoma	REV3L (9):	--3-- |  1916_AZD5363_GDSC2(6) |  1918_AZD8186_GDSC2(4) |  2111_VE821_GDSC2(3) | Small Cell Lung Carcinoma	RHEB (9):	--3-- |  329_QL-XI-92_GDSC1(4) |  435_C-75_GDSC1(3) |  1909_Venetoclax_GDSC2(6) | Small Cell Lung Carcinoma	RICTOR (9):	--3-- |  1218_JQ1_GDSC1(3) |  1038_NU7441_GDSC2(6) |  1581_Bromosporine_GDSC2(3) | Small Cell Lung Carcinoma	RNASEH2A (5):	--2-- |  62_BMS-536924_GDSC1(3) |  1363_BAY AKT1_GDSC1(3) | Small Cell Lung Carcinoma	ROS1 (29):	--3-- |  104_Bortezomib_GDSC1(17) |  1409_AZD4877_GDSC1(19) |  1085_Sorafenib_GDSC2(11) | Small Cell Lung Carcinoma	RPTOR (19):	--3-- |  157_JNK-9L_GDSC1(15) |  461_NSC319726_GDSC1(11) |  1088_Irinotecan_GDSC2(8) | Small Cell Lung Carcinoma	RRAS (2):	--1-- |  151_QS11_GDSC1(2) | Small Cell Lung Carcinoma	RRAS2 (4):	--2-- |  245_UNC0638_GDSC1(2) |  1175_Rucaparib_GDSC1(2) | Small Cell Lung Carcinoma	RUNX1T1 (16):	--3-- |  256_JW-7-24-1_GDSC1(10) |  1005_Cisplatin_GDSC1(8) |  1922_Cediranib_GDSC2(7) | Small Cell Lung Carcinoma	SCG5 (4):	--2-- |  110_Seliciclib_GDSC1(2) |  1009_Tretinoin_GDSC1(2) | Small Cell Lung Carcinoma	SET (6):	--3-- |  1017_Olaparib_GDSC2(3) |  1177_Niraparib_GDSC2(3) |  1614_WZ4003_GDSC2(3) | Small Cell Lung Carcinoma	SETBP1 (14):	--2-- |  1617_AZD5582_GDSC2(11) |  1817_Romidepsin_GDSC2(9) | Small Cell Lung Carcinoma	SETD1A (9):	--4-- |  196_Phenformin_GDSC1(4) |  230_GSK429286A_GDSC1(3) |  260_NG-25_GDSC1(5) |  1042_Doramapimod_GDSC2(2) | Small Cell Lung Carcinoma	SF3B1 (15):	--3-- |  196_Phenformin_GDSC1(9) |  1005_Cisplatin_GDSC1(7) |  2044_Pyridostatin_GDSC2(8) | Small Cell Lung Carcinoma	SGK1 (6):	--2-- |  1908_Ulixertinib_GDSC2(3) |  2111_VE821_GDSC2(3) | Small Cell Lung Carcinoma	SHOC2 (6):	--2-- |  252_WZ3105_GDSC1(4) |  461_NSC319726_GDSC1(3) | Small Cell Lung Carcinoma	SMO (6):	--2-- |  176_IPA-3_GDSC1(4) |  1017_Olaparib_GDSC2(3) | Small Cell Lung Carcinoma	SMYD3 (33):	--3-- |  1254_GSK-J4_GDSC1(17) |  1046_Wee1 Inhibitor_GDSC2(18) |  1910_ABT737_GDSC2(24) | Small Cell Lung Carcinoma	SOS1 (9):	--2-- |  1011_Navitoclax_GDSC1(4) |  1910_ABT737_GDSC2(8) | Small Cell Lung Carcinoma	SQSTM1 (9):	--3-- |  87_GW843682X_GDSC1(3) |  363_PF-00299804_GDSC1(6) |  1930_Telomerase Inhibitor IX_GDSC2(7) | Small Cell Lung Carcinoma	SRC (7):	--2-- |  1617_AZD5582_GDSC2(5) |  1853_OF-1_GDSC2(3) | Small Cell Lung Carcinoma	SS18 (5):	--2-- |  2011_ICL-SIRT078_GDSC2(3) |  2038_UNC0638_GDSC2(3) | Small Cell Lung Carcinoma	STAT3 (5):	--2-- |  1170_CCT-018159_GDSC1(2) |  1918_AZD8186_GDSC2(3) | Small Cell Lung Carcinoma	STAT5B (8):	--2-- |  62_BMS-536924_GDSC1(5) |  179_5-Fluorouracil_GDSC1(7) | Small Cell Lung Carcinoma	STAT6 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  2148_POMHEX_GDSC2(4) | Small Cell Lung Carcinoma	SYK (4):	--2-- |  89_Parthenolide_GDSC1(2) |  1413_EphB4_9721_GDSC1(2) | Small Cell Lung Carcinoma	TERT (8):	--2-- |  1014_Refametinib_GDSC1(3) |  1058_Pictilisib_GDSC1(6) | Small Cell Lung Carcinoma	TLX3 (4):	--2-- |  245_UNC0638_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Small Cell Lung Carcinoma	TSHR (11):	--2-- |  196_Phenformin_GDSC1(7) |  366_TWS119_GDSC1(8) | Small Cell Lung Carcinoma	UBR5 (16):	--4-- |  179_5-Fluorouracil_GDSC1(11) |  265_Tubastatin A_GDSC1(7) |  1071_CRT0105446_GDSC1(3) |  1186_FS112_GDSC1(10) | Small Cell Lung Carcinoma	USP8 (14):	--4-- |  35_NVP-TAE684_GDSC1(6) |  140_Vinorelbine_GDSC1(8) |  1510_Linsitinib_GDSC2(5) |  2096_VX-11e_GDSC2(4) | Small Cell Lung Carcinoma	VAV1 (12):	--2-- |  260_NG-25_GDSC1(7) |  1249_BMS-345541_GDSC2(7) | Small Cell Lung Carcinoma	VAV2 (19):	--3-- |  1011_Navitoclax_GDSC2(14) |  1068_Obatoclax Mesylate_GDSC2(10) |  1084_Rapamycin_GDSC2(5) | Small Cell Lung Carcinoma	VEGFA (10):	--2-- |  245_UNC0638_GDSC1(6) |  1446_PI3Ka_4409_GDSC1(6) | Small Cell Lung Carcinoma	WWP1 (15):	--3-- |  179_5-Fluorouracil_GDSC1(8) |  1058_Pictilisib_GDSC1(8) |  1026_Tanespimycin_GDSC2(9) | Small Cell Lung Carcinoma	WWTR1 (11):	--3-- |  223_ZSTK474_GDSC1(6) |  252_WZ3105_GDSC1(8) |  1054_Palbociclib_GDSC1(3) | Small Cell Lung Carcinoma	XIAP (2):	--1-- |  153_Midostaurin_GDSC1(2) | Small Cell Lung Carcinoma	XPO1 (19):	--4-- |  224_AS605240_GDSC1(9) |  300_CX-5461_GDSC1(11) |  1060_PD0325901_GDSC1(9) |  1593_Entinostat_GDSC2(12) | Small Cell Lung Carcinoma	YAP1 (4):	--2-- |  1012_Vorinostat_GDSC2(2) |  1069_EHT-1864_GDSC2(2) | Squamous Cell Lung Carcinoma	ABL1 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	ABL2 (5):	--2-- |  1037_BX795_GDSC1(4) |  1422_FGFR_3831_GDSC1(4) | Squamous Cell Lung Carcinoma	AFF4 (2):	--2-- |  1248_Daporinad_GDSC1(1) |  1363_BAY AKT1_GDSC1(1) | Squamous Cell Lung Carcinoma	AGO1 (2):	--1-- |  1371_PLX-4720_GDSC1(2) | Squamous Cell Lung Carcinoma	AKT3 (3):	--2-- |  1434_JAK3_7406_GDSC1(2) |  1458_PARP_9495_GDSC1(2) | Squamous Cell Lung Carcinoma	ARHGEF28 (5):	--1-- |  1427_AZD5582_GDSC1(5) | Squamous Cell Lung Carcinoma	AXL (5):	--2-- |  1001_AICA Ribonucleotide_GDSC1(4) |  1908_Ulixertinib_GDSC2(4) | Squamous Cell Lung Carcinoma	BCL9 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1458_PARP_9495_GDSC1(2) | Squamous Cell Lung Carcinoma	BRD4 (3):	--2-- |  1060_PD0325901_GDSC1(1) |  1052_RO-3306_GDSC2(2) | Squamous Cell Lung Carcinoma	CD79B (5):	--2-- |  282_Pelitinib_GDSC1(1) |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	COP1 (5):	--2-- |  1192_GSK269962A_GDSC1(4) |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	DNMT1 (5):	--2-- |  1014_Refametinib_GDSC1(4) |  1186_FS112_GDSC1(1) | Squamous Cell Lung Carcinoma	DOT1L (4):	--1-- |  1372_Trametinib_GDSC2(4) | Squamous Cell Lung Carcinoma	EGFR (7):	--3-- |  362_CI-1033_GDSC1(4) |  1248_Daporinad_GDSC1(2) |  1459_PARP_0108_GDSC1(3) | Squamous Cell Lung Carcinoma	ESR1 (2):	--2-- |  442_IMD-0354_GDSC1(1) |  1136_Capivasertib_GDSC1(1) | Squamous Cell Lung Carcinoma	ETV1 (4):	--1-- |  264_ACY-1215_GDSC1(4) | Squamous Cell Lung Carcinoma	ETV4 (3):	--2-- |  1511_Epirubicin_GDSC2(1) |  1559_Luminespib_GDSC2(2) | Squamous Cell Lung Carcinoma	EZH1 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1458_PARP_9495_GDSC1(2) | Squamous Cell Lung Carcinoma	FGFR1 (5):	--2-- |  1133_Serdemetan_GDSC1(3) |  2044_Pyridostatin_GDSC2(4) | Squamous Cell Lung Carcinoma	FLT1 (5):	--2-- |  1558_Lapatinib_GDSC2(3) |  1924_Ipatasertib_GDSC2(3) | Squamous Cell Lung Carcinoma	FLT3 (6):	--1-- |  1261_rTRAIL_GDSC1(6) | Squamous Cell Lung Carcinoma	FLT4 (4):	--4-- |  1463_AZD1332_GDSC1(1) |  1007_Docetaxel_GDSC2(1) |  1008_Methotrexate_GDSC2(1) |  1057_Dactolisib_GDSC2(1) | Squamous Cell Lung Carcinoma	FYN (3):	--1-- |  199_Pazopanib_GDSC1(3) | Squamous Cell Lung Carcinoma	GAB2 (3):	--1-- |  1425_BPTES_GDSC1(3) | Squamous Cell Lung Carcinoma	GNA12 (2):	--2-- |  1463_AZD1332_GDSC1(1) |  1561_Taselisib_GDSC2(1) | Squamous Cell Lung Carcinoma	GTF2I (3):	--1-- |  1382_AZD3514_GDSC1(3) | Squamous Cell Lung Carcinoma	HGF (5):	--1-- |  1192_GSK269962A_GDSC1(5) | Squamous Cell Lung Carcinoma	IL6ST (2):	--1-- |  1371_PLX-4720_GDSC1(2) | Squamous Cell Lung Carcinoma	INSR (6):	--2-- |  1186_FS112_GDSC1(2) |  1908_Ulixertinib_GDSC2(5) | Squamous Cell Lung Carcinoma	JAK2 (6):	--2-- |  1617_AZD5582_GDSC2(5) |  1827_Dihydrorotenone_GDSC2(4) | Squamous Cell Lung Carcinoma	KDR (6):	--3-- |  382_Apitolisib_GDSC1(2) |  449_CD532_GDSC1(2) |  474_ARRY-520_GDSC1(2) | Squamous Cell Lung Carcinoma	KSR2 (9):	--2-- |  1259_Talazoparib_GDSC1(6) |  1427_AZD5582_GDSC1(6) | Squamous Cell Lung Carcinoma	LGR5 (4):	--1-- |  1014_Refametinib_GDSC1(4) | Squamous Cell Lung Carcinoma	LTK (2):	--1-- |  1371_PLX-4720_GDSC1(2) | Squamous Cell Lung Carcinoma	MAP2K2 (2):	--2-- |  461_NSC319726_GDSC1(1) |  1463_AZD1332_GDSC1(1) | Squamous Cell Lung Carcinoma	MDM4 (3):	--1-- |  179_5-Fluorouracil_GDSC1(3) | Squamous Cell Lung Carcinoma	MECOM (5):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1827_Dihydrorotenone_GDSC2(4) | Squamous Cell Lung Carcinoma	MEF2B (3):	--2-- |  1458_PARP_9495_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	MET (2):	--1-- |  1371_PLX-4720_GDSC1(2) | Squamous Cell Lung Carcinoma	MLLT3 (4):	--2-- |  1359_965-D2_GDSC1(3) |  1739_JAK_8517_GDSC2(3) | Squamous Cell Lung Carcinoma	MYBL1 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1185_KU-60019_GDSC1(2) | Squamous Cell Lung Carcinoma	NTRK1 (2):	--2-- |  1459_PARP_0108_GDSC1(1) |  2148_POMHEX_GDSC2(1) | Squamous Cell Lung Carcinoma	NTRK2 (5):	--2-- |  264_ACY-1215_GDSC1(4) |  446_MIM1_GDSC1(4) | Squamous Cell Lung Carcinoma	NTRK3 (2):	--1-- |  1053_MK-2206_GDSC1(2) | Squamous Cell Lung Carcinoma	NUF2 (2):	--2-- |  1012_Vorinostat_GDSC2(1) |  2148_POMHEX_GDSC2(1) | Squamous Cell Lung Carcinoma	PAK1 (5):	--2-- |  282_Pelitinib_GDSC1(1) |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	PIK3CA (4):	--2-- |  432_Flavopiridol_GDSC1(2) |  1186_FS112_GDSC1(2) | Squamous Cell Lung Carcinoma	PIK3CG (3):	--2-- |  1803_Acetalax_GDSC2(2) |  1919_Osimertinib_GDSC2(2) | Squamous Cell Lung Carcinoma	PLCG2 (4):	--1-- |  1001_AICA Ribonucleotide_GDSC1(4) | Squamous Cell Lung Carcinoma	PTPN11 (2):	--1-- |  476_SB505124_GDSC1(2) | Squamous Cell Lung Carcinoma	RAB35 (3):	--2-- |  1371_PLX-4720_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	RET (5):	--2-- |  372_Pilaralisib_GDSC1(3) |  1037_BX795_GDSC1(4) | Squamous Cell Lung Carcinoma	RHOA (3):	--2-- |  1803_Acetalax_GDSC2(2) |  1919_Osimertinib_GDSC2(2) | Squamous Cell Lung Carcinoma	RPTOR (5):	--2-- |  1559_Luminespib_GDSC2(2) |  1932_NVP-ADW742_GDSC2(4) | Squamous Cell Lung Carcinoma	RUNX1T1 (1):	--1-- |  1463_AZD1332_GDSC1(1) | Squamous Cell Lung Carcinoma	SMYD3 (4):	--1-- |  1617_AZD5582_GDSC2(4) | Squamous Cell Lung Carcinoma	TSHR (4):	--2-- |  1024_Lestaurtinib_GDSC1(2) |  1007_Docetaxel_GDSC2(3) | Squamous Cell Lung Carcinoma	UBR5 (4):	--1-- |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	USP8 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	VAV1 (3):	--3-- |  1006_Cytarabine_GDSC1(1) |  1012_Vorinostat_GDSC1(1) |  1463_AZD1332_GDSC1(1) | Squamous Cell Lung Carcinoma	VAV2 (2):	--1-- |  1371_PLX-4720_GDSC1(2) | Squamous Cell Lung Carcinoma	XPO1 (3):	--2-- |  1371_PLX-4720_GDSC1(2) |  1403_AZD6094_GDSC1(2) | Squamous Cell Lung Carcinoma	YAP1 (4):	--3-- |  1559_Luminespib_GDSC2(2) |  1712_Eg5_9814_GDSC2(1) |  1922_Cediranib_GDSC2(1) | T-Lymphoblastic Leukemia	ABL2 (4):	--1-- |  253_XMD14-99_GDSC1(4) | T-Lymphoblastic Leukemia	AFF4 (3):	--2-- |  2046_MK-8776_GDSC2(2) |  2159_UNC0379_GDSC2(2) | T-Lymphoblastic Leukemia	AGO1 (3):	--1-- |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	AKT1 (2):	--1-- |  206_Ruxolitinib_GDSC1(2) | T-Lymphoblastic Leukemia	AKT3 (4):	--2-- |  205_Avagacestat_GDSC1(3) |  293_Amuvatinib_GDSC1(3) | T-Lymphoblastic Leukemia	ARHGEF28 (5):	--2-- |  1259_Talazoparib_GDSC1(3) |  1091_BMS-536924_GDSC2(3) | T-Lymphoblastic Leukemia	ARID3B (5):	--2-- |  62_BMS-536924_GDSC1(4) |  111_Salubrinal_GDSC1(4) | T-Lymphoblastic Leukemia	ATXN7 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	AURKB (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1853_OF-1_GDSC2(3) | T-Lymphoblastic Leukemia	AXL (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1939_UMI-77_GDSC2(1) | T-Lymphoblastic Leukemia	BCL3 (2):	--2-- |  1048_Mirin_GDSC1(1) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	BCL6 (1):	--1-- |  1624_I-BET-762_GDSC2(1) | T-Lymphoblastic Leukemia	BCL9 (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	BRAF (5):	--2-- |  1718_JAK1_8709_GDSC2(3) |  1918_AZD8186_GDSC2(4) | T-Lymphoblastic Leukemia	BRD3 (4):	--3-- |  1037_BX795_GDSC1(2) |  1464_TTK_3146_GDSC1(2) |  1558_Lapatinib_GDSC2(1) | T-Lymphoblastic Leukemia	CALR (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	CCND1 (4):	--1-- |  1016_Temsirolimus_GDSC2(4) | T-Lymphoblastic Leukemia	CCND3 (4):	--2-- |  1037_BX795_GDSC1(2) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	CD276 (2):	--2-- |  1048_Mirin_GDSC1(1) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	COP1 (5):	--3-- |  1048_Mirin_GDSC1(2) |  1050_ZM447439_GDSC1(2) |  1135_AZD4547_GDSC1(2) | T-Lymphoblastic Leukemia	CREB1 (3):	--3-- |  1048_Mirin_GDSC1(1) |  1050_ZM447439_GDSC1(1) |  1135_AZD4547_GDSC1(1) | T-Lymphoblastic Leukemia	CSF3R (2):	--2-- |  1048_Mirin_GDSC1(1) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	DDX4 (3):	--1-- |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	EIF4A2 (4):	--2-- |  1014_Refametinib_GDSC1(3) |  1062_Selumetinib_GDSC1(3) | T-Lymphoblastic Leukemia	ERBB2 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	ERBB3 (6):	--3-- |  55_A-770041_GDSC1(4) |  2010_HKMTI-1-005_GDSC2(3) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	ERBB4 (6):	--3-- |  62_BMS-536924_GDSC1(4) |  1392_Bleomycin (10 uM)_GDSC1(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	ETV1 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  1835_Elephantin_GDSC2(2) | T-Lymphoblastic Leukemia	ETV4 (2):	--2-- |  1490_SN-38_GDSC1(1) |  2156_5-azacytidine_GDSC2(1) | T-Lymphoblastic Leukemia	EZH1 (6):	--2-- |  63_BMS-509744_GDSC1(4) |  1732_TAF1_5496_GDSC2(4) | T-Lymphoblastic Leukemia	FGF3 (3):	--2-- |  211_TL-2-105_GDSC1(1) |  574_Wnt-C59_GDSC1(2) | T-Lymphoblastic Leukemia	FGFR4 (6):	--2-- |  1827_Dihydrorotenone_GDSC2(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	FLT1 (4):	--3-- |  1037_BX795_GDSC1(2) |  1464_TTK_3146_GDSC1(2) |  1558_Lapatinib_GDSC2(1) | T-Lymphoblastic Leukemia	FLT3 (7):	--2-- |  55_A-770041_GDSC1(5) |  2044_Pyridostatin_GDSC2(3) | T-Lymphoblastic Leukemia	FLT4 (6):	--2-- |  51_Dasatinib_GDSC1(5) |  55_A-770041_GDSC1(5) | T-Lymphoblastic Leukemia	FURIN (6):	--3-- |  1416_AZD8931_GDSC1(2) |  1249_BMS-345541_GDSC2(2) |  2173_PFI-1_GDSC2(4) | T-Lymphoblastic Leukemia	FYN (3):	--3-- |  1006_Cytarabine_GDSC1(1) |  1426_AZD7969_GDSC1(1) |  1490_SN-38_GDSC1(1) | T-Lymphoblastic Leukemia	GAB1 (6):	--2-- |  261_TL-1-85_GDSC1(2) |  1853_OF-1_GDSC2(4) | T-Lymphoblastic Leukemia	GLI1 (3):	--1-- |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	GNA11 (4):	--2-- |  1048_Mirin_GDSC1(2) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	GNA12 (4):	--2-- |  1052_RO-3306_GDSC2(2) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	GNA13 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	GNAQ (4):	--2-- |  1014_Refametinib_GDSC2(2) |  1931_MIRA-1_GDSC2(3) | T-Lymphoblastic Leukemia	GNB1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1853_OF-1_GDSC2(3) | T-Lymphoblastic Leukemia	GTF2I (4):	--2-- |  1052_RO-3306_GDSC2(2) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	HDAC1 (4):	--2-- |  1052_RO-3306_GDSC2(2) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	HGF (3):	--2-- |  427_Ara-G_GDSC1(1) |  1026_Tanespimycin_GDSC1(2) | T-Lymphoblastic Leukemia	HIF1A (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	HMGA2 (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	IDH2 (3):	--1-- |  1014_Refametinib_GDSC1(3) | T-Lymphoblastic Leukemia	INSR (5):	--3-- |  207_AS601245_GDSC1(2) |  476_SB505124_GDSC1(3) |  1720_AZD5991_GDSC2(1) | T-Lymphoblastic Leukemia	IRS1 (2):	--1-- |  1777_GSK2276186C_GDSC2(2) | T-Lymphoblastic Leukemia	IRS2 (3):	--2-- |  362_CI-1033_GDSC1(1) |  1023_GW441756_GDSC1(2) | T-Lymphoblastic Leukemia	JAK2 (7):	--3-- |  1053_MK-2206_GDSC1(3) |  1840_630600_GDSC2(2) |  2173_PFI-1_GDSC2(4) | T-Lymphoblastic Leukemia	KDR (4):	--2-- |  1079_Dasatinib_GDSC2(3) |  2037_GSK343_GDSC2(3) | T-Lymphoblastic Leukemia	KIT (4):	--2-- |  205_Avagacestat_GDSC1(3) |  293_Amuvatinib_GDSC1(3) | T-Lymphoblastic Leukemia	KLF5 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	KSR2 (4):	--2-- |  329_QL-XI-92_GDSC1(2) |  1368_BAY-MPS1_GDSC1(3) | T-Lymphoblastic Leukemia	LCK (4):	--2-- |  1014_Refametinib_GDSC1(3) |  2010_HKMTI-1-005_GDSC2(2) | T-Lymphoblastic Leukemia	LRP6 (5):	--2-- |  55_A-770041_GDSC1(4) |  262_VX-11e_GDSC1(3) | T-Lymphoblastic Leukemia	LTK (4):	--1-- |  62_BMS-536924_GDSC1(4) | T-Lymphoblastic Leukemia	MAP2K1 (4):	--2-- |  1259_Talazoparib_GDSC1(1) |  1079_Dasatinib_GDSC2(3) | T-Lymphoblastic Leukemia	MAP2K2 (3):	--3-- |  1001_AICA Ribonucleotide_GDSC1(1) |  1007_Docetaxel_GDSC2(1) |  1021_Axitinib_GDSC2(1) | T-Lymphoblastic Leukemia	MAP3K13 (5):	--2-- |  329_QL-XI-92_GDSC1(3) |  1060_PD0325901_GDSC1(2) | T-Lymphoblastic Leukemia	MAPK3 (5):	--2-- |  2010_HKMTI-1-005_GDSC2(3) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	MDM2 (4):	--1-- |  55_A-770041_GDSC1(4) | T-Lymphoblastic Leukemia	MECOM (4):	--1-- |  62_BMS-536924_GDSC1(4) | T-Lymphoblastic Leukemia	MEF2D (1):	--1-- |  1050_ZM447439_GDSC1(1) | T-Lymphoblastic Leukemia	MET (4):	--3-- |  1183_CRT0160829_GDSC1(1) |  1558_Lapatinib_GDSC2(1) |  1813_Fludarabine_GDSC2(2) | T-Lymphoblastic Leukemia	MLLT10 (7):	--2-- |  55_A-770041_GDSC1(5) |  1392_Bleomycin (10 uM)_GDSC1(4) | T-Lymphoblastic Leukemia	MLLT3 (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	MPL (4):	--1-- |  2173_PFI-1_GDSC2(4) | T-Lymphoblastic Leukemia	MSI2 (4):	--2-- |  262_VX-11e_GDSC1(3) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	MST1R (3):	--1-- |  1048_Mirin_GDSC1(3) | T-Lymphoblastic Leukemia	MTOR (4):	--1-- |  1392_Bleomycin (10 uM)_GDSC1(4) | T-Lymphoblastic Leukemia	MYBL1 (4):	--2-- |  205_Avagacestat_GDSC1(3) |  293_Amuvatinib_GDSC1(3) | T-Lymphoblastic Leukemia	MYC (5):	--2-- |  55_A-770041_GDSC1(4) |  1079_Dasatinib_GDSC2(4) | T-Lymphoblastic Leukemia	NADK (5):	--2-- |  376_Brivanib, BMS-540215_GDSC1(4) |  1183_CRT0160829_GDSC1(2) | T-Lymphoblastic Leukemia	NCSTN (4):	--2-- |  1048_Mirin_GDSC1(2) |  1183_CRT0160829_GDSC1(2) | T-Lymphoblastic Leukemia	NFE2 (3):	--2-- |  2046_MK-8776_GDSC2(2) |  2159_UNC0379_GDSC2(2) | T-Lymphoblastic Leukemia	NFE2L2 (2):	--1-- |  206_Ruxolitinib_GDSC1(2) | T-Lymphoblastic Leukemia	NRAS (6):	--2-- |  1015_CI-1040_GDSC1(4) |  2010_HKMTI-1-005_GDSC2(3) | T-Lymphoblastic Leukemia	NRG1 (8):	--3-- |  1369_BAY-MPS-combo-1 (paclitaxel 5 uM)_GDSC1(5) |  1425_BPTES_GDSC1(5) |  1778_GSK2110183B_GDSC2(1) | T-Lymphoblastic Leukemia	NTRK1 (5):	--2-- |  1853_OF-1_GDSC2(4) |  2111_VE821_GDSC2(2) | T-Lymphoblastic Leukemia	NTRK2 (4):	--2-- |  1052_RO-3306_GDSC2(2) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	PAX8 (5):	--2-- |  1732_TAF1_5496_GDSC2(4) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	PDGFRA (3):	--2-- |  1495_Olaparib_GDSC1(2) |  1739_JAK_8517_GDSC2(1) | T-Lymphoblastic Leukemia	PDGFRB (3):	--2-- |  362_CI-1033_GDSC1(1) |  1023_GW441756_GDSC1(2) | T-Lymphoblastic Leukemia	PIK3CA (3):	--2-- |  1368_BAY-MPS1_GDSC1(1) |  1052_RO-3306_GDSC2(2) | T-Lymphoblastic Leukemia	PIK3CD (6):	--3-- |  62_BMS-536924_GDSC1(4) |  1392_Bleomycin (10 uM)_GDSC1(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	PIK3CG (3):	--2-- |  1362_BAY ACCi_GDSC1(2) |  1495_Olaparib_GDSC1(2) | T-Lymphoblastic Leukemia	PLCG1 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	PLCG2 (4):	--2-- |  238_Idelalisib_GDSC1(3) |  1016_Temsirolimus_GDSC1(2) | T-Lymphoblastic Leukemia	PRKCI (2):	--1-- |  206_Ruxolitinib_GDSC1(2) | T-Lymphoblastic Leukemia	RAC1 (3):	--2-- |  1037_BX795_GDSC1(2) |  1558_Lapatinib_GDSC2(1) | T-Lymphoblastic Leukemia	RAC2 (2):	--1-- |  1362_BAY ACCi_GDSC1(2) | T-Lymphoblastic Leukemia	RET (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	RPS6KA4 (6):	--2-- |  376_Brivanib, BMS-540215_GDSC1(4) |  1778_GSK2110183B_GDSC2(5) | T-Lymphoblastic Leukemia	RPS6KB2 (2):	--2-- |  1048_Mirin_GDSC1(1) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	RUNX1T1 (5):	--3-- |  1070_CRT0105950_GDSC1(2) |  1052_RO-3306_GDSC2(2) |  2159_UNC0379_GDSC2(2) | T-Lymphoblastic Leukemia	SCG5 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	SETBP1 (4):	--2-- |  1037_BX795_GDSC1(2) |  1243_Piperlongumine_GDSC1(2) | T-Lymphoblastic Leukemia	SF3B1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1853_OF-1_GDSC2(3) | T-Lymphoblastic Leukemia	SGK1 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1362_BAY ACCi_GDSC1(2) | T-Lymphoblastic Leukemia	SMYD3 (3):	--2-- |  1495_Olaparib_GDSC1(2) |  1739_JAK_8517_GDSC2(1) | T-Lymphoblastic Leukemia	SOS1 (5):	--2-- |  71_Pyrimethamine_GDSC1(2) |  238_Idelalisib_GDSC1(3) | T-Lymphoblastic Leukemia	SQSTM1 (5):	--2-- |  55_A-770041_GDSC1(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	STAT3 (6):	--3-- |  329_QL-XI-92_GDSC1(1) |  1048_Mirin_GDSC1(3) |  1219_PFI-1_GDSC1(3) | T-Lymphoblastic Leukemia	STAT5A (3):	--2-- |  2046_MK-8776_GDSC2(2) |  2159_UNC0379_GDSC2(2) | T-Lymphoblastic Leukemia	STAT5B (6):	--2-- |  55_A-770041_GDSC1(4) |  1392_Bleomycin (10 uM)_GDSC1(4) | T-Lymphoblastic Leukemia	STAT6 (4):	--2-- |  35_NVP-TAE684_GDSC1(2) |  238_Idelalisib_GDSC1(3) | T-Lymphoblastic Leukemia	TAL1 (2):	--2-- |  1001_AICA Ribonucleotide_GDSC1(1) |  1490_SN-38_GDSC1(1) | T-Lymphoblastic Leukemia	TLX3 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	UBR5 (4):	--2-- |  1052_RO-3306_GDSC2(2) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	VAV2 (5):	--1-- |  1732_TAF1_5496_GDSC2(5) | T-Lymphoblastic Leukemia	VEGFA (2):	--1-- |  1070_CRT0105950_GDSC1(2) | T-Lymphoblastic Leukemia	WWP1 (6):	--2-- |  62_BMS-536924_GDSC1(4) |  1853_OF-1_GDSC2(4) | T-Lymphoblastic Leukemia	XIAP (3):	--1-- |  1185_KU-60019_GDSC1(3) | T-Lymphoblastic Leukemia	YAP1 (4):	--2-- |  1014_Refametinib_GDSC1(3) |  1062_Selumetinib_GDSC1(3) | Thyroid Gland Carcinoma	ALK (6):	--2-- |  152_CP466722_GDSC1(5) |  1005_Cisplatin_GDSC1(5) | Thyroid Gland Carcinoma	AXL (1):	--1-- |  1378_Bleomycin (50 uM)_GDSC2(1) | Thyroid Gland Carcinoma	CARD11 (3):	--3-- |  167_OSU-03012_GDSC1(1) |  1058_Pictilisib_GDSC1(1) |  1062_Selumetinib_GDSC1(1) | Thyroid Gland Carcinoma	CCNE1 (4):	--2-- |  226_GSK1070916_GDSC1(3) |  1427_AZD5582_GDSC1(3) | Thyroid Gland Carcinoma	CSF3R (6):	--2-- |  226_GSK1070916_GDSC1(3) |  356_AT7867_GDSC1(5) | Thyroid Gland Carcinoma	DNMT1 (6):	--1-- |  282_Pelitinib_GDSC1(6) | Thyroid Gland Carcinoma	EGFR (3):	--1-- |  1185_KU-60019_GDSC1(3) | Thyroid Gland Carcinoma	ERBB4 (7):	--2-- |  1170_CCT-018159_GDSC1(5) |  1183_CRT0160829_GDSC1(5) | Thyroid Gland Carcinoma	ERG (4):	--1-- |  328_SNX-2112_GDSC1(4) | Thyroid Gland Carcinoma	GNAS (3):	--2-- |  272_AR-42_GDSC1(2) |  308_Foretinib_GDSC1(2) | Thyroid Gland Carcinoma	GTF2I (3):	--2-- |  185_Linsitinib_GDSC1(2) |  1190_Gemcitabine_GDSC2(1) | Thyroid Gland Carcinoma	HGF (2):	--2-- |  133_Doxorubicin_GDSC1(1) |  1006_Cytarabine_GDSC1(1) | Thyroid Gland Carcinoma	JAK3 (5):	--2-- |  152_CP466722_GDSC1(4) |  203_BMS-345541_GDSC1(3) | Thyroid Gland Carcinoma	KDM5A (2):	--2-- |  133_Doxorubicin_GDSC1(1) |  1006_Cytarabine_GDSC1(1) | Thyroid Gland Carcinoma	LRP6 (4):	--2-- |  1026_Tanespimycin_GDSC1(1) |  1091_BMS-536924_GDSC1(3) | Thyroid Gland Carcinoma	MECOM (3):	--2-- |  272_AR-42_GDSC1(2) |  308_Foretinib_GDSC1(2) | Thyroid Gland Carcinoma	MET (4):	--1-- |  151_QS11_GDSC1(4) | Thyroid Gland Carcinoma	MKI67 (5):	--2-- |  156_AZD6482_GDSC1(3) |  203_BMS-345541_GDSC1(3) | Thyroid Gland Carcinoma	MTOR (5):	--2-- |  225_Genentech Cpd 10_GDSC1(4) |  1005_Cisplatin_GDSC1(4) | Thyroid Gland Carcinoma	NRAS (3):	--2-- |  185_Linsitinib_GDSC1(2) |  1190_Gemcitabine_GDSC2(1) | Thyroid Gland Carcinoma	PDGFRB (4):	--2-- |  1185_KU-60019_GDSC1(3) |  1617_AZD5582_GDSC2(3) | Thyroid Gland Carcinoma	PIK3CA (4):	--1-- |  1236_UNC0638_GDSC1(4) | Thyroid Gland Carcinoma	PIK3CD (3):	--2-- |  376_Brivanib, BMS-540215_GDSC1(2) |  1414_Fulvestrant_GDSC1(2) | Thyroid Gland Carcinoma	PLCG1 (4):	--2-- |  226_GSK1070916_GDSC1(3) |  1561_Taselisib_GDSC2(3) | Thyroid Gland Carcinoma	PLCG2 (2):	--1-- |  1062_Selumetinib_GDSC1(2) | Thyroid Gland Carcinoma	PRKACA (2):	--1-- |  134_Etoposide_GDSC1(2) | Thyroid Gland Carcinoma	RAB35 (4):	--2-- |  156_AZD6482_GDSC1(3) |  1185_KU-60019_GDSC1(3) | Thyroid Gland Carcinoma	RICTOR (2):	--1-- |  1143_HG-5-88-01_GDSC1(2) | Thyroid Gland Carcinoma	RUNX1T1 (5):	--2-- |  152_CP466722_GDSC1(4) |  303_PIK-93_GDSC1(4) | Thyroid Gland Carcinoma	UBR5 (5):	--2-- |  295_NVP-BHG712_GDSC1(3) |  306_Fedratinib_GDSC1(4) | Thyroid Gland Carcinoma	USP8 (1):	--1-- |  1809_Teniposide_GDSC2(1) | 